1	The	DT	O	the	det	4	SENT_1	[p1l1105t88r1148b110],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	4	SENT_1	[p1l1157t88r1387b117],
3	lournal	JJ	O	lournal	amod	4	SENT_1	[p1l1395t88r1479b115],
4	(	NN	O	(	_	0	SENT_1	[p1l1489t88r1565b116],
5	2013	CD	DATE	2013	dep	4	SENT_1	[p1l1489t88r1565b116],
6	)	CD	NUMBER	)	number	7	SENT_1	[p1l1489t88r1565b116],
7	13	CD	NUMBER	13	dep	5	SENT_1	[p1l1576t89r1609b114],
8	,	,	O	,	_	0	SENT_1	[p1l1576t89r1609b114],
9	21-26	CD	NUMBER	21-26	appos	5	SENT_1	[p1l1619t89r1686b110],
10	©	CD	NUMBER	©	num	11	SENT_1	[p1l1105t120r1121b139],
11	2013	CD	DATE	2013	dep	4	SENT_1	[p1l1129t120r1175b139],
12	Macmillan	NNP	ORGANIZATION	Macmillan	nn	14	SENT_1	[p1l1185t119r1279b139],
13	Publishers	NNPS	ORGANIZATION	Publishers	nn	14	SENT_1	[p1l1289t119r1380b139],
14	Limited	NNP	ORGANIZATION	Limited	dep	11	SENT_1	[p1l1389t119r1461b139],
15	.	.	O	.	_	0	SENT_1	[p1l1389t119r1461b139],

1	All	DT	O	all	det	2	SENT_2	[p1l1470t119r1492b139],
2	rights	NNS	O	rights	nsubj	3	SENT_2	[p1l1501t119r1552b145],
3	reserved	VBD	O	reserve	_	0	SENT_2	[p1l1561t119r1636b139],
4	1470-269X	NN	O	1470-269x	dobj	3	SENT_2	[p1l1646t119r1780b141],
5	/	:	O	/	punct	7	SENT_2	[p1l1646t119r1780b141],
6	13	CD	NUMBER	13	num	7	SENT_2	[p1l1646t119r1780b141],
7	www.nature.com/tpj	NN	O	www.nature.com/tpj	dep	4	SENT_2	[p1l1105t166r1300b191],

1	ORIGINAL	JJ	O	original	amod	2	SENT_3	[p1l1665t230r1919b270],
2	ARTICLE	NN	O	article	_	0	SENT_3	[p1l1939t230r2149b270],

1	Serotonin	NN	MISC	serotonin	nn	6	SENT_4	[p1l14t364r427b437],
2	receptor	NN	O	receptor	nn	6	SENT_4	[p1l474t371r836b461],
3	2A	NN	O	2a	nn	6	SENT_4	[p1l873t365r987b436],
4	(	CD	NUMBER	(	num	6	SENT_4	[p1l1025t363r1384b457],
5	HTRZA	NN	O	htrza	nn	6	SENT_4	[p1l1025t363r1384b457],
6	)	NN	O	)	_	0	SENT_4	[p1l1025t363r1384b457],
7	gene	NN	O	gene	nn	8	SENT_4	[p1l1426t385r1637b461],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_4	[p1l16t487r640b585],
9	predicts	VBZ	O	predict	rcmod	6	SENT_4	[p1l688t487r1025b585],
10	treatment	NN	O	treatment	nn	11	SENT_4	[p1l1064t495r1497b561],
11	response	NN	O	response	dobj	9	SENT_4	[p1l1537t509r1913b585],
12	to	TO	O	to	_	0	SENT_4	[p1l1953t495r2038b561],
13	venlafaxine	NN	O	venlafaxine	nn	14	SENT_4	[p1l9t611r500b685],
14	XR	NN	O	xr	prep_to	9	SENT_4	[p1l540t613r655b685],
15	in	IN	O	in	_	0	SENT_4	[p1l695t613r764b684],
16	generalized	VBN	O	generalize	prepc_in	6	SENT_4	[p1l808t611r1303b709],
17	anxiety	NN	O	anxiety	nn	18	SENT_4	[p1l1346t613r1660b709],
18	disorder	NN	O	disorder	dobj	16	SENT_4	[p1l1698t611r2052b685],

1	FW	NNP	ORGANIZATION	FW	nn	2	SENT_5	[p1l13t797r76b831],
2	Lohoff	NNP	O	Lohoff	_	0	SENT_5	[p1l96t791r286b839],
3	”	NN	O	”	dep	2	SENT_5	[p1l96t791r286b839],
4	,	,	O	,	_	0	SENT_5	[p1l96t791r286b839],
5	TD	NNP	O	TD	nn	7	SENT_5	[p1l306t797r366b831],
6	Aquino	NNP	O	Aquino	nn	7	SENT_5	[p1l384t791r566b843],
7	‘	NNP	O	‘	dep	2	SENT_5	[p1l384t791r566b843],
8	,	,	O	,	_	0	SENT_5	[p1l384t791r566b843],
9	S	NNP	O	S	nn	10	SENT_5	[p1l11t855r31b890],
10	Narasimhanz	NNP	O	Narasimhanz	dep	2	SENT_5	[p1l53t849r333b897],
11	,	,	O	,	_	0	SENT_5	[p1l53t849r333b897],
12	PK	NNP	O	PK	nn	13	SENT_5	[p1l357t855r407b889],
13	Multaniz	NNP	O	Multaniz	conj_and	3	SENT_5	[p1l428t849r617b897],
14	,	,	O	,	_	0	SENT_5	[p1l428t849r617b897],
15	B	NNP	O	B	nn	17	SENT_5	[p1l13t913r34b947],
16	Etemad	NNP	O	Etemad	nn	17	SENT_5	[p1l56t907r224b948],
17	‘	NN	O	‘	conj_and	3	SENT_5	[p1l56t907r224b948],
18	and	CC	O	and	_	0	SENT_5	[p1l250t912r325b948],
19	K	NN	PERSON	k	nn	20	SENT_5	[p1l348t913r372b947],
20	Rickelsl	NN	PERSON	rickelsl	conj_and	3	SENT_5	[p1l392t907r539b948],

1	‘	NN	O	‘	nn	2	SENT_6	[p1l11t1002r106b1031],
2	Mood	NN	O	mood	_	0	SENT_6	[p1l11t1002r106b1031],
3	&	CC	O	&	_	0	SENT_6	[p1l119t1006r140b1031],
4	Anxiety	NN	O	anxiety	nn	5	SENT_6	[p1l151t1006r255b1038],
5	Disorders	NNS	O	disorder	conj_and	2	SENT_6	[p1l266t1005r393b1031],
6	Section	NN	O	section	dep	2	SENT_6	[p1l406t1006r510b1036],
7	,	,	O	,	_	0	SENT_6	[p1l406t1006r510b1036],
8	Department	NNP	ORGANIZATION	Department	appos	6	SENT_6	[p1l526t1007r693b1038],
9	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l11t1043r39b1068],
10	Psychiatry	NNP	ORGANIZATION	Psychiatry	nn	12	SENT_6	[p1l45t1043r190b1076],
11	,	,	O	,	_	0	SENT_6	[p1l45t1043r190b1076],
12	University	NNP	ORGANIZATION	University	prep_of	8	SENT_6	[p1l204t1043r339b1075],
13	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l347t1043r375b1068],
14	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	15	SENT_6	[p1l381t1043r561b1076],
15	School	NNP	ORGANIZATION	School	prep_of	12	SENT_6	[p1l570t1043r661b1068],
16	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l669t1043r698b1068],
17	Medicine	NNP	ORGANIZATION	Medicine	prep_of	15	SENT_6	[p1l11t1080r140b1110],
18	,	,	O	,	_	0	SENT_6	[p1l11t1080r140b1110],
19	Philadelphia	NNP	LOCATION	Philadelphia	conj_and	17	SENT_6	[p1l157t1080r332b1113],
20	,	,	O	,	_	0	SENT_6	[p1l157t1080r332b1113],
21	PA	NN	ORGANIZATION	pa	prep_of	15	SENT_6	[p1l348t1081r388b1110],
22	,	,	O	,	_	0	SENT_6	[p1l348t1081r388b1110],
23	USA	NNP	LOCATION	USA	prep_of	15	SENT_6	[p1l406t1081r459b1105],
24	and	CC	O	and	_	0	SENT_6	[p1l473t1080r527b1105],
25	2Department	NN	O	2department	prep_of	15	SENT_6	[p1l10t1114r192b1151],
26	of	IN	O	of	_	0	SENT_6	[p1l204t1118r233b1143],
27	Psychiatry	NNP	O	Psychiatry	nn	29	SENT_6	[p1l242t1118r387b1150],
28	,	,	O	,	_	0	SENT_6	[p1l242t1118r387b1150],
29	Psychiatric	NNP	O	Psychiatric	prep_of	8	SENT_6	[p1l403t1118r549b1150],

1	Pharmacogenetics	NNP	O	Pharmacogenetics	nn	10	SENT_7	[p1l11t1230r262b1263],
2	Laboratory	NNP	O	Laboratory	nn	10	SENT_7	[p1l275t1230r431b1263],
3	,	,	O	,	_	0	SENT_7	[p1l275t1230r431b1263],
4	Center	NNP	O	Center	dep	10	SENT_7	[p1l448t1231r539b1255],
5	for	IN	O	for	dep	4	SENT_7	[p1l550t1230r588b1255],
6	Neurobiology	NNP	O	Neurobiology	pobj	5	SENT_7	[p1l11t1267r198b1300],
7	and	CC	O	and	_	0	SENT_7	[p1l209t1267r263b1292],
8	Behavior	NNP	O	Behavior	pobj	5	SENT_7	[p1l274t1267r398b1298],
9	,	,	O	,	_	0	SENT_7	[p1l274t1267r398b1298],
10	University	NNP	ORGANIZATION	University	_	0	SENT_7	[p1l416t1268r550b1300],
11	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l561t1267r590b1292],
12	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	13	SENT_7	[p1l11t1304r191b1337],
13	School	NNP	ORGANIZATION	School	prep_of	10	SENT_7	[p1l203t1304r294b1330],
14	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l305t1305r334b1330],
15	Medicine	NNP	ORGANIZATION	Medicine	nn	17	SENT_7	[p1l343t1304r473b1335],
16	,	,	O	,	_	0	SENT_7	[p1l343t1304r473b1335],
17	Philadelphia	NNP	LOCATION	Philadelphia	prep_of	13	SENT_7	[p1l489t1304r664b1338],
18	,	,	O	,	_	0	SENT_7	[p1l489t1304r664b1338],
19	PA	NN	ORGANIZATION	pa	dep	10	SENT_7	[p1l11t1343r52b1372],
20	,	,	O	,	_	0	SENT_7	[p1l11t1343r52b1372],
21	USA	NNP	LOCATION	USA	appos	19	SENT_7	[p1l69t1343r123b1367],

1	Correspondence	NN	O	correspondence	_	0	SENT_8	[p1l10t1499r272b1533],
2	:	:	O	:	_	0	SENT_8	[p1l10t1499r272b1533],
3	Dr	NNP	O	Dr	nn	5	SENT_8	[p1l11t1538r45b1562],
4	FW	NNP	ORGANIZATION	FW	nn	5	SENT_8	[p1l58t1538r102b1562],
5	Lohoff	NNP	ORGANIZATION	Lohoff	dep	1	SENT_8	[p1l116t1537r213b1567],
6	,	,	O	,	_	0	SENT_8	[p1l116t1537r213b1567],
7	Department	NNP	ORGANIZATION	Department	appos	1	SENT_8	[p1l229t1538r404b1570],
8	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l416t1537r444b1562],
9	Psychiatry	NNP	ORGANIZATION	Psychiatry	prep_of	7	SENT_8	[p1l457t1537r608b1570],
10	,	,	O	,	_	0	SENT_8	[p1l457t1537r608b1570],
11	Translational	JJ	ORGANIZATION	translational	amod	13	SENT_8	[p1l9t1574r191b1600],
12	Research	NNP	ORGANIZATION	Research	nn	13	SENT_8	[p1l207t1574r331b1600],
13	Laboratory	NNP	ORGANIZATION	Laboratory	appos	1	SENT_8	[p1l346t1574r508b1608],
14	,	,	O	,	_	0	SENT_8	[p1l346t1574r508b1608],
15	Center	NNP	O	Center	appos	1	SENT_8	[p1l523t1575r621b1600],
16	for	IN	O	for	_	0	SENT_8	[p1l631t1574r672b1600],
17	Neurobiology	NNP	O	Neurobiology	prep_for	15	SENT_8	[p1l11t1612r210b1645],
18	and	CC	O	and	_	0	SENT_8	[p1l223t1612r275b1637],
19	Behavior	NNP	O	Behavior	prep_for	15	SENT_8	[p1l291t1612r421b1642],
20	,	,	O	,	_	0	SENT_8	[p1l291t1612r421b1642],
21	University	NNP	ORGANIZATION	University	appos	1	SENT_8	[p1l437t1612r578b1645],
22	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l591t1612r618b1637],
23	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	24	SENT_8	[p1l11t1649r194b1683],
24	School	NNP	ORGANIZATION	School	prep_of	21	SENT_8	[p1l209t1649r303b1675],
25	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l318t1650r346b1675],
26	Medicine	NNP	ORGANIZATION	Medicine	prep_of	24	SENT_8	[p1l359t1649r498b1680],
27	,	,	O	,	_	0	SENT_8	[p1l359t1649r498b1680],
28	125	CD	NUMBER	125	num	31	SENT_8	[p1l515t1650r567b1675],
29	South	NNP	O	South	nn	31	SENT_8	[p1l582t1649r664b1675],
30	31st	NNP	ORDINAL	31st	nn	31	SENT_8	[p1l12t1688r71b1712],
31	Street	NNP	O	Street	appos	1	SENT_8	[p1l84t1688r174b1717],
32	,	,	O	,	_	0	SENT_8	[p1l84t1688r174b1717],
33	Room	NNP	O	Room	appos	1	SENT_8	[p1l190t1688r272b1712],
34	2213	CD	DATE	2213	num	33	SENT_8	[p1l286t1688r367b1717],
35	,	,	O	,	_	0	SENT_8	[p1l286t1688r367b1717],
36	Philadelphia	NNP	LOCATION	Philadelphia	appos	1	SENT_8	[p1l384t1687r566b1720],
37	,	,	O	,	_	0	SENT_8	[p1l384t1687r566b1720],
38	PA	NN	O	pa	appos	1	SENT_8	[p1l11t1725r47b1749],
39	19104	CD	NUMBER	19104	num	38	SENT_8	[p1l61t1725r160b1755],
40	,	,	O	,	_	0	SENT_8	[p1l61t1725r160b1755],
41	USA	NNP	LOCATION	USA	appos	1	SENT_8	[p1l176t1725r241b1750],
42	.	.	O	.	_	0	SENT_8	[p1l176t1725r241b1750],

1	E-mail	NN	O	e-mail	_	0	SENT_9	[p1l11t1762r106b1787],
2	:	:	O	:	_	0	SENT_9	[p1l11t1762r106b1787],
3	|	CD	NUMBER	|	num	4	SENT_9	[p1l121t1762r535b1795],
4	ohoff@mai	NNS	O	ohoff@mai	dep	1	SENT_9	[p1l121t1762r535b1795],
5	|	CD	NUMBER	|	dep	4	SENT_9	[p1l121t1762r535b1795],
6	.	.	O	.	_	0	SENT_9	[p1l121t1762r535b1795],

1	med.upenn.edu	NN	O	med.upenn.edu	_	0	SENT_10	[p1l121t1762r535b1795],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l11t2719r145b2744],
2	2	CD	DATE	2	dobj	1	SENT_11	[p1l159t2719r176b2744],
3	May	NNP	DATE	May	tmod	1	SENT_11	[p1l190t2720r255b2752],
4	2011	CD	DATE	2011	num	3	SENT_11	[p1l267t2719r349b2749],
5	;	:	O	;	_	0	SENT_11	[p1l267t2719r349b2749],
6	revised	VBN	O	revise	parataxis	1	SENT_11	[p1l364t2719r471b2744],
7	29	CD	DATE	29	dobj	6	SENT_11	[p1l485t2719r522b2744],
8	July	NNP	DATE	July	tmod	6	SENT_11	[p1l533t2719r589b2752],
9	2011	CD	DATE	2011	num	8	SENT_11	[p1l10t2757r92b2787],
10	;	:	O	;	_	0	SENT_11	[p1l10t2757r92b2787],
11	accepted	VBN	O	accept	parataxis	1	SENT_11	[p1l107t2756r244b2789],
12	8	CD	DATE	8	dobj	11	SENT_11	[p1l257t2757r275b2781],
13	September	NNP	DATE	September	tmod	11	SENT_11	[p1l289t2756r458b2789],
14	2011	CD	DATE	2011	num	13	SENT_11	[p1l470t2757r552b2787],
15	;	:	O	;	_	0	SENT_11	[p1l470t2757r552b2787],
16	published	VBN	O	publish	parataxis	1	SENT_11	[p1l11t2794r159b2827],
17	online	NN	O	online	prep	16	SENT_11	[p1l173t2794r268b2819],
18	18	CD	DATE	18	dep	17	SENT_11	[p1l283t2794r318b2819],
19	October	NNP	DATE	October	tmod	16	SENT_11	[p1l331t2794r456b2819],
20	2011	CD	DATE	2011	num	19	SENT_11	[p1l469t2794r538b2819],

1	Generalized	NNP	O	Generalized	nn	3	SENT_12	[p1l750t786r962b817],
2	anxiety	NN	O	anxiety	nn	3	SENT_12	[p1l986t787r1117b827],
3	disorder	NN	O	disorder	nsubj	11	SENT_12	[p1l1139t786r1287b817],
4	(	CD	NUMBER	(	num	6	SENT_12	[p1l1308t786r1421b825],
5	GAD	NN	O	gad	nn	6	SENT_12	[p1l1308t786r1421b825],
6	)	NN	O	)	dep	3	SENT_12	[p1l1308t786r1421b825],
7	is	VBZ	O	be	cop	11	SENT_12	[p1l1445t787r1468b817],
8	a	DT	O	a	det	11	SENT_12	[p1l1490t795r1507b817],
9	chronic	JJ	O	chronic	amod	11	SENT_12	[p1l1531t786r1665b817],
10	psychiatric	JJ	O	psychiatric	amod	11	SENT_12	[p1l1689t786r1880b827],
11	disorder	NN	O	disorder	_	0	SENT_12	[p1l1902t786r2050b817],
12	with	IN	O	with	_	0	SENT_12	[p1l2070t786r2148b817],
13	significant	JJ	O	significant	amod	14	SENT_12	[p1l749t833r934b874],
14	morbidity	NN	O	morbidity	prep_with	11	SENT_12	[p1l953t833r1129b874],
15	and	CC	O	and	_	0	SENT_12	[p1l1148t833r1213b864],
16	mortality	NN	O	mortality	conj_and	14	SENT_12	[p1l1235t833r1406b874],
17	.	.	O	.	_	0	SENT_12	[p1l1235t833r1406b874],

1	Antidepressant	JJ	O	antidepressant	amod	2	SENT_13	[p1l1426t833r1698b874],
2	drugs	NNS	O	drug	nsubj	6	SENT_13	[p1l1716t833r1816b874],
3	are	VBP	O	be	cop	6	SENT_13	[p1l1835t842r1889b864],
4	the	DT	O	the	det	6	SENT_13	[p1l1907t833r1965b864],
5	preferred	JJ	O	preferred	amod	6	SENT_13	[p1l1986t833r2148b874],
6	choice	NN	O	choice	_	0	SENT_13	[p1l749t879r865b911],
7	for	IN	O	for	_	0	SENT_13	[p1l880t879r931b911],
8	treatment	NN	O	treatment	prep_for	6	SENT_13	[p1l945t883r1134b917],
9	;	:	O	;	_	0	SENT_13	[p1l945t883r1134b917],
10	however	RB	O	however	advmod	16	SENT_13	[p1l1154t879r1318b917],
11	,	,	O	,	_	0	SENT_13	[p1l1154t879r1318b917],
12	treatment	NN	O	treatment	nn	13	SENT_13	[p1l1335t883r1516b911],
13	response	NN	O	response	nsubj	16	SENT_13	[p1l1533t889r1690b921],
14	is	VBZ	O	be	cop	16	SENT_13	[p1l1707t880r1730b911],
15	often	RB	O	often	advmod	16	SENT_13	[p1l1746t879r1837b911],
16	variable	JJ	O	variable	parataxis	6	SENT_13	[p1l1854t879r2004b911],
17	.	.	O	.	_	0	SENT_13	[p1l1854t879r2004b911],

1	Several	JJ	O	several	amod	2	SENT_14	[p1l2023t879r2148b911],
2	studies	NNS	O	study	nsubj	7	SENT_14	[p1l749t926r873b957],
3	in	IN	O	in	_	0	SENT_14	[p1l890t927r919b957],
4	major	JJ	O	major	amod	5	SENT_14	[p1l938t927r1041b967],
5	depression	NN	O	depression	prep_in	2	SENT_14	[p1l1056t926r1248b967],
6	have	VBP	O	have	aux	7	SENT_14	[p1l1267t926r1350b957],
7	implicated	VBN	O	implicate	_	0	SENT_14	[p1l1367t926r1554b967],
8	a	DT	O	a	det	9	SENT_14	[p1l1573t935r1590b957],
9	role	NN	O	role	dobj	7	SENT_14	[p1l1609t926r1673b957],
10	of	IN	O	of	_	0	SENT_14	[p1l1690t926r1725b957],
11	the	DT	O	the	det	17	SENT_14	[p1l1739t926r1796b957],
12	serotonin	NN	O	serotonin	nn	17	SENT_14	[p1l1812t927r1980b957],
13	receptor	NN	O	receptor	nn	17	SENT_14	[p1l2000t930r2151b967],
14	gene	NN	O	gene	nn	17	SENT_14	[p1l749t982r837b1014],
15	(	CD	NUMBER	(	num	17	SENT_14	[p1l865t973r1011b1012],
16	HTRZA	NN	O	htrza	nn	17	SENT_14	[p1l865t973r1011b1012],
17	)	NN	O	)	prep_of	9	SENT_14	[p1l865t973r1011b1012],
18	in	IN	O	in	_	0	SENT_14	[p1l1040t974r1069b1004],
19	treatment	NN	O	treatment	nn	20	SENT_14	[p1l1097t976r1278b1004],
20	response	NN	O	response	prep_in	17	SENT_14	[p1l1305t982r1463b1014],
21	to	TO	O	to	_	0	SENT_14	[p1l1490t977r1525b1004],
22	antidepressants	NNS	O	antidepressant	prep_to	7	SENT_14	[p1l1553t973r1843b1014],
23	.	.	O	.	_	0	SENT_14	[p1l1553t973r1843b1014],

1	We	PRP	O	we	nsubj	2	SENT_15	[p1l1870t974r1929b1004],
2	tested	VBD	O	test	_	0	SENT_15	[p1l1956t973r2064b1004],
3	the	DT	O	the	det	4	SENT_15	[p1l2092t973r2149b1004],
4	hypothesis	NN	O	hypothesis	dobj	2	SENT_15	[p1l751t1019r942b1061],
5	that	IN	O	that	complm	14	SENT_15	[p1l963t1019r1035b1051],
6	the	DT	O	the	det	9	SENT_15	[p1l1055t1019r1113b1051],
7	genetic	JJ	O	genetic	amod	9	SENT_15	[p1l1134t1020r1267b1061],
8	polymorphism	NN	O	polymorphism	nn	9	SENT_15	[p1l1290t1019r1551b1061],
9	rs7997012	NN	O	rs7997012	nsubj	14	SENT_15	[p1l1575t1020r1767b1051],
10	in	IN	O	in	_	0	SENT_15	[p1l1791t1020r1820b1050],
11	the	DT	O	the	det	13	SENT_15	[p1l1843t1019r1900b1051],
12	HTR2A	NN	O	htr2a	nn	13	SENT_15	[p1l1923t1020r2040b1050],
13	gene	NN	O	gene	prep_in	9	SENT_15	[p1l2061t1029r2149b1060],
14	predicts	VBZ	O	predict	ccomp	2	SENT_15	[p1l751t1066r891b1107],
15	treatment	NN	O	treatment	nn	16	SENT_15	[p1l912t1070r1093b1097],
16	outcome	NN	O	outcome	dobj	14	SENT_15	[p1l1113t1070r1274b1097],
17	in	IN	O	in	_	0	SENT_15	[p1l1296t1067r1325b1097],
18	GAD	NN	O	gad	nn	19	SENT_15	[p1l1348t1067r1431b1097],
19	patients	NNS	O	patient	prep_in	14	SENT_15	[p1l1455t1067r1596b1107],
20	treated	VBN	O	treat	partmod	19	SENT_15	[p1l1616t1066r1743b1097],
21	with	IN	O	with	_	0	SENT_15	[p1l1765t1066r1843b1097],
22	venlafaxine	NN	O	venlafaxine	nn	23	SENT_15	[p1l1864t1066r2069b1097],
23	XR	NN	O	xr	prep_with	20	SENT_15	[p1l2090t1067r2147b1097],
24	.	.	O	.	_	0	SENT_15	[p1l2090t1067r2147b1097],

1	Treatment	NN	O	treatment	nn	2	SENT_16	[p1l748t1114r938b1144],
2	response	NN	O	response	nsubjpass	4	SENT_16	[p1l964t1122r1121b1154],
3	was	VBD	O	be	auxpass	4	SENT_16	[p1l1146t1122r1214b1144],
4	assessed	VBN	O	assess	_	0	SENT_16	[p1l1240t1113r1387b1144],
5	in	IN	O	in	_	0	SENT_16	[p1l1416t1114r1444b1144],
6	156	CD	NUMBER	156	num	7	SENT_16	[p1l1474t1114r1540b1144],
7	patients	NNS	O	patient	prep_in	4	SENT_16	[p1l1568t1114r1709b1154],
8	that	IN	O	that	nsubj	9	SENT_16	[p1l1734t1113r1807b1144],
9	participated	VBD	O	participate	rcmod	7	SENT_16	[p1l1833t1113r2047b1154],
10	in	IN	O	in	advmod	9	SENT_16	[p1l2075t1114r2104b1144],
11	a	DT	O	a	dep	10	SENT_16	[p1l2131t1122r2149b1144],

1	6-month	JJ	DURATION	6-month	amod	4	SENT_17	[p1l750t1234r906b1266],
2	open-label	JJ	O	open-label	amod	4	SENT_17	[p1l924t1234r1114b1276],
3	clinical	JJ	O	clinical	amod	4	SENT_17	[p1l1132t1234r1252b1266],
4	trial	NN	O	trial	_	0	SENT_17	[p1l1269t1234r1335b1266],
5	of	IN	O	of	_	0	SENT_17	[p1l1352t1234r1387b1266],
6	venlafaxine	NN	O	venlafaxine	nn	7	SENT_17	[p1l1400t1234r1605b1266],
7	XR	NN	O	xr	prep_of	4	SENT_17	[p1l1621t1235r1669b1266],
8	for	IN	O	for	_	0	SENT_17	[p1l1683t1234r1733b1266],
9	GAD	NN	O	gad	prep_for	4	SENT_17	[p1l1748t1235r1842b1266],
10	.	.	O	.	_	0	SENT_17	[p1l1748t1235r1842b1266],

1	Primary	JJ	O	primary	amod	2	SENT_18	[p1l1862t1235r1998b1276],
2	analysis	NN	O	analysis	nsubj	3	SENT_18	[p1l2014t1234r2149b1276],
3	included	VBD	O	include	_	0	SENT_18	[p1l750t1281r904b1313],
4	Hamilton	NNP	ORGANIZATION	Hamilton	nn	6	SENT_18	[p1l921t1281r1084b1313],
5	Anxiety	NN	ORGANIZATION	anxiety	nn	6	SENT_18	[p1l1099t1282r1236b1322],
6	Scale	NNP	ORGANIZATION	Scale	dobj	3	SENT_18	[p1l1250t1281r1340b1312],
7	(	CD	NUMBER	(	num	8	SENT_18	[p1l1355t1281r1513b1320],
8	HAM-A	NN	O	ham-a	dep	6	SENT_18	[p1l1355t1281r1513b1320],
9	)	CD	NUMBER	)	num	10	SENT_18	[p1l1355t1281r1513b1320],
10	reduction	NN	O	reduction	dep	8	SENT_18	[p1l1529t1281r1700b1313],
11	at	IN	O	at	_	0	SENT_18	[p1l1716t1285r1749b1313],
12	6	CD	DURATION	6	num	13	SENT_18	[p1l1763t1282r1783b1312],
13	months	NNS	NUMBER	month	prep_at	3	SENT_18	[p1l1799t1281r1944b1313],
14	.	.	O	.	_	0	SENT_18	[p1l1799t1281r1944b1313],

1	Secondary	JJ	O	secondary	amod	3	SENT_19	[p1l1962t1281r2150b1322],
2	outcome	NN	O	outcome	nn	3	SENT_19	[p1l749t1332r910b1359],
3	measure	NN	O	measure	nsubj	8	SENT_19	[p1l925t1337r1076b1359],
4	was	VBD	O	be	cop	8	SENT_19	[p1l1087t1337r1155b1359],
5	the	DT	O	the	det	8	SENT_19	[p1l1168t1328r1225b1359],
6	Clinical	JJ	O	clinical	amod	8	SENT_19	[p1l1239t1328r1367b1359],
7	Global	JJ	O	global	amod	8	SENT_19	[p1l1383t1328r1498b1359],
8	Impression	NN	O	impression	_	0	SENT_19	[p1l1515t1329r1707b1369],
9	of	IN	O	of	_	0	SENT_19	[p1l1722t1328r1756b1359],
10	Improvement	NN	O	improvement	nn	14	SENT_19	[p1l1770t1329r2016b1369],
11	(	CD	NUMBER	(	num	14	SENT_19	[p1l2028t1328r2148b1367],
12	CGI-I	NN	O	cgi-i	nn	14	SENT_19	[p1l2028t1328r2148b1367],
13	)	NN	O	)	nn	14	SENT_19	[p1l2028t1328r2148b1367],
14	score	NN	NUMBER	score	prep_of	8	SENT_19	[p1l749t1384r841b1406],
15	at	IN	O	at	_	0	SENT_19	[p1l855t1378r889b1406],
16	6	CD	DURATION	6	num	17	SENT_19	[p1l902t1376r922b1406],
17	months	NNS	NUMBER	month	prep_at	8	SENT_19	[p1l937t1375r1083b1406],
18	.	.	O	.	_	0	SENT_19	[p1l937t1375r1083b1406],

1	Genotype	NN	O	genotype	nn	4	SENT_20	[p1l1099t1376r1277b1416],
2	and	CC	O	and	_	0	SENT_20	[p1l1291t1375r1356b1406],
3	allele	NN	O	allele	nn	4	SENT_20	[p1l1371t1375r1461b1406],
4	frequencies	NNS	O	frequency	nsubjpass	6	SENT_20	[p1l1474t1375r1681b1416],
5	were	VBD	O	be	auxpass	6	SENT_20	[p1l1694t1384r1781b1406],
6	compared	VBN	O	compare	_	0	SENT_20	[p1l1795t1375r1978b1416],
7	between	IN	O	between	_	0	SENT_20	[p1l1994t1375r2148b1406],
8	groups	NNS	O	group	prep_between	6	SENT_20	[p1l749t1506r873b1538],
9	using	VBG	O	use	partmod	8	SENT_20	[p1l891t1497r984b1538],
10	x2	NN	O	x2	nn	12	SENT_20	[p1l1002t1492r1040b1536],
11	contingency	NN	O	contingency	nn	12	SENT_20	[p1l1056t1497r1281b1538],
12	analysis	NN	O	analysis	dobj	9	SENT_20	[p1l1297t1496r1443b1538],
13	.	.	O	.	_	0	SENT_20	[p1l1297t1496r1443b1538],

1	The	DT	O	the	det	2	SENT_21	[p1l1459t1496r1526b1528],
2	frequency	NN	O	frequency	nsubj	6	SENT_21	[p1l1541t1496r1723b1538],
3	of	IN	O	of	_	0	SENT_21	[p1l1738t1496r1773b1528],
4	the	DT	O	the	det	5	SENT_21	[p1l1787t1496r1844b1528],
5	G-allele	JJ	MISC	g-allele	prep_of	2	SENT_21	[p1l1861t1496r1995b1528],
6	differed	VBD	O	differ	_	0	SENT_21	[p1l2012t1496r2148b1528],
7	significantly	RB	O	significantly	advmod	6	SENT_21	[p1l749t1543r964b1584],
8	between	IN	O	between	_	0	SENT_21	[p1l999t1543r1152b1575],
9	responders	NNS	O	responder	nsubj	10	SENT_21	[p1l1189t1543r1385b1584],
10	(	VBP	O	(	prepc_between	6	SENT_21	[p1l1419t1543r1531b1582],
11	70	CD	PERCENT	70	num	12	SENT_21	[p1l1419t1543r1531b1582],
12	%	NN	PERCENT	%	dobj	10	SENT_21	[p1l1419t1543r1531b1582],
13	)	CD	NUMBER	)	tmod	10	SENT_21	[p1l1419t1543r1531b1582],
14	and	CC	O	and	_	0	SENT_21	[p1l1566t1543r1631b1575],
15	nonresponders	NNS	O	nonresponder	nsubj	16	SENT_21	[p1l1668t1543r1937b1584],
16	(	VBP	O	(	conj_and	10	SENT_21	[p1l1971t1543r2082b1583],
17	56	CD	PERCENT	56	num	18	SENT_21	[p1l1971t1543r2082b1583],
18	%	NN	PERCENT	%	nn	27	SENT_21	[p1l1971t1543r2082b1583],
19	)	CD	NUMBER	)	number	21	SENT_21	[p1l1971t1543r2082b1583],
20	at	IN	O	at	quantmod	21	SENT_21	[p1l2117t1547r2151b1575],
21	6	CD	DURATION	6	num	22	SENT_21	[p1l750t1591r770b1621],
22	months	NNS	NUMBER	month	tmod	18	SENT_21	[p1l789t1590r924b1621],
23	(	CD	NUMBER	(	num	24	SENT_21	[p1l942t1590r1119b1629],
24	P	NN	O	p	dep	18	SENT_21	[p1l942t1590r1119b1629],
25	=	JJ	O	=	amod	27	SENT_21	[p1l942t1590r1119b1629],
26	0.05	CD	NUMBER	0.05	tmod	25	SENT_21	[p1l942t1590r1119b1629],
27	)	NN	O	)	dobj	16	SENT_21	[p1l942t1590r1119b1629],
28	using	VBG	O	use	xcomp	16	SENT_21	[p1l1138t1591r1231b1631],
29	the	DT	O	the	det	31	SENT_21	[p1l1250t1590r1307b1621],
30	HAM-A	NN	O	ham-a	nn	31	SENT_21	[p1l1326t1591r1456b1621],
31	scale	NN	O	scale	dobj	28	SENT_21	[p1l1471t1590r1557b1621],
32	as	IN	O	as	_	0	SENT_21	[p1l1574t1599r1608b1621],
33	outcome	NN	O	outcome	nn	34	SENT_21	[p1l1626t1594r1786b1621],
34	measure	NN	O	measure	prep_as	28	SENT_21	[p1l1806t1599r1966b1621],
35	.	.	O	.	_	0	SENT_21	[p1l1806t1599r1966b1621],

1	Similarly	RB	O	similarly	_	0	SENT_22	[p1l1986t1590r2147b1631],
2	,	,	O	,	_	0	SENT_22	[p1l1986t1590r2147b1631],
3	using	VBG	O	use	dep	1	SENT_22	[p1l750t1637r844b1678],
4	the	DT	O	the	det	6	SENT_22	[p1l866t1637r923b1668],
5	CG	NN	O	cg	nn	6	SENT_22	[p1l945t1638r1035b1668],
6	|	NN	O	|	pobj	3	SENT_22	[p1l945t1638r1035b1668],
7	.	.	O	.	_	0	SENT_22	[p1l945t1638r1035b1668],

1	—	NN	O	—	_	0	SENT_23	[p1l945t1638r1035b1668],
2	.	.	O	.	_	0	SENT_23	[p1l945t1638r1035b1668],

1	|	RB	O	|	_	0	SENT_24	[p1l945t1638r1035b1668],
2	as	IN	O	as	_	0	SENT_24	[p1l1058t1646r1092b1668],
3	outcome	NN	O	outcome	prep_as	1	SENT_24	[p1l1113t1640r1284b1675],
4	,	,	O	,	_	0	SENT_24	[p1l1113t1640r1284b1675],
5	the	DT	O	the	det	6	SENT_24	[p1l1307t1637r1364b1668],
6	G	NN	O	g	appos	3	SENT_24	[p1l1386t1637r1521b1668],
7	—	CD	NUMBER	—	num	6	SENT_24	[p1l1386t1637r1521b1668],
8	alle	FW	O	alle	nn	9	SENT_24	[p1l1386t1637r1521b1668],
9	|	FW	O	|	amod	6	SENT_24	[p1l1386t1637r1521b1668],
10	e	SYM	O	e	dep	13	SENT_24	[p1l1386t1637r1521b1668],
11	was	VBD	O	be	auxpass	13	SENT_24	[p1l1541t1646r1608b1668],
12	significantly	RB	O	significantly	advmod	13	SENT_24	[p1l1629t1637r1845b1678],
13	associated	VBN	O	associate	dep	1	SENT_24	[p1l1865t1637r2049b1668],
14	with	IN	O	with	_	0	SENT_24	[p1l2070t1637r2148b1668],
15	improvement	NN	O	improvement	nn	17	SENT_24	[p1l750t1684r996b1725],
16	(	CD	NUMBER	(	num	17	SENT_24	[p1l1028t1684r1215b1723],
17	P	NN	O	p	prep_with	13	SENT_24	[p1l1028t1684r1215b1723],
18	=	JJ	O	=	amod	20	SENT_24	[p1l1028t1684r1215b1723],
19	0.01	CD	NUMBER	0.01	num	20	SENT_24	[p1l1028t1684r1215b1723],
20	)	NN	O	)	nsubjpass	13	SENT_24	[p1l1028t1684r1215b1723],
21	.	.	O	.	_	0	SENT_24	[p1l1028t1684r1215b1723],

1	Assuming	VBG	O	assume	_	0	SENT_25	[p1l1249t1684r1423b1725],
2	a	DT	O	a	det	4	SENT_25	[p1l1457t1693r1474b1715],
3	dominant	JJ	O	dominant	amod	4	SENT_25	[p1l1508t1684r1686b1715],
4	effect	NN	O	effect	dobj	1	SENT_25	[p1l1716t1684r1816b1715],
5	of	IN	O	of	_	0	SENT_25	[p1l1847t1684r1882b1715],
6	the	DT	O	the	det	7	SENT_25	[p1l1912t1684r1970b1715],
7	G	NN	O	g	prep_of	4	SENT_25	[p1l2003t1684r2147b1722],
8	—	VBD	O	—	dep	1	SENT_25	[p1l2003t1684r2147b1722],
9	a	DT	O	a	det	11	SENT_25	[p1l2003t1684r2147b1722],
10	|	JJ	O	|	amod	11	SENT_25	[p1l2003t1684r2147b1722],
11	|	NN	O	|	dobj	8	SENT_25	[p1l2003t1684r2147b1722],
12	e	SYM	O	e	dep	11	SENT_25	[p1l2003t1684r2147b1722],
13	|	FW	O	|	nsubj	1	SENT_25	[p1l2003t1684r2147b1722],
14	e	LS	O	e	dep	16	SENT_25	[p1l2003t1684r2147b1722],
15	,	,	O	,	_	0	SENT_25	[p1l2003t1684r2147b1722],
16	improvement	NN	O	improvement	dep	13	SENT_25	[p1l750t1731r996b1772],
17	differed	VBD	O	differ	partmod	16	SENT_25	[p1l1034t1730r1171b1762],
18	significantly	RB	O	significantly	advmod	17	SENT_25	[p1l1211t1731r1426b1772],
19	between	IN	O	between	_	0	SENT_25	[p1l1466t1731r1620b1762],
20	groups	NNS	O	group	prep_between	17	SENT_25	[p1l1661t1740r1785b1772],
21	(	CD	NUMBER	(	num	22	SENT_25	[p1l1825t1731r2021b1770],
22	P	NN	O	p	dep	20	SENT_25	[p1l1825t1731r2021b1770],
23	=	JJ	O	=	amod	22	SENT_25	[p1l1825t1731r2021b1770],
24	0.001	CD	NUMBER	0.001	tmod	23	SENT_25	[p1l1825t1731r2021b1770],
25	,	,	O	,	_	0	SENT_25	[p1l1825t1731r2021b1770],
26	odds	NNS	O	odds	nn	27	SENT_25	[p1l2063t1731r2149b1762],
27	ratio	NN	O	ratio	appos	20	SENT_25	[p1l751t1777r983b1817],
28	=	JJ	O	=	amod	30	SENT_25	[p1l751t1777r983b1817],
29	4.72	CD	NUMBER	4.72	tmod	28	SENT_25	[p1l751t1777r983b1817],
30	)	NN	O	)	dep	27	SENT_25	[p1l751t1777r983b1817],
31	.	.	O	.	_	0	SENT_25	[p1l751t1777r983b1817],

1	Similar	JJ	O	similar	amod	2	SENT_26	[p1l1017t1777r1138b1809],
2	trends	NNS	O	trend	nsubjpass	4	SENT_26	[p1l1166t1777r1279b1809],
3	were	VBD	O	be	auxpass	4	SENT_26	[p1l1308t1787r1395b1809],
4	observed	VBN	O	observe	_	0	SENT_26	[p1l1426t1777r1588b1809],
5	for	IN	O	for	_	0	SENT_26	[p1l1617t1777r1668b1809],
6	remission	NN	O	remission	prep_for	4	SENT_26	[p1l1698t1778r1865b1809],
7	although	IN	O	although	mark	8	SENT_26	[p1l1897t1777r2058b1819],
8	not	RB	O	not	dep	6	SENT_26	[p1l2091t1781r2150b1809],
9	statistically	RB	O	statistically	advmod	10	SENT_26	[p1l749t1824r944b1865],
10	significant	JJ	O	significant	dep	8	SENT_26	[p1l956t1824r1150b1865],
11	.	.	O	.	_	0	SENT_26	[p1l956t1824r1150b1865],

1	We	PRP	O	we	nsubj	2	SENT_27	[p1l1164t1825r1222b1856],
2	show	VBP	O	show	_	0	SENT_27	[p1l1235t1824r1330b1855],
3	for	IN	O	for	_	0	SENT_27	[p1l1340t1824r1391b1856],
4	the	DT	O	the	det	6	SENT_27	[p1l1402t1824r1459b1855],
5	first	JJ	ORDINAL	first	amod	6	SENT_27	[p1l1471t1824r1537b1856],
6	time	NN	O	time	prep_for	2	SENT_27	[p1l1549t1825r1629b1855],
7	a	DT	O	a	det	9	SENT_27	[p1l1642t1833r1660b1856],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_27	[p1l1675t1824r1992b1865],
9	effect	NN	O	effect	dobj	2	SENT_27	[p1l2005t1824r2104b1856],
10	of	IN	O	of	_	0	SENT_27	[p1l2116t1824r2151b1856],
11	the	DT	O	the	det	14	SENT_27	[p1l749t1871r806b1903],
12	HTR2A	NN	O	htr2a	nn	14	SENT_27	[p1l845t1872r967b1903],
13	rs7997012	NN	O	rs7997012	nn	14	SENT_27	[p1l1005t1872r1197b1903],
14	variant	NN	O	variant	prep_of	9	SENT_27	[p1l1234t1872r1359b1903],
15	in	IN	O	in	_	0	SENT_27	[p1l1396t1872r1425b1902],
16	anxiety	NN	O	anxiety	nn	17	SENT_27	[p1l1464t1872r1595b1913],
17	disorders	NNS	O	disorder	prep_in	14	SENT_27	[p1l1632t1871r1804b1909],
18	,	,	O	,	_	0	SENT_27	[p1l1632t1871r1804b1909],
19	suggesting	VBG	O	suggest	partmod	2	SENT_27	[p1l1844t1872r2039b1913],
20	that	IN	O	that	complm	23	SENT_27	[p1l2078t1871r2151b1903],
21	pharmacogenetic	JJ	O	pharmacogenetic	amod	22	SENT_27	[p1l751t1918r1068b1959],
22	effects	NNS	O	effect	nsubj	23	SENT_27	[p1l1092t1918r1206b1950],
23	cross	VBP	O	cross	ccomp	19	SENT_27	[p1l1229t1927r1317b1950],
24	diagnostic	JJ	O	diagnostic	amod	25	SENT_27	[p1l1341t1918r1526b1959],
25	categories	NNS	O	category	dobj	23	SENT_27	[p1l1550t1919r1743b1959],
26	.	.	O	.	_	0	SENT_27	[p1l1550t1919r1743b1959],

1	Our	PRP$	O	we	poss	2	SENT_28	[p1l1770t1919r1839b1950],
2	data	NNS	O	datum	nsubj	3	SENT_28	[p1l1861t1918r1938b1950],
3	document	VBP	O	document	_	0	SENT_28	[p1l1963t1918r2151b1950],
4	that	IN	O	that	complm	14	SENT_28	[p1l749t1965r821b1997],
5	individuals	NNS	O	individual	nsubj	14	SENT_28	[p1l837t1965r1027b1997],
6	with	IN	O	with	_	0	SENT_28	[p1l1042t1965r1120b1996],
7	the	DT	O	the	det	9	SENT_28	[p1l1137t1965r1195b1997],
8	HTR2A	NN	O	htr2a	nn	9	SENT_28	[p1l1213t1966r1334b1996],
9	rs7997012	NN	O	rs7997012	prep_with	5	SENT_28	[p1l1351t1966r1542b1997],
10	single	JJ	O	single	amod	13	SENT_28	[p1l1559t1965r1663b2006],
11	nucleotide	NN	O	nucleotide	nn	13	SENT_28	[p1l1680t1965r1869b1997],
12	polymorphism	NN	O	polymorphism	nn	13	SENT_28	[p1l1887t1965r2148b2007],
13	G-allele	NN	MISC	g-allele	dep	9	SENT_28	[p1l750t2012r884b2044],
14	have	VBP	O	have	ccomp	3	SENT_28	[p1l900t2012r982b2044],
15	better	JJR	O	better	amod	17	SENT_28	[p1l999t2012r1106b2044],
16	treatment	NN	O	treatment	nn	17	SENT_28	[p1l1119t2016r1299b2044],
17	outcome	NN	O	outcome	dobj	14	SENT_28	[p1l1313t2016r1474b2044],
18	over	IN	O	over	_	0	SENT_28	[p1l1489t2021r1567b2044],
19	time	NN	O	time	prep_over	17	SENT_28	[p1l1580t2013r1670b2044],
20	.	.	O	.	_	0	SENT_28	[p1l1580t2013r1670b2044],

1	Future	JJ	DATE	future	amod	2	SENT_29	[p1l1689t2013r1801b2044],
2	studies	NNS	O	study	nsubj	8	SENT_29	[p1l1816t2012r1940b2044],
3	with	IN	O	with	_	0	SENT_29	[p1l1953t2012r2031b2044],
4	larger	JJR	O	larger	amod	6	SENT_29	[p1l2048t2012r2151b2054],
5	sample	NN	O	sample	nn	6	SENT_29	[p1l749t2059r876b2101],
6	sizes	NNS	O	size	prep_with	2	SENT_29	[p1l898t2060r978b2091],
7	are	VBP	O	be	cop	8	SENT_29	[p1l1000t2069r1054b2091],
8	necessary	JJ	O	necessary	_	0	SENT_29	[p1l1078t2069r1249b2101],
9	to	TO	O	to	aux	11	SENT_29	[p1l1270t2063r1306b2091],
10	further	RB	O	further	advmod	11	SENT_29	[p1l1326t2059r1451b2091],
11	characterize	VB	O	characterize	xcomp	8	SENT_29	[p1l1472t2059r1689b2091],
12	this	DT	O	this	det	13	SENT_29	[p1l1711t2059r1773b2091],
13	effect	NN	O	effect	dobj	11	SENT_29	[p1l1796t2059r1895b2091],
14	in	IN	O	in	_	0	SENT_29	[p1l1917t2060r1946b2090],
15	treatment	NN	O	treatment	nn	16	SENT_29	[p1l1970t2063r2151b2091],
16	response	NN	O	response	prep_in	13	SENT_29	[p1l751t2115r907b2148],
17	to	TO	O	to	_	0	SENT_29	[p1l924t2110r959b2137],
18	antidepressants	NNS	O	antidepressant	prep_to	11	SENT_29	[p1l977t2106r1257b2148],
19	in	IN	O	in	_	0	SENT_29	[p1l1274t2107r1303b2137],
20	GAD	NN	O	gad	prep_in	11	SENT_29	[p1l1322t2107r1416b2138],
21	.	.	O	.	_	0	SENT_29	[p1l1322t2107r1416b2138],

1	The	DT	O	the	det	3	SENT_30	[p1l753t2153r812b2184],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_30	[p1l834t2153r1165b2194],
3	journal	NN	O	journal	dep	6	SENT_30	[p1l1183t2153r1308b2192],
4	(	CD	NUMBER	(	dep	3	SENT_30	[p1l1327t2153r1446b2192],
5	2013	CD	DATE	2013	dep	6	SENT_30	[p1l1327t2153r1446b2192],
6	)	CD	NUMBER	)	dep	12	SENT_30	[p1l1327t2153r1446b2192],
7	13	CD	NUMBER	13	dep	6	SENT_30	[p1l1471t2154r1523b2191],
8	,	,	O	,	_	0	SENT_30	[p1l1471t2154r1523b2191],
9	21-26	CD	NUMBER	21-26	appos	7	SENT_30	[p1l1547t2154r1669b2191],
10	;	:	O	;	_	0	SENT_30	[p1l1547t2154r1669b2191],
11	doi	FW	O	doi	dep	7	SENT_30	[p1l1693t2153r2147b2194],
12	:10.1038	CD	NUMBER	:10.1038	_	0	SENT_30	[p1l1693t2153r2147b2194],
13	/	:	O	/	punct	14	SENT_30	[p1l1693t2153r2147b2194],
14	tpj	NN	O	tpj	dep	12	SENT_30	[p1l1693t2153r2147b2194],
15	.2011.47	CD	NUMBER	.2011.47	num	14	SENT_30	[p1l1693t2153r2147b2194],
16	;	:	O	;	_	0	SENT_30	[p1l1693t2153r2147b2194],
17	published	VBN	O	publish	partmod	12	SENT_30	[p1l751t2200r921b2242],
18	online	NN	O	online	prep	17	SENT_30	[p1l938t2200r1047b2232],
19	18	CD	DATE	18	dep	18	SENT_30	[p1l1065t2201r1107b2232],
20	October	NNP	DATE	October	tmod	17	SENT_30	[p1l1124t2200r1271b2232],
21	2011	CD	DATE	2011	num	20	SENT_30	[p1l1285t2201r1369b2232],

1	Keywords	NNPS	O	Keywords	_	0	SENT_31	[p1l749t2297r920b2330],
2	:	:	O	:	_	0	SENT_31	[p1l749t2297r920b2330],
3	pharmacogenetics	NNS	O	pharmacogenetic	dep	1	SENT_31	[p1l941t2297r1214b2330],
4	;	:	O	;	_	0	SENT_31	[p1l941t2297r1214b2330],
5	HTR2A	NN	O	htr2a	dep	3	SENT_31	[p1l1239t2298r1343b2328],
6	;	:	O	;	_	0	SENT_31	[p1l1239t2298r1343b2328],
7	anxiety	NN	O	anxiety	nn	8	SENT_31	[p1l1367t2298r1472b2330],
8	disorders	NNS	O	disorder	dep	3	SENT_31	[p1l1493t2297r1631b2328],
9	;	:	O	;	_	0	SENT_31	[p1l1493t2297r1631b2328],
10	treatment	NN	O	treatment	nn	11	SENT_31	[p1l1654t2300r1798b2322],
11	response	NN	O	response	dep	8	SENT_31	[p1l1820t2305r1954b2330],
12	;	:	O	;	_	0	SENT_31	[p1l1820t2305r1954b2330],
13	venlafaxine	NN	O	venlafaxine	dep	3	SENT_31	[p1l1977t2297r2148b2328],
14	;	:	O	;	_	0	SENT_31	[p1l1977t2297r2148b2328],
15	rs7997012	NN	O	rs7997012	dep	13	SENT_31	[p1l750t2335r903b2360],

1	Introduction	NN	O	introduction	_	0	SENT_32	[p1l750t2511r987b2539],

1	Generalized	NNP	O	Generalized	nn	3	SENT_33	[p1l749t2603r954b2632],
2	anxiety	NN	O	anxiety	nn	3	SENT_33	[p1l974t2605r1103b2640],
3	disorder	NN	O	disorder	nsubj	13	SENT_33	[p1l1123t2604r1262b2632],
4	(	CD	NUMBER	(	num	6	SENT_33	[p1l1284t2604r1390b2639],
5	GAD	NN	O	gad	nn	6	SENT_33	[p1l1284t2604r1390b2639],
6	)	NN	O	)	dep	3	SENT_33	[p1l1284t2604r1390b2639],
7	is	VBZ	O	be	cop	13	SENT_33	[p1l1412t2605r1437b2632],
8	a	DT	O	a	det	13	SENT_33	[p1l1458t2612r1475b2632],
9	highly	RB	O	highly	advmod	10	SENT_33	[p1l1495t2603r1607b2640],
10	prevalent	JJ	O	prevalent	amod	13	SENT_33	[p1l1626t2604r1789b2641],
11	chronic	JJ	O	chronic	amod	13	SENT_33	[p1l1809t2603r1941b2632],
12	psychiatric	JJ	O	psychiatric	amod	13	SENT_33	[p1l1961t2604r2150b2640],
13	disorder	NN	O	disorder	_	0	SENT_33	[p1l749t2650r889b2678],
14	with	IN	O	with	_	0	SENT_33	[p1l912t2650r991b2678],
15	significant	JJ	O	significant	amod	16	SENT_33	[p1l1015t2650r1197b2687],
16	morbidity	NN	O	morbidity	prep_with	13	SENT_33	[p1l1220t2650r1394b2687],
17	and	CC	O	and	_	0	SENT_33	[p1l1417t2650r1481b2678],
18	mortality	NN	O	mortality	prep_with	13	SENT_33	[p1l1505t2650r1672b2687],
19	.	.	O	.	_	0	SENT_33	[p1l1505t2650r1672b2687],

1	Currently	RB	DATE	currently	advmod	8	SENT_34	[p1l1699t2650r1871b2687],
2	,	,	O	,	_	0	SENT_34	[p1l1699t2650r1871b2687],
3	antidepressant	JJ	O	antidepressant	amod	4	SENT_34	[p1l1898t2650r2150b2687],
4	drugs	NNS	O	drug	nsubj	8	SENT_34	[p1l749t2697r842b2734],
5	are	VBP	O	be	cop	8	SENT_34	[p1l869t2705r918b2725],
6	the	DT	O	the	det	8	SENT_34	[p1l945t2697r1000b2725],
7	preferred	JJ	O	preferred	amod	8	SENT_34	[p1l1026t2697r1182b2734],
8	choice	NN	O	choice	_	0	SENT_34	[p1l1208t2697r1319b2725],
9	for	IN	O	for	_	0	SENT_34	[p1l1346t2697r1394b2725],
10	acute	JJ	O	acute	amod	13	SENT_34	[p1l1420t2701r1510b2725],
11	and	CC	O	and	_	0	SENT_34	[p1l1537t2697r1601b2725],
12	chronic	JJ	O	chronic	conj_and	10	SENT_34	[p1l1628t2697r1759b2725],
13	treatment	NN	O	treatment	prep_for	8	SENT_34	[p1l1786t2701r1965b2731],
14	;	:	O	;	_	0	SENT_34	[p1l1786t2701r1965b2731],
15	however	RB	O	however	advmod	21	SENT_34	[p1l1994t2697r2147b2731],
16	,	,	O	,	_	0	SENT_34	[p1l1994t2697r2147b2731],
17	treatment	NN	O	treatment	nn	18	SENT_34	[p1l749t2747r920b2772],
18	response	NN	O	response	nsubj	21	SENT_34	[p1l931t2752r1080b2781],
19	is	VBZ	O	be	cop	21	SENT_34	[p1l1092t2745r1117b2772],
20	often	RB	O	often	advmod	21	SENT_34	[p1l1129t2744r1219b2772],
21	Variable	JJ	O	variable	parataxis	8	SENT_34	[p1l1230t2744r1365b2772],
22	ranging	VBG	O	range	xcomp	21	SENT_34	[p1l1377t2745r1511b2781],
23	from	IN	O	from	_	0	SENT_34	[p1l1522t2744r1605b2772],
24	40-70	CD	PERCENT	40-70	num	25	SENT_34	[p1l1617t2744r1761b2778],
25	%	NN	PERCENT	%	prep_from	22	SENT_34	[p1l1617t2744r1761b2778],
26	,	,	O	,	_	0	SENT_34	[p1l1617t2744r1761b2778],
27	*	CD	NUMBER	*	number	28	SENT_34	[p1l1768t2740r1809b2757],
28	3	CD	NUMBER	3	appos	25	SENT_34	[p1l1768t2740r1809b2757],
29	with	IN	O	with	_	0	SENT_34	[p1l1820t2744r1899b2772],
30	some	DT	O	some	det	31	SENT_34	[p1l1912t2752r2000b2772],
31	patients	NNS	O	patient	prep_with	28	SENT_34	[p1l2012t2745r2149b2781],
32	responding	VBG	O	respond	partmod	28	SENT_34	[p1l749t2791r944b2828],
33	well	RB	O	well	advmod	32	SENT_34	[p1l959t2791r1030b2819],
34	to	TO	O	to	_	0	SENT_34	[p1l1047t2794r1081b2819],
35	medications	NNS	O	medication	prep_to	32	SENT_34	[p1l1099t2791r1309b2819],
36	while	IN	O	while	mark	38	SENT_34	[p1l1326t2791r1421b2819],
37	others	NNS	O	other	nsubj	38	SENT_34	[p1l1439t2791r1545b2819],
38	fail	VBP	O	fail	advcl	21	SENT_34	[p1l1563t2791r1616b2819],
39	treatment	NN	O	treatment	dobj	38	SENT_34	[p1l1633t2794r1813b2819],
40	.	.	O	.	_	0	SENT_34	[p1l1633t2794r1813b2819],

1	In	IN	O	in	_	0	SENT_35	[p1l1832t2792r1868b2819],
2	general	JJ	O	general	pobj	1	SENT_35	[p1l1885t2791r2019b2828],
3	,	,	O	,	_	0	SENT_35	[p1l1885t2791r2019b2828],
4	only	RB	O	only	advmod	5	SENT_35	[p1l2039t2791r2117b2828],
5	a	DT	O	a	appos	2	SENT_35	[p1l2133t2799r2150b2819],

1	HTRZA	NN	O	htrza	nn	5	SENT_36	[p1l822t2996r983b3039],
2	and	CC	O	and	_	0	SENT_36	[p1l1001t2994r1088b3039],
3	antidepressant	JJ	O	antidepressant	nn	5	SENT_36	[p1l1108t2994r1468b3054],
4	treatment	NN	O	treatment	nn	5	SENT_36	[p1l1486t2999r1733b3039],
5	response	NN	O	response	nsubj	34	SENT_36	[p1l1752t3008r1962b3054],
6	in	IN	O	in	_	0	SENT_36	[p1l1982t2994r2024b3039],
7	GAD	NN	O	gad	nn	9	SENT_36	[p1l2044t2996r2148b3039],
8	FW	NN	O	fw	nn	9	SENT_36	[p1l1836t3067r1898b3107],
9	Lohoff	NNP	O	Lohoff	prep_in	5	SENT_36	[p1l1918t3066r2046b3107],
10	et	FW	O	et	nn	12	SENT_36	[p1l2064t3071r2100b3107],
11	al	FW	O	al	nn	12	SENT_36	[p1l2116t3066r2152b3107],
12	third	NN	ORDINAL	third	nsubj	16	SENT_36	[p2l11t84r185b141],
13	of	IN	O	of	_	0	SENT_36	[p2l215t84r287b141],
14	GAD	NN	O	gad	nn	15	SENT_36	[p2l313t85r480b141],
15	patients	NNS	O	patient	prep_of	12	SENT_36	[p2l510t87r792b160],
16	achieve	VBP	O	achieve	rcmod	5	SENT_36	[p2l823t84r1086b142],
17	remission	NN	O	remission	dobj	16	SENT_36	[p2l1117t87r1458b142],
18	in	IN	O	in	_	0	SENT_36	[p2l1488t87r1559b141],
19	the	DT	O	the	det	21	SENT_36	[p2l1588t84r1700b142],
20	acute	JJ	O	acute	amod	21	SENT_36	[p2l1732t91r1916b142],
21	phase	NN	O	phase	nsubj	29	SENT_36	[p2l1946t84r2147b160],
22	of	IN	O	of	_	0	SENT_36	[p2l11t176r83b234],
23	treatment	NN	O	treatment	prep_of	21	SENT_36	[p2l132t170r583b247],
24	,	,	O	,	_	0	SENT_36	[p2l132t170r583b247],
25	“	NN	O	“	prep_of	21	SENT_36	[p2l132t170r583b247],
26	and	CC	O	and	_	0	SENT_36	[p2l640t177r772b234],
27	those	DT	O	those	det	28	SENT_36	[p2l824t177r1013b234],
28	patients	NNS	O	patient	prep_of	21	SENT_36	[p2l1067t179r1349b252],
29	achieving	VBG	O	achieve	prepc_in	16	SENT_36	[p2l1404t176r1747b252],
30	an	DT	O	a	det	32	SENT_36	[p2l1800t193r1884b234],
31	initial	JJ	O	initial	amod	32	SENT_36	[p2l1938t177r2147b234],
32	response	NN	O	response	dobj	29	SENT_36	[p2l11t288r315b347],
33	often	RB	O	often	advmod	34	SENT_36	[p2l346t271r529b329],
34	suffer	VBP	O	suffer	_	0	SENT_36	[p2l560t271r753b329],
35	relapse	NN	O	relapse	dobj	34	SENT_36	[p2l781t264r1127b347],
36	.	.	O	.	_	0	SENT_36	[p2l781t264r1127b347],

1	“	NN	O	“	nsubjpass	20	SENT_37	[p2l781t264r1127b347],
2	The	DT	O	the	det	5	SENT_37	[p2l1154t271r1286b329],
3	underlying	VBG	O	underlie	amod	5	SENT_37	[p2l1314t271r1706b347],
4	neurobiological	JJ	O	neurobiological	amod	5	SENT_37	[p2l1733t271r2147b329, p2l11t367r172b443],
5	mechanisms	NNS	O	mechanism	nsubj	10	SENT_37	[p2l205t367r646b425],
6	of	IN	O	of	_	0	SENT_37	[p2l680t367r752b425],
7	treatment	NN	O	treatment	nn	8	SENT_37	[p2l780t374r1130b425],
8	response	NN	O	response	prep_of	5	SENT_37	[p2l1163t384r1468b443],
9	remain	VBP	O	remain	cop	10	SENT_37	[p2l1502t370r1751b425],
10	unknown	JJ	O	unknown	rcmod	1	SENT_37	[p2l1782t367r2143b437],
11	,	,	O	,	_	0	SENT_37	[p2l1782t367r2143b437],
12	and	CC	O	and	_	0	SENT_37	[p2l11t461r142b519],
13	currently	RB	DATE	currently	conj_and	1	SENT_37	[p2l184t462r508b537],
14	all	DT	O	all	det	15	SENT_37	[p2l548t461r629b519],
15	pharmacotherapy	NN	O	pharmacotherapy	nsubjpass	20	SENT_37	[p2l670t461r1302b537],
16	for	IN	O	for	_	0	SENT_37	[p2l1341t461r1439b519],
17	GAD	NN	O	gad	prep_for	15	SENT_37	[p2l1480t463r1647b519],
18	is	VBZ	O	be	auxpass	20	SENT_37	[p2l1689t464r1740b519],
19	essentially	RB	O	essentially	advmod	20	SENT_37	[p2l1782t461r2150b537],
20	determined	VBN	O	determine	_	0	SENT_37	[p2l11t557r419b615],
21	on	IN	O	on	_	0	SENT_37	[p2l458t574r549b615],
22	a	DT	O	a	det	24	SENT_37	[p2l589t574r623b615],
23	‘	JJ	O	‘	amod	24	SENT_37	[p2l664t557r824b615],
24	trial	NN	O	trial	prep_on	20	SENT_37	[p2l664t557r824b615],
25	and	CC	O	and	_	0	SENT_37	[p2l864t557r995b615],
26	error	NN	O	error	nn	28	SENT_37	[p2l1035t574r1203b615],
27	basis	NN	O	basis	nn	28	SENT_37	[p2l1239t557r1446b615],
28	’	NN	O	’	prep_on	20	SENT_37	[p2l1239t557r1446b615],
29	.	.	O	.	_	0	SENT_37	[p2l1239t557r1446b615],

1	However	RB	O	however	advmod	5	SENT_38	[p2l1491t560r1815b627],
2	,	,	O	,	_	0	SENT_38	[p2l1491t560r1815b627],
3	growing	VBG	O	grow	amod	4	SENT_38	[p2l1859t560r2149b633],
4	evidence	NN	O	evidence	nsubj	5	SENT_38	[p2l11t652r320b709],
5	suggests	VBZ	O	suggest	_	0	SENT_38	[p2l361t659r644b727],
6	that	IN	O	that	_	0	SENT_38	[p2l683t652r827b709],
7	genetic	JJ	O	genetic	amod	11	SENT_38	[p2l865t655r1119b727],
8	factors	NNS	O	factor	nn	11	SENT_38	[p2l1157t651r1389b709],
9	inﬂuence	NN	O	inﬂuence	nn	11	SENT_38	[p2l1428t651r1758b709],
10	treatment	NN	O	treatment	nn	11	SENT_38	[p2l1798t659r2148b709],
11	response	NN	O	response	prep_that	5	SENT_38	[p2l11t763r315b822],
12	and	CC	O	and	_	0	SENT_38	[p2l362t747r493b804],
13	tolerability	NN	O	tolerability	conj_and	11	SENT_38	[p2l539t747r929b822],
14	to	TO	O	to	_	0	SENT_38	[p2l972t754r1041b804],
15	medication	NN	O	medication	prep_to	5	SENT_38	[p2l1088t747r1506b804],
16	.	.	O	.	_	0	SENT_38	[p2l1088t747r1506b804],

1	The	DT	O	the	det	2	SENT_39	[p2l1554t747r1687b804],
2	majority	NN	O	majority	nsubjpass	11	SENT_39	[p2l1733t750r2037b822],
3	of	IN	O	of	_	0	SENT_39	[p2l2080t746r2152b804],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_39	[p2l10t842r624b918],
5	studies	NNS	O	study	prep_of	2	SENT_39	[p2l655t842r894b900],
6	of	IN	O	of	_	0	SENT_39	[p2l925t842r996b900],
7	antidepressant	JJ	O	antidepressant	amod	8	SENT_39	[p2l1022t842r1537b918],
8	drugs	NNS	O	drug	prep_of	5	SENT_39	[p2l1566t842r1756b918],
9	have	VBP	O	have	aux	11	SENT_39	[p2l1786t842r1950b900],
10	been	VBN	O	be	auxpass	11	SENT_39	[p2l1978t842r2148b900],
11	carried	VBN	O	carry	_	0	SENT_39	[p2l11t937r251b995],
12	out	RP	O	out	prt	11	SENT_39	[p2l290t944r407b995],
13	in	IN	O	in	_	0	SENT_39	[p2l446t940r516b994],
14	populations	NNS	O	population	prep_in	11	SENT_39	[p2l554t937r977b1013],
15	with	IN	O	with	_	0	SENT_39	[p2l1015t937r1177b994],
16	major	JJ	O	major	amod	20	SENT_39	[p2l1216t940r1423b1013],
17	depressive	JJ	O	depressive	amod	20	SENT_39	[p2l1462t937r1821b1013],
18	disorder	NN	O	disorder	nn	20	SENT_39	[p2l1862t937r2148b995],
19	(	CD	NUMBER	(	num	20	SENT_39	[p2l14t1023r285b1102],
20	MDD	NN	ORGANIZATION	mdd	prep_with	14	SENT_39	[p2l14t1023r285b1102],
21	)	CD	NUMBER	)	number	22	SENT_39	[p2l14t1023r285b1102],
22	8	CD	NUMBER	8	dobj	11	SENT_39	[p2l14t1023r285b1102],
23	while	IN	O	while	mark	28	SENT_39	[p2l309t1030r502b1088],
24	only	RB	O	only	advmod	27	SENT_39	[p2l528t1030r687b1106],
25	a	DT	O	a	det	27	SENT_39	[p2l710t1047r745b1088],
26	few	JJ	O	few	amod	27	SENT_39	[p2l768t1030r891b1088],
27	reports	NNS	O	report	nsubj	28	SENT_39	[p2l914t1037r1157b1106],
28	exist	VBP	O	exist	advcl	35	SENT_39	[p2l1183t1033r1344b1088],
29	for	IN	O	for	_	0	SENT_39	[p2l1368t1030r1466b1088],
30	anxiety	NN	O	anxiety	nn	31	SENT_39	[p2l1490t1033r1754b1106],
31	disorders	NNS	O	disorder	prep_for	28	SENT_39	[p2l1776t1023r2146b1088],
32	.9	CD	NUMBER	.9	num	34	SENT_39	[p2l1776t1023r2146b1088],
33	Recent	JJ	O	recent	amod	34	SENT_39	[p2l88t1128r325b1183],
34	data	NNS	O	datum	nsubj	35	SENT_39	[p2l350t1126r499b1183],
35	indicate	VBP	O	indicate	rcmod	22	SENT_39	[p2l524t1126r806b1183],
36	a	DT	O	a	det	38	SENT_39	[p2l834t1142r868b1183],
37	potential	JJ	O	potential	amod	38	SENT_39	[p2l893t1126r1213b1201],
38	role	NN	O	role	dobj	35	SENT_39	[p2l1239t1125r1371b1183],
39	of	IN	O	of	_	0	SENT_39	[p2l1398t1125r1470b1183],
40	the	DT	O	the	det	41	SENT_39	[p2l1491t1125r1603b1183],
41	gene	NN	O	gene	prep_of	38	SENT_39	[p2l1629t1142r1792b1201],
42	encoding	VBG	O	encode	xcomp	11	SENT_39	[p2l1819t1125r2149b1201],
43	the	DT	O	the	det	49	SENT_39	[p2l11t1221r123b1279],
44	serotonin	NN	O	serotonin	nn	49	SENT_39	[p2l156t1224r493b1279],
45	receptor	NN	O	receptor	nn	49	SENT_39	[p2l524t1228r814b1297],
46	2A	NN	O	2a	nn	49	SENT_39	[p2l845t1223r937b1278],
47	(	CD	NUMBER	(	num	49	SENT_39	[p2l971t1221r1265b1293],
48	HTRZA	NN	O	htrza	nn	49	SENT_39	[p2l971t1221r1265b1293],
49	)	NN	O	)	dobj	42	SENT_39	[p2l971t1221r1265b1293],
50	and	CC	O	and	_	0	SENT_39	[p2l1300t1221r1431b1279],
51	treatment	NN	O	treatment	nn	52	SENT_39	[p2l1461t1228r1811b1279],
52	response	NN	O	response	dobj	42	SENT_39	[p2l1842t1238r2146b1297],
53	to	TO	O	to	_	0	SENT_39	[p2l11t1323r80b1374],
54	antidepressant	JJ	O	antidepressant	amod	55	SENT_39	[p2l124t1316r639b1392],
55	drugs	NNS	O	drug	prep_to	42	SENT_39	[p2l681t1316r871b1392],
56	in	IN	O	in	_	0	SENT_39	[p2l914t1319r985b1373],
57	MDD	NN	O	mdd	prep_in	55	SENT_39	[p2l1025t1318r1233b1374],
58	.	.	O	.	_	0	SENT_39	[p2l1025t1318r1233b1374],

1	Several	JJ	O	several	amod	3	SENT_40	[p2l1281t1316r1525b1374],
2	small	JJ	O	small	amod	3	SENT_40	[p2l1569t1316r1753b1374],
3	studies	NNS	O	study	nsubjpass	15	SENT_40	[p2l1797t1316r2037b1374],
4	of	IN	O	of	_	0	SENT_40	[p2l2080t1316r2152b1374],
5	various	JJ	O	various	amod	7	SENT_40	[p2l8t1414r264b1468],
6	antidepressant	JJ	O	antidepressant	amod	7	SENT_40	[p2l297t1411r812b1486],
7	drugs	NNS	O	drug	prep_of	3	SENT_40	[p2l844t1411r1034b1486],
8	in	IN	O	in	_	0	SENT_40	[p2l1066t1414r1136b1468],
9	various	JJ	O	various	amod	11	SENT_40	[p2l1165t1414r1420b1468],
10	MDD	NN	O	mdd	nn	11	SENT_40	[p2l1451t1413r1640b1468],
11	samples	NNS	O	sample	prep_in	7	SENT_40	[p2l1675t1411r1950b1486],
12	have	VBP	O	have	aux	15	SENT_40	[p2l1982t1411r2147b1468],
13	been	VBN	O	be	auxpass	15	SENT_40	[p2l9t1506r178b1564],
14	previously	RB	DATE	previously	advmod	15	SENT_40	[p2l234t1506r603b1582],
15	investigated	VBN	O	investigate	_	0	SENT_40	[p2l657t1506r1085b1582],
16	for	IN	O	for	_	0	SENT_40	[p2l1141t1506r1239b1564],
17	polymorphisms	NNS	O	polymorphism	prep_for	15	SENT_40	[p2l1294t1506r1849b1582],
18	in	IN	O	in	_	0	SENT_40	[p2l1907t1509r1978b1563],
19	the	DT	O	the	det	22	SENT_40	[p2l2034t1506r2146b1564],
20	HT	NNP	O	HT	nn	22	SENT_40	[p2l7t1603r122b1658],
21	RZA	NNP	O	RZA	nn	22	SENT_40	[p2l114t1602r255b1658],
22	gene	NN	O	gene	prep_in	17	SENT_40	[p2l289t1617r452b1676],
23	and	CC	O	and	_	0	SENT_40	[p2l485t1601r616b1658],
24	treatment	NN	O	treatment	nn	25	SENT_40	[p2l646t1608r997b1658],
25	response	NN	O	response	prep_in	17	SENT_40	[p2l1027t1617r1332b1676],
26	and/or	JJ	O	and/or	amod	28	SENT_40	[p2l1365t1600r1601b1666],
27	adverse	JJ	O	adverse	amod	28	SENT_40	[p2l1632t1601r1891b1658],
28	events	NNS	O	event	nsubj	29	SENT_40	[p2l1924t1608r2147b1658],
29	(	VBP	O	(	rcmod	22	SENT_40	[p2l14t1693r136b1766],
30	for	IN	O	for	_	0	SENT_40	[p2l14t1693r136b1766],
31	review	NN	O	review	nn	32	SENT_40	[p2l180t1697r410b1751],
32	Kato	NNP	PERSON	Kato	prep_for	29	SENT_40	[p2l454t1696r612b1751],
33	and	CC	O	and	_	0	SENT_40	[p2l659t1694r790b1751],
34	Serrettis	NNP	O	Serrettis	conj_and	32	SENT_40	[p2l835t1687r1163b1766],
35	)	CD	NUMBER	)	num	34	SENT_40	[p2l835t1687r1163b1766],
36	.	.	O	.	_	0	SENT_40	[p2l835t1687r1163b1766],

1	While	IN	O	while	mark	5	SENT_41	[p2l1211t1694r1424b1751],
2	some	DT	O	some	det	3	SENT_41	[p2l1471t1711r1652b1751],
3	studies	NNS	O	study	nsubj	5	SENT_41	[p2l1700t1694r1939b1751],
4	were	VBD	O	be	cop	5	SENT_41	[p2l1983t1711r2147b1751],
5	positive	JJ	O	positive	advcl	9	SENT_41	[p2l10t1793r285b1866],
6	others	NNS	O	other	nsubj	9	SENT_41	[p2l312t1790r530b1848],
7	could	MD	O	could	aux	9	SENT_41	[p2l557t1790r752b1848],
8	not	RB	O	not	neg	9	SENT_41	[p2l777t1797r898b1848],
9	confirm	VB	O	confirm	_	0	SENT_41	[p2l924t1790r1204b1848],
10	previous	JJ	O	previous	amod	11	SENT_41	[p2l1230t1793r1529b1866],
11	results	NNS	O	result	dobj	9	SENT_41	[p2l1555t1790r1799b1860],
12	;	:	O	;	_	0	SENT_41	[p2l1555t1790r1799b1860],
13	however	RB	O	however	advmod	22	SENT_41	[p2l1828t1790r2143b1860],
14	,	,	O	,	_	0	SENT_41	[p2l1828t1790r2143b1860],
15	new	JJ	O	new	amod	16	SENT_41	[p2l11t1902r158b1943],
16	interest	NN	O	interest	nsubjpass	22	SENT_41	[p2l195t1888r460b1943],
17	in	IN	O	in	_	0	SENT_41	[p2l500t1888r570b1942],
18	the	DT	O	the	det	20	SENT_41	[p2l610t1885r722b1943],
19	HTRZA	NN	O	htrza	nn	20	SENT_41	[p2l759t1886r1007b1942],
20	gene	NN	O	gene	prep_in	16	SENT_41	[p2l1050t1902r1213b1961],
21	was	VBD	O	be	auxpass	22	SENT_41	[p2l1252t1902r1380b1943],
22	generated	VBN	O	generate	parataxis	9	SENT_41	[p2l1421t1885r1767b1961],
23	by	IN	O	by	_	0	SENT_41	[p2l1804t1885r1891b1961],
24	recent	JJ	O	recent	amod	25	SENT_41	[p2l1929t1892r2148b1943],
25	findings	NNS	O	finding	agent	22	SENT_41	[p2l11t1980r299b2056],
26	of	IN	O	of	_	0	SENT_41	[p2l376t1980r447b2037],
27	pharmacogenetic	JJ	O	pharmacogenetic	amod	28	SENT_41	[p2l518t1980r1132b2056],
28	studies	NNS	O	study	prep_of	25	SENT_41	[p2l1209t1980r1449b2038],
29	using	VBG	O	use	xcomp	22	SENT_41	[p2l1524t1983r1716b2056],
30	the	DT	O	the	det	35	SENT_41	[p2l1791t1980r1903b2038],
31	large	JJ	O	large	amod	35	SENT_41	[p2l1979t1980r2146b2056],
32	STAR	NN	O	star	nn	35	SENT_41	[p2l11t2074r280b2130],
33	*	NN	O	*	nn	35	SENT_41	[p2l11t2074r280b2130],
34	D	NN	O	d	nn	35	SENT_41	[p2l11t2074r280b2130],
35	sample	NN	O	sample	dobj	29	SENT_41	[p2l306t2065r640b2148],
36	.	.	O	.	_	0	SENT_41	[p2l306t2065r640b2148],

1	”	NN	O	”	nn	2	SENT_42	[p2l306t2065r640b2148],
2	McMahon	NNP	PERSON	McMahon	_	0	SENT_42	[p2l662t2073r1028b2130],
3	et	FW	O	et	dep	2	SENT_42	[p2l1052t2078r1112b2130],
4	all	DT	O	all	dep	3	SENT_42	[p2l1129t2066r1273b2130],
5	.	.	O	.	_	0	SENT_42	[p2l1129t2066r1273b2130],

1	“	NN	O	“	nsubj	2	SENT_43	[p2l1129t2066r1273b2130],
2	genotyped	VBD	O	genotype	_	0	SENT_43	[p2l1300t2072r1673b2148],
3	68	CD	NUMBER	68	num	5	SENT_43	[p2l1698t2074r1778b2130],
4	candidate	NN	O	candidate	nn	5	SENT_43	[p2l1804t2073r2147b2130],
5	genes	NNS	O	gene	dobj	2	SENT_43	[p2l11t2186r205b2245],
6	in	IN	O	in	_	0	SENT_43	[p2l228t2172r299b2226],
7	1953	CD	DATE	1953	num	8	SENT_43	[p2l326t2171r489b2227],
8	patients	NNS	O	patient	prep_in	2	SENT_43	[p2l513t2172r795b2245],
9	with	IN	O	with	_	0	SENT_43	[p2l817t2169r978b2227],
10	MDD	NN	O	mdd	prep_with	8	SENT_43	[p2l999t2172r1188b2226],
11	from	IN	O	from	_	0	SENT_43	[p2l1211t2169r1381b2227],
12	the	DT	O	the	det	16	SENT_43	[p2l1404t2169r1516b2227],
13	STAR	NN	O	star	nn	16	SENT_43	[p2l1540t2171r1808b2227],
14	*	NN	O	*	nn	16	SENT_43	[p2l1540t2171r1808b2227],
15	D	NN	O	d	nn	16	SENT_43	[p2l1540t2171r1808b2227],
16	trial	NN	O	trial	prep_from	2	SENT_43	[p2l1832t2169r1973b2227],
17	who	WP	O	who	nsubj	22	SENT_43	[p2l1993t2169r2147b2227],
18	were	VBD	O	be	cop	20	SENT_43	[p2l9t2281r172b2322],
19	moderately	RB	O	moderately	advmod	20	SENT_43	[p2l228t2264r630b2340],
20	depressed	JJ	O	depressed	rcmod	16	SENT_43	[p2l683t2264r1023b2340],
21	and	CC	O	and	_	0	SENT_43	[p2l1078t2264r1209b2322],
22	treated	JJ	O	treated	rcmod	16	SENT_43	[p2l1263t2264r1508b2322],
23	open-label	JJ	O	open-label	amod	20	SENT_43	[p2l1563t2264r1933b2340],
24	with	IN	O	with	_	0	SENT_43	[p2l1986t2264r2147b2322],
25	citalopram	NN	O	citalopram	prep_with	20	SENT_43	[p2l11t2359r392b2434],
26	for	IN	O	for	_	0	SENT_43	[p2l438t2358r536b2416],
27	up	RB	DURATION	up	quantmod	29	SENT_43	[p2l579t2375r669b2434],
28	to	TO	DURATION	to	dep	29	SENT_43	[p2l715t2366r784b2416],
29	12	CD	DURATION	12	num	30	SENT_43	[p2l836t2360r914b2416],
30	weeks	NNS	NUMBER	week	prep_for	25	SENT_43	[p2l958t2359r1183b2416],
31	.	.	O	.	_	0	SENT_43	[p2l958t2359r1183b2416],

1	The	DT	O	the	det	3	SENT_44	[p2l1232t2359r1364b2416],
2	main	JJ	O	main	amod	3	SENT_44	[p2l1410t2362r1591b2416],
3	finding	NN	O	finding	nsubj	7	SENT_44	[p2l1637t2358r1896b2434],
4	was	VBD	O	be	cop	7	SENT_44	[p2l1938t2375r2066b2416],
5	a	DT	O	a	det	7	SENT_44	[p2l2113t2375r2148b2416],
6	robust	JJ	O	robust	amod	7	SENT_44	[p2l11t2454r233b2512],
7	association	NN	O	association	_	0	SENT_44	[p2l263t2457r653b2512],
8	between	IN	O	between	_	0	SENT_44	[p2l679t2454r976b2512],
9	the	DT	O	the	det	17	SENT_44	[p2l1005t2454r1117b2512],
10	rs799	NN	O	rs799	npadvmod	12	SENT_44	[p2l1147t2456r1332b2512],
11	7012	CD	NUMBER	7012	num	10	SENT_44	[p2l1344t2456r1510b2512],
12	single	JJ	O	single	amod	17	SENT_44	[p2l1541t2454r1743b2530],
13	nucleotide	NN	O	nucleotide	nn	17	SENT_44	[p2l1772t2454r2146b2512],
14	polymorphism	NN	O	polymorphism	nn	17	SENT_44	[p2l10t2549r535b2625],
15	(	CD	NUMBER	(	num	17	SENT_44	[p2l588t2549r774b2621],
16	SNP	NN	O	snp	nn	17	SENT_44	[p2l588t2549r774b2621],
17	)	NN	O	)	prep_between	7	SENT_44	[p2l588t2549r774b2621],
18	in	IN	O	in	_	0	SENT_44	[p2l826t2552r896b2606],
19	the	DT	O	the	det	22	SENT_44	[p2l945t2549r1058b2607],
20	HT	NNP	O	HT	nn	22	SENT_44	[p2l1105t2552r1220b2606],
21	RZA	NNP	O	RZA	nn	22	SENT_44	[p2l1212t2551r1352b2606],
22	gene	NN	O	gene	prep_in	17	SENT_44	[p2l1404t2566r1567b2625],
23	and	CC	O	and	_	0	SENT_44	[p2l1618t2549r1749b2607],
24	treatment	NN	O	treatment	nn	25	SENT_44	[p2l1798t2556r2148b2607],
25	outcome	NN	O	outcome	prep_in	17	SENT_44	[p2l11t2635r405b2699],
26	.	.	O	.	_	0	SENT_44	[p2l11t2635r405b2699],

1	”	NN	O	”	npadvmod	2	SENT_45	[p2l11t2635r405b2699],
2	Since	IN	O	since	prep	10	SENT_45	[p2l442t2643r624b2699],
3	then	RB	O	then	pobj	2	SENT_45	[p2l658t2642r838b2712],
4	,	,	O	,	_	0	SENT_45	[p2l658t2642r838b2712],
5	several	JJ	O	several	amod	7	SENT_45	[p2l877t2642r1113b2699],
6	other	JJ	O	other	amod	7	SENT_45	[p2l1147t2642r1335b2699],
7	groups	NNS	O	group	nsubj	10	SENT_45	[p2l1366t2659r1602b2717],
8	have	VBP	O	have	aux	10	SENT_45	[p2l1635t2642r1800b2699],
9	independently	RB	O	independently	advmod	10	SENT_45	[p2l1833t2642r2147b2717, p2l11t2738r239b2814],
10	replicated	VBN	O	replicate	_	0	SENT_45	[p2l272t2738r620b2814],
11	the	DT	O	the	det	12	SENT_45	[p2l656t2738r768b2796],
12	finding	NN	O	finding	dobj	10	SENT_45	[p2l805t2738r1064b2814],
13	(	CD	NUMBER	(	num	14	SENT_45	[p2l1103t2738r1309b2810],
14	Table	NNP	O	Table	tmod	10	SENT_45	[p2l1103t2738r1309b2810],
15	1	CD	NUMBER	1	num	14	SENT_45	[p2l1352t2739r1432b2810],
16	)	CD	NUMBER	)	dep	14	SENT_45	[p2l1352t2739r1432b2810],
17	.	.	O	.	_	0	SENT_45	[p2l1352t2739r1432b2810],

1	Peters	NNP	PERSON	Peters	dep	4	SENT_46	[p2l1472t2741r1676b2796],
2	et	FW	O	et	nn	4	SENT_46	[p2l1714t2744r1774b2796],
3	al.	FW	O	al.	nn	4	SENT_46	[p2l1804t2738r1882b2796],
4	(	FW	O	(	dep	7	SENT_46	[p2l1926t2738r2144b2810],
5	2009	CD	DATE	2009	num	6	SENT_46	[p2l1926t2738r2144b2810],
6	)	NN	O	)	nsubj	12	SENT_46	[p2l1926t2738r2144b2810],
7	used	VBD	O	use	_	0	SENT_46	[p2l9t2833r169b2891],
8	the	DT	O	the	det	10	SENT_46	[p2l219t2833r331b2891],
9	same	JJ	O	same	amod	10	SENT_46	[p2l384t2850r558b2891],
10	sample	NN	O	sample	dobj	7	SENT_46	[p2l611t2833r855b2909],
11	and	CC	O	and	_	0	SENT_46	[p2l907t2833r1038b2890],
12	reconfirmed	VBD	O	reconfirm	conj_and	7	SENT_46	[p2l1088t2833r1521b2891],
13	the	DT	O	the	det	14	SENT_46	[p2l1571t2833r1683b2891],
14	association	NN	O	association	dobj	12	SENT_46	[p2l1735t2836r2143b2891],
15	.	.	O	.	_	0	SENT_46	[p2l1735t2836r2143b2891],

1	Lucae	NNP	O	Lucae	nn	2	SENT_47	[p2l11t2928r211b2983],
2	et	NNP	O	et	nsubj	4	SENT_47	[p2l236t2932r296b2983],
3	611.12	CD	NUMBER	611.12	num	2	SENT_47	[p2l313t2919r461b2983],
4	confirmed	VBD	O	confirm	_	0	SENT_47	[p2l484t2926r849b2983],
5	an	DT	O	a	det	6	SENT_47	[p2l873t2943r958b2983],
6	association	NN	O	association	dobj	4	SENT_47	[p2l982t2929r1372b2983],
7	of	IN	O	of	_	0	SENT_47	[p2l1396t2926r1467b2983],
8	the	DT	O	the	det	11	SENT_47	[p2l1486t2926r1598b2983],
9	rs799	NN	O	rs799	nn	11	SENT_47	[p2l1623t2927r1808b2983],
10	7012	CD	NUMBER	7012	num	11	SENT_47	[p2l1820t2927r1985b2983],
11	SNP	NN	O	snp	prep_of	6	SENT_47	[p2l2010t2928r2148b2983],

1	and	CC	O	and	dep	4	SENT_48	[p2l11t3020r142b3078],
2	antidepressant	JJ	O	antidepressant	amod	4	SENT_48	[p2l165t3021r680b3096],
3	treatment	NN	O	treatment	nn	4	SENT_48	[p2l702t3028r1051b3078],
4	response	NN	O	response	_	0	SENT_48	[p2l1073t3037r1378b3096],
5	in	IN	O	in	_	0	SENT_48	[p2l1401t3023r1471b3077],
6	two	CD	NUMBER	two	num	7	SENT_48	[p2l1492t3028r1622b3078],
7	samples	NNS	O	sample	prep_in	4	SENT_48	[p2l1647t3020r1923b3096],
8	of	IN	O	of	_	0	SENT_48	[p2l1946t3020r2017b3078],
9	the	DT	O	the	det	11	SENT_48	[p2l2034t3020r2146b3078],
10	German	JJ	MISC	german	amod	11	SENT_48	[p2l12t3116r297b3172],
11	origin	NN	O	origin	prep_of	7	SENT_48	[p2l330t3117r558b3190],
12	.	.	O	.	_	0	SENT_48	[p2l330t3117r558b3190],

1	Horstmann	NNP	PERSON	Horstmann	nsubj	22	SENT_49	[p2l596t3117r1000b3172],
2	et	FW	O	et	nn	4	SENT_49	[p2l1033t3120r1094b3172],
3	(	FW	O	(	dep	4	SENT_49	[p2l1121t3106r1267b3172],
4	11.13	CD	NUMBER	11.13	advmod	7	SENT_49	[p2l1121t3106r1267b3172],
5	could	MD	O	could	aux	7	SENT_49	[p2l1302t3114r1498b3172],
6	also	RB	O	also	advmod	7	SENT_49	[p2l1532t3114r1666b3172],
7	replicate	VB	O	replicate	_	0	SENT_49	[p2l1700t3114r2000b3190],
8	the	DT	O	the	det	9	SENT_49	[p2l2034t3114r2147b3172],
9	association	NN	O	association	iobj	7	SENT_49	[p2l11t3213r402b3268],
10	of	IN	O	of	_	0	SENT_49	[p2l429t3210r500b3268],
11	the	DT	O	the	det	12	SENT_49	[p2l523t3210r635b3268],
12	rs799	NN	O	rs799	prep_of	9	SENT_49	[p2l663t3212r848b3268],
13	7012	CD	NUMBER	7012	num	14	SENT_49	[p2l860t3212r1026b3268],
14	SNP	NN	ORGANIZATION	snp	dobj	7	SENT_49	[p2l1054t3212r1192b3268],
15	in	IN	O	in	_	0	SENT_49	[p2l1218t3213r1289b3267],
16	a	DT	O	a	det	17	SENT_49	[p2l1316t3227r1350b3268],
17	sample	NN	O	sample	prep_in	14	SENT_49	[p2l1379t3210r1623b3286],
18	from	IN	O	from	_	0	SENT_49	[p2l1651t3210r1820b3268],
19	Munich	NNP	LOCATION	Munich	prep_from	7	SENT_49	[p2l1846t3210r2143b3280],
20	,	,	O	,	_	0	SENT_49	[p2l1846t3210r2143b3280],
21	but	CC	O	but	_	0	SENT_49	[p2l9t3305r127b3362],
22	found	VBD	O	find	conj_but	7	SENT_49	[p2l155t3304r366b3362],
23	stronger	JJR	O	stronger	amod	24	SENT_49	[p2l395t3312r684b3380],
24	support	NN	O	support	dobj	22	SENT_49	[p2l713t3312r981b3380],
25	for	IN	O	for	_	0	SENT_49	[p2l1009t3304r1107b3362],
26	the	DT	O	the	det	30	SENT_49	[p2l1134t3305r1246b3362],
27	HT	NNP	O	HT	nn	30	SENT_49	[p2l1276t3307r1381b3362],
28	RZA	NNP	O	RZA	nn	30	SENT_49	[p2l1384t3306r1525b3362],
29	SNP	NN	O	snp	nn	30	SENT_49	[p2l1553t3306r1691b3362],
30	rs17288723	NN	O	rs17288723	prep_for	22	SENT_49	[p2l1718t3306r2143b3362],
31	.	.	O	.	_	0	SENT_49	[p2l1718t3306r2143b3362],

1	Uher	NNP	PERSON	Uher	tmod	7	SENT_50	[p2l11t3398r185b3455],
2	et	FW	O	et	nn	3	SENT_50	[p2l221t3404r281b3455],
3	al.	FW	O	al.	dep	1	SENT_50	[p2l312t3391r459b3455],
4	”	FW	O	”	nsubj	7	SENT_50	[p2l312t3391r459b3455],
5	could	MD	O	could	aux	7	SENT_50	[p2l496t3398r692b3455],
6	not	RB	O	not	neg	7	SENT_50	[p2l728t3405r848b3455],
7	confirm	VB	O	confirm	_	0	SENT_50	[p2l886t3398r1166b3455],
8	the	DT	O	the	det	10	SENT_50	[p2l1203t3398r1315b3455],
9	rs7997012	NN	O	rs7997012	nn	10	SENT_50	[p2l1353t3400r1715b3455],
10	SNP	NN	ORGANIZATION	snp	dobj	7	SENT_50	[p2l1754t3400r1892b3455],
11	in	IN	O	in	_	0	SENT_50	[p2l1928t3401r1998b3454],
12	the	DT	O	the	det	15	SENT_50	[p2l2034t3398r2147b3455],
13	genome-based	JJ	O	genome-based	amod	15	SENT_50	[p3l11t26r518b102],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_50	[p3l576t26r979b102],
15	drugs	NNS	O	drug	prep_in	10	SENT_50	[p3l1038t26r1228b102],
16	for	IN	O	for	_	0	SENT_50	[p3l1288t26r1386b84],
17	depression	NN	O	depression	nn	18	SENT_50	[p3l1445t26r1820b102],
18	sample	NN	O	sample	prep_for	7	SENT_50	[p3l1880t26r2144b102],
19	;	:	O	;	_	0	SENT_50	[p3l1880t26r2144b102],
20	however	RB	O	however	advmod	23	SENT_50	[p3l11t121r325b191],
21	,	,	O	,	_	0	SENT_50	[p3l11t121r325b191],
22	they	PRP	O	they	nsubj	23	SENT_50	[p3l404t121r562b197],
23	found	VBD	O	find	parataxis	7	SENT_50	[p3l633t121r844b178],
24	several	JJ	O	several	amod	26	SENT_50	[p3l920t121r1156b179],
25	other	JJ	O	other	amod	26	SENT_50	[p3l1230t121r1418b179],
26	SNPs	NNS	O	snp	nsubj	27	SENT_50	[p3l1493t122r1661b179],
27	(	VBP	O	(	ccomp	23	SENT_50	[p3l1739t121r2143b193],
28	rs9316233	NN	O	rs9316233	nn	33	SENT_50	[p3l1739t121r2143b193],
29	,	,	O	,	_	0	SENT_50	[p3l1739t121r2143b193],
30	rs7324218	NN	O	rs7324218	conj_and	28	SENT_50	[p3l11t218r372b274],
31	and	CC	O	and	_	0	SENT_50	[p3l418t216r549b274],
32	rs2Z24721	NN	O	rs2z24721	conj_and	28	SENT_50	[p3l591t216r977b288],
33	)	NN	O	)	dobj	27	SENT_50	[p3l591t216r977b288],
34	in	IN	O	in	_	0	SENT_50	[p3l1025t219r1095b273],
35	the	DT	O	the	det	37	SENT_50	[p3l1138t216r1250b274],
36	HTRZA	NN	O	htrza	nn	37	SENT_50	[p3l1291t218r1538b273],
37	gene	NN	O	gene	prep_in	27	SENT_50	[p3l1584t233r1747b292],
38	associated	VBN	O	associate	partmod	37	SENT_50	[p3l1793t216r2148b274],
39	with	IN	O	with	_	0	SENT_50	[p3l9t311r170b368],
40	treatment	NN	O	treatment	nn	41	SENT_50	[p3l196t318r546b369],
41	response	NN	O	response	prep_with	38	SENT_50	[p3l573t328r877b387],
42	to	TO	O	to	_	0	SENT_50	[p3l905t318r974b368],
43	antidepressants	NNS	O	antidepressant	prep_to	38	SENT_50	[p3l1003t311r1567b387],
44	.	.	O	.	_	0	SENT_50	[p3l1003t311r1567b387],

1	Taken	VBN	O	take	partmod	6	SENT_51	[p3l1596t311r1806b369],
2	together	RB	O	together	advmod	1	SENT_51	[p3l1832t311r2143b387],
3	,	,	O	,	_	0	SENT_51	[p3l1832t311r2143b387],
4	several	JJ	O	several	amod	5	SENT_51	[p3l12t405r249b462],
5	studies	NNS	O	study	nsubj	6	SENT_51	[p3l307t405r546b462],
6	document	VBP	O	document	_	0	SENT_51	[p3l604t405r965b462],
7	a	DT	O	a	det	8	SENT_51	[p3l1022t422r1056b462],
8	role	NN	O	role	dobj	6	SENT_51	[p3l1112t405r1244b462],
9	of	IN	O	of	_	0	SENT_51	[p3l1302t405r1374b462],
10	the	DT	O	the	det	14	SENT_51	[p3l1425t405r1538b462],
11	HT	NNP	O	HT	nn	14	SENT_51	[p3l1596t407r1701b461],
12	RZA	NNP	O	RZA	nn	14	SENT_51	[p3l1704t406r1845b461],
13	variant	JJ	O	variant	amod	14	SENT_51	[p3l1897t408r2148b462],
14	rs7997012	NN	O	rs7997012	prep_of	8	SENT_51	[p3l9t501r373b558],
15	and	CC	O	and	_	0	SENT_51	[p3l406t500r537b557],
16	antidepressant	JJ	O	antidepressant	amod	18	SENT_51	[p3l569t500r1085b576],
17	treatment	NN	O	treatment	nn	18	SENT_51	[p3l1117t507r1467b558],
18	response	NN	O	response	conj_and	8	SENT_51	[p3l1498t517r1803b576],
19	in	IN	O	in	_	0	SENT_51	[p3l1836t503r1906b557],
20	MDD	NN	ORGANIZATION	mdd	prep_in	18	SENT_51	[p3l1937t502r2145b570],
21	,	,	O	,	_	0	SENT_51	[p3l1937t502r2145b570],
22	with	IN	O	with	_	0	SENT_51	[p3l8t593r169b650],
23	similar	JJ	O	similar	amod	25	SENT_51	[p3l200t593r439b650],
24	effect	NN	O	effect	nn	25	SENT_51	[p3l469t593r659b650],
25	sizes	NNS	O	size	prep_with	6	SENT_51	[p3l690t596r863b650],
26	.	.	O	.	_	0	SENT_51	[p3l690t596r863b650],

1	In	IN	O	in	_	0	SENT_52	[p3l87t691r159b746],
2	this	DT	O	this	det	3	SENT_52	[p3l194t689r323b747],
3	study	NN	O	study	prep_in	6	SENT_52	[p3l361t689r562b765],
4	,	,	O	,	_	0	SENT_52	[p3l361t689r562b765],
5	we	PRP	O	we	nsubj	6	SENT_52	[p3l600t706r695b747],
6	addressed	VBD	O	address	_	0	SENT_52	[p3l732t689r1074b747],
7	the	DT	O	the	det	9	SENT_52	[p3l1108t689r1220b747],
8	following	VBG	O	follow	amod	9	SENT_52	[p3l1256t689r1595b765],
9	question	NN	O	question	dobj	6	SENT_52	[p3l1629t692r1953b765],
10	:	:	O	:	_	0	SENT_52	[p3l1629t692r1953b765],
11	does	VBZ	O	do	dep	6	SENT_52	[p3l1993t689r2149b747],
12	the	DT	O	the	det	14	SENT_52	[p3l9t784r122b842],
13	HTRZA	NN	O	htrza	nn	14	SENT_52	[p3l159t786r409b841],
14	rs7997012	NN	O	rs7997012	dobj	11	SENT_52	[p3l444t786r808b842],
15	variant	JJ	O	variant	acomp	6	SENT_52	[p3l841t787r1092b842],
16	predict	VBP	O	predict	ccomp	15	SENT_52	[p3l1127t784r1375b860],
17	antidepressant	JJ	O	antidepressant	amod	19	SENT_52	[p3l1412t784r1928b860],
18	treatment	NN	O	treatment	nn	19	SENT_52	[p3l1963t791r2148b842, p3l9t886r196b936],
19	response	NN	O	response	dobj	16	SENT_52	[p3l224t895r529b954],
20	in	IN	O	in	_	0	SENT_52	[p3l558t881r628b935],
21	patients	NNS	O	patient	prep_in	19	SENT_52	[p3l657t881r939b954],
22	with	IN	O	with	_	0	SENT_52	[p3l966t878r1127b936],
23	anxiety	NN	O	anxiety	nn	24	SENT_52	[p3l1157t881r1421b954],
24	disorders	NNS	O	disorder	prep_with	21	SENT_52	[p3l1448t878r1798b936],
25	?	.	O	?	_	0	SENT_52	[p3l1448t878r1798b936],

1	We	PRP	O	we	nsubj	2	SENT_53	[p3l1827t881r1936b936],
2	show	VBP	O	show	_	0	SENT_53	[p3l1967t879r2151b936],
3	for	IN	O	for	_	0	SENT_53	[p3l9t974r108b1032],
4	the	DT	O	the	det	6	SENT_53	[p3l146t974r259b1032],
5	first	JJ	ORDINAL	first	amod	6	SENT_53	[p3l301t974r437b1032],
6	time	NN	O	time	prep_for	2	SENT_53	[p3l476t977r635b1032],
7	a	DT	O	a	det	9	SENT_53	[p3l677t991r712b1032],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_53	[p3l751t974r1366b1050],
9	effect	NN	O	effect	dobj	2	SENT_53	[p3l1407t974r1598b1032],
10	of	IN	O	of	_	0	SENT_53	[p3l1639t974r1710b1032],
11	the	DT	O	the	det	12	SENT_53	[p3l1746t974r1858b1032],
12	HTRZA	NNP	O	HTRZA	prep_of	9	SENT_53	[p3l1901t976r2150b1031],
13	rs799	CD	NUMBER	rs799	num	12	SENT_53	[p3l9t1070r195b1126],
14	7012	CD	NUMBER	7012	num	15	SENT_53	[p3l207t1070r373b1126],
15	variant	NN	O	variant	dep	2	SENT_53	[p3l394t1072r645b1126],
16	in	IN	O	in	_	0	SENT_53	[p3l668t1072r738b1126],
17	GAD	NN	O	gad	prep_in	15	SENT_53	[p3l763t1070r948b1139],
18	,	,	O	,	_	0	SENT_53	[p3l763t1070r948b1139],
19	suggesting	VBG	O	suggest	partmod	2	SENT_53	[p3l977t1072r1348b1144],
20	that	IN	O	that	complm	23	SENT_53	[p3l1369t1069r1513b1126],
21	pharmacogenetic	JJ	O	pharmacogenetic	amod	22	SENT_53	[p3l1535t1069r2149b1144],
22	effects	NNS	O	effect	nsubj	23	SENT_53	[p3l10t1163r231b1221],
23	cross	VBP	O	cross	ccomp	19	SENT_53	[p3l264t1180r433b1221],
24	diagnostic	JJ	O	diagnostic	amod	25	SENT_53	[p3l467t1164r830b1239],
25	categories	NNS	O	category	dobj	23	SENT_53	[p3l862t1167r1229b1239],
26	.	.	O	.	_	0	SENT_53	[p3l862t1167r1229b1239],

1	Our	PRP$	O	we	poss	2	SENT_54	[p3l1267t1165r1401b1221],
2	data	NNS	O	datum	nsubj	3	SENT_54	[p3l1432t1164r1581b1221],
3	document	VBP	O	document	_	0	SENT_54	[p3l1614t1164r1975b1221],
4	that	IN	O	that	complm	12	SENT_54	[p3l2006t1164r2150b1221],
5	individuals	NNS	O	individual	nsubj	12	SENT_54	[p3l9t1258r402b1315],
6	with	IN	O	with	_	0	SENT_54	[p3l442t1258r604b1315],
7	the	DT	O	the	det	11	SENT_54	[p3l644t1258r757b1315],
8	HTRZA	NNP	O	HTRZA	nn	11	SENT_54	[p3l799t1260r1049b1314],
9	rs7997012	CD	NUMBER	rs7997012	num	11	SENT_54	[p3l1089t1260r1452b1315],
10	SNP	NN	MISC	snp	nn	11	SENT_54	[p3l1494t1260r1633b1315],
11	G-allele	NN	MISC	g-allele	prep_with	5	SENT_54	[p3l1674t1258r1941b1315],
12	have	VBP	O	have	ccomp	3	SENT_54	[p3l1983t1258r2148b1315],
13	better	JJR	O	better	amod	15	SENT_54	[p3l7t1352r214b1409],
14	treatment	NN	O	treatment	nn	15	SENT_54	[p3l243t1359r594b1409],
15	outcome	NN	O	outcome	dobj	12	SENT_54	[p3l623t1359r933b1409],
16	over	IN	O	over	_	0	SENT_54	[p3l964t1369r1116b1409],
17	time	NN	O	time	prep_over	15	SENT_54	[p3l1144t1355r1322b1409],
18	.	.	O	.	_	0	SENT_54	[p3l1144t1355r1322b1409],

1	Subjects	NNS	O	subject	_	0	SENT_55	[p3l10t1563r326b1639],
2	and	CC	O	and	_	0	SENT_55	[p3l356t1563r497b1621],
3	methods	NNS	O	method	conj_and	1	SENT_55	[p3l532t1563r866b1621],

1	Patients	NNS	O	patient	nsubj	5	SENT_56	[p3l10t1754r288b1810],
2	for	IN	O	for	_	0	SENT_56	[p3l331t1752r428b1809],
3	this	DT	O	this	det	4	SENT_56	[p3l468t1752r598b1809],
4	study	NN	O	study	prep_for	1	SENT_56	[p3l641t1752r834b1828],
5	participated	VBD	O	participate	_	0	SENT_56	[p3l872t1752r1296b1828],
6	in	IN	O	in	_	0	SENT_56	[p3l1336t1755r1407b1809],
7	an	DT	O	a	det	14	SENT_56	[p3l1449t1769r1533b1809],
8	18-month	JJ	DURATION	18-month	amod	14	SENT_56	[p3l1580t1752r1948b1822],
9	,	,	O	,	_	0	SENT_56	[p3l1580t1752r1948b1822],
10	onecenter	NN	O	onecenter	dep	14	SENT_56	[p3l1995t1769r2148b1810, p3l10t1854r242b1917],
11	,	,	O	,	_	0	SENT_56	[p3l1995t1769r2148b1810, p3l10t1854r242b1917],
12	relapse	NN	O	relapse	dep	14	SENT_56	[p3l312t1847r553b1922],
13	prevention	NN	O	prevention	nn	14	SENT_56	[p3l618t1849r1008b1922],
14	study	NN	O	study	prep_in	5	SENT_56	[p3l1075t1846r1267b1922],
15	that	WDT	O	that	nsubj	16	SENT_56	[p3l1329t1846r1473b1904],
16	comprised	VBD	O	comprise	rcmod	14	SENT_56	[p3l1538t1846r1904b1922],
17	three	CD	NUMBER	three	num	19	SENT_56	[p3l1968t1847r2148b1904],
18	treatment	NN	O	treatment	nn	19	SENT_56	[p3l9t1947r360b1997],
19	phases	NNS	O	phase	dobj	16	SENT_56	[p3l396t1933r714b2015],
20	.	.	O	.	_	0	SENT_56	[p3l396t1933r714b2015],

1	”	NN	O	”	nn	2	SENT_57	[p3l396t1933r714b2015],
2	A	NN	O	a	dep	8	SENT_57	[p3l752t1941r803b1996],
3	6-month	JJ	DURATION	6-month	amod	5	SENT_57	[p3l842t1939r1152b1997],
4	open-label	JJ	O	open-label	amod	5	SENT_57	[p3l1190t1940r1560b2015],
5	venlafaxine	NN	O	venlafaxine	dep	2	SENT_57	[p3l1596t1939r2008b1997],
6	XR	NN	O	xr	dep	8	SENT_57	[p3l2047t1942r2151b1996],
7	(	CD	NUMBER	(	num	6	SENT_57	[p3l13t2036r215b2108],
8	VEN	NNP	O	VEN	dep	17	SENT_57	[p3l13t2036r215b2108],
9	)	CD	NUMBER	)	num	8	SENT_57	[p3l13t2036r215b2108],
10	ﬂexible-dose	JJ	O	ﬂexible-dose	amod	12	SENT_57	[p3l263t2036r708b2094],
11	treatment	NN	O	treatment	nn	12	SENT_57	[p3l753t2043r1103b2094],
12	phase	NN	O	phase	dep	8	SENT_57	[p3l1147t2036r1348b2112],
13	(	CD	NUMBER	(	number	14	SENT_57	[p3l1396t2036r1669b2108],
14	75	CD	NUMBER	75	num	15	SENT_57	[p3l1396t2036r1669b2108],
15	—	NN	O	—	dep	12	SENT_57	[p3l1396t2036r1669b2108],
16	225	CD	NUMBER	225	num	17	SENT_57	[p3l1396t2036r1669b2108],
17	mg	NN	O	mg	dep	22	SENT_57	[p3l1690t2053r1802b2112],
18	per	IN	O	per	_	0	SENT_57	[p3l1843t2053r1955b2112],
19	day	NN	DURATION	day	prep_per	17	SENT_57	[p3l1999t2036r2146b2112],
20	)	CD	NUMBER	)	num	19	SENT_57	[p3l1999t2036r2146b2112],
21	(	CD	NUMBER	(	num	22	SENT_57	[p3l13t2131r234b2203],
22	Phase	NN	O	phase	dep	24	SENT_57	[p3l13t2131r234b2203],
23	I	PRP	O	I	nsubj	24	SENT_57	[p3l281t2131r348b2203],
24	)	VBP	O	)	_	0	SENT_57	[p3l281t2131r348b2203],
25	,	,	O	,	_	0	SENT_57	[p3l281t2131r348b2203],
26	a	DT	O	a	det	27	SENT_57	[p3l399t2147r434b2188],
27	6-month	JJ	DURATION	6-month	nsubj	28	SENT_57	[p3l482t2131r792b2188],
28	randomized	VBN	O	randomize	parataxis	24	SENT_57	[p3l837t2131r1278b2201],
29	,	,	O	,	_	0	SENT_57	[p3l837t2131r1278b2201],
30	double-blind	JJ	O	double-blind	amod	38	SENT_57	[p3l1329t2131r1802b2201],
31	,	,	O	,	_	0	SENT_57	[p3l1329t2131r1802b2201],
32	placebocontrolled	JJ	O	placebocontrolled	amod	38	SENT_57	[p3l1852t2131r2148b2206, p3l10t2226r375b2283],
33	relapse	NN	O	relapse	nn	38	SENT_57	[p3l423t2226r665b2301],
34	phase	NN	O	phase	nn	38	SENT_57	[p3l714t2226r914b2301],
35	(	CD	NUMBER	(	num	38	SENT_57	[p3l968t2226r1189b2298],
36	Phase	NN	O	phase	nn	38	SENT_57	[p3l968t2226r1189b2298],
37	II	CD	NUMBER	ii	num	38	SENT_57	[p3l1239t2226r1312b2298],
38	)	NN	O	)	dobj	24	SENT_57	[p3l1239t2226r1312b2298],
39	and	CC	O	and	_	0	SENT_57	[p3l1365t2226r1496b2283],
40	a	DT	O	a	det	42	SENT_57	[p3l1545t2242r1580b2283],
41	final	JJ	O	final	amod	42	SENT_57	[p3l1628t2225r1787b2283],
42	6-month	JJ	DURATION	6-month	conj_and	24	SENT_57	[p3l1839t2226r2149b2283],
43	randomized	VBN	O	randomize	partmod	42	SENT_57	[p3l9t2321r450b2391],
44	,	,	O	,	_	0	SENT_57	[p3l9t2321r450b2391],
45	double-blind	JJ	O	double-blind	amod	53	SENT_57	[p3l482t2321r955b2391],
46	,	,	O	,	_	0	SENT_57	[p3l482t2321r955b2391],
47	placebo-controlled	JJ	O	placebo-controlled	amod	53	SENT_57	[p3l986t2321r1653b2397],
48	relapse	NN	O	relapse	nn	53	SENT_57	[p3l1679t2321r1921b2397],
49	phase	NN	O	phase	nn	53	SENT_57	[p3l1948t2321r2148b2397],
50	(	CD	NUMBER	(	num	53	SENT_57	[p3l13t2416r234b2488],
51	Phase	NN	O	phase	nn	53	SENT_57	[p3l13t2416r234b2488],
52	III	CD	NUMBER	iii	num	53	SENT_57	[p3l268t2416r390b2488],
53	)	NN	O	)	dobj	43	SENT_57	[p3l268t2416r390b2488],
54	.	.	O	.	_	0	SENT_57	[p3l268t2416r390b2488],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nn	2	SENT_58	[p3l427t2416r1068b2491],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_58	[p3l1102t2416r1377b2491],
3	was	VBD	O	be	auxpass	4	SENT_58	[p3l1409t2432r1536b2473],
4	carried	VBN	O	carry	_	0	SENT_58	[p3l1571t2416r1810b2473],
5	out	RP	O	out	prt	4	SENT_58	[p3l1842t2423r1959b2473],
6	only	RB	O	only	advmod	4	SENT_58	[p3l1992t2416r2152b2491],
7	for	IN	O	for	_	0	SENT_58	[p3l9t2511r108b2569],
8	patients	NNS	O	patient	prep_for	4	SENT_58	[p3l155t2514r438b2587],
9	from	IN	O	from	_	0	SENT_58	[p3l488t2511r657b2569],
10	Phase	NN	O	phase	prep_from	4	SENT_58	[p3l708t2511r904b2569],
11	1	CD	NUMBER	1	num	10	SENT_58	[p3l956t2514r996b2569],
12	.	.	O	.	_	0	SENT_58	[p3l956t2514r996b2569],

1	Detailed	JJ	O	detailed	amod	2	SENT_59	[p3l1050t2511r1344b2569],
2	methodology	NN	O	methodology	nsubjpass	8	SENT_59	[p3l1393t2511r1872b2587],
3	of	IN	O	of	_	0	SENT_59	[p3l1919t2511r1991b2569],
4	the	DT	O	the	det	6	SENT_59	[p3l2036t2511r2148b2569],
5	clinical	JJ	O	clinical	amod	6	SENT_59	[p3l10t2605r265b2663],
6	trial	NN	O	trial	prep_of	2	SENT_59	[p3l293t2605r434b2663],
7	is	VBZ	O	be	auxpass	8	SENT_59	[p3l463t2608r513b2663],
8	described	VBN	O	describe	_	0	SENT_59	[p3l543t2605r874b2663],
9	elsewhere	RB	O	elsewhere	advmod	8	SENT_59	[p3l902t2599r1332b2663],
10	.	.	O	.	_	0	SENT_59	[p3l902t2599r1332b2663],

1	”	NN	O	”	nn	2	SENT_60	[p3l902t2599r1332b2663],
2	Brieﬂy	NN	O	brieﬂy	nsubj	12	SENT_60	[p3l1364t2605r1602b2681],
3	,	,	O	,	_	0	SENT_60	[p3l1364t2605r1602b2681],
4	to	TO	O	to	aux	6	SENT_60	[p3l1635t2613r1704b2663],
5	be	VB	O	be	auxpass	6	SENT_60	[p3l1731t2605r1811b2663],
6	included	VBN	O	include	purpcl	12	SENT_60	[p3l1840t2605r2150b2663],
7	in	IN	O	in	_	0	SENT_60	[p3l9t2703r80b2757],
8	the	DT	O	the	det	9	SENT_60	[p3l110t2700r223b2758],
9	study	NN	O	study	prep_in	6	SENT_60	[p3l257t2700r458b2776],
10	,	,	O	,	_	0	SENT_60	[p3l257t2700r458b2776],
11	subjects	NNS	O	subject	nsubj	12	SENT_60	[p3l496t2700r772b2775],
12	had	VBD	O	have	_	0	SENT_60	[p3l804t2700r936b2757],
13	to	TO	O	to	aux	16	SENT_60	[p3l966t2707r1036b2757],
14	be	VB	O	be	cop	16	SENT_60	[p3l1065t2700r1146b2758],
15	18	CD	DURATION	18	number	16	SENT_60	[p3l1184t2701r1260b2757],
16	years	NNS	NUMBER	year	xcomp	12	SENT_60	[p3l1291t2717r1468b2776],
17	or	CC	O	or	_	0	SENT_60	[p3l1501t2717r1572b2757],
18	older	JJR	O	older	conj_or	16	SENT_60	[p3l1603t2700r1783b2758],
19	and	CC	O	and	_	0	SENT_60	[p3l1814t2700r1945b2757],
20	meet	VB	O	meet	xcomp	12	SENT_60	[p3l1976t2707r2150b2758],
21	the	DT	O	the	det	25	SENT_60	[p3l9t2794r122b2852],
22	Diagnostic	JJ	MISC	diagnostic	amod	25	SENT_60	[p3l158t2797r534b2870],
23	and	CC	O	and	_	0	SENT_60	[p3l569t2795r700b2852],
24	Statistical	JJ	O	statistical	amod	25	SENT_60	[p3l735t2795r1073b2852],
25	Manual	NN	O	manual	dobj	20	SENT_60	[p3l1106t2794r1376b2852],
26	of	IN	O	of	_	0	SENT_60	[p3l1411t2794r1482b2852],
27	Mental	JJ	O	mental	amod	28	SENT_60	[p3l1511t2795r1762b2852],
28	Disorders	NNS	O	disorder	prep_of	25	SENT_60	[p3l1797t2794r2144b2865],
29	,	,	O	,	_	0	SENT_60	[p3l1797t2794r2144b2865],
30	Fourth	JJ	ORDINAL	fourth	amod	33	SENT_60	[p3l10t2889r246b2947],
31	Edition	NN	O	edition	nn	33	SENT_60	[p3l277t2890r535b2947],
32	(	NN	O	(	nn	33	SENT_60	[p3l569t2890r891b2962],
33	DSM-IV	NN	O	dsm-iv	appos	28	SENT_60	[p3l569t2890r891b2962],
34	)	CD	NUMBER	)	num	35	SENT_60	[p3l569t2890r891b2962],
35	criteria	NNS	O	criterion	dobj	16	SENT_60	[p3l926t2892r1172b2947],
36	for	IN	O	for	_	0	SENT_60	[p3l1203t2889r1301b2947],
37	GAD	NN	O	gad	prep_for	35	SENT_60	[p3l1332t2891r1499b2947],
38	as	IN	O	as	mark	39	SENT_60	[p3l1531t2906r1596b2947],
39	determined	VBN	O	determine	advcl	16	SENT_60	[p3l1628t2889r2036b2947],
40	by	IN	O	by	_	0	SENT_60	[p3l2064t2890r2152b2965],
41	the	DT	O	the	det	44	SENT_60	[p3l9t2985r122b3043],
42	Structured	NNP	ORGANIZATION	Structured	nn	44	SENT_60	[p3l158t2985r525b3043],
43	Clinical	JJ	ORGANIZATION	clinical	amod	44	SENT_60	[p3l561t2985r834b3043],
44	Interview	NN	ORGANIZATION	interview	prep_by	39	SENT_60	[p3l871t2988r1207b3043],
45	and	CC	O	and	_	0	SENT_60	[p3l1242t2985r1372b3043],
46	a	DT	O	a	det	48	SENT_60	[p3l1408t3002r1442b3043],
47	psychiatric	JJ	O	psychiatric	amod	48	SENT_60	[p3l1477t2985r1863b3061],
48	evaluation	NN	O	evaluation	conj_and	44	SENT_60	[p3l1899t2985r2148b3043, p3l9t3083r172b3137],
49	.	.	O	.	_	0	SENT_60	[p3l1899t2985r2148b3043, p3l9t3083r172b3137],

1	Patients	NNS	O	patient	nsubj	2	SENT_61	[p3l222t3082r492b3137],
2	had	VBD	O	have	_	0	SENT_61	[p3l537t3080r666b3137],
3	to	TO	O	to	aux	4	SENT_61	[p3l710t3087r778b3137],
4	have	VB	O	have	xcomp	2	SENT_61	[p3l823t3080r985b3137],
5	sufficient	JJ	O	sufficient	amod	6	SENT_61	[p3l1031t3079r1349b3137],
6	symptoms	NNS	O	symptom	nsubj	8	SENT_61	[p3l1394t3087r1749b3155],
7	to	TO	O	to	aux	8	SENT_61	[p3l1794t3087r1863b3137],
8	require	VB	O	require	conj_and	8	SENT_61	[p3l1907t3083r2148b3155],
9	anxiolytic	JJ	O	anxiolytic	amod	11	SENT_61	[p3l10t3175r354b3250],
10	drug	NN	O	drug	nn	11	SENT_61	[p3l398t3175r556b3250],
11	therapy	NN	O	therapy	dobj	8	SENT_61	[p3l598t3175r873b3250],
12	,	,	O	,	_	0	SENT_61	[p3l598t3175r873b3250],
13	including	VBG	O	include	_	0	SENT_61	[p3l922t3175r1254b3250],
14	a	DT	O	a	det	15	SENT_61	[p3l1298t3191r1332b3232],
15	score	NN	NUMBER	score	prep_including	11	SENT_61	[p3l1377t3191r1548b3232],
16	of	IN	O	of	_	0	SENT_61	[p3l1594t3174r1665b3232],
17	220	CD	NUMBER	220	prep_of	15	SENT_61	[p3l1715t3176r1860b3240],
18	on	IN	O	on	_	0	SENT_61	[p3l1905t3191r1996b3232],
19	the	DT	O	the	det	25	SENT_61	[p3l2038t3175r2148b3232],
20	Hamilton	NNP	ORGANIZATION	Hamilton	dep	21	SENT_61	[p3l10t3270r344b3328],
21	Anxiety	NN	ORGANIZATION	anxiety	amod	25	SENT_61	[p3l378t3272r651b3346],
22	Scale	NNP	ORGANIZATION	Scale	nn	25	SENT_61	[p3l685t3270r852b3328],
23	(	CD	NUMBER	(	num	25	SENT_61	[p3l893t3270r1195b3342],
24	HAM-A	NN	O	ham-a	nn	25	SENT_61	[p3l893t3270r1195b3342],
25	)	NN	O	)	prep_on	8	SENT_61	[p3l893t3270r1195b3342],
26	at	IN	O	at	_	0	SENT_61	[p3l1236t3277r1298b3328],
27	screen	NN	O	screen	prep_at	25	SENT_61	[p3l1336t3287r1549b3328],
28	and	CC	O	and	_	0	SENT_61	[p3l1587t3270r1717b3328],
29	at	IN	O	at	_	0	SENT_61	[p3l1752t3277r1815b3328],
30	baseline	NN	O	baseline	prep_at	8	SENT_61	[p3l1848t3270r2145b3340],
31	,	,	O	,	_	0	SENT_61	[p3l1848t3270r2145b3340],
32	and	CC	O	and	_	0	SENT_61	[p3l10t3365r140b3422],
33	a	DT	O	a	det	34	SENT_61	[p3l164t3381r198b3422],
34	score	NN	NUMBER	score	conj_and	30	SENT_61	[p3l224t3381r394b3422],
35	of	IN	O	of	_	0	SENT_61	[p3l420t3364r492b3422],
36	>	JJR	O	>	prep_of	34	SENT_61	[p3l521t3367r623b3430],
37	4	CD	NUMBER	4	dep	8	SENT_61	[p3l521t3367r623b3430],
38	on	IN	O	on	_	0	SENT_61	[p3l649t3381r739b3422],
39	the	DT	O	the	det	42	SENT_61	[p3l763t3365r874b3422],
40	Clinical	JJ	O	clinical	amod	42	SENT_61	[p3l900t3365r1165b3422],
41	Global	JJ	O	global	amod	42	SENT_61	[p3l1191t3365r1417b3422],
42	Impressions	NNS	O	impression	prep_on	8	SENT_61	[p3l1442t3366r2152b3440],
43	.	.	O	.	_	0	SENT_61	[p3l1442t3366r2152b3440],

1	—	NN	O	—	_	0	SENT_62	[p3l1442t3366r2152b3440],
2	.	.	O	.	_	0	SENT_62	[p3l1442t3366r2152b3440],

1	Severity	NN	O	severity	_	0	SENT_63	[p3l1442t3366r2152b3440],
2	(	CD	NUMBER	(	num	4	SENT_63	[p3l13t3459r278b3531],
3	CGI-S	NN	O	cgi-s	nn	4	SENT_63	[p3l13t3459r278b3531],
4	)	NN	O	)	dep	1	SENT_63	[p3l13t3459r278b3531],
5	.	.	O	.	_	0	SENT_63	[p3l13t3459r278b3531],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_64	[p3l315t3462r586b3517],
2	were	VBD	O	be	auxpass	4	SENT_64	[p3l617t3476r777b3517],
3	also	RB	O	also	advmod	4	SENT_64	[p3l811t3459r942b3517],
4	assessed	VBN	O	assess	_	0	SENT_64	[p3l976t3459r1250b3517],
5	with	IN	O	with	_	0	SENT_64	[p3l1281t3459r1439b3517],
6	the	DT	O	the	det	10	SENT_64	[p3l1471t3459r1581b3517],
7	17-item	NNP	O	17-item	nn	10	SENT_64	[p3l1620t3461r1880b3517],
8	Hamilton	NNP	O	Hamilton	nn	10	SENT_64	[p3l1913t3459r2149b3517, p3l9t3562r127b3613],
9	Depression	NNP	O	Depression	nn	10	SENT_64	[p3l153t3558r532b3631],
10	Scale	NNP	O	Scale	prep_with	4	SENT_64	[p3l558t3555r725b3613],
11	(	CD	NUMBER	(	num	13	SENT_64	[p3l755t3555r1084b3627],
12	HAM-D	NN	O	ham-d	nn	13	SENT_64	[p3l755t3555r1084b3627],
13	)	NN	O	)	dep	10	SENT_64	[p3l755t3555r1084b3627],
14	.	.	O	.	_	0	SENT_64	[p3l755t3555r1084b3627],

1	A	DT	O	a	det	4	SENT_65	[p3l1112t3557r1163b3612],
2	HAM-D	NN	O	ham-d	nn	4	SENT_65	[p3l1188t3557r1451b3613],
3	cutoff	NN	O	cutoff	nn	4	SENT_65	[p3l1477t3555r1682b3613],
4	score	NN	NUMBER	score	nsubjpass	9	SENT_65	[p3l1705t3572r1876b3613],
5	of	IN	O	of	_	0	SENT_65	[p3l1902t3555r1972b3613],
6	<	JJR	O	<	prep_of	4	SENT_65	[p3l2004t3565r2053b3620],
7	18	CD	NUMBER	18	dep	6	SENT_65	[p3l2073t3557r2148b3613],
8	was	VBD	O	be	auxpass	9	SENT_65	[p3l8t3667r133b3707],
9	used	VBN	O	use	_	0	SENT_65	[p3l161t3650r318b3708],
10	to	TO	O	to	aux	11	SENT_65	[p3l346t3657r414b3707],
11	exclude	VB	O	exclude	xcomp	9	SENT_65	[p3l444t3650r707b3708],
12	more	JJR	O	more	dobj	11	SENT_65	[p3l737t3667r915b3708],
13	seriously	RB	O	seriously	advmod	11	SENT_65	[p3l946t3650r1246b3726],
14	depressed	JJ	O	depressed	amod	15	SENT_65	[p3l1272t3650r1604b3726],
15	patients	NNS	O	patient	pobj	13	SENT_65	[p3l1632t3653r1923b3726],
16	,	,	O	,	_	0	SENT_65	[p3l1632t3653r1923b3726],
17	and	CC	O	and	_	0	SENT_65	[p3l1957t3650r2086b3707],
18	a	DT	O	a	det	20	SENT_65	[p3l2115t3667r2150b3707],
19	cutoff	JJ	O	cutoff	amod	20	SENT_65	[p3l10t3743r215b3800],
20	score	NN	NUMBER	score	nsubjpass	32	SENT_65	[p3l235t3760r407b3800],
21	of	IN	O	of	_	0	SENT_65	[p3l430t3743r500b3800],
22	<	JJR	O	<	amod	23	SENT_65	[p3l530t3759r578b3800],
23	2	CD	NUMBER	2	prep_of	20	SENT_65	[p3l593t3745r632b3800],
24	on	IN	O	on	_	0	SENT_65	[p3l655t3760r745b3800],
25	the	DT	O	the	det	27	SENT_65	[p3l767t3744r877b3800],
26	suicide	NN	O	suicide	nn	27	SENT_65	[p3l902t3744r1136b3800],
27	item	NN	O	item	prep_on	23	SENT_65	[p3l1160t3746r1316b3800],
28	of	IN	O	of	_	0	SENT_65	[p3l1339t3743r1409b3800],
29	the	DT	O	the	det	30	SENT_65	[p3l1427t3744r1537b3800],
30	HAM-D	NN	O	ham-d	prep_of	23	SENT_65	[p3l1561t3745r1825b3800],
31	was	VBD	O	be	auxpass	32	SENT_65	[p3l1845t3760r1971b3800],
32	used	VBN	O	use	conj_and	9	SENT_65	[p3l1993t3743r2150b3800],
33	to	TO	O	to	aux	34	SENT_65	[p4l9t36r78b86],
34	exclude	VB	O	exclude	xcomp	32	SENT_65	[p4l102t29r364b86],
35	suicidal	JJ	O	suicidal	amod	36	SENT_65	[p4l390t28r648b86],
36	patients	NNS	O	patient	dobj	34	SENT_65	[p4l671t31r962b104],
37	.	.	O	.	_	0	SENT_65	[p4l671t31r962b104],

1	Patient	NN	O	patient	nn	2	SENT_66	[p4l991t31r1232b86],
2	health	NN	O	health	nsubjpass	4	SENT_66	[p4l1255t28r1476b86],
3	was	VBD	O	be	auxpass	4	SENT_66	[p4l1496t45r1622b86],
4	determined	VBN	O	determine	_	0	SENT_66	[p4l1647t28r2044b86],
5	by	IN	O	by	_	0	SENT_66	[p4l2065t28r2151b104],
6	physical	JJ	O	physical	amod	7	SENT_66	[p4l9t124r292b200],
7	examination	NN	O	examination	agent	4	SENT_66	[p4l351t127r807b194],
8	,	,	O	,	_	0	SENT_66	[p4l351t127r807b194],
9	medical	JJ	O	medical	amod	10	SENT_66	[p4l871t124r1141b182],
10	history	NN	O	history	appos	7	SENT_66	[p4l1201t124r1452b200],
11	,	,	O	,	_	0	SENT_66	[p4l1201t124r1452b200],
12	and	CC	O	and	_	0	SENT_66	[p4l1517t124r1646b182],
13	if	IN	O	if	conj_and	4	SENT_66	[p4l1704t124r1754b181],
14	necessary	JJ	O	necessary	dep	13	SENT_66	[p4l1809t141r2145b200],
15	,	,	O	,	_	0	SENT_66	[p4l1809t141r2145b200],
16	laboratory	NN	O	laboratory	nn	17	SENT_66	[p4l9t219r366b294],
17	tests	NNS	O	test	dep	13	SENT_66	[p4l392t226r540b276],
18	and	CC	O	and	_	0	SENT_66	[p4l570t219r700b276],
19	electrocardiogram	NN	O	electrocardiogram	dep	13	SENT_66	[p4l728t219r1367b294],
20	.	.	O	.	_	0	SENT_66	[p4l728t219r1367b294],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_67	[p4l87t314r428b371],
2	criteria	NNS	O	criterion	nsubj	9	SENT_67	[p4l486t317r732b371],
3	were	VBD	O	be	cop	9	SENT_67	[p4l786t330r950b371],
4	any	DT	O	any	det	9	SENT_67	[p4l1008t330r1137b389],
5	current	JJ	DATE	current	amod	9	SENT_67	[p4l1191t321r1448b371],
6	anxiety	NN	O	anxiety	nn	9	SENT_67	[p4l1505t317r1769b389],
7	spectrum	NN	O	spectrum	nn	9	SENT_67	[p4l1824t321r2149b389],
8	DSM-IV	NN	O	dsm-iv	nn	9	SENT_67	[p4l10t411r286b467],
9	diagnosis	NN	O	diagnosis	_	0	SENT_67	[p4l327t409r654b485],
10	at	IN	O	at	_	0	SENT_67	[p4l698t416r761b467],
11	the	DT	O	the	det	12	SENT_67	[p4l803t409r915b467],
12	threshold	NN	O	threshold	prep_at	9	SENT_67	[p4l958t409r1298b467],
13	but	CC	O	but	_	0	SENT_67	[p4l1338t409r1457b467],
14	not	RB	O	not	neg	15	SENT_67	[p4l1499t417r1619b467],
15	sub-threshold	JJ	O	sub-threshold	conj_but	9	SENT_67	[p4l1663t409r2149b467],

1	Table	NNP	O	Table	_	0	SENT_68	[p4l9t548r101b576],
2	1	CD	NUMBER	1	num	5	SENT_68	[p4l118t549r129b575],
3	Positive	JJ	O	positive	amod	5	SENT_68	[p4l175t549r298b576],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_68	[p4l314t549r600b584],
5	studies	NNS	O	study	dep	1	SENT_68	[p4l614t549r727b576],
6	of	IN	O	of	_	0	SENT_68	[p4l741t549r774b576],
7	the	DT	O	the	det	10	SENT_68	[p4l786t549r839b576],
8	HTR2A	NN	O	htr2a	nn	10	SENT_68	[p4l855t550r964b576],
9	SNP	NN	O	snp	nn	10	SENT_68	[p4l978t550r1043b576],
10	rs7997012	NN	O	rs7997012	prep_of	5	SENT_68	[p4l1058t549r1226b576],

1	Study	NN	O	study	nn	3	SENT_69	[p4l10t682r160b744],
2	Phenotype	NN	O	phenotype	nn	3	SENT_69	[p4l616t682r890b745],
3	N	NN	O	n	_	0	SENT_69	[p4l1147t684r1187b729],
4	Antidepressant	JJ	O	antidepressant	amod	6	SENT_69	[p4l1320t682r1714b745],
5	Ethnicity	NN	O	ethnicity	nn	6	SENT_69	[p4l1829t682r2054b744],
6	treatment	NN	O	treatment	dep	3	SENT_69	[p4l1325t765r1584b806],

1	McMahon	NNP	PERSON	McMahon	_	0	SENT_70	[p4l11t931r289b979],
2	et	FW	O	et	nn	5	SENT_70	[p4l319t937r367b979],
3	al.	FW	O	al.	nn	5	SENT_70	[p4l389t925r504b979],
4	‘	FW	O	‘	nn	5	SENT_70	[p4l389t925r504b979],
5	°	FW	O	°	dep	1	SENT_70	[p4l389t925r504b979],
6	MDD	NN	O	mdd	nn	9	SENT_70	[p4l617t933r760b978],
7	1953	CD	DATE	1953	num	9	SENT_70	[p4l1100t933r1235b979],
8	Citalopram	NNP	O	Citalopram	nn	9	SENT_70	[p4l1322t931r1625b994],
9	Mixed	NNP	O	Mixed	dep	1	SENT_70	[p4l1830t931r1996b979],

1	(	RB	O	(	dep	3	SENT_71	[p4l615t1008r868b1067],
2	STAR	NN	O	star	nn	3	SENT_71	[p4l615t1008r868b1067],
3	*	NN	O	*	dep	4	SENT_71	[p4l615t1008r868b1067],
4	D	NN	O	d	_	0	SENT_71	[p4l615t1008r868b1067],
5	)	CD	NUMBER	)	num	4	SENT_71	[p4l615t1008r868b1067],

1	Peters	NNP	PERSON	Peters	_	0	SENT_72	[p4l11t1165r170b1211],
2	et	FW	O	et	nn	3	SENT_72	[p4l196t1169r245b1211],
3	al.	FW	O	al.	dep	1	SENT_72	[p4l268t1157r381b1211],
4	28	CD	NUMBER	28	num	5	SENT_72	[p4l268t1157r381b1211],
5	MDD	NN	O	mdd	dep	3	SENT_72	[p4l617t1165r760b1210],
6	1953	CD	DATE	1953	num	8	SENT_72	[p4l1101t1165r1235b1211],
7	Citalopram	NNP	O	Citalopram	nn	8	SENT_72	[p4l1322t1163r1625b1226],
8	Mixed	NNP	O	Mixed	dep	1	SENT_72	[p4l1830t1163r1996b1211],

1	(	RB	O	(	dep	3	SENT_73	[p4l615t1241r868b1300],
2	STAR	NN	O	star	nn	3	SENT_73	[p4l615t1241r868b1300],
3	*	NN	O	*	dep	4	SENT_73	[p4l615t1241r868b1300],
4	D	NN	O	d	_	0	SENT_73	[p4l615t1241r868b1300],
5	)	CD	NUMBER	)	num	4	SENT_73	[p4l615t1241r868b1300],

1	Lucae	NNP	O	Lucae	_	0	SENT_74	[p4l11t1319r163b1365],
2	et	FW	O	et	dep	1	SENT_74	[p4l191t1323r239b1365],
3	al.	FW	O	al.	nn	5	SENT_74	[p4l261t1311r376b1365],
4	”	FW	O	”	nn	5	SENT_74	[p4l261t1311r376b1365],
5	MDD	NN	O	mdd	npadvmod	12	SENT_74	[p4l617t1319r760b1364],
6	(	CD	PERCENT	(	number	7	SENT_74	[p4l787t1317r956b1376],
7	85	CD	PERCENT	85	num	8	SENT_74	[p4l787t1317r956b1376],
8	%	NN	PERCENT	%	npadvmod	11	SENT_74	[p4l787t1317r956b1376],
9	)	CD	NUMBER	)	number	10	SENT_74	[p4l787t1317r956b1376],
10	186	CD	NUMBER	186	num	8	SENT_74	[p4l1136t1318r1236b1365],
11	Various	JJ	O	various	amod	5	SENT_74	[p4l1319t1318r1520b1365],
12	European	JJ	MISC	european	amod	2	SENT_74	[p4l1830t1319r2083b1380],

1	Bipolar	JJ	O	bipolar	amod	2	SENT_75	[p4l617t1394r805b1456],
2	(	NN	O	(	_	0	SENT_75	[p4l829t1394r998b1453],
3	15	CD	PERCENT	15	num	4	SENT_75	[p4l829t1394r998b1453],
4	%	NN	PERCENT	%	dep	2	SENT_75	[p4l829t1394r998b1453],
5	)	CD	NUMBER	)	dep	2	SENT_75	[p4l829t1394r998b1453],

1	Horstmann	NNP	PERSON	Horstmann	dep	7	SENT_76	[p4l11t1473r311b1519],
2	et	FW	O	et	dep	1	SENT_76	[p4l340t1477r389b1519],
3	al.	FW	O	al.	nn	4	SENT_76	[p4l412t1466r525b1519],
4	‘	FW	O	‘	dep	2	SENT_76	[p4l412t1466r525b1519],
5	3	CD	NUMBER	3	num	6	SENT_76	[p4l412t1466r525b1519],
6	MDD	NN	ORGANIZATION	mdd	dep	7	SENT_76	[p4l617t1473r760b1518],
7	305	CD	NUMBER	305	_	0	SENT_76	[p4l1136t1473r1234b1519],
8	Various	JJ	O	various	amod	9	SENT_76	[p4l1319t1472r1520b1519],
9	European	JJ	MISC	european	dep	7	SENT_76	[p4l1830t1473r2083b1534],

1	Lohoff	NNP	O	Lohoff	dep	9	SENT_77	[p4l11t1627r182b1675],
2	et	FW	O	et	nn	3	SENT_77	[p4l207t1633r255b1675],
3	al.	FW	O	al.	dep	1	SENT_77	[p4l277t1627r353b1685],
4	,	,	O	,	_	0	SENT_77	[p4l277t1627r353b1685],
5	GAD	NN	O	gad	appos	3	SENT_77	[p4l615t1629r741b1675],
6	112	CD	NUMBER	112	dep	9	SENT_77	[p4l1136t1629r1235b1674],
7	Venlafaxine	NNP	O	Venlafaxine	nn	9	SENT_77	[p4l1319t1627r1637b1675],
8	XR	NNP	O	XR	nn	9	SENT_77	[p4l1662t1629r1735b1675],
9	European	NNP	MISC	European	dep	16	SENT_77	[p4l1830t1629r2083b1690],
10	present	JJ	DATE	present	amod	14	SENT_77	[p4l10t1709r212b1766],
11	study	NN	O	study	nn	14	SENT_77	[p4l234t1704r383b1766],
12	Trial	NN	O	trial	nn	14	SENT_77	[p4l36t1789r148b1836],
13	length	NN	O	length	nn	14	SENT_77	[p4l169t1789r330b1851],
14	Results	NNS	O	result	dep	9	SENT_77	[p4l382t1789r557b1836],
15	OR	NN	O	or	nn	16	SENT_77	[p4l1009t1791r1082b1836],
16	OR	NN	O	or	_	0	SENT_77	[p4l1564t1791r1638b1836],
17	dominant	JJ	O	dominant	amod	20	SENT_77	[p4l1662t1789r1914b1836],
18	model	NN	O	model	nn	20	SENT_77	[p4l1936t1789r2095b1836],
19	(	NN	O	(	nn	20	SENT_77	[p4l85t1874r276b1932],
20	weeks	NNS	DURATION	week	nsubj	21	SENT_77	[p4l85t1874r276b1932],
21	)	VBP	O	)	rcmod	16	SENT_77	[p4l85t1874r276b1932],
22	GG+GA	NN	O	gg+ga	dobj	21	SENT_77	[p4l1564t1875r1763b1920],
23	vs	CC	O	vs	_	0	SENT_77	[p4l1789t1888r1837b1920],
24	AA	NN	O	aa	conj_vs	22	SENT_77	[p4l1858t1876r1927b1920],

1	12	CD	NUMBER	12	num	2	SENT_78	[p4l148t2044r211b2089],
2	A/A	NN	O	a/a	_	0	SENT_78	[p4l377t2043r673b2096],
3	=	JJ	O	=	amod	8	SENT_78	[p4l377t2043r673b2096],
4	18	CD	PERCENT	18	number	5	SENT_78	[p4l377t2043r673b2096],
5	%	NN	PERCENT	%	amod	8	SENT_78	[p4l377t2043r673b2096],
6	reduction	NN	O	reduction	nn	8	SENT_78	[p4l699t2043r954b2090],
7	2.26	CD	NUMBER	2.26	num	8	SENT_78	[p4l1006t2045r1125b2090],
8	response	NN	O	response	dep	2	SENT_78	[p4l1152t2057r1386b2105],
9	*	CD	NUMBER	*	num	11	SENT_78	[p4l1561t2043r1898b2090],
10	Unavailab	NNP	O	Unavailab	nn	11	SENT_78	[p4l1561t2043r1898b2090],
11	|	NN	O	|	npadvmod	2	SENT_78	[p4l1561t2043r1898b2090],
12	e	SYM	O	e	dep	11	SENT_78	[p4l1561t2043r1898b2090],
13	in	IN	O	in	_	0	SENT_78	[p4l381t2120r425b2165],
14	risk	NN	O	risk	prep_in	2	SENT_78	[p4l454t2119r539b2165],
15	for	IN	O	for	dep	2	SENT_78	[p4l560t2119r635b2165],
16	being	VBG	O	be	cop	17	SENT_78	[p4l660t2119r807b2180],
17	nonresponder	JJ	O	nonresponder	pcomp	15	SENT_78	[p4l382t2196r761b2257],

1	12	CD	NUMBER	12	num	2	SENT_79	[p4l149t2274r211b2318],
2	A-allele	NN	O	a-allele	_	0	SENT_79	[p4l378t2272r574b2319],
3	associated	VBN	O	associate	partmod	2	SENT_79	[p4l598t2272r871b2319],
4	1.43	CD	NUMBER	1.43	num	5	SENT_79	[p4l1008t2274r1123b2319],
5	response	NN	O	response	nsubj	8	SENT_79	[p4l1152t2286r1386b2334],
6	*	CD	NUMBER	*	num	8	SENT_79	[p4l1561t2272r1898b2319],
7	Unavailab	NNP	O	Unavailab	nn	8	SENT_79	[p4l1561t2272r1898b2319],
8	|	NN	O	|	xcomp	3	SENT_79	[p4l1561t2272r1898b2319],
9	e	SYM	O	e	dep	2	SENT_79	[p4l1561t2272r1898b2319],

1	1.52	CD	NUMBER	1.52	num	2	SENT_80	[p4l1008t2350r1124b2395],
2	remission	NN	O	remission	_	0	SENT_80	[p4l1152t2349r1401b2395],

1	6	CD	NUMBER	6	num	2	SENT_81	[p4l182t2425r212b2471],
2	G-allele	NN	O	g-allele	nsubj	3	SENT_81	[p4l381t2424r581b2471],
3	associated	VBN	O	associate	_	0	SENT_81	[p4l606t2424r879b2471],
4	1.31	CD	NUMBER	1.31	num	5	SENT_81	[p4l1008t2425r1113b2471],
5	remission	NN	O	remission	nsubj	7	SENT_81	[p4l1152t2425r1401b2471],
6	5.99	CD	NUMBER	5.99	num	7	SENT_81	[p4l1561t2425r1680b2471],
7	remission	NN	O	remission	xcomp	3	SENT_81	[p4l1708t2425r1957b2471],
8	with	IN	O	with	_	0	SENT_81	[p4l378t2500r494b2547],
9	better	JJR	O	better	amod	10	SENT_81	[p4l523t2500r684b2547],
10	outcome	NN	O	outcome	prep_with	7	SENT_81	[p4l706t2505r946b2547],

1	5	CD	NUMBER	5	nsubj	2	SENT_82	[p4l181t2578r210b2623],
2	G	NN	O	g	_	0	SENT_82	[p4l381t2576r581b2623],
3	—	CD	NUMBER	—	dobj	2	SENT_82	[p4l381t2576r581b2623],
4	a	DT	O	a	det	7	SENT_82	[p4l381t2576r581b2623],
5	|	NN	O	|	nn	7	SENT_82	[p4l381t2576r581b2623],
6	|	NN	O	|	nn	7	SENT_82	[p4l381t2576r581b2623],
7	ele	NN	O	ele	nsubj	8	SENT_82	[p4l381t2576r581b2623],
8	associated	VBN	O	associate	rcmod	3	SENT_82	[p4l606t2576r879b2623],
9	1.57	CD	NUMBER	1.57	num	10	SENT_82	[p4l1008t2578r1125b2623],
10	remission	NN	O	remission	nsubj	12	SENT_82	[p4l1152t2577r1401b2623],
11	2.07	CD	NUMBER	2.07	num	12	SENT_82	[p4l1561t2578r1680b2623],
12	remission	NN	O	remission	xcomp	8	SENT_82	[p4l1708t2577r1957b2623],
13	with	IN	O	with	_	0	SENT_82	[p4l378t2652r494b2699],
14	better	JJR	O	better	amod	15	SENT_82	[p4l523t2652r684b2699],
15	outcome	NN	O	outcome	prep_with	12	SENT_82	[p4l706t2658r946b2699],

1	24	CD	NUMBER	24	nsubj	2	SENT_83	[p4l146t2730r211b2774],
2	G	NN	O	g	_	0	SENT_83	[p4l381t2728r581b2775],
3	—	CD	NUMBER	—	dobj	2	SENT_83	[p4l381t2728r581b2775],
4	a	DT	O	a	det	7	SENT_83	[p4l381t2728r581b2775],
5	|	NN	O	|	nn	7	SENT_83	[p4l381t2728r581b2775],
6	|	NN	O	|	nn	7	SENT_83	[p4l381t2728r581b2775],
7	ele	NN	O	ele	nsubj	8	SENT_83	[p4l381t2728r581b2775],
8	associated	VBN	O	associate	rcmod	3	SENT_83	[p4l606t2728r879b2775],
9	1.50	CD	NUMBER	1.50	num	10	SENT_83	[p4l1008t2730r1125b2775],
10	response	NN	O	response	nsubj	12	SENT_83	[p4l1152t2742r1386b2790],
11	3.35	CD	NUMBER	3.35	num	12	SENT_83	[p4l1564t2730r1678b2775],
12	response	NN	O	response	xcomp	8	SENT_83	[p4l1708t2742r1942b2790],
13	with	IN	O	with	_	0	SENT_83	[p4l378t2804r494b2851],
14	better	JJR	O	better	amod	15	SENT_83	[p4l523t2804r684b2851],
15	outcome	NN	O	outcome	prep_with	12	SENT_83	[p4l706t2809r946b2851],
16	1.88	CD	NUMBER	1.88	num	17	SENT_83	[p4l1008t2805r1125b2851],
17	improvement	NN	O	improvement	dep	15	SENT_83	[p4l1152t2805r1518b2866],
18	4.98	CD	NUMBER	4.98	num	19	SENT_83	[p4l1560t2805r1680b2851],
19	improvement	NN	O	improvement	dep	17	SENT_83	[p4l1707t2805r2074b2865],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_84	[p4l9t2909r190b2931],
2	:	:	O	:	_	0	SENT_84	[p4l9t2909r190b2931],
3	GAD	NN	O	gad	dep	1	SENT_84	[p4l203t2909r269b2936],
4	,	,	O	,	_	0	SENT_84	[p4l203t2909r269b2936],
5	generalized	VBN	O	generalize	partmod	3	SENT_84	[p4l282t2909r427b2938],
6	anxiety	NN	O	anxiety	nn	7	SENT_84	[p4l439t2909r531b2938],
7	disorder	NN	O	disorder	dobj	5	SENT_84	[p4l542t2909r651b2936],
8	;	:	O	;	_	0	SENT_84	[p4l542t2909r651b2936],
9	MDD	NN	ORGANIZATION	mdd	dep	1	SENT_84	[p4l666t2910r740b2936],
10	,	,	O	,	_	0	SENT_84	[p4l666t2910r740b2936],
11	major	JJ	O	major	amod	13	SENT_84	[p4l754t2909r826b2938],
12	depressive	JJ	O	depressive	amod	13	SENT_84	[p4l837t2909r967b2938],
13	disorder	NN	O	disorder	appos	9	SENT_84	[p4l979t2909r1089b2936],
14	;	:	O	;	_	0	SENT_84	[p4l979t2909r1089b2936],
15	OR	NN	O	or	dep	1	SENT_84	[p4l1102t2909r1146b2936],
16	,	,	O	,	_	0	SENT_84	[p4l1102t2909r1146b2936],
17	odds	NNS	O	odds	nn	18	SENT_84	[p4l1159t2909r1219b2931],
18	ratio	NN	O	ratio	appos	15	SENT_84	[p4l1232t2909r1294b2936],
19	;	:	O	;	_	0	SENT_84	[p4l1232t2909r1294b2936],
20	SNP	NN	ORGANIZATION	snp	dep	1	SENT_84	[p4l1308t2909r1366b2936],
21	,	,	O	,	_	0	SENT_84	[p4l1308t2909r1366b2936],
22	single	JJ	O	single	amod	24	SENT_84	[p4l1379t2909r1451b2938],
23	nucleotide	NN	O	nucleotide	nn	24	SENT_84	[p4l1464t2909r1596b2931],
24	polymorphism	NN	O	polymorphism	appos	20	SENT_84	[p4l1609t2909r1799b2938],
25	.	.	O	.	_	0	SENT_84	[p4l1609t2909r1799b2938],

1	*	RB	O	*	advmod	2	SENT_85	[p4l10t2950r20b2960],
2	Indicates	VBZ	O	indicate	_	0	SENT_85	[p4l33t2949r144b2971],
3	trend	NN	O	trend	nsubj	2	SENT_85	[p4l154t2949r221b2971],
4	since	IN	O	since	mark	7	SENT_85	[p4l234t2950r296b2971],
5	P	NN	O	p	nn	6	SENT_85	[p4l309t2950r323b2971],
6	value	NN	O	value	nsubj	7	SENT_85	[p4l331t2949r397b2971],
7	is	VBZ	O	be	dep	3	SENT_85	[p4l410t2950r426b2971],
8	slightly	RB	O	slightly	advmod	7	SENT_85	[p4l437t2949r527b2978],
9	above	IN	O	above	_	0	SENT_85	[p4l538t2949r613b2971],
10	0.05	CD	NUMBER	0.05	prep_above	7	SENT_85	[p4l625t2950r688b2971],
11	.	.	O	.	_	0	SENT_85	[p4l625t2950r688b2971],

1	The	DT	O	the	det	4	SENT_86	[p4l9t3072r59b3094],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	4	SENT_86	[p4l72t3072r336b3101],
3	Journal	NNP	O	Journal	nn	4	SENT_86	[p4l347t3072r441b3099],
4	level	NN	O	level	_	0	SENT_86	[p4l9t3255r189b3325],
5	,	,	O	,	_	0	SENT_86	[p4l9t3255r189b3325],
6	current	JJ	DATE	current	amod	9	SENT_86	[p4l240t3262r497b3313],
7	or	CC	O	or	_	0	SENT_86	[p4l543t3272r615b3312],
8	past	JJ	DATE	past	amod	9	SENT_86	[p4l660t3262r802b3331],
9	history	NN	O	history	appos	4	SENT_86	[p4l848t3255r1098b3331],
10	of	IN	O	of	_	0	SENT_86	[p4l1143t3255r1214b3312],
11	bipolar	JJ	O	bipolar	amod	12	SENT_86	[p4l1254t3255r1506b3331],
12	disorder	NN	O	disorder	prep_of	9	SENT_86	[p4l1552t3255r1852b3325],
13	,	,	O	,	_	0	SENT_86	[p4l1552t3255r1852b3325],
14	schizophrenia	NN	O	schizophrenia	conj_or	12	SENT_86	[p4l1905t3255r2147b3313, p4l8t3350r299b3425],
15	,	,	O	,	_	0	SENT_86	[p4l1905t3255r2147b3313, p4l8t3350r299b3425],
16	other	JJ	O	other	amod	18	SENT_86	[p4l335t3349r523b3407],
17	psychotic	JJ	O	psychotic	amod	18	SENT_86	[p4l552t3350r892b3425],
18	disorders	NNS	O	disorder	conj_or	12	SENT_86	[p4l922t3349r1237b3407],
19	or	CC	O	or	_	0	SENT_86	[p4l1268t3366r1340b3407],
20	dementia	NN	O	dementia	prep_of	9	SENT_86	[p4l1369t3350r1720b3407],
21	.	.	O	.	_	0	SENT_86	[p4l1369t3350r1720b3407],

1	An	DT	O	a	det	2	SENT_87	[p4l1753t3351r1854b3406],
2	episode	NN	O	episode	nsubj	35	SENT_87	[p4l1883t3350r2147b3425],
3	of	IN	O	of	_	0	SENT_87	[p5l9t17r81b74],
4	major	JJ	O	major	amod	5	SENT_87	[p5l105t20r313b93],
5	depression	NN	O	depression	prep_of	2	SENT_87	[p5l341t17r717b93],
6	in	IN	O	in	_	0	SENT_87	[p5l746t20r816b74],
7	the	DT	DURATION	the	det	10	SENT_87	[p5l845t17r957b75],
8	previous	JJ	DURATION	previous	amod	10	SENT_87	[p5l986t20r1286b93],
9	6	CD	DURATION	6	num	10	SENT_87	[p5l1318t19r1355b74],
10	months	NNS	NUMBER	month	prep_in	5	SENT_87	[p5l1384t17r1658b75],
11	or	CC	O	or	_	0	SENT_87	[p5l1688t34r1759b74],
12	depressive	JJ	O	depressive	amod	13	SENT_87	[p5l1788t17r2148b93],
13	symptomatology	NN	O	symptomatology	conj_or	5	SENT_87	[p5l10t112r612b188],
14	at	IN	O	at	_	0	SENT_87	[p5l665t119r728b170],
15	intake	NN	O	intake	nn	17	SENT_87	[p5l782t112r1000b170],
16	(	CD	NUMBER	(	num	17	SENT_87	[p5l1058t112r1416b184],
17	HAM-D	NN	O	ham-d	prep_at	13	SENT_87	[p5l1058t112r1416b184],
18	>	JJR	O	>	dep	5	SENT_87	[p5l1058t112r1416b184],
19	18	CD	NUMBER	18	num	20	SENT_87	[p5l1438t112r1560b184],
20	)	NN	O	)	dep	18	SENT_87	[p5l1438t112r1560b184],
21	,	,	O	,	_	0	SENT_87	[p5l1438t112r1560b184],
22	and	CC	O	and	_	0	SENT_87	[p5l1620t112r1751b170],
23	substance	NN	O	substance	nn	24	SENT_87	[p5l1807t112r2147b170],
24	abuse	NN	O	abuse	prep_of	2	SENT_87	[p5l9t207r204b264],
25	or	CC	O	or	_	0	SENT_87	[p5l232t223r303b264],
26	dependence	NN	O	dependence	conj_and	5	SENT_87	[p5l329t206r753b282],
27	during	IN	O	during	_	0	SENT_87	[p5l781t207r1016b282],
28	the	DT	DURATION	the	det	31	SENT_87	[p5l1041t206r1153b264],
29	past	JJ	DURATION	past	amod	31	SENT_87	[p5l1180t214r1322b282],
30	6	CD	DURATION	6	num	31	SENT_87	[p5l1350t208r1387b264],
31	months	NNS	NUMBER	month	prep_during	24	SENT_87	[p5l1414t206r1687b264],
32	were	VBD	O	be	cop	35	SENT_87	[p5l1712t223r1875b264],
33	further	JJ	O	further	amod	35	SENT_87	[p5l1903t206r2150b264],
34	exclusion	NN	O	exclusion	nn	35	SENT_87	[p5l9t302r346b360],
35	criteria	NNS	O	criterion	_	0	SENT_87	[p5l386t305r650b360],
36	.	.	O	.	_	0	SENT_87	[p5l386t305r650b360],

1	Occasional	JJ	O	occasional	amod	3	SENT_88	[p5l695t302r1079b360],
2	recreational	JJ	O	recreational	amod	3	SENT_88	[p5l1118t302r1537b360],
3	drug	NN	O	drug	nsubj	14	SENT_88	[p5l1578t302r1739b378],
4	or	CC	O	or	_	0	SENT_88	[p5l1778t319r1849b360],
5	alcohol	NN	O	alcohol	nn	6	SENT_88	[p5l1888t302r2148b360],
6	use	NN	O	use	conj_or	3	SENT_88	[p5l7t413r120b454],
7	was	VBD	O	be	cop	14	SENT_88	[p5l142t413r270b454],
8	not	RB	O	not	neg	11	SENT_88	[p5l294t404r415b454],
9	an	DT	O	a	det	11	SENT_88	[p5l439t413r524b454],
10	exclusion	NN	O	exclusion	nn	11	SENT_88	[p5l547t397r884b454],
11	criterion	NN	O	criterion	attr	14	SENT_88	[p5l908t400r1228b467],
12	,	,	O	,	_	0	SENT_88	[p5l908t400r1228b467],
13	thus	RB	O	thus	advmod	14	SENT_88	[p5l1256t397r1408b454],
14	allowing	VBG	O	allow	_	0	SENT_88	[p5l1433t397r1738b472],
15	our	PRP$	O	we	poss	16	SENT_88	[p5l1760t413r1879b454],
16	sample	NN	O	sample	dobj	14	SENT_88	[p5l1903t397r2147b472],
17	more	RBR	O	more	advmod	18	SENT_88	[p5l9t508r190b549],
18	closely	RB	O	closely	advmod	14	SENT_88	[p5l223t492r463b567],
19	to	TO	O	to	aux	20	SENT_88	[p5l493t499r562b549],
20	represent	VB	O	represent	xcomp	14	SENT_88	[p5l595t499r921b567],
21	GAD	NN	O	gad	nn	22	SENT_88	[p5l954t493r1121b549],
22	patients	NNS	O	patient	dobj	20	SENT_88	[p5l1153t495r1435b567],
23	in	IN	O	in	_	0	SENT_88	[p5l1468t495r1539b549],
24	the	DT	O	the	det	25	SENT_88	[p5l1571t492r1683b549],
25	community	NN	O	community	prep_in	20	SENT_88	[p5l1716t495r2144b567],
26	.	.	O	.	_	0	SENT_88	[p5l1716t495r2144b567],

1	Urine	NN	O	urine	nn	3	SENT_89	[p5l8t590r205b645],
2	drug	NN	O	drug	nn	3	SENT_89	[p5l251t587r412b663],
3	screens	NNS	O	screen	nsubjpass	14	SENT_89	[p5l455t604r704b645],
4	for	IN	O	for	_	0	SENT_89	[p5l749t587r847b645],
5	benzodiazepines	NNS	O	benzodiazepine	prep_for	3	SENT_89	[p5l887t587r1472b663],
6	(	CD	NUMBER	(	num	8	SENT_89	[p5l1520t587r1676b659],
7	BZ	NN	O	bz	nn	8	SENT_89	[p5l1520t587r1676b659],
8	)	NN	O	)	dep	5	SENT_89	[p5l1520t587r1676b659],
9	,	,	O	,	_	0	SENT_89	[p5l1520t587r1676b659],
10	opiates	NNS	O	opiate	prep_for	3	SENT_89	[p5l1726t590r1973b663],
11	and	CC	O	and	_	0	SENT_89	[p5l2018t587r2149b645],
12	tetrahydrocannabinol	NN	O	tetrahydrocannabinol	conj_and	5	SENT_89	[p5l9t682r786b758],
13	were	VBD	O	be	auxpass	14	SENT_89	[p5l823t699r987b740],
14	conducted	VBN	O	conduct	_	0	SENT_89	[p5l1027t682r1399b740],
15	at	IN	O	at	_	0	SENT_89	[p5l1438t689r1502b740],
16	regular	JJ	O	regular	amod	17	SENT_89	[p5l1539t682r1785b758],
17	intervals	NNS	O	interval	prep_at	14	SENT_89	[p5l1822t682r2144b740],
18	.	.	O	.	_	0	SENT_89	[p5l1822t682r2144b740],

1	Female	JJ	O	female	amod	2	SENT_90	[p5l9t777r255b835],
2	patients	NNS	O	patient	nsubjpass	17	SENT_90	[p5l284t780r566b853],
3	who	WP	O	who	nsubj	10	SENT_90	[p5l592t777r745b834],
4	were	VBD	O	be	cop	8	SENT_90	[p5l772t794r935b835],
5	pregnant	JJ	O	pregnant	amod	8	SENT_90	[p5l963t784r1301b853],
6	,	,	O	,	_	0	SENT_90	[p5l963t784r1301b853],
7	breast	NN	O	breast	dep	8	SENT_90	[p5l1331t777r1541b835],
8	feeding	NN	O	feeding	rcmod	2	SENT_90	[p5l1568t777r1829b853],
9	or	CC	O	or	_	0	SENT_90	[p5l1857t794r1928b834],
10	had	VBD	O	have	rcmod	2	SENT_90	[p5l1954t777r2086b834],
11	a	DT	O	a	det	15	SENT_90	[p5l2114t794r2149b834],
12	positive	JJ	O	positive	amod	15	SENT_90	[p5l8t874r284b947],
13	urine	NN	O	urine	nn	15	SENT_90	[p5l311t874r497b929],
14	pregnancy	NN	O	pregnancy	nn	15	SENT_90	[p5l525t888r900b947],
15	test	NN	O	test	dobj	10	SENT_90	[p5l925t879r1049b929],
16	were	VBD	O	be	auxpass	17	SENT_90	[p5l1075t888r1238b929],
17	excluded	VBN	O	exclude	_	0	SENT_90	[p5l1269t871r1603b929],
18	.	.	O	.	_	0	SENT_90	[p5l1269t871r1603b929],

1	Fertile	JJ	O	fertile	amod	2	SENT_91	[p5l1636t872r1853b929],
2	females	NNS	O	female	nsubj	3	SENT_91	[p5l1883t871r2148b929],
3	had	VBD	O	have	_	0	SENT_91	[p5l9t967r140b1024],
4	to	TO	O	to	aux	5	SENT_91	[p5l182t974r251b1024],
5	use	VB	O	use	xcomp	3	SENT_91	[p5l293t984r405b1025],
6	an	DT	O	a	det	9	SENT_91	[p5l449t984r534b1024],
7	accepted	VBN	O	accept	amod	9	SENT_91	[p5l576t967r883b1043],
8	contraceptive	NN	O	contraceptive	nn	9	SENT_91	[p5l926t970r1406b1043],
9	method	NN	O	method	dobj	5	SENT_91	[p5l1449t967r1743b1037],
10	,	,	O	,	_	0	SENT_91	[p5l1449t967r1743b1037],
11	and	CC	O	and	_	0	SENT_91	[p5l1791t967r1922b1024],
12	urine	NN	O	urine	nn	14	SENT_91	[p5l1962t970r2148b1025],
13	pregnancy	NN	O	pregnancy	nn	14	SENT_91	[p5l8t1079r382b1138],
14	tests	NNS	O	test	nsubjpass	16	SENT_91	[p5l404t1069r557b1120],
15	were	VBD	O	be	auxpass	16	SENT_91	[p5l580t1079r743b1120],
16	performed	VBN	O	perform	conj_and	3	SENT_91	[p5l768t1062r1137b1138],
17	at	IN	O	at	_	0	SENT_91	[p5l1162t1069r1226b1120],
18	regular	JJ	O	regular	amod	19	SENT_91	[p5l1249t1062r1495b1138],
19	intervals	NNS	O	interval	prep_at	16	SENT_91	[p5l1518t1062r1840b1120],
20	.	.	O	.	_	0	SENT_91	[p5l1518t1062r1840b1120],

1	Patients	NNS	O	patient	nsubjpass	14	SENT_92	[p5l1870t1065r2148b1120],
2	on	IN	O	on	_	0	SENT_92	[p5l9t1173r100b1214],
3	a	DT	O	a	det	6	SENT_92	[p5l132t1173r167b1214],
4	low	JJ	O	low	amod	6	SENT_92	[p5l197t1156r325b1214],
5	daily	JJ	SET	daily	amod	6	SENT_92	[p5l355t1156r528b1232],
6	dose	NN	O	dose	prep_on	1	SENT_92	[p5l557t1156r712b1214],
7	of	IN	O	of	_	0	SENT_92	[p5l745t1156r816b1214],
8	BZ	NN	O	bz	nn	9	SENT_92	[p5l843t1159r932b1213],
9	anxiolytics	NNS	O	anxiolytic	prep_of	6	SENT_92	[p5l963t1157r1347b1232],
10	or	CC	O	or	_	0	SENT_92	[p5l1379t1173r1451b1214],
11	on	IN	O	on	_	0	SENT_92	[p5l1482t1173r1573b1214],
12	hypnotics	NNS	O	hypnotic	prep_on	1	SENT_92	[p5l1603t1156r1954b1232],
13	were	VBD	O	be	auxpass	14	SENT_92	[p5l1984t1173r2147b1214],
14	allowed	VBN	O	allow	_	0	SENT_92	[p5l9t1252r283b1310],
15	to	TO	O	to	aux	16	SENT_92	[p5l325t1259r395b1310],
16	enter	VB	O	enter	xcomp	14	SENT_92	[p5l439t1259r621b1310],
17	the	DT	O	the	det	18	SENT_92	[p5l663t1252r776b1310],
18	trial	NN	O	trial	dobj	16	SENT_92	[p5l820t1252r978b1322],
19	,	,	O	,	_	0	SENT_92	[p5l820t1252r978b1322],
20	and	CC	O	and	_	0	SENT_92	[p5l1027t1252r1158b1310],
21	were	VBD	O	be	auxpass	22	SENT_92	[p5l1199t1269r1363b1310],
22	tapered	VBN	O	taper	conj_and	14	SENT_92	[p5l1407t1252r1670b1328],
23	off	RP	O	off	prt	22	SENT_92	[p5l1713t1252r1811b1310],
24	their	PRP$	O	they	poss	25	SENT_92	[p5l1850t1252r2018b1310],
25	BZ	NN	O	bz	dobj	22	SENT_92	[p5l2061t1255r2149b1309],
26	during	IN	O	during	_	0	SENT_92	[p5l9t1347r244b1422],
27	the	DT	DURATION	the	det	30	SENT_92	[p5l279t1347r392b1404],
28	first	JJ	DURATION	first	amod	30	SENT_92	[p5l429t1346r565b1404],
29	12	CD	DURATION	12	num	30	SENT_92	[p5l607t1348r685b1404],
30	weeks	NNS	NUMBER	week	prep_during	22	SENT_92	[p5l719t1347r927b1404],
31	of	IN	O	of	_	0	SENT_92	[p5l965t1346r1037b1404],
32	VEN	NNP	O	VEN	nn	33	SENT_92	[p5l1067t1349r1226b1404],
33	treatment	NN	O	treatment	prep_of	30	SENT_92	[p5l1260t1354r1629b1404],
34	.	.	O	.	_	0	SENT_92	[p5l1260t1354r1629b1404],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_93	[p5l1670t1349r1948b1404],
2	were	VBD	O	be	auxpass	3	SENT_93	[p5l1984t1363r2148b1404],
3	recruited	VBN	O	recruit	_	0	SENT_93	[p5l9t1442r324b1499],
4	at	IN	O	at	_	0	SENT_93	[p5l357t1449r420b1499],
5	the	DT	O	the	det	6	SENT_93	[p5l452t1442r564b1499],
6	University	NNP	ORGANIZATION	University	prep_at	3	SENT_93	[p5l598t1444r967b1517],
7	of	IN	ORGANIZATION	of	_	0	SENT_93	[p5l998t1441r1069b1499],
8	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	nn	10	SENT_93	[p5l1098t1442r1568b1517],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_93	[p5l1599t1442r1878b1499],
10	Center	NNP	ORGANIZATION	Center	prep_of	6	SENT_93	[p5l1912t1443r2150b1499],
11	with	IN	O	with	_	0	SENT_93	[p5l7t1537r168b1595],
12	approval	NN	O	approval	prep_with	10	SENT_93	[p5l215t1537r522b1613],
13	and	CC	O	and	_	0	SENT_93	[p5l570t1537r701b1595],
14	oversight	NN	O	oversight	conj_and	12	SENT_93	[p5l748t1537r1074b1613],
15	by	IN	O	by	_	0	SENT_93	[p5l1119t1537r1206b1613],
16	the	DT	O	the	det	19	SENT_93	[p5l1250t1537r1362b1595],
17	Institutional	JJ	ORGANIZATION	institutional	amod	19	SENT_93	[p5l1411t1537r1854b1595],
18	Review	NNP	ORGANIZATION	Review	nn	19	SENT_93	[p5l1902t1540r2151b1595],
19	Board	NNP	ORGANIZATION	Board	agent	3	SENT_93	[p5l9t1632r212b1689],
20	of	IN	ORGANIZATION	of	_	0	SENT_93	[p5l245t1632r317b1689],
21	the	DT	ORGANIZATION	the	det	22	SENT_93	[p5l345t1632r457b1690],
22	University	NNP	ORGANIZATION	University	prep_of	19	SENT_93	[p5l491t1634r860b1708],
23	of	IN	ORGANIZATION	of	_	0	SENT_93	[p5l890t1632r962b1689],
24	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	prep_of	22	SENT_93	[p5l991t1632r1479b1708],
25	.	.	O	.	_	0	SENT_93	[p5l991t1632r1479b1708],

1	Written	VBN	O	write	csubjpass	5	SENT_94	[p5l1515t1634r1787b1690],
2	informed	JJ	O	informed	amod	3	SENT_94	[p5l1820t1632r2149b1690],
3	consent	NN	O	consent	dobj	1	SENT_94	[p5l9t1735r286b1786],
4	was	VBD	O	be	auxpass	5	SENT_94	[p5l323t1745r451b1785],
5	obtained	VBN	O	obtain	_	0	SENT_94	[p5l490t1728r802b1786],
6	before	IN	O	before	_	0	SENT_94	[p5l838t1728r1057b1786],
7	performing	VBG	O	perform	prepc_before	5	SENT_94	[p5l1096t1728r1498b1804],
8	any	DT	O	any	det	10	SENT_94	[p5l1536t1745r1665b1804],
9	study	NN	O	study	nn	10	SENT_94	[p5l1702t1728r1894b1804],
10	procedures	NNS	O	procedure	dobj	7	SENT_94	[p5l1930t1745r2148b1804, p5l9t1822r215b1880],
11	.	.	O	.	_	0	SENT_94	[p5l1930t1745r2148b1804, p5l9t1822r215b1880],

1	After	IN	O	after	_	0	SENT_95	[p5l243t1822r417b1880],
2	the	DT	O	the	det	4	SENT_95	[p5l441t1823r553b1880],
3	4	CD	NUMBER	4	num	4	SENT_95	[p5l581t1824r744b1880],
4	—	NN	O	—	prep_after	13	SENT_95	[p5l581t1824r744b1880],
5	28	CD	DURATION	28	num	6	SENT_95	[p5l581t1824r744b1880],
6	days	NNS	NUMBER	day	tmod	4	SENT_95	[p5l772t1823r925b1898],
7	screening	JJ	O	screening	amod	8	SENT_95	[p5l953t1825r1289b1898],
8	period	NN	O	period	tmod	13	SENT_95	[p5l1312t1822r1556b1898],
9	,	,	O	,	_	0	SENT_95	[p5l1312t1822r1556b1898],
10	eligible	JJ	O	eligible	amod	11	SENT_95	[p5l1587t1822r1840b1898],
11	patients	NNS	O	patient	nsubjpass	13	SENT_95	[p5l1866t1825r2148b1898],
12	were	VBD	O	be	auxpass	13	SENT_95	[p5l7t1935r170b1976],
13	started	VBN	O	start	_	0	SENT_95	[p5l203t1918r440b1976],
14	on	IN	O	on	_	0	SENT_95	[p5l470t1935r561b1975],
15	VEN	NNP	O	VEN	nn	17	SENT_95	[p5l590t1920r748b1975],
16	37.5	CD	NUMBER	37.5	num	17	SENT_95	[p5l779t1919r923b1976],
17	mg	NN	O	mg	prep_on	13	SENT_95	[p5l944t1935r1056b1994],
18	for	IN	O	for	_	0	SENT_95	[p5l1084t1918r1183b1975],
19	1	CD	DURATION	1	num	20	SENT_95	[p5l1218t1920r1247b1975],
20	week	NN	NUMBER	week	prep_for	13	SENT_95	[p5l1281t1918r1460b1976],
21	followed	VBN	O	follow	partmod	20	SENT_95	[p5l1488t1918r1795b1976],
22	by	IN	O	by	_	0	SENT_95	[p5l1823t1918r1910b1994],
23	75	CD	NUMBER	75	num	24	SENT_95	[p5l1943t1920r2018b1975],
24	mg	NN	O	mg	agent	21	SENT_95	[p5l2039t1935r2150b1994],
25	per	IN	O	per	_	0	SENT_95	[p5l8t2030r120b2089],
26	day	NN	DURATION	day	prep_per	24	SENT_95	[p5l146t2013r271b2089],
27	for	IN	O	for	_	0	SENT_95	[p5l295t2013r394b2071],
28	the	DT	O	the	det	30	SENT_95	[p5l420t2013r532b2071],
29	second	JJ	ORDINAL	second	amod	30	SENT_95	[p5l561t2013r805b2071],
30	week	NN	DURATION	week	prep_for	26	SENT_95	[p5l829t2013r1024b2071],
31	.	.	O	.	_	0	SENT_95	[p5l829t2013r1024b2071],

1	After	IN	O	after	_	0	SENT_96	[p5l1054t2013r1228b2071],
2	the	DT	O	the	det	4	SENT_96	[p5l1253t2013r1366b2071],
3	second	JJ	ORDINAL	second	amod	4	SENT_96	[p5l1395t2013r1639b2071],
4	week	NN	DURATION	week	prep_after	9	SENT_96	[p5l1663t2013r1858b2083],
5	,	,	O	,	_	0	SENT_96	[p5l1663t2013r1858b2083],
6	ﬂexible	JJ	O	ﬂexible	amod	7	SENT_96	[p5l1889t2013r2147b2071],
7	dosing	NN	O	dosing	nsubjpass	9	SENT_96	[p5l9t2107r244b2183],
8	was	VBD	O	be	auxpass	9	SENT_96	[p5l310t2124r438b2165],
9	used	VBN	O	use	_	0	SENT_96	[p5l507t2107r667b2165],
10	in	IN	O	in	_	0	SENT_96	[p5l736t2110r806b2164],
11	a	DT	O	a	det	12	SENT_96	[p5l876t2124r910b2165],
12	range	NN	O	range	prep_in	9	SENT_96	[p5l979t2124r1172b2183],
13	of	IN	O	of	_	0	SENT_96	[p5l1243t2107r1315b2165],
14	75-225	CD	NUMBER	75-225	num	15	SENT_96	[p5l1385t2109r1629b2165],
15	mg	NN	O	mg	prep_of	12	SENT_96	[p5l1650t2124r1761b2183],
16	per	IN	O	per	_	0	SENT_96	[p5l1828t2124r1940b2183],
17	day	NN	DURATION	day	prep_per	15	SENT_96	[p5l2009t2108r2144b2183],
18	.	.	O	.	_	0	SENT_96	[p5l2009t2108r2144b2183],

1	Every	DT	O	every	det	2	SENT_97	[p5l9t2206r204b2279],
2	attempt	NN	O	attempt	nsubjpass	4	SENT_97	[p5l233t2210r511b2279],
3	was	VBD	O	be	auxpass	4	SENT_97	[p5l540t2220r668b2261],
4	made	VBN	O	make	_	0	SENT_97	[p5l700t2203r891b2261],
5	to	TO	O	to	aux	6	SENT_97	[p5l923t2210r992b2261],
6	raise	VB	O	raise	xcomp	4	SENT_97	[p5l1024t2206r1181b2261],
7	the	DT	O	the	det	8	SENT_97	[p5l1213t2203r1325b2261],
8	patient	NN	O	patient	poss	11	SENT_97	[p5l1357t2203r1656b2279],
9	’s	POS	O	’s	_	0	SENT_97	[p5l1357t2203r1656b2279],
10	daily	JJ	SET	daily	amod	11	SENT_97	[p5l1689t2203r1862b2279],
11	dose	NN	O	dose	dobj	6	SENT_97	[p5l1891t2203r2046b2261],
12	to	TO	O	to	_	0	SENT_97	[p5l2078t2210r2148b2261],
13	225	CD	NUMBER	225	num	14	SENT_97	[p5l10t2300r132b2356],
14	mg	NN	O	mg	prep_to	6	SENT_97	[p5l153t2315r264b2374],
15	by	IN	O	by	_	0	SENT_97	[p5l308t2298r396b2374],
16	week	NN	DURATION	week	prep_by	6	SENT_97	[p5l438t2298r618b2356],
17	8	CD	NUMBER	8	num	16	SENT_97	[p5l664t2300r720b2368],
18	,	,	O	,	_	0	SENT_97	[p5l664t2300r720b2368],
19	unless	IN	O	unless	mark	22	SENT_97	[p5l771t2298r989b2356],
20	adverse	JJ	O	adverse	amod	21	SENT_97	[p5l1038t2298r1297b2356],
21	events	NNS	O	event	nsubj	22	SENT_97	[p5l1346t2305r1569b2356],
22	prevented	VBD	O	prevent	advcl	4	SENT_97	[p5l1616t2298r1972b2374],
23	this	DT	O	this	det	24	SENT_97	[p5l2018t2298r2148b2356],
24	increase	NN	O	increase	nsubj	28	SENT_97	[p5l9t2396r292b2450],
25	or	CC	O	or	_	0	SENT_97	[p5l326t2409r398b2450],
26	the	DT	O	the	det	27	SENT_97	[p5l429t2393r542b2450],
27	patient	NN	O	patient	nsubj	28	SENT_97	[p5l575t2396r827b2468],
28	was	VBD	O	be	ccomp	22	SENT_97	[p5l858t2409r986b2450],
29	in	IN	O	in	_	0	SENT_97	[p5l1019t2396r1090b2450],
30	remission	NN	O	remission	prep_in	28	SENT_97	[p5l1123t2396r1483b2450],
31	.	.	O	.	_	0	SENT_97	[p5l1123t2396r1483b2450],

1	After	IN	O	after	_	0	SENT_98	[p5l1519t2392r1693b2450],
2	12	CD	DURATION	12	num	3	SENT_98	[p5l1731t2394r1808b2450],
3	weeks	NNS	NUMBER	week	prep_after	28	SENT_98	[p5l1839t2393r2047b2450],
4	of	IN	O	of	_	0	SENT_98	[p5l2081t2392r2153b2450],
5	treatment	NN	O	treatment	prep_of	3	SENT_98	[p5l9t2514r376b2577],
6	,	,	O	,	_	0	SENT_98	[p5l9t2514r376b2577],
7	patients	NNS	O	patient	nsubjpass	28	SENT_98	[p5l408t2510r690b2583],
8	who	WP	O	who	nsubj	10	SENT_98	[p5l717t2507r870b2565],
9	were	VBD	O	be	cop	10	SENT_98	[p5l897t2524r1060b2565],
10	unimproved	JJ	O	unimproved	rcmod	7	SENT_98	[p5l1088t2507r1527b2583],
11	or	CC	O	or	_	0	SENT_98	[p5l1555t2524r1626b2565],
12	worse	JJR	O	worse	conj_or	10	SENT_98	[p5l1653t2524r1873b2578],
13	,	,	O	,	_	0	SENT_98	[p5l1653t2524r1873b2578],
14	having	VBG	O	have	partmod	7	SENT_98	[p5l1905t2507r2150b2583],
15	a	DT	O	a	det	18	SENT_98	[p5l9t2619r44b2659],
16	Clinical	JJ	O	clinical	amod	18	SENT_98	[p5l70t2602r343b2660],
17	Global	JJ	O	global	amod	18	SENT_98	[p5l369t2602r601b2659],
18	Impression	NN	O	impression	dobj	14	SENT_98	[p5l627t2604r1018b2678],
19	of	IN	O	of	_	0	SENT_98	[p5l1044t2602r1115b2659],
20	Improvement	NN	O	improvement	nn	23	SENT_98	[p5l1136t2604r1623b2678],
21	(	CD	NUMBER	(	num	23	SENT_98	[p5l1651t2602r1891b2674],
22	CGI-I	NN	O	cgi-i	nn	23	SENT_98	[p5l1651t2602r1891b2674],
23	)	NN	O	)	prep_of	18	SENT_98	[p5l1651t2602r1891b2674],
24	of	IN	O	of	_	0	SENT_98	[p5l1920t2602r1991b2659],
25	24	CD	NUMBER	24	prep_of	18	SENT_98	[p5l2023t2604r2144b2672],
26	,	,	O	,	_	0	SENT_98	[p5l2023t2604r2144b2672],
27	were	VBD	O	be	auxpass	28	SENT_98	[p5l7t2714r170b2755],
28	discontinued	VBN	O	discontinue	_	0	SENT_98	[p5l233t2697r698b2755],
29	from	IN	O	from	_	0	SENT_98	[p5l760t2697r930b2755],
30	the	DT	O	the	det	31	SENT_98	[p5l991t2697r1104b2755],
31	program	NN	O	program	prep_from	28	SENT_98	[p5l1166t2714r1466b2773],
32	as	IN	O	as	_	0	SENT_98	[p5l1529t2714r1594b2755],
33	unresponsive	JJ	O	unresponsive	prep_as	28	SENT_98	[p5l1655t2700r2144b2773],
34	.	.	O	.	_	0	SENT_98	[p5l1655t2700r2144b2773],

1	Patients	NNS	O	patient	nsubj	3	SENT_99	[p5l9t2794r288b2849],
2	minimally	RB	O	minimally	advmod	3	SENT_99	[p5l353t2792r724b2867],
3	improved	VBD	O	improve	_	0	SENT_99	[p5l787t2791r1128b2867],
4	(	CD	NUMBER	(	num	6	SENT_99	[p5l1197t2792r1412b2863],
5	CGI-I	NN	O	cgi-i	nn	6	SENT_99	[p5l1197t2792r1412b2863],
6	score	NN	TIME	score	nsubjpass	11	SENT_99	[p5l1480t2808r1655b2849],
7	of	IN	TIME	of	_	0	SENT_99	[p5l1721t2791r1793b2849],
8	3	CD	TIME	3	num	9	SENT_99	[p5l1855t2792r1917b2864],
9	)	NN	O	)	prep_of	6	SENT_99	[p5l1855t2792r1917b2864],
10	were	VBD	O	be	auxpass	11	SENT_99	[p5l1984t2808r2147b2849],
11	continued	VBN	O	continue	ccomp	3	SENT_99	[p5l9t2887r373b2945],
12	in	IN	O	in	_	0	SENT_99	[p5l408t2890r478b2944],
13	the	DT	O	the	det	14	SENT_99	[p5l512t2887r625b2945],
14	program	NN	O	program	prep_in	11	SENT_99	[p5l661t2904r961b2963],
15	to	TO	O	to	aux	16	SENT_99	[p5l996t2894r1066b2945],
16	assess	VB	O	assess	xcomp	11	SENT_99	[p5l1103t2904r1299b2945],
17	whether	IN	O	whether	complm	27	SENT_99	[p5l1333t2887r1628b2945],
18	or	CC	O	or	_	0	SENT_99	[p5l1662t2904r1734b2944],
19	not	RB	O	not	ccomp	16	SENT_99	[p5l1768t2894r1889b2944],
20	longer	JJR	O	longer	nsubj	27	SENT_99	[p5l1923t2887r2149b2963],
21	than	IN	O	than	_	0	SENT_99	[p5l9t2982r173b3040],
22	3	CD	DURATION	3	num	23	SENT_99	[p5l213t2984r248b3040],
23	months	NNS	NUMBER	month	prep_than	20	SENT_99	[p5l290t2982r563b3040],
24	of	IN	O	of	_	0	SENT_99	[p5l602t2982r674b3040],
25	treatment	NN	O	treatment	prep_of	23	SENT_99	[p5l708t2989r1059b3040],
26	may	MD	O	may	aux	27	SENT_99	[p5l1096t2999r1249b3058],
27	produce	VB	O	produce	ccomp	16	SENT_99	[p5l1284t2982r1570b3058],
28	further	JJ	O	further	amod	30	SENT_99	[p5l1609t2982r1856b3040],
29	clinical	JJ	O	clinical	amod	30	SENT_99	[p5l1893t2982r2148b3040],
30	improvement	NN	O	improvement	dobj	27	SENT_99	[p5l9t3079r510b3152],
31	.	.	O	.	_	0	SENT_99	[p5l9t3079r510b3152],

1	DNA	NN	MISC	dna	nsubjpass	3	SENT_100	[p5l86t3174r255b3229],
2	was	VBD	O	be	auxpass	3	SENT_100	[p5l285t3189r413b3230],
3	obtained	VBN	O	obtain	_	0	SENT_100	[p5l448t3172r777b3242],
4	,	,	O	,	_	0	SENT_100	[p5l448t3172r777b3242],
5	and	CC	O	and	_	0	SENT_100	[p5l817t3172r948b3230],
6	treatment	NN	O	treatment	nn	7	SENT_100	[p5l981t3179r1332b3230],
7	response	NN	O	response	nsubjpass	9	SENT_100	[p5l1365t3189r1670b3248],
8	was	VBD	O	be	auxpass	9	SENT_100	[p5l1704t3189r1832b3230],
9	assessed	VBN	O	assess	conj_and	3	SENT_100	[p5l1867t3172r2149b3230],
10	in	IN	O	in	_	0	SENT_100	[p5l9t3270r79b3324],
11	156	CD	NUMBER	156	num	12	SENT_100	[p5l112t3269r233b3325],
12	patients	NNS	O	patient	prep_in	9	SENT_100	[p5l261t3270r543b3343],
13	(	CD	NUMBER	(	npadvmod	14	SENT_100	[p5l575t3267r1346b3343],
14	European	JJ	MISC	european	amod	12	SENT_100	[p5l575t3267r1346b3343],
15	.	.	O	.	_	0	SENT_100	[p5l575t3267r1346b3343],

1	—	NN	O	—	_	0	SENT_101	[p5l575t3267r1346b3343],
2	.	.	O	.	_	0	SENT_101	[p5l575t3267r1346b3343],

1	Americans	NNPS	MISC	Americans	nsubj	2	SENT_102	[p5l575t3267r1346b3343],
2	(	VBP	O	(	_	0	SENT_102	[p5l1378t3267r1518b3339],
3	EA	NN	O	ea	nn	5	SENT_102	[p5l1378t3267r1518b3339],
4	)	NN	O	)	nn	5	SENT_102	[p5l1378t3267r1518b3339],
5	n	NN	O	n	dobj	2	SENT_102	[p5l1550t3284r1589b3325],
6	=	JJ	O	=	amod	5	SENT_102	[p5l1608t3295r1659b3313],
7	112	CD	NUMBER	112	tmod	6	SENT_102	[p5l1683t3269r1823b3337],
8	;	:	O	;	_	0	SENT_102	[p5l1683t3269r1823b3337],
9	AfricanAmericans	NNP	O	AfricanAmericans	dep	5	SENT_102	[p5l1854t3267r2151b3325, p5l7t3363r378b3419],
10	(	CD	NUMBER	(	num	9	SENT_102	[p5l410t3362r558b3434],
11	AA	NN	O	aa	nn	13	SENT_102	[p5l410t3362r558b3434],
12	)	NN	O	)	nn	13	SENT_102	[p5l410t3362r558b3434],
13	n	NN	O	n	dep	9	SENT_102	[p5l589t3378r628b3419],
14	:	:	O	:	_	0	SENT_102	[p5l647t3390r699b3408],
15	41	CD	NUMBER	41	dep	5	SENT_102	[p5l717t3363r819b3431],
16	;	:	O	;	_	0	SENT_102	[p5l717t3363r819b3431],
17	others	NNS	O	other	dep	15	SENT_102	[p5l851t3362r1069b3419],
18	11	CD	NUMBER	11	dep	17	SENT_102	[p5l1097t3378r1136b3419],
19	:	:	O	:	_	0	SENT_102	[p5l1155t3390r1206b3408],
20	3	CD	NUMBER	3	num	21	SENT_102	[p5l1226t3362r1288b3434],
21	)	NN	O	)	dep	5	SENT_102	[p5l1226t3362r1288b3434],
22	that	WDT	O	that	nsubj	23	SENT_102	[p5l1318t3362r1461b3419],
23	participated	VBD	O	participate	rcmod	21	SENT_102	[p5l1487t3362r1911b3437],
24	in	IN	O	in	_	0	SENT_102	[p5l1938t3365r2008b3419],
25	the	DT	O	the	det	28	SENT_102	[p5l2035t3362r2148b3419],
26	6-month	JJ	DURATION	6-month	amod	28	SENT_102	[p5l11t3457r321b3515],
27	open-label	JJ	O	open-label	amod	28	SENT_102	[p5l355t3457r726b3533],
28	phase	NN	O	phase	prep_in	23	SENT_102	[p5l760t3457r960b3533],
29	of	IN	O	of	_	0	SENT_102	[p5l996t3457r1068b3515],
30	venlafaxine	NN	O	venlafaxine	nn	31	SENT_102	[p5l1095t3457r1507b3515],
31	XR	NN	O	xr	prep_of	28	SENT_102	[p5l1542t3460r1663b3515],
32	.	.	O	.	_	0	SENT_102	[p5l1542t3460r1663b3515],

1	Mean	NN	O	mean	nn	2	SENT_103	[p5l1700t3460r1898b3515],
2	age	NN	O	age	nsubj	8	SENT_103	[p5l1933t3474r2046b3533],
3	of	IN	O	of	_	0	SENT_103	[p5l2081t3457r2153b3515],
4	our	PRP$	O	we	poss	5	SENT_103	[p5l9t3569r128b3609],
5	population	NN	O	population	prep_of	2	SENT_103	[p5l154t3552r547b3628],
6	was	VBD	O	be	cop	8	SENT_103	[p5l573t3569r701b3609],
7	49.6	CD	DURATION	49.6	num	8	SENT_103	[p5l731t3553r879b3609],
8	years	NNS	NUMBER	year	_	0	SENT_103	[p5l906t3569r1083b3628],
9	(	JJ	O	(	amod	10	SENT_103	[p5l1116t3552r1352b3628],
10	range	NN	O	range	attr	8	SENT_103	[p5l1116t3552r1352b3628],
11	:	:	O	:	_	0	SENT_103	[p5l1116t3552r1352b3628],
12	18-85	CD	NUMBER	18-85	num	13	SENT_103	[p5l1390t3553r1590b3609],
13	years	NNS	NUMBER	year	tmod	14	SENT_103	[p5l1620t3552r1843b3628],
14	)	RB	O	)	amod	10	SENT_103	[p5l1620t3552r1843b3628],
15	,	,	O	,	_	0	SENT_103	[p5l1620t3552r1843b3628],
16	and	CC	O	and	_	0	SENT_103	[p5l1876t3552r2008b3609],
17	the	DT	O	the	det	19	SENT_103	[p5l2035t3552r2148b3610],
18	gender	NN	O	gender	nn	19	SENT_103	[p5l9t3647r250b3723],
19	distribution	NN	O	distribution	nsubj	20	SENT_103	[p5l307t3647r726b3705],
20	included	VBD	O	include	conj_and	8	SENT_103	[p5l784t3647r1093b3705],
21	64	CD	NUMBER	64	num	22	SENT_103	[p5l1154t3649r1234b3704],
22	males	NNS	O	male	dobj	20	SENT_103	[p5l1293t3647r1493b3705],
23	and	CC	O	and	_	0	SENT_103	[p5l1552t3647r1684b3705],
24	92	CD	NUMBER	92	num	25	SENT_103	[p5l1742t3648r1825b3704],
25	females	NNS	O	female	dobj	20	SENT_103	[p5l1883t3647r2148b3705],
26	(	CD	NUMBER	(	num	27	SENT_103	[p5l12t3741r236b3813],
27	males	NNS	O	male	npadvmod	28	SENT_103	[p5l12t3741r236b3813],
28	=	JJ	O	=	amod	25	SENT_103	[p5l255t3770r306b3788],
29	41	CD	PERCENT	41	num	30	SENT_103	[p5l326t3743r478b3799],
30	%	NN	PERCENT	%	dep	25	SENT_103	[p5l326t3743r478b3799],
31	and	CC	O	and	_	0	SENT_103	[p5l503t3741r634b3799],
32	females	NNS	O	female	conj_and	22	SENT_103	[p5l657t3741r922b3799],
33	=	JJ	O	=	rcmod	32	SENT_103	[p5l942t3770r993b3788],
34	59	CD	PERCENT	59	num	35	SENT_103	[p5l1013t3742r1209b3814],
35	%	NN	PERCENT	%	iobj	33	SENT_103	[p5l1013t3742r1209b3814],
36	)	CD	NUMBER	)	dobj	33	SENT_103	[p5l1013t3742r1209b3814],
37	.	.	O	.	_	0	SENT_103	[p5l1013t3742r1209b3814],

1	Primary	JJ	O	primary	amod	2	SENT_104	[p5l1238t3744r1518b3817],
2	analysis	NN	O	analysis	nsubj	3	SENT_104	[p5l1539t3742r1815b3817],
3	included	VBD	O	include	_	0	SENT_104	[p5l1839t3741r2149b3799],

1	HAM-A	JJ	O	ham-a	amod	2	SENT_105	[p6l9t19r271b75],
2	reduction	NN	O	reduction	nsubjpass	9	SENT_105	[p6l317t18r659b76],
3	at	IN	O	at	_	0	SENT_105	[p6l706t25r770b75],
4	6	CD	DURATION	6	num	5	SENT_105	[p6l818t20r855b75],
5	months	NNS	NUMBER	month	prep_at	2	SENT_105	[p6l902t18r1194b88],
6	,	,	O	,	_	0	SENT_105	[p6l902t18r1194b88],
7	response	NN	O	response	appos	5	SENT_105	[p6l1245t35r1550b94],
8	was	VBD	O	be	auxpass	9	SENT_105	[p6l1595t35r1723b75],
9	defined	VBN	O	define	dep	19	SENT_105	[p6l1771t18r2036b76],
10	as	IN	O	as	_	0	SENT_105	[p6l2083t35r2148b75],
11	HAM-A	NN	O	ham-a	nn	12	SENT_105	[p6l9t114r271b169],
12	reduction	NN	O	reduction	prep_as	9	SENT_105	[p6l323t112r666b170],
13	of	IN	O	of	_	0	SENT_105	[p6l720t112r792b170],
14	250	CD	PERCENT	250	num	15	SENT_105	[p6l852t114r1069b177],
15	%	NN	PERCENT	%	prep_of	12	SENT_105	[p6l852t114r1069b177],
16	and	CC	O	and	_	0	SENT_105	[p6l1123t112r1254b170],
17	remission	NN	O	remission	prep_of	12	SENT_105	[p6l1307t115r1649b170],
18	was	VBD	O	be	auxpass	19	SENT_105	[p6l1701t129r1829b170],
19	defined	VBN	O	define	_	0	SENT_105	[p6l1883t112r2149b170],
20	as	IN	O	as	_	0	SENT_105	[p6l9t224r74b265],
21	HAM-A	NN	O	ham-a	prep_as	19	SENT_105	[p6l110t209r372b265],
22	<	JJR	O	<	nsubjpass	19	SENT_105	[p6l417t217r465b272],
23	7	CD	NUMBER	7	amod	22	SENT_105	[p6l486t210r538b265],
24	.	.	O	.	_	0	SENT_105	[p6l486t210r538b265],

1	Secondary	JJ	O	secondary	amod	3	SENT_106	[p6l577t207r943b283],
2	outcome	NN	O	outcome	nn	3	SENT_106	[p6l976t215r1285b265],
3	measure	NN	O	measure	nsubj	7	SENT_106	[p6l1321t224r1611b265],
4	was	VBD	O	be	cop	7	SENT_106	[p6l1645t224r1773b265],
5	the	DT	O	the	det	7	SENT_106	[p6l1808t207r1920b265],
6	CGI-I	NN	MISC	cgi-i	nn	7	SENT_106	[p6l1957t209r2147b265],
7	score	NN	NUMBER	score	_	0	SENT_106	[p6l10t320r185b361],
8	at	IN	O	at	_	0	SENT_106	[p6l219t310r282b361],
9	6	CD	DURATION	6	num	10	SENT_106	[p6l315t305r352b361],
10	months	NNS	NUMBER	month	prep_at	7	SENT_106	[p6l385t303r677b361],
11	.	.	O	.	_	0	SENT_106	[p6l385t303r677b361],

1	Improvement	NN	O	improvement	nsubjpass	3	SENT_107	[p6l713t306r1200b379],
2	was	VBD	O	be	auxpass	3	SENT_107	[p6l1230t320r1358b361],
3	defined	VBN	O	define	ccomp	13	SENT_107	[p6l1391t303r1656b361],
4	as	IN	O	as	_	0	SENT_107	[p6l1688t320r1752b361],
5	CGI-I	NN	O	cgi-i	prep_as	3	SENT_107	[p6l1786t305r1977b361],
6	of	IN	O	of	_	0	SENT_107	[p6l2010t303r2081b361],
7	1	CD	NUMBER	1	prep_of	5	SENT_107	[p6l2114t305r2143b360],
8	and	CC	O	and	_	0	SENT_107	[p6l9t397r140b455],
9	2	CD	NUMBER	2	prep_of	5	SENT_107	[p6l199t399r255b467],
10	,	,	O	,	_	0	SENT_107	[p6l199t399r255b467],
11	remission	NN	O	remission	nsubjpass	13	SENT_107	[p6l316t400r659b455],
12	was	VBD	O	be	auxpass	13	SENT_107	[p6l714t414r842b455],
13	defined	VBN	O	define	_	0	SENT_107	[p6l901t397r1166b455],
14	as	IN	O	as	_	0	SENT_107	[p6l1224t414r1288b455],
15	CGI-I	NN	O	cgi-i	prep_as	13	SENT_107	[p6l1348t399r1538b455],
16	of	IN	O	of	_	0	SENT_107	[p6l1597t397r1668b455],
17	1	CD	NUMBER	1	prep_of	15	SENT_107	[p6l1728t399r1779b455],
18	.	.	O	.	_	0	SENT_107	[p6l1728t399r1779b455],

1	The	DT	O	the	det	3	SENT_108	[p6l1839t397r1971b455],
2	last	JJ	O	last	amod	3	SENT_108	[p6l2030t397r2149b455],
3	observation	NN	O	observation	nsubj	4	SENT_108	[p6l9t493r424b550],
4	carried	VBD	O	carry	_	0	SENT_108	[p6l480t493r720b550],
5	forward	RB	O	forward	advmod	4	SENT_108	[p6l776t492r1049b550],
6	(	JJ	O	(	amod	10	SENT_108	[p6l1108t493r1354b565],
7	LOCF	NN	O	locf	nn	10	SENT_108	[p6l1108t493r1354b565],
8	)	CD	NUMBER	)	num	10	SENT_108	[p6l1108t493r1354b565],
9	imputation	NN	O	imputation	nn	10	SENT_108	[p6l1413t496r1815b568],
10	method	NN	O	method	nsubjpass	12	SENT_108	[p6l1871t493r2149b550],
11	was	VBD	O	be	auxpass	12	SENT_108	[p6l7t605r135b646],
12	used	VBN	O	use	ccomp	4	SENT_108	[p6l164t588r325b646],
13	for	IN	O	for	_	0	SENT_108	[p6l355t588r453b646],
14	this	DT	O	this	det	15	SENT_108	[p6l482t588r611b646],
15	study	NN	O	study	prep_for	12	SENT_108	[p6l644t588r836b664],
16	to	TO	O	to	aux	17	SENT_108	[p6l864t595r934b646],
17	account	VB	O	account	xcomp	12	SENT_108	[p6l966t595r1247b646],
18	for	IN	O	for	_	0	SENT_108	[p6l1277t588r1375b646],
19	missing	VBG	O	miss	amod	20	SENT_108	[p6l1405t591r1676b664],
20	data	NNS	O	datum	prep_for	17	SENT_108	[p6l1706t588r1872b646],
21	.	.	O	.	_	0	SENT_108	[p6l1706t588r1872b646],

1	Due	JJ	O	due	_	0	SENT_109	[p6l1908t591r2047b646],
2	to	TO	O	to	_	0	SENT_109	[p6l2078t595r2148b646],
3	differences	NNS	O	difference	prep_due_to	14	SENT_109	[p6l9t683r390b741],
4	in	IN	O	in	_	0	SENT_109	[p6l446t686r516b740],
5	allele	NN	O	allele	nn	6	SENT_109	[p6l573t683r754b741],
6	frequencies	NNS	O	frequency	prep_in	3	SENT_109	[p6l811t683r1213b759],
7	for	IN	O	for	_	0	SENT_109	[p6l1269t683r1367b741],
8	the	DT	O	the	det	10	SENT_109	[p6l1422t683r1534b741],
9	rs7997012	NN	O	rs7997012	nn	10	SENT_109	[p6l1590t685r1954b741],
10	SNP	NN	O	snp	prep_for	6	SENT_109	[p6l2010t685r2149b741],
11	between	IN	O	between	_	0	SENT_109	[p6l7t778r304b836],
12	ethnic	JJ	O	ethnic	amod	13	SENT_109	[p6l347t778r572b836],
13	groups	NNS	O	group	prep_between	10	SENT_109	[p6l615t795r850b854],
14	(	VBP	O	(	_	0	SENT_109	[p6l898t778r1015b850],
15	EA	NN	O	ea	dobj	14	SENT_109	[p6l898t778r1015b850],
16	minor	JJ	O	minor	amod	18	SENT_109	[p6l1056t781r1275b835],
17	allele	NN	O	allele	nn	18	SENT_109	[p6l1318t778r1499b836],
18	frequency	NN	O	frequency	nsubj	14	SENT_109	[p6l1543t778r1913b854],
19	:	:	O	:	_	0	SENT_109	[p6l1543t778r1913b854],
20	0.37045	CD	NUMBER	0.37045	dep	18	SENT_109	[p6l1960t779r2151b836, p6l9t874r177b942],
21	;	:	O	;	_	0	SENT_109	[p6l1960t779r2151b836, p6l9t874r177b942],
22	AA	NN	O	aa	dep	18	SENT_109	[p6l217t874r320b929],
23	minor	JJ	O	minor	amod	25	SENT_109	[p6l356t875r575b930],
24	allele	NN	O	allele	nn	25	SENT_109	[p6l612t872r794b930],
25	frequency	NN	O	frequency	dep	22	SENT_109	[p6l832t872r1201b948],
26	:	:	O	:	_	0	SENT_109	[p6l832t872r1201b948],
27	<	JJR	O	<	dep	18	SENT_109	[p6l1254t873r1513b944],
28	0.01	CD	NUMBER	0.01	num	29	SENT_109	[p6l1254t873r1513b944],
29	)	NN	O	)	dep	27	SENT_109	[p6l1254t873r1513b944],
30	,	,	O	,	_	0	SENT_109	[p6l1254t873r1513b944],
31	primary	JJ	O	primary	amod	32	SENT_109	[p6l1554t875r1837b948],
32	analysis	NN	O	analysis	appos	18	SENT_109	[p6l1873t873r2148b948],
33	was	VBD	O	be	auxpass	34	SENT_109	[p6l7t985r135b1025],
34	carried	VBN	O	carry	rcmod	32	SENT_109	[p6l174t968r413b1026],
35	out	RP	O	out	prt	34	SENT_109	[p6l451t975r568b1025],
36	separated	VBN	O	separate	partmod	32	SENT_109	[p6l606t968r938b1044],
37	by	IN	O	by	_	0	SENT_109	[p6l973t968r1061b1044],
38	ethnicity	NN	O	ethnicity	agent	36	SENT_109	[p6l1096t968r1427b1044],
39	.	.	O	.	_	0	SENT_109	[p6l1096t968r1427b1044],

1	Genotyping	NN	O	genotyping	nsubjpass	8	SENT_110	[p6l1471t969r1894b1044],
2	of	IN	O	of	_	0	SENT_110	[p6l1931t968r2002b1025],
3	the	DT	O	the	det	6	SENT_110	[p6l2035t968r2148b1026],
4	HTRZA	NN	O	htrza	nn	6	SENT_110	[p6l9t1065r259b1120],
5	variant	JJ	O	variant	amod	6	SENT_110	[p6l308t1066r559b1121],
6	rs7997012	NN	O	rs7997012	prep_of	1	SENT_110	[p6l612t1065r976b1121],
7	was	VBD	O	be	auxpass	8	SENT_110	[p6l1028t1080r1155b1121],
8	performed	VBN	O	perform	_	0	SENT_110	[p6l1209t1063r1578b1139],
9	using	VBG	O	use	xcomp	8	SENT_110	[p6l1630t1066r1823b1139],
10	Applied	NNP	O	Applied	nn	11	SENT_110	[p6l1874t1063r2149b1139],
11	Biosystems	NNP	O	Biosystems	dobj	9	SENT_110	[p6l9t1160r395b1233],
12	(	CD	NUMBER	(	num	13	SENT_110	[p6l428t1158r597b1230],
13	AB1	NN	O	ab1	dep	25	SENT_110	[p6l428t1158r597b1230],
14	)	CD	NUMBER	)	number	15	SENT_110	[p6l428t1158r597b1230],
15	(	CD	NUMBER	(	dep	13	SENT_110	[p6l632t1158r866b1229],
16	Foster	NNP	LOCATION	Foster	nn	21	SENT_110	[p6l632t1158r866b1229],
17	City	NNP	LOCATION	City	nn	21	SENT_110	[p6l895t1159r1052b1233],
18	,	,	O	,	_	0	SENT_110	[p6l895t1159r1052b1233],
19	CA	NNP	LOCATION	CA	appos	21	SENT_110	[p6l1087t1159r1208b1228],
20	,	,	O	,	_	0	SENT_110	[p6l1087t1159r1208b1228],
21	USA	NNP	LOCATION	USA	dep	15	SENT_110	[p6l1241t1158r1411b1229],
22	)	CD	NUMBER	)	num	21	SENT_110	[p6l1241t1158r1411b1229],
23	‘	CD	NUMBER	‘	dep	25	SENT_110	[p6l1445t1157r2146b1233],
24	Assays-on-demand	JJ	O	assays-on-demand	amod	25	SENT_110	[p6l1445t1157r2146b1233],
25	’	NN	O	’	dep	9	SENT_110	[p6l1445t1157r2146b1233],
26	as	IN	O	as	amod	25	SENT_110	[p6l9t1270r74b1311],
27	per	IN	O	per	_	0	SENT_110	[p6l118t1270r230b1329],
28	manufacturer	NN	O	manufacturer	nn	29	SENT_110	[p6l273t1253r755b1311],
29	protocol	NN	O	protocol	prep_per	25	SENT_110	[p6l797t1253r1114b1329],
30	.	.	O	.	_	0	SENT_110	[p6l797t1253r1114b1329],

1	Quality	JJ	O	quality	amod	2	SENT_111	[p6l1164t1253r1428b1329],
2	control	NN	O	control	nsubjpass	4	SENT_111	[p6l1470t1253r1726b1311],
3	was	VBD	O	be	auxpass	4	SENT_111	[p6l1769t1270r1897b1311],
4	maintained	VBN	O	maintain	_	0	SENT_111	[p6l1942t1256r2148b1311, p6l9t1348r232b1406],
5	by	IN	O	by	_	0	SENT_111	[p6l258t1348r346b1424],
6	genotyping	VBG	O	genotype	agent	4	SENT_111	[p6l372t1351r778b1424],
7	10	CD	PERCENT	10	number	8	SENT_111	[p6l812t1350r959b1406],
8	%	NN	PERCENT	%	amod	9	SENT_111	[p6l812t1350r959b1406],
9	duplicates	NNS	O	duplicate	dobj	6	SENT_111	[p6l989t1348r1345b1424],
10	of	IN	O	of	_	0	SENT_111	[p6l1376t1348r1447b1406],
11	subjects	NNS	O	subject	prep_of	9	SENT_111	[p6l1474t1348r1769b1424],
12	.	.	O	.	_	0	SENT_111	[p6l1474t1348r1769b1424],

1	Genotype	NN	O	genotype	nn	4	SENT_112	[p6l1804t1350r2147b1424],
2	and	CC	O	and	_	0	SENT_112	[p6l9t1443r140b1500],
3	allele	NN	O	allele	nn	4	SENT_112	[p6l204t1443r385b1500],
4	frequencies	NNS	O	frequency	nsubjpass	6	SENT_112	[p6l449t1442r851b1518],
5	were	VBD	O	be	auxpass	6	SENT_112	[p6l913t1459r1076b1500],
6	compared	VBN	O	compare	_	0	SENT_112	[p6l1141t1443r1491b1518],
7	between	IN	O	between	_	0	SENT_112	[p6l1551t1443r1849b1500],
8	groups	NNS	O	group	prep_between	6	SENT_112	[p6l1912t1459r2147b1518],

1	HTRZA	NN	O	htrza	nn	5	SENT_113	[p6l10t1685r170b1728],
2	and	CC	O	and	_	0	SENT_113	[p6l188t1683r276b1728],
3	antidepressant	JJ	O	antidepressant	conj_and	1	SENT_113	[p6l296t1683r656b1743],
4	treatment	NN	O	treatment	nn	5	SENT_113	[p6l674t1688r921b1728],
5	response	NN	O	response	_	0	SENT_113	[p6l941t1697r1151b1743],
6	in	IN	O	in	_	0	SENT_113	[p6l1171t1683r1213b1728],
7	GAD	NN	O	gad	prep_in	5	SENT_113	[p6l1233t1685r1337b1728],
8	@	IN	O	@	_	0	SENT_113	[p6l2024t1671r2151b1795],
9	FW	NNP	ORGANIZATION	FW	nn	10	SENT_113	[p6l11t1756r74b1796],
10	Lohoff	NNP	ORGANIZATION	Lohoff	prep_@	7	SENT_113	[p6l93t1755r221b1796],
11	et	FW	O	et	nn	12	SENT_113	[p6l239t1760r275b1796],
12	al	FW	O	al	dep	10	SENT_113	[p6l292t1755r328b1796],
13	'	''	DATE	'	_	0	SENT_113	[p6l2116t1750r2142b1767],
14	23	CD	DATE	23	dep	5	SENT_113	[p6l2079t1845r2148b1889],

1	using	VBG	O	use	_	0	SENT_114	[p6l8t2053r200b2125],
2	>	JJR	O	>	npadvmod	3	SENT_114	[p6l264t2068r301b2106],
3	<	JJR	O	<	acomp	1	SENT_114	[p6l264t2068r301b2106],
4	2	CD	NUMBER	2	num	6	SENT_114	[p6l327t2043r356b2076],
5	contingency	NN	O	contingency	nn	6	SENT_114	[p6l400t2053r844b2126],
6	analysis	NN	O	analysis	dep	3	SENT_114	[p6l885t2050r1179b2126],
7	.	.	O	.	_	0	SENT_114	[p6l885t2050r1179b2126],

1	A	DT	O	a	det	3	SENT_115	[p6l1226t2051r1277b2107],
2	two	CD	NUMBER	two	num	3	SENT_115	[p6l1320t2050r1676b2108],
3	—	CD	NUMBER	—	nsubjpass	13	SENT_115	[p6l1320t2050r1676b2108],
4	tai1ed	VBN	O	tai1e	partmod	3	SENT_115	[p6l1320t2050r1676b2108],
5	type	NN	O	type	nn	8	SENT_115	[p6l1719t2057r1870b2126],
6	I	CD	NUMBER	i	num	8	SENT_115	[p6l1915t2052r1937b2107],
7	error	NN	O	error	nn	8	SENT_115	[p6l1982t2067r2151b2108],
8	rate	NN	O	rate	dobj	4	SENT_115	[p6l9t2153r140b2203],
9	of	IN	O	of	_	0	SENT_115	[p6l171t2145r243b2203],
10	5	CD	PERCENT	5	num	11	SENT_115	[p6l269t2147r377b2203],
11	%	NN	PERCENT	%	prep_of	8	SENT_115	[p6l269t2147r377b2203],
12	was	VBD	O	be	auxpass	13	SENT_115	[p6l404t2162r533b2203],
13	chosen	VBN	O	choose	_	0	SENT_115	[p6l563t2146r812b2203],
14	for	IN	O	for	_	0	SENT_115	[p6l841t2145r939b2203],
15	the	DT	O	the	det	16	SENT_115	[p6l968t2145r1080b2203],
16	analysis	NN	O	analysis	prep_for	13	SENT_115	[p6l1112t2146r1405b2221],
17	.	.	O	.	_	0	SENT_115	[p6l1112t2146r1405b2221],

1	Results	NNS	O	result	_	0	SENT_116	[p6l12t2375r280b2432],

1	Genotype	NN	O	genotype	nn	2	SENT_117	[p6l11t2565r355b2639],
2	distributions	NNS	O	distribution	nsubj	3	SENT_117	[p6l402t2564r851b2621],
3	were	VBD	O	be	_	0	SENT_117	[p6l896t2580r1060b2621],
4	in	IN	O	in	_	0	SENT_117	[p6l1107t2567r1177b2621],
5	accordance	NN	O	accordance	_	0	SENT_117	[p6l1224t2564r1618b2621],
6	with	IN	O	with	_	0	SENT_117	[p6l1664t2564r1825b2621],
7	Hardy	NNP	PERSON	Hardy	nn	9	SENT_117	[p6l1872t2564r2148b2639],
8	Weinberg	NNP	PERSON	Weinberg	nn	9	SENT_117	[p6l8t2659r348b2734],
9	equilibrium	NN	O	equilibrium	prep_in_accordance_with	3	SENT_117	[p6l371t2659r805b2734],
10	.	.	O	.	_	0	SENT_117	[p6l371t2659r805b2734],

1	The	DT	O	the	det	3	SENT_118	[p6l831t2659r963b2716],
2	concordance	NN	O	concordance	nn	3	SENT_118	[p6l989t2659r1440b2716],
3	rate	NN	O	rate	nsubj	6	SENT_118	[p6l1464t2666r1595b2716],
4	was	VBD	O	be	cop	6	SENT_118	[p6l1617t2675r1745b2716],
5	100	CD	PERCENT	100	num	6	SENT_118	[p6l1775t2660r1966b2716],
6	%	NN	PERCENT	%	_	0	SENT_118	[p6l1775t2660r1966b2716],
7	with	IN	O	with	_	0	SENT_118	[p6l1988t2659r2149b2716],
8	respect	NN	O	respect	_	0	SENT_118	[p6l9t2761r255b2830],
9	to	TO	O	to	_	0	SENT_118	[p6l280t2761r349b2812],
10	the	DT	O	the	det	12	SENT_118	[p6l375t2754r488b2812],
11	10	CD	PERCENT	10	num	12	SENT_118	[p6l520t2756r667b2812],
12	%	NN	PERCENT	%	prep_with_respect_to	6	SENT_118	[p6l520t2756r667b2812],
13	of	IN	O	of	_	0	SENT_118	[p6l693t2754r764b2812],
14	samples	NNS	O	sample	prep_of	12	SENT_118	[p6l786t2754r1062b2830],
15	that	WDT	O	that	nsubjpass	17	SENT_118	[p6l1088t2754r1231b2812],
16	were	VBD	O	be	auxpass	17	SENT_118	[p6l1254t2771r1417b2812],
17	genotyped	VBN	O	genotype	rcmod	14	SENT_118	[p6l1444t2754r1817b2830],
18	twice	RB	O	twice	advmod	17	SENT_118	[p6l1842t2757r2026b2812],
19	for	IN	O	for	_	0	SENT_118	[p6l2052t2754r2150b2812],
20	quality	NN	O	quality	nn	21	SENT_118	[p6l10t2849r259b2925],
21	control	NN	O	control	prep_for	17	SENT_118	[p6l308t2849r582b2907],
22	.	.	O	.	_	0	SENT_118	[p6l308t2849r582b2907],

1	Allelic	JJ	MISC	allelic	amod	2	SENT_119	[p6l637t2849r859b2907],
2	frequencies	NNS	O	frequency	nsubj	4	SENT_119	[p6l910t2849r1311b2925],
3	were	VBD	O	be	cop	4	SENT_119	[p6l1362t2866r1525b2907],
4	consistent	JJ	O	consistent	_	0	SENT_119	[p6l1578t2852r1939b2907],
5	with	IN	O	with	_	0	SENT_119	[p6l1988t2849r2149b2906],
6	those	DT	O	those	prep_with	4	SENT_119	[p6l9t2944r198b3002],
7	reported	VBN	O	report	partmod	6	SENT_119	[p6l234t2944r532b3020],
8	in	IN	O	in	_	0	SENT_119	[p6l567t2947r638b3001],
9	the	DT	O	the	det	11	SENT_119	[p6l673t2944r785b3002],
10	HapMap	NN	ORGANIZATION	hapmap	nn	11	SENT_119	[p6l822t2946r1122b3020],
11	database	NN	O	database	prep_in	7	SENT_119	[p6l1158t2944r1458b3002],
12	for	IN	O	for	_	0	SENT_119	[p6l1495t2944r1593b3001],
13	Utah	NNP	LOCATION	Utah	nn	14	SENT_119	[p6l1627t2944r1801b3002],
14	residents	NNS	O	resident	prep_for	11	SENT_119	[p6l1836t2944r2149b3002],
15	with	IN	O	with	_	0	SENT_119	[p6l8t3038r169b3096],
16	Northern	NN	O	northern	prep_with	7	SENT_119	[p6l193t3038r523b3096],
17	and	CC	O	and	_	0	SENT_119	[p6l550t3039r682b3096],
18	Western	NNP	LOCATION	Western	nn	20	SENT_119	[p6l706t3041r994b3096],
19	Europe	NNP	LOCATION	Europe	nn	20	SENT_119	[p6l1021t3041r1266b3114],
20	ancestry	NN	O	ancestry	prep_with	7	SENT_119	[p6l1294t3046r1589b3114],
21	from	IN	O	from	_	0	SENT_119	[p6l1613t3038r1782b3096],
22	the	DT	O	the	det	24	SENT_119	[p6l1808t3039r1921b3096],
23	CEPH	NN	O	ceph	nn	24	SENT_119	[p6l1949t3040r2148b3096],
24	collection	NN	O	collection	prep_from	7	SENT_119	[p6l10t3134r378b3192],
25	.	.	O	.	_	0	SENT_119	[p6l10t3134r378b3192],

1	Treatment	NN	O	treatment	nn	2	SENT_120	[p6l417t3136r784b3192],
2	response	NN	O	response	_	0	SENT_120	[p6l820t3151r1125b3210],
3	to	TO	O	to	dep	2	SENT_120	[p6l1163t3141r1233b3191],
4	VEN	NNP	O	VEN	pobj	3	SENT_120	[p6l1269t3136r1427b3191],
5	based	VBN	O	base	partmod	4	SENT_120	[p6l1460t3134r1657b3192],
6	on	IN	O	on	_	0	SENT_120	[p6l1695t3151r1786b3191],
7	genotype	NN	O	genotype	prep_on	5	SENT_120	[p6l1823t3141r2148b3210],
8	for	IN	O	for	_	0	SENT_120	[p6l10t3228r108b3286],
9	the	DT	O	the	det	11	SENT_120	[p6l137t3229r249b3286],
10	EA	NN	O	ea	nn	11	SENT_120	[p6l281t3230r373b3285],
11	sample	NN	O	sample	prep_for	5	SENT_120	[p6l404t3229r649b3304],
12	using	VBG	O	use	partmod	11	SENT_120	[p6l678t3231r871b3304],
13	the	DT	O	the	det	16	SENT_120	[p6l900t3228r1012b3286],
14	HAM-A	NN	O	ham-a	nn	16	SENT_120	[p6l1044t3230r1305b3286],
15	outcome	NN	O	outcome	nn	16	SENT_120	[p6l1336t3236r1645b3286],
16	measure	NN	O	measure	dobj	12	SENT_120	[p6l1676t3245r1967b3286],
17	over	IN	O	over	_	0	SENT_120	[p6l1998t3245r2150b3286],
18	time	NN	O	time	prep_over	12	SENT_120	[p6l9t3326r168b3380],
19	(	CD	NUMBER	(	num	21	SENT_120	[p6l206t3323r349b3395],
20	last	JJ	O	last	amod	21	SENT_120	[p6l206t3323r349b3395],
21	observation	NN	O	observation	nsubj	22	SENT_120	[p6l383t3323r798b3380],
22	carried	VBD	O	carry	dep	12	SENT_120	[p6l833t3323r1072b3380],
23	forward	RB	O	forward	advmod	25	SENT_120	[p6l1106t3322r1379b3380],
24	(	CD	NUMBER	(	num	25	SENT_120	[p6l1416t3323r1689b3395],
25	LOCF	NN	O	locf	dobj	22	SENT_120	[p6l1416t3323r1689b3395],
26	)	CD	NUMBER	)	num	27	SENT_120	[p6l1416t3323r1689b3395],
27	)	NN	O	)	nsubjpass	29	SENT_120	[p6l1416t3323r1689b3395],
28	is	VBZ	O	be	auxpass	29	SENT_120	[p6l1727t3326r1777b3380],
29	shown	VBN	O	show	rcmod	25	SENT_120	[p6l1814t3323r2046b3380],
30	in	IN	O	in	prep	29	SENT_120	[p6l2079t3326r2149b3380],

1	Figure	NNP	O	Figure	_	0	SENT_121	[p7l10t22r224b95],
2	1	CD	NUMBER	1	dep	1	SENT_121	[p7l255t21r307b77],
3	.	.	O	.	_	0	SENT_121	[p7l255t21r307b77],

1	Patients	NNS	O	patient	nsubj	7	SENT_122	[p7l336t22r607b77],
2	with	IN	O	with	_	0	SENT_122	[p7l628t19r786b77],
3	at	IN	O	at	quantmod	5	SENT_122	[p7l809t26r871b77],
4	least	JJS	O	least	mwe	3	SENT_122	[p7l894t19r1047b77],
5	one	CD	NUMBER	one	num	6	SENT_122	[p7l1070t36r1197b77],
6	G-allele	NN	MISC	g-allele	prep_with	1	SENT_122	[p7l1221t19r1480b77],
7	showed	VBD	O	show	_	0	SENT_122	[p7l1505t19r1766b77],
8	significant	JJ	O	significant	amod	9	SENT_122	[p7l1790t19r2150b95],
9	reduction	NN	O	reduction	dobj	7	SENT_122	[p7l10t114r344b171],
10	in	IN	O	in	_	0	SENT_122	[p7l390t117r459b171],
11	HAM	NN	O	ham	prep_in	7	SENT_122	[p7l507t115r765b171],
12	.	.	O	.	_	0	SENT_122	[p7l507t115r765b171],

1	—	NN	O	—	_	0	SENT_123	[p7l507t115r765b171],
2	.	.	O	.	_	0	SENT_123	[p7l507t115r765b171],

1	A	DT	O	a	det	2	SENT_124	[p7l507t115r765b171],
2	score	NN	NUMBER	score	nsubj	33	SENT_124	[p7l812t130r983b171],
3	when	WRB	O	when	advmod	17	SENT_124	[p7l1029t114r1223b171],
4	compared	VBN	O	compare	_	0	SENT_124	[p7l1270t114r1613b189],
5	with	IN	O	with	prepc_compared_with	17	SENT_124	[p7l1658t114r1816b171],
6	the	DT	O	the	det	8	SENT_124	[p7l1863t114r1974b171],
7	A/A	NNP	O	A/A	nn	8	SENT_124	[p7l2020t113r2151b179],
8	group	NN	O	group	pobj	17	SENT_124	[p7l9t225r210b284],
9	at	IN	O	at	_	0	SENT_124	[p7l246t216r308b266],
10	the	DT	O	the	det	13	SENT_124	[p7l343t209r454b266],
11	main	JJ	O	main	amod	13	SENT_124	[p7l490t212r668b266],
12	study	NN	O	study	nn	13	SENT_124	[p7l705t209r893b284],
13	endpoint	NN	O	endpoint	prep_at	8	SENT_124	[p7l926t209r1243b284],
14	of	IN	O	of	_	0	SENT_124	[p7l1279t208r1349b266],
15	6	CD	DURATION	6	prep_of	13	SENT_124	[p7l1382t210r1419b266],
16	months	NNS	NUMBER	month	nsubj	17	SENT_124	[p7l1455t209r1723b266],
17	(	VBP	O	(	dep	2	SENT_124	[p7l1762t208r1914b281],
18	A/A	NN	O	a/a	nn	19	SENT_124	[p7l1762t208r1914b281],
19	group	NN	O	group	nsubj	20	SENT_124	[p7l1949t225r2149b284],
20	mean	VB	O	mean	ccomp	17	SENT_124	[p7l9t321r202b362],
21	HAM-A	NN	O	ham-a	dobj	20	SENT_124	[p7l228t306r501b362],
22	:	:	O	:	_	0	SENT_124	[p7l228t306r501b362],
23	11.38	CD	NUMBER	11.38	dep	21	SENT_124	[p7l536t306r735b374],
24	,	,	O	,	_	0	SENT_124	[p7l536t306r735b374],
25	s.e.	NN	O	s.e.	appos	23	SENT_124	[p7l766t321r888b362],
26	:	:	O	:	_	0	SENT_124	[p7l766t321r888b362],
27	1.64	CD	NUMBER	1.64	dep	21	SENT_124	[p7l922t306r1079b374],
28	;	:	O	;	_	0	SENT_124	[p7l922t306r1079b374],
29	G/A	NN	O	g/a	dep	21	SENT_124	[p7l1110t304r1314b369],
30	+	CC	O	+	_	0	SENT_124	[p7l1110t304r1314b369],
31	G/G	NN	O	g/g	nn	32	SENT_124	[p7l1333t304r1478b369],
32	group	NN	O	group	dep	21	SENT_124	[p7l1501t321r1702b380],
33	mean	VB	O	mean	_	0	SENT_124	[p7l1727t321r1921b362],
34	HAMA	NNP	O	HAMA	dobj	33	SENT_124	[p7l1945t306r2149b361, p7l8t400r75b456],
35	:	:	O	:	_	0	SENT_124	[p7l1945t306r2149b361, p7l8t400r75b456],
36	6.58	CD	NUMBER	6.58	dep	34	SENT_124	[p7l126t400r287b469],
37	,	,	O	,	_	0	SENT_124	[p7l126t400r287b469],
38	s.e.	NN	O	s.e.	appos	36	SENT_124	[p7l337t416r459b457],
39	:	:	O	:	_	0	SENT_124	[p7l337t416r459b457],
40	0.71	CD	NUMBER	0.71	dep	34	SENT_124	[p7l507t400r670b468],
41	;	:	O	;	_	0	SENT_124	[p7l507t400r670b468],
42	one	CD	NUMBER	one	number	43	SENT_124	[p7l719t416r1012b475],
43	—	CD	NUMBER	—	num	45	SENT_124	[p7l719t416r1012b475],
44	way	NN	O	way	nn	45	SENT_124	[p7l719t416r1012b475],
45	analysis	NN	O	analysis	dep	34	SENT_124	[p7l1054t399r1321b475],
46	of	IN	O	of	_	0	SENT_124	[p7l1367t399r1437b456],
47	variance	NN	O	variance	prep_of	45	SENT_124	[p7l1475t402r1764b457],
48	(	CD	NUMBER	(	num	47	SENT_124	[p7l1813t399r2145b471],
49	ANOVA	NNP	O	ANOVA	dep	45	SENT_124	[p7l1813t399r2145b471],
50	)	CD	NUMBER	)	num	49	SENT_124	[p7l1813t399r2145b471],
51	:	:	O	:	_	0	SENT_124	[p7l1813t399r2145b471],
52	F	NN	O	f	dep	34	SENT_124	[p7l10t496r114b551],
53	:	:	O	:	_	0	SENT_124	[p7l10t496r114b551],
54	7.15	CD	NUMBER	7.15	dep	34	SENT_124	[p7l138t496r296b563],
55	;	:	O	;	_	0	SENT_124	[p7l138t496r296b563],
56	P	NN	O	p	dep	34	SENT_124	[p7l340t494r745b566],
57	=	JJ	O	=	amod	59	SENT_124	[p7l340t494r745b566],
58	0.0086	CD	NUMBER	0.0086	tmod	57	SENT_124	[p7l340t494r745b566],
59	)	NN	O	)	dep	56	SENT_124	[p7l340t494r745b566],
60	.	.	O	.	_	0	SENT_124	[p7l340t494r745b566],

1	Exploratory	JJ	O	exploratory	amod	2	SENT_125	[p7l793t494r1198b570],
2	analysis	NN	O	analysis	nsubj	3	SENT_125	[p7l1240t494r1507b570],
3	showed	VBD	O	show	_	0	SENT_125	[p7l1553t494r1813b552],
4	that	IN	O	that	complm	11	SENT_125	[p7l1856t494r1996b552],
5	the	DT	O	the	det	6	SENT_125	[p7l2038t494r2148b552],
6	difference	NN	O	difference	nsubj	11	SENT_125	[p7l10t588r349b646],
7	between	IN	O	between	_	0	SENT_125	[p7l374t589r664b646],
8	groups	NNS	O	group	prep_between	6	SENT_125	[p7l690t605r920b664],
9	was	VBD	O	be	cop	11	SENT_125	[p7l945t605r1071b646],
10	statistically	RB	O	statistically	advmod	11	SENT_125	[p7l1099t589r1484b664],
11	significant	JJ	O	significant	ccomp	3	SENT_125	[p7l1509t588r1868b664],
12	as	IN	O	as	_	0	SENT_125	[p7l1895t605r1958b646],
13	early	JJ	O	early	advmod	17	SENT_125	[p7l1985t589r2152b664],
14	as	IN	O	as	_	0	SENT_125	[p7l10t701r74b741],
15	week	NN	DURATION	week	prep_as	13	SENT_125	[p7l111t684r287b742],
16	12	CD	NUMBER	12	number	17	SENT_125	[p7l329t685r405b741],
17	(	CD	NUMBER	(	prep_as	11	SENT_125	[p7l447t684r762b760],
18	one	CD	NUMBER	one	num	21	SENT_125	[p7l447t684r762b760],
19	—	NN	O	—	nn	21	SENT_125	[p7l447t684r762b760],
20	way	NN	O	way	nn	21	SENT_125	[p7l447t684r762b760],
21	ANOVA	NNP	O	ANOVA	dep	17	SENT_125	[p7l797t685r1082b741],
22	:	:	O	:	_	0	SENT_125	[p7l797t685r1082b741],
23	F	NN	O	f	dep	17	SENT_125	[p7l1126t685r1412b753],
24	=	JJ	O	=	amod	23	SENT_125	[p7l1126t685r1412b753],
25	3.67	CD	NUMBER	3.67	tmod	24	SENT_125	[p7l1126t685r1412b753],
26	;	:	O	;	_	0	SENT_125	[p7l1126t685r1412b753],
27	P	NN	O	p	dep	17	SENT_125	[p7l1451t684r1813b756],
28	:0.057	CD	NUMBER	:0.057	num	29	SENT_125	[p7l1451t684r1813b756],
29	)	NN	O	)	dep	27	SENT_125	[p7l1451t684r1813b756],
30	,	,	O	,	_	0	SENT_125	[p7l1451t684r1813b756],
31	week	NN	DURATION	week	appos	17	SENT_125	[p7l1854t684r2030b742],
32	16	CD	NUMBER	16	number	33	SENT_125	[p7l2072t686r2149b741],
33	(	CD	NUMBER	(	amod	37	SENT_125	[p7l13t779r329b855],
34	one	CD	NUMBER	one	num	36	SENT_125	[p7l13t779r329b855],
35	—	NN	O	—	nn	36	SENT_125	[p7l13t779r329b855],
36	way	NN	O	way	dep	33	SENT_125	[p7l13t779r329b855],
37	ANOVA	NNP	O	ANOVA	dep	31	SENT_125	[p7l353t781r639b837],
38	:	:	O	:	_	0	SENT_125	[p7l353t781r639b837],
39	F	NN	O	f	dep	17	SENT_125	[p7l672t781r707b836],
40	=	JJ	O	=	quantmod	41	SENT_125	[p7l725t807r777b825],
41	5.44	CD	NUMBER	5.44	dep	39	SENT_125	[p7l797t782r959b849],
42	;	:	O	;	_	0	SENT_125	[p7l797t782r959b849],
43	P	NN	O	p	dep	17	SENT_125	[p7l988t782r1100b836],
44	:	:	O	:	_	0	SENT_125	[p7l988t782r1100b836],
45	0.021	CD	NUMBER	0.021	num	46	SENT_125	[p7l1119t779r1330b851],
46	)	NN	O	)	dep	17	SENT_125	[p7l1119t779r1330b851],
47	and	CC	O	and	_	0	SENT_125	[p7l1364t779r1492b837],
48	week	NN	DURATION	week	conj_and	46	SENT_125	[p7l1519t779r1695b837],
49	20	CD	NUMBER	20	number	50	SENT_125	[p7l1722t781r1805b837],
50	(	CD	NUMBER	(	amod	54	SENT_125	[p7l1836t779r2152b855],
51	one	CD	NUMBER	one	num	53	SENT_125	[p7l1836t779r2152b855],
52	—	NN	O	—	nn	53	SENT_125	[p7l1836t779r2152b855],
53	way	NN	O	way	dep	50	SENT_125	[p7l1836t779r2152b855],
54	ANOVA	NNP	O	ANOVA	dep	48	SENT_125	[p7l8t874r293b930],
55	:	:	O	:	_	0	SENT_125	[p7l8t874r293b930],
56	F	NN	O	f	dep	17	SENT_125	[p7l327t875r362b930],
57	=	JJ	O	=	amod	56	SENT_125	[p7l380t901r431b919],
58	4.48	CD	NUMBER	4.48	tmod	57	SENT_125	[p7l450t874r613b942],
59	;	:	O	;	_	0	SENT_125	[p7l450t874r613b942],
60	P	NN	O	p	dep	17	SENT_125	[p7l642t875r689b930],
61	=	JJ	O	=	amod	63	SENT_125	[p7l703t901r754b919],
62	0.036	CD	NUMBER	0.036	tmod	61	SENT_125	[p7l773t873r1005b945],
63	)	NN	O	)	dep	60	SENT_125	[p7l773t873r1005b945],
64	.	.	O	.	_	0	SENT_125	[p7l773t873r1005b945],

1	Results	NNS	O	result	nsubjpass	21	SENT_126	[p7l87t969r330b1027],
2	for	IN	O	for	_	0	SENT_126	[p7l375t969r473b1027],
3	the	DT	O	the	det	7	SENT_126	[p7l516t969r628b1027],
4	EA	NN	O	ea	nn	7	SENT_126	[p7l674t971r767b1026],
5	sample	NN	O	sample	nn	7	SENT_126	[p7l812t969r1056b1045],
6	(	CD	NUMBER	(	num	7	SENT_126	[p7l1105t969r1408b1041],
7	n	NN	O	n	prep_for	1	SENT_126	[p7l1105t969r1408b1041],
8	=	JJ	O	=	advmod	11	SENT_126	[p7l1105t969r1408b1041],
9	112	CD	NUMBER	112	num	10	SENT_126	[p7l1105t969r1408b1041],
10	)	NN	O	)	dep	8	SENT_126	[p7l1105t969r1408b1041],
11	using	VBG	O	use	partmod	7	SENT_126	[p7l1455t972r1647b1045],
12	a	DT	O	a	det	15	SENT_126	[p7l1691t986r1725b1027],
13	categorical	JJ	O	categorical	amod	15	SENT_126	[p7l1770t969r2149b1045],
14	outcome	NN	O	outcome	nn	15	SENT_126	[p7l10t1073r319b1123],
15	measure	NN	O	measure	dobj	11	SENT_126	[p7l355t1082r645b1123],
16	of	IN	O	of	_	0	SENT_126	[p7l681t1065r753b1123],
17	response/improvement	NN	O	response/improvement	prep_of	15	SENT_126	[p7l783t1065r1607b1141],
18	and	CC	O	and	_	0	SENT_126	[p7l1642t1066r1773b1123],
19	remission	NN	O	remission	conj_and	17	SENT_126	[p7l1807t1069r2149b1123],
20	are	VBP	O	be	auxpass	21	SENT_126	[p7l10t1177r111b1218],
21	shown	VBN	O	show	_	0	SENT_126	[p7l143t1161r375b1218],
22	in	IN	O	in	_	0	SENT_126	[p7l405t1164r475b1218],
23	Table	NNP	O	Table	prep_in	21	SENT_126	[p7l503t1161r688b1218],
24	2	CD	NUMBER	2	num	23	SENT_126	[p7l720t1162r777b1218],
25	.	.	O	.	_	0	SENT_126	[p7l720t1162r777b1218],

1	We	PRP	O	we	nsubj	2	SENT_127	[p7l809t1163r918b1218],
2	observed	VBD	O	observe	_	0	SENT_127	[p7l950t1161r1262b1218],
3	a	DT	O	a	det	5	SENT_127	[p7l1292t1177r1327b1218],
4	significant	JJ	O	significant	amod	5	SENT_127	[p7l1358t1160r1728b1236],
5	association	NN	O	association	dobj	2	SENT_127	[p7l1758t1164r2149b1218],
6	for	IN	O	for	_	0	SENT_127	[p7l9t1256r108b1314],
7	response	NN	O	response	nn	10	SENT_127	[p7l158t1273r463b1332],
8	(	CD	NUMBER	(	num	10	SENT_127	[p7l519t1256r828b1328],
9	HAM-A	NN	O	ham-a	nn	10	SENT_127	[p7l519t1256r828b1328],
10	)	NN	O	)	prep_for	2	SENT_127	[p7l519t1256r828b1328],
11	and	CC	O	and	_	0	SENT_127	[p7l884t1256r1015b1314],
12	improvement	NN	O	improvement	nn	15	SENT_127	[p7l1066t1259r1550b1332],
13	(	CD	NUMBER	(	num	15	SENT_127	[p7l1605t1256r1845b1328],
14	CGI-I	NN	O	cgi-i	nn	15	SENT_127	[p7l1605t1256r1845b1328],
15	)	NN	O	)	prep_for	2	SENT_127	[p7l1605t1256r1845b1328],
16	after	IN	O	after	_	0	SENT_127	[p7l1901t1256r2059b1314],
17	6	CD	DURATION	6	num	18	SENT_127	[p7l2112t1258r2149b1314],
18	months	NNS	NUMBER	month	prep_after	2	SENT_127	[p7l9t1351r283b1408],
19	of	IN	O	of	_	0	SENT_127	[p7l335t1351r406b1408],
20	treatment	NN	O	treatment	prep_of	18	SENT_127	[p7l452t1358r820b1409],
21	.	.	O	.	_	0	SENT_127	[p7l452t1358r820b1409],

1	In	IN	O	in	_	0	SENT_128	[p7l876t1353r949b1408],
2	addition	NN	O	addition	prep_in	20	SENT_128	[p7l1000t1351r1317b1421],
3	,	,	O	,	_	0	SENT_128	[p7l1000t1351r1317b1421],
4	similar	JJ	O	similar	amod	2	SENT_128	[p7l1374t1351r1613b1408],
5	to	TO	O	to	_	0	SENT_128	[p7l1663t1358r1732b1408],
6	previously	RB	DATE	previously	advmod	7	SENT_128	[p7l1783t1351r2152b1427],
7	reported	VBN	O	report	amod	8	SENT_128	[p7l9t1444r308b1520],
8	findings	NNS	O	finding	prep_to	4	SENT_128	[p7l351t1437r808b1520],
9	,12	CD	NUMBER	,12	number	10	SENT_128	[p7l351t1437r808b1520],
10	'13	CD	NUMBER	'13	nsubj	20	SENT_128	[p7l351t1437r808b1520],
11	we	PRP	O	we	nsubj	12	SENT_128	[p7l851t1461r947b1502],
12	show	VBP	O	show	rcmod	10	SENT_128	[p7l993t1444r1177b1502],
13	a	DT	O	a	det	15	SENT_128	[p7l1218t1461r1252b1502],
14	dominant	JJ	O	dominant	amod	15	SENT_128	[p7l1296t1444r1648b1502],
15	effect	NN	O	effect	dobj	12	SENT_128	[p7l1692t1444r1882b1502],
16	of	IN	O	of	_	0	SENT_128	[p7l1926t1444r1997b1502],
17	the	DT	O	the	det	19	SENT_128	[p7l2036t1444r2148b1502],
18	G-allele	JJ	O	g-allele	amod	19	SENT_128	[p7l11t1539r278b1597],
19	(	NN	O	(	prep_of	15	SENT_128	[p7l313t1540r440b1612],
20	see	VBP	O	see	_	0	SENT_128	[p7l313t1540r440b1612],
21	also	RB	O	also	advmod	20	SENT_128	[p7l472t1540r606b1597],
22	Figure	NNP	O	Figure	dobj	20	SENT_128	[p7l638t1542r853b1615],
23	1	CD	NUMBER	1	num	24	SENT_128	[p7l891t1540r970b1611],
24	)	CD	NUMBER	)	dep	22	SENT_128	[p7l891t1540r970b1611],
25	.	.	O	.	_	0	SENT_128	[p7l891t1540r970b1611],

1	Patients	NNS	O	patient	nsubj	36	SENT_129	[p7l1006t1542r1284b1597],
2	with	IN	O	with	_	0	SENT_129	[p7l1314t1539r1476b1597],
3	one	CD	NUMBER	one	prep_with	1	SENT_129	[p7l1507t1556r1635b1597],
4	or	CC	O	or	_	0	SENT_129	[p7l1668t1556r1739b1597],
5	two	CD	NUMBER	two	num	6	SENT_129	[p7l1769t1547r1899b1597],
6	copies	NNS	O	copy	conj_or	1	SENT_129	[p7l1932t1542r2149b1615],
7	of	IN	O	of	_	0	SENT_129	[p7l10t1635r81b1693],
8	the	DT	O	the	det	10	SENT_129	[p7l118t1635r231b1693],
9	rs7997012	NN	O	rs7997012	nn	10	SENT_129	[p7l273t1637r636b1693],
10	G-allele	NN	O	g-allele	prep_of	6	SENT_129	[p7l678t1635r945b1693],
11	did	VBD	O	do	_	0	SENT_129	[p7l989t1635r1101b1693],
12	respond	VB	O	respond	ccomp	11	SENT_129	[p7l1141t1635r1425b1711],
13	significantly	RB	O	significantly	advmod	14	SENT_129	[p7l1467t1635r1906b1711],
14	better	JJR	O	better	acomp	12	SENT_129	[p7l1943t1635r2150b1693],
15	than	IN	O	than	_	0	SENT_129	[p7l9t1730r174b1788],
16	patients	NNS	O	patient	prep_than	14	SENT_129	[p7l215t1733r497b1806],
17	with	IN	O	with	_	0	SENT_129	[p7l538t1730r700b1788],
18	an	DT	O	a	det	20	SENT_129	[p7l742t1747r827b1788],
19	A/A	NN	O	a/a	nn	20	SENT_129	[p7l867t1730r1000b1795],
20	genotype	NN	O	genotype	prep_with	16	SENT_129	[p7l1041t1737r1367b1806],
21	(	CD	NUMBER	(	num	22	SENT_129	[p7l1413t1730r1481b1802],
22	P	NN	O	p	dep	12	SENT_129	[p7l1413t1730r1481b1802],
23	=	JJ	O	=	amod	22	SENT_129	[p7l1496t1732r1734b1800],
24	0.02	CD	NUMBER	0.02	tmod	23	SENT_129	[p7l1496t1732r1734b1800],
25	;	:	O	;	_	0	SENT_129	[p7l1496t1732r1734b1800],
26	odds	NNS	O	odds	dep	22	SENT_129	[p7l1781t1730r1944b1788],
27	ratio	NN	O	ratio	nn	30	SENT_129	[p7l1987t1733r2148b1788],
28	(	CD	NUMBER	(	num	30	SENT_129	[p7l13t1825r167b1897],
29	OR	NN	O	or	nn	30	SENT_129	[p7l13t1825r167b1897],
30	)	NN	O	)	dep	26	SENT_129	[p7l13t1825r167b1897],
31	=	JJ	O	=	amod	33	SENT_129	[p7l189t1853r241b1871],
32	3.35	CD	NUMBER	3.35	tmod	31	SENT_129	[p7l261t1825r454b1897],
33	)	NN	O	)	dep	30	SENT_129	[p7l261t1825r454b1897],
34	,	,	O	,	_	0	SENT_129	[p7l261t1825r454b1897],
35	and	CC	O	and	_	0	SENT_129	[p7l492t1825r622b1882],
36	showed	VBD	O	show	conj_and	11	SENT_129	[p7l656t1825r922b1882],
37	better	JJR	O	better	amod	38	SENT_129	[p7l952t1825r1160b1882],
38	improvement	NN	O	improvement	dobj	36	SENT_129	[p7l1191t1828r1675b1900],
39	at	IN	O	at	_	0	SENT_129	[p7l1708t1832r1771b1882],
40	6	CD	DURATION	6	num	41	SENT_129	[p7l1805t1826r1842b1882],
41	months	NNS	NUMBER	month	prep_at	36	SENT_129	[p7l1875t1825r2148b1882],
42	(	CD	NUMBER	(	num	43	SENT_129	[p7l13t1920r376b1992],
43	P	NN	O	p	dobj	11	SENT_129	[p7l13t1920r376b1992],
44	=	JJ	O	=	amod	43	SENT_129	[p7l13t1920r376b1992],
45	0.002	CD	NUMBER	0.002	tmod	44	SENT_129	[p7l13t1920r376b1992],
46	,	,	O	,	_	0	SENT_129	[p7l13t1920r376b1992],
47	OR	NN	O	or	nsubj	50	SENT_129	[p7l418t1920r807b1992],
48	=	JJ	O	=	amod	50	SENT_129	[p7l418t1920r807b1992],
49	4.98	CD	NUMBER	4.98	num	50	SENT_129	[p7l418t1920r807b1992],
50	)	NN	O	)	conj_and	11	SENT_129	[p7l418t1920r807b1992],
51	.	.	O	.	_	0	SENT_129	[p7l418t1920r807b1992],

1	For	IN	O	for	_	0	SENT_130	[p7l848t1923r959b1978],
2	the	DT	O	the	det	6	SENT_130	[p7l994t1920r1107b1978],
3	combined	JJ	O	combined	amod	6	SENT_130	[p7l1144t1920r1498b1978],
4	sample	NN	O	sample	nn	6	SENT_130	[p7l1536t1920r1780b1996],
5	(	NN	O	(	nn	6	SENT_130	[p7l1820t1920r1954b1992],
6	n	NN	O	n	prep_for	16	SENT_130	[p7l1820t1920r1954b1992],
7	:	:	O	:	_	0	SENT_130	[p7l1820t1920r1954b1992],
8	156	CD	NUMBER	156	num	9	SENT_130	[p7l1978t1920r2144b1992],
9	)	NN	O	)	dep	6	SENT_130	[p7l1978t1920r2144b1992],
10	,	,	O	,	_	0	SENT_130	[p7l1978t1920r2144b1992],
11	the	DT	O	the	det	12	SENT_130	[p7l9t2015r122b2073],
12	frequency	NN	O	frequency	nsubj	16	SENT_130	[p7l154t2015r508b2091],
13	of	IN	O	of	_	0	SENT_130	[p7l538t2015r609b2073],
14	the	DT	O	the	det	15	SENT_130	[p7l636t2015r749b2073],
15	G-allele	JJ	MISC	g-allele	prep_of	12	SENT_130	[p7l782t2015r1049b2073],
16	differed	VBD	O	differ	_	0	SENT_130	[p7l1083t2015r1353b2073],
17	significantly	RB	O	significantly	advmod	16	SENT_130	[p7l1386t2015r1825b2091],
18	between	IN	O	between	_	0	SENT_130	[p7l1852t2015r2150b2073],
19	responders	NNS	O	responder	nsubj	20	SENT_130	[p7l10t2110r390b2185],
20	(	VBP	O	(	prepc_between	16	SENT_130	[p7l438t2110r638b2182],
21	70	CD	PERCENT	70	num	22	SENT_130	[p7l438t2110r638b2182],
22	%	NN	PERCENT	%	dobj	20	SENT_130	[p7l438t2110r638b2182],
23	)	CD	NUMBER	)	tmod	20	SENT_130	[p7l438t2110r638b2182],
24	and	CC	O	and	_	0	SENT_130	[p7l687t2110r818b2167],
25	nonresponders	NNS	O	nonresponder	nsubj	26	SENT_130	[p7l862t2110r1389b2185],
26	(	VBP	O	(	conj_and	20	SENT_130	[p7l1436t2110r1636b2182],
27	56	CD	PERCENT	56	num	28	SENT_130	[p7l1436t2110r1636b2182],
28	%	NN	PERCENT	%	nn	37	SENT_130	[p7l1436t2110r1636b2182],
29	)	CD	NUMBER	)	number	31	SENT_130	[p7l1436t2110r1636b2182],
30	at	IN	O	at	quantmod	31	SENT_130	[p7l1685t2117r1748b2167],
31	6	CD	DURATION	6	num	32	SENT_130	[p7l1794t2111r1831b2167],
32	months	NNS	NUMBER	month	tmod	28	SENT_130	[p7l1875t2110r2148b2167],
33	(	CD	NUMBER	(	num	34	SENT_130	[p7l13t2205r338b2277],
34	P	NN	O	p	dep	28	SENT_130	[p7l13t2205r338b2277],
35	=	JJ	O	=	amod	37	SENT_130	[p7l13t2205r338b2277],
36	0.05	CD	NUMBER	0.05	tmod	35	SENT_130	[p7l13t2205r338b2277],
37	)	NN	O	)	dobj	26	SENT_130	[p7l13t2205r338b2277],
38	using	VBG	O	use	xcomp	26	SENT_130	[p7l396t2208r588b2281],
39	the	DT	O	the	det	41	SENT_130	[p7l641t2205r754b2263],
40	HAM-A	NN	O	ham-a	nn	41	SENT_130	[p7l811t2207r1073b2262],
41	scale	NN	O	scale	dobj	38	SENT_130	[p7l1129t2205r1291b2263],
42	as	IN	O	as	_	0	SENT_130	[p7l1348t2222r1413b2263],
43	outcome	NN	O	outcome	nn	44	SENT_130	[p7l1470t2212r1779b2263],
44	measure	NN	O	measure	prep_as	38	SENT_130	[p7l1835t2222r2145b2263],
45	.	.	O	.	_	0	SENT_130	[p7l1835t2222r2145b2263],

1	Similarly	RB	O	similarly	_	0	SENT_131	[p7l10t2300r335b2376],
2	,	,	O	,	_	0	SENT_131	[p7l10t2300r335b2376],
3	using	VBG	O	use	dep	1	SENT_131	[p7l414t2303r607b2376],
4	the	DT	O	the	det	5	SENT_131	[p7l681t2300r794b2358],
5	CGI	NNP	O	CGI	pobj	3	SENT_131	[p7l872t2301r1062b2358],
6	.	.	O	.	_	0	SENT_131	[p7l872t2301r1062b2358],

1	—	NN	O	—	_	0	SENT_132	[p7l872t2301r1062b2358],
2	.	.	O	.	_	0	SENT_132	[p7l872t2301r1062b2358],

1	I	PRP	O	I	nsubjpass	9	SENT_133	[p7l872t2301r1062b2358],
2	as	RB	O	as	prep	1	SENT_133	[p7l1140t2317r1205b2357],
3	outcome	NN	O	outcome	pobj	2	SENT_133	[p7l1282t2307r1610b2370],
4	,	,	O	,	_	0	SENT_133	[p7l1282t2307r1610b2370],
5	the	DT	O	the	det	6	SENT_133	[p7l1691t2300r1803b2358],
6	G-allele	NN	MISC	g-allele	appos	3	SENT_133	[p7l1881t2300r2148b2358],
7	was	VBD	O	be	auxpass	9	SENT_133	[p7l8t2412r135b2452],
8	significantly	RB	O	significantly	advmod	9	SENT_133	[p7l182t2395r621b2471],
9	associated	VBN	O	associate	_	0	SENT_133	[p7l663t2395r1019b2453],
10	with	IN	O	with	_	0	SENT_133	[p7l1061t2395r1223b2452],
11	improvement	NN	O	improvement	nn	13	SENT_133	[p7l1267t2398r1751b2471],
12	(	CD	NUMBER	(	num	13	SENT_133	[p7l1798t2395r1865b2467],
13	P	NN	O	p	prep_with	9	SENT_133	[p7l1798t2395r1865b2467],
14	=	JJ	O	=	amod	13	SENT_133	[p7l1880t2395r2145b2467],
15	0.01	CD	NUMBER	0.01	num	16	SENT_133	[p7l1880t2395r2145b2467],
16	)	NN	O	)	dep	14	SENT_133	[p7l1880t2395r2145b2467],
17	.	.	O	.	_	0	SENT_133	[p7l1880t2395r2145b2467],

1	Assuming	VBG	O	assume	_	0	SENT_134	[p7l8t2491r357b2565],
2	a	DT	O	a	det	4	SENT_134	[p7l386t2506r421b2547],
3	dominant	JJ	O	dominant	amod	4	SENT_134	[p7l451t2490r803b2547],
4	effect	NN	O	effect	dobj	1	SENT_134	[p7l834t2489r1025b2547],
5	of	IN	O	of	_	0	SENT_134	[p7l1055t2489r1126b2547],
6	the	DT	O	the	det	7	SENT_134	[p7l1151t2490r1264b2547],
7	G-allele	NN	O	g-allele	prep_of	4	SENT_134	[p7l1296t2489r1581b2560],
8	,	,	O	,	_	0	SENT_134	[p7l1296t2489r1581b2560],
9	and	CC	O	and	_	0	SENT_134	[p7l1618t2489r1749b2547],
10	a	DT	O	a	det	12	SENT_134	[p7l1779t2506r1814b2547],
11	recessive	JJ	O	recessive	amod	12	SENT_134	[p7l1843t2492r2148b2547],
12	effect	NN	O	effect	dobj	1	SENT_134	[p7l10t2585r201b2643],
13	of	IN	O	of	_	0	SENT_134	[p7l250t2585r321b2643],
14	the	DT	O	the	det	15	SENT_134	[p7l365t2585r477b2643],
15	A-allele	NN	O	a-allele	prep_of	12	SENT_134	[p7l526t2585r806b2655],
16	,	,	O	,	_	0	SENT_134	[p7l526t2585r806b2655],
17	improvement	NN	O	improvement	appos	15	SENT_134	[p7l859t2588r1343b2661],
18	differed	VBD	O	differ	dep	1	SENT_134	[p7l1392t2585r1662b2643],
19	significantly	RB	O	significantly	advmod	18	SENT_134	[p7l1712t2585r2151b2661],
20	between	IN	O	between	_	0	SENT_134	[p7l7t2680r305b2738],
21	groups	NNS	O	group	prep_between	18	SENT_134	[p7l340t2697r576b2756],
22	(	CD	NUMBER	(	num	23	SENT_134	[p7l615t2680r979b2752],
23	P	NN	O	p	npadvmod	24	SENT_134	[p7l615t2680r979b2752],
24	=	JJ	O	=	amod	21	SENT_134	[p7l615t2680r979b2752],
25	0.001	CD	NUMBER	0.001	nsubj	1	SENT_134	[p7l615t2680r979b2752],
26	,	,	O	,	_	0	SENT_134	[p7l615t2680r979b2752],
27	OR	NN	O	or	appos	25	SENT_134	[p7l1020t2680r1409b2752],
28	=	JJ	O	=	amod	30	SENT_134	[p7l1020t2680r1409b2752],
29	4.72	CD	NUMBER	4.72	tmod	28	SENT_134	[p7l1020t2680r1409b2752],
30	)	NN	O	)	dep	27	SENT_134	[p7l1020t2680r1409b2752],
31	.	.	O	.	_	0	SENT_134	[p7l1020t2680r1409b2752],

1	Similar	JJ	O	similar	amod	2	SENT_135	[p7l1450t2680r1697b2738],
2	trends	NNS	O	trend	nsubjpass	4	SENT_135	[p7l1732t2680r1951b2738],
3	were	VBD	O	be	auxpass	4	SENT_135	[p7l1985t2697r2148b2738],
4	observed	VBN	O	observe	_	0	SENT_135	[p7l10t2775r323b2832],
5	for	IN	O	for	_	0	SENT_135	[p7l362t2774r460b2832],
6	remission	NN	O	remission	prep_for	4	SENT_135	[p7l499t2778r841b2832],
7	in	IN	O	in	_	0	SENT_135	[p7l881t2778r952b2832],
8	the	DT	O	the	det	10	SENT_135	[p7l992t2775r1104b2832],
9	combined	JJ	O	combined	amod	10	SENT_135	[p7l1146t2775r1500b2832],
10	sample	NN	O	sample	prep_in	6	SENT_135	[p7l1541t2775r1786b2850],
11	although	IN	O	although	mark	18	SENT_135	[p7l1828t2775r2149b2850],
12	not	RB	O	not	neg	14	SENT_135	[p7l9t2877r130b2928],
13	statistically	RB	O	statistically	advmod	14	SENT_135	[p7l161t2870r560b2946],
14	significant	JJ	O	significant	amod	16	SENT_135	[p7l588t2870r959b2946],
15	(	NN	O	(	nn	16	SENT_135	[p7l992t2870r1165b2942],
16	data	NNS	O	datum	nsubj	18	SENT_135	[p7l992t2870r1165b2942],
17	not	RB	O	not	neg	18	SENT_135	[p7l1195t2877r1315b2928],
18	shown	VBN	O	show	advcl	4	SENT_135	[p7l1346t2870r1623b2942],
19	)	NN	O	)	dobj	18	SENT_135	[p7l1346t2870r1623b2942],
20	.	.	O	.	_	0	SENT_135	[p7l1346t2870r1623b2942],

1	As	IN	O	as	mark	9	SENT_136	[p7l85t2967r165b3023],
2	the	DT	O	the	det	3	SENT_136	[p7l194t2965r306b3023],
3	majority	NN	O	majority	nsubj	9	SENT_136	[p7l336t2968r640b3041],
4	of	IN	O	of	_	0	SENT_136	[p7l667t2965r739b3023],
5	our	PRP$	O	we	poss	6	SENT_136	[p7l763t2982r882b3023],
6	patients	NNS	O	patient	prep_of	3	SENT_136	[p7l909t2968r1191b3041],
7	were	VBD	O	be	aux	9	SENT_136	[p7l1218t2982r1382b3023],
8	already	RB	O	already	advmod	9	SENT_136	[p7l1413t2965r1669b3041],
9	participating	VBG	O	participate	advcl	29	SENT_136	[p7l1694t2968r2150b3041],
10	in	IN	O	in	_	0	SENT_136	[p7l10t3063r80b3117],
11	various	JJ	O	various	amod	13	SENT_136	[p7l107t3063r363b3117],
12	treatment	NN	O	treatment	nn	13	SENT_136	[p7l394t3067r745b3117],
13	phases	NNS	O	phase	prep_in	9	SENT_136	[p7l773t3060r1006b3135],
14	of	IN	O	of	_	0	SENT_136	[p7l1037t3059r1109b3117],
15	this	DT	O	this	det	17	SENT_136	[p7l1134t3060r1264b3117],
16	clinical	JJ	O	clinical	amod	17	SENT_136	[p7l1295t3060r1550b3117],
17	trial	NN	O	trial	prep_of	13	SENT_136	[p7l1581t3060r1722b3117],
18	at	IN	O	at	_	0	SENT_136	[p7l1753t3067r1816b3117],
19	the	DT	O	the	det	20	SENT_136	[p7l1846t3060r1958b3117],
20	time	NN	O	time	prep_at	9	SENT_136	[p7l1990t3063r2148b3117],
21	we	PRP	O	we	nsubj	22	SENT_136	[p7l8t3172r103b3213],
22	collected	VBD	O	collect	rcmod	20	SENT_136	[p7l172t3155r488b3213],
23	DNA	NN	MISC	dna	dobj	22	SENT_136	[p7l555t3157r741b3225],
24	,	,	O	,	_	0	SENT_136	[p7l555t3157r741b3225],
25	our	PRP$	O	we	poss	26	SENT_136	[p7l814t3172r932b3213],
26	sample	NN	O	sample	nsubjpass	29	SENT_136	[p7l1000t3155r1245b3231],
27	should	MD	O	should	aux	29	SENT_136	[p7l1315t3155r1554b3213],
28	be	VB	O	be	auxpass	29	SENT_136	[p7l1618t3155r1698b3213],
29	considered	VBN	O	consider	_	0	SENT_136	[p7l1767t3155r2149b3213],
30	nonrandom	JJ	O	nonrandom	dobj	29	SENT_136	[p8l9t17r434b74],
31	and	CC	O	and	_	0	SENT_136	[p8l460t17r590b74],
32	overrepresents	NNS	O	overrepresent	nn	33	SENT_136	[p8l616t24r1127b93],
33	completers	NNS	O	completer	conj_and	30	SENT_136	[p8l1153t17r1557b93],
34	.	.	O	.	_	0	SENT_136	[p8l1153t17r1557b93],

1	Completer	NNP	O	Completer	nn	2	SENT_137	[p8l1588t17r1963b93],
2	rates	NNS	O	rate	nsubj	27	SENT_137	[p8l1987t24r2149b75],
3	were	VBD	O	be	cop	27	SENT_137	[p8l8t129r171b170],
4	for	IN	O	for	_	0	SENT_137	[p8l201t112r299b169],
5	the	DT	O	the	det	7	SENT_137	[p8l327t112r439b170],
6	EA	NN	O	ea	nn	7	SENT_137	[p8l469t113r562b169],
7	sample	NN	O	sample	prep_for	27	SENT_137	[p8l592t112r855b188],
8	:	:	O	:	_	0	SENT_137	[p8l592t112r855b188],
9	baseline	NN	O	baseline	dep	7	SENT_137	[p8l886t112r1192b170],
10	:	:	O	:	_	0	SENT_137	[p8l886t112r1192b170],
11	11	CD	NUMBER	11	dep	7	SENT_137	[p8l1226t129r1265b169],
12	:	:	O	:	_	0	SENT_137	[p8l1284t140r1335b158],
13	112	CD	NUMBER	112	dep	7	SENT_137	[p8l1359t113r1499b181],
14	;	:	O	;	_	0	SENT_137	[p8l1359t113r1499b181],
15	week	NN	DURATION	week	dep	7	SENT_137	[p8l1530t112r1710b170],
16	12	CD	NUMBER	12	num	15	SENT_137	[p8l1742t113r1838b169],
17	:	:	O	:	_	0	SENT_137	[p8l1742t113r1838b169],
18	n	NN	O	n	dep	7	SENT_137	[p8l1872t129r1910b169],
19	=	JJ	O	=	amod	18	SENT_137	[p8l1930t140r1981b158],
20	103	CD	NUMBER	103	tmod	19	SENT_137	[p8l2005t113r2145b181],
21	;	:	O	;	_	0	SENT_137	[p8l2005t113r2145b181],
22	week	NN	DURATION	week	dep	7	SENT_137	[p8l8t206r187b264],
23	24	CD	NUMBER	24	num	22	SENT_137	[p8l210t208r310b264],
24	:	:	O	:	_	0	SENT_137	[p8l210t208r310b264],
25	n	NN	O	n	dep	7	SENT_137	[p8l340t223r379b264],
26	=	JJ	O	=	amod	27	SENT_137	[p8l398t235r449b253],
27	89	CD	NUMBER	89	_	0	SENT_137	[p8l469t208r569b277],
28	,	,	O	,	_	0	SENT_137	[p8l469t208r569b277],
29	which	WDT	O	which	nsubj	30	SENT_137	[p8l596t206r816b264],
30	represents	VBZ	O	represent	rcmod	27	SENT_137	[p8l840t214r1197b282],
31	an	DT	O	a	det	33	SENT_137	[p8l1222t223r1307b264],
32	attrition	NN	O	attrition	nn	33	SENT_137	[p8l1332t209r1625b264],
33	rate	NN	O	rate	dobj	30	SENT_137	[p8l1650t214r1780b264],
34	of	IN	O	of	_	0	SENT_137	[p8l1806t206r1878b264],
35	~	NN	O	~	prep_of	33	SENT_137	[p8l1909t235r1959b252],
36	21	CD	PERCENT	21	number	37	SENT_137	[p8l1975t208r2145b264],
37	%	NN	PERCENT	%	amod	35	SENT_137	[p8l1975t208r2145b264],
38	.	.	O	.	_	0	SENT_137	[p8l1975t208r2145b264],

1	In	IN	O	in	_	0	SENT_138	[p8l10t305r83b359],
2	comparison	NN	O	comparison	prep_in	20	SENT_138	[p8l105t305r539b378],
3	,	,	O	,	_	0	SENT_138	[p8l105t305r539b378],
4	the	DT	O	the	det	6	SENT_138	[p8l566t302r678b360],
5	attrition	NN	O	attrition	nn	6	SENT_138	[p8l702t305r996b360],
6	rate	NN	O	rate	nsubj	20	SENT_138	[p8l1018t309r1148b360],
7	for	IN	O	for	_	0	SENT_138	[p8l1171t302r1270b360],
8	the	DT	DURATION	the	det	11	SENT_138	[p8l1290t302r1403b360],
9	first	JJ	DURATION	first	amod	11	SENT_138	[p8l1426t302r1562b360],
10	6	CD	DURATION	6	num	11	SENT_138	[p8l1586t304r1622b360],
11	months	NNS	NUMBER	month	prep_for	6	SENT_138	[p8l1645t302r1919b360],
12	of	IN	O	of	_	0	SENT_138	[p8l1942t302r2014b360],
13	our	PRP$	O	we	poss	16	SENT_138	[p8l2032t319r2150b360],
14	clinical	JJ	O	clinical	amod	16	SENT_138	[p8l10t395r265b453],
15	treatment	NN	O	treatment	nn	16	SENT_138	[p8l292t402r642b453],
16	trial	NN	O	trial	prep_of	11	SENT_138	[p8l669t395r810b453],
17	was	VBD	O	be	cop	20	SENT_138	[p8l836t412r964b453],
18	~	CD	PERCENT	~	number	19	SENT_138	[p8l1003t388r1307b453],
19	42	CD	PERCENT	42	num	20	SENT_138	[p8l1003t388r1307b453],
20	%	NN	PERCENT	%	_	0	SENT_138	[p8l1003t388r1307b453],
21	.15	CD	NUMBER	.15	num	23	SENT_138	[p8l1003t388r1307b453],
22	Exploratory	JJ	O	exploratory	amod	23	SENT_138	[p8l1337t395r1753b471],
23	analysis	NN	O	analysis	dep	20	SENT_138	[p8l1779t395r2054b471],
24	of	IN	O	of	_	0	SENT_138	[p8l2082t395r2153b453],
25	only	RB	O	only	advmod	27	SENT_138	[p8l10t491r170b566],
26	EA	NN	O	ea	nn	27	SENT_138	[p8l202t492r295b548],
27	completers	NNS	O	completer	prep_of	23	SENT_138	[p8l330t491r715b566],
28	at	IN	O	at	_	0	SENT_138	[p8l752t498r815b548],
29	week	NN	DURATION	week	nn	32	SENT_138	[p8l847t491r1027b548],
30	24	CD	NUMBER	24	num	32	SENT_138	[p8l1060t492r1142b548],
31	(	NN	O	(	nn	32	SENT_138	[p8l1181t491r1315b563],
32	n	NN	O	n	prep_at	27	SENT_138	[p8l1181t491r1315b563],
33	:	:	O	:	_	0	SENT_138	[p8l1181t491r1315b563],
34	89	CD	NUMBER	89	num	35	SENT_138	[p8l1335t491r1440b563],
35	)	NN	O	)	nsubj	36	SENT_138	[p8l1335t491r1440b563],
36	reveals	VBZ	O	reveal	dep	23	SENT_138	[p8l1479t491r1716b548],
37	statistically	RB	O	statistically	advmod	38	SENT_138	[p8l1753t491r2152b566],
38	significant	JJ	O	significant	amod	39	SENT_138	[p8l11t586r382b662],
39	differences	NNS	O	difference	nsubj	43	SENT_138	[p8l409t586r790b644],
40	between	IN	O	between	_	0	SENT_138	[p8l816t586r1113b644],
41	genotype	NN	O	genotype	nn	42	SENT_138	[p8l1140t593r1466b662],
42	groups	NNS	O	group	prep_between	39	SENT_138	[p8l1495t603r1731b662],
43	(	VBP	O	(	ccomp	36	SENT_138	[p8l1762t586r1917b658],
44	A/A	NN	O	a/a	nn	45	SENT_138	[p8l1762t586r1917b658],
45	group	NN	O	group	nsubj	46	SENT_138	[p8l1944t603r2149b662],
46	mean	VB	O	mean	ccomp	43	SENT_138	[p8l9t698r206b739],
47	HAM-A	NN	O	ham-a	dobj	46	SENT_138	[p8l264t683r543b739],
48	:	:	O	:	_	0	SENT_138	[p8l264t683r543b739],
49	8.41	CD	NUMBER	8.41	dep	47	SENT_138	[p8l607t683r773b751],
50	,	,	O	,	_	0	SENT_138	[p8l607t683r773b751],
51	s.e.	NN	O	s.e.	appos	49	SENT_138	[p8l838t698r964b739],
52	:	:	O	:	_	0	SENT_138	[p8l838t698r964b739],
53	1.41	CD	NUMBER	1.41	dep	47	SENT_138	[p8l1032t683r1195b751],
54	;	:	O	;	_	0	SENT_138	[p8l1032t683r1195b751],
55	G/A	NN	O	g/a	dep	47	SENT_138	[p8l1258t681r1466b746],
56	+	CC	O	+	_	0	SENT_138	[p8l1258t681r1466b746],
57	G/G	NN	O	g/g	nn	58	SENT_138	[p8l1486t681r1631b746],
58	group	NN	O	group	dep	47	SENT_138	[p8l1689t698r1895b757],
59	mean	VB	O	mean	dep	46	SENT_138	[p8l1953t698r2149b739],
60	HAM-A	NN	O	ham-a	dobj	59	SENT_138	[p8l10t777r289b833],
61	:	:	O	:	_	0	SENT_138	[p8l10t777r289b833],
62	4.62	CD	NUMBER	4.62	dep	23	SENT_138	[p8l317t777r484b846],
63	,	,	O	,	_	0	SENT_138	[p8l317t777r484b846],
64	s.e.	NN	O	s.e.	appos	62	SENT_138	[p8l514t793r640b834],
65	:	:	O	:	_	0	SENT_138	[p8l514t793r640b834],
66	0.55	CD	NUMBER	0.55	dep	62	SENT_138	[p8l668t777r836b845],
67	;	:	O	;	_	0	SENT_138	[p8l668t777r836b845],
68	one-way	JJ	O	one-way	amod	69	SENT_138	[p8l864t793r1163b852],
69	ANOVA	NNP	O	ANOVA	dep	66	SENT_138	[p8l1183t777r1474b833],
70	:	:	O	:	_	0	SENT_138	[p8l1183t777r1474b833],
71	F	NN	O	f	dep	62	SENT_138	[p8l1502t778r1537b833],
72	=	JJ	O	=	quantmod	73	SENT_138	[p8l1556t804r1608b822],
73	6.24	CD	NUMBER	6.24	dep	71	SENT_138	[p8l1628t777r1794b846],
74	;	:	O	;	_	0	SENT_138	[p8l1628t777r1794b846],
75	P	NN	O	p	dep	62	SENT_138	[p8l1818t778r1865b833],
76	=	JJ	O	=	amod	78	SENT_138	[p8l1880t804r1932b822],
77	0.01	CD	NUMBER	0.01	tmod	76	SENT_138	[p8l1950t776r2145b848],
78	)	NN	O	)	dep	75	SENT_138	[p8l1950t776r2145b848],
79	.	.	O	.	_	0	SENT_138	[p8l1950t776r2145b848],

1	The	DT	O	the	det	3	SENT_139	[p8l1261t1044r1363b1089],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_139	[p8l1390t1044r1931b1103],
3	Journal	NNP	O	Journal	_	0	SENT_139	[p8l1954t1044r2147b1099],

1	@	SYM	O	@	dep	6	SENT_140	[p8l8t1178r71b1239],
2	HTRZA	NN	O	htrza	nn	6	SENT_140	[p8l406t1185r484b1206],
3	and	CC	O	and	_	0	SENT_140	[p8l493t1184r536b1206],
4	antidepressant	JJ	O	antidepressant	nn	6	SENT_140	[p8l546t1184r721b1213],
5	treatment	NN	O	treatment	nn	6	SENT_140	[p8l730t1187r851b1206],
6	response	NN	O	response	dep	11	SENT_140	[p8l860t1190r963b1213],
7	in	IN	O	in	_	0	SENT_140	[p8l972t1184r993b1206],
8	CAD	NNP	O	CAD	prep_in	6	SENT_140	[p8l1003t1185r1054b1206],
9	°	CD	NUMBER	°	num	8	SENT_140	[p8l53t1216r66b1225],
10	FW	NNP	O	FW	nn	11	SENT_140	[p8l901t1220r932b1239],
11	Lohoff	NNP	O	Lohoff	dep	14	SENT_140	[p8l941t1219r1004b1239],
12	et	FW	O	et	nn	13	SENT_140	[p8l1013t1221r1030b1239],
13	al	FW	O	al	dep	11	SENT_140	[p8l1038t1219r1056b1239],
14	24	CD	NUMBER	24	_	0	SENT_140	[p8l9t1271r45b1292],

1	Table	NNP	O	Table	_	0	SENT_141	[p8l8t1367r101b1394],
2	2	CD	NUMBER	2	num	5	SENT_141	[p8l116t1368r134b1394],
3	6-month	JJ	DURATION	6-month	amod	5	SENT_141	[p8l172t1368r312b1394],
4	outcome	NN	O	outcome	nn	5	SENT_141	[p8l327t1371r470b1394],
5	data	NNS	O	datum	dep	1	SENT_141	[p8l485t1368r565b1394],
6	:	:	O	:	_	0	SENT_141	[p8l485t1368r565b1394],
7	response/improvement	NN	O	response/improvement	nn	10	SENT_141	[p8l582t1368r968b1403],
8	(	CD	NUMBER	(	num	10	SENT_141	[p8l982t1368r1125b1401],
9	HAM-A	NN	O	ham-a	nn	10	SENT_141	[p8l982t1368r1125b1401],
10	)	NN	O	)	dep	1	SENT_141	[p8l982t1368r1125b1401],
11	and	CC	O	and	_	0	SENT_141	[p8l1140t1368r1200b1394],
12	remission	NN	O	remission	nn	15	SENT_141	[p8l1216t1368r1370b1394],
13	(	CD	NUMBER	(	num	15	SENT_141	[p8l1386t1368r1481b1401],
14	CGI	NN	O	cgus	nn	15	SENT_141	[p8l1386t1368r1481b1401],
15	)	NN	O	)	conj_and	10	SENT_141	[p8l1386t1368r1481b1401],
16	,	,	O	,	_	0	SENT_141	[p8l1386t1368r1481b1401],
17	European	JJ	MISC	european	appos	15	SENT_141	[p8l1498t1368r1825b1403],
18	.	.	O	.	_	0	SENT_141	[p8l1498t1368r1825b1403],

1	—	NN	O	—	_	0	SENT_142	[p8l1498t1368r1825b1403],
2	.	.	O	.	_	0	SENT_142	[p8l1498t1368r1825b1403],

1	American	JJ	MISC	american	amod	2	SENT_143	[p8l1498t1368r1825b1403],
2	sample	NN	O	sample	_	0	SENT_143	[p8l1841t1368r1955b1403],
3	(	NN	O	(	nn	4	SENT_143	[p8l1971t1368r2115b1401],
4	n	NN	O	n	dep	2	SENT_143	[p8l1971t1368r2115b1401],
5	:112	CD	NUMBER	:112	num	6	SENT_143	[p8l1971t1368r2115b1401],
6	)	NN	O	)	dep	2	SENT_143	[p8l1971t1368r2115b1401],

1	HTRZA	NN	O	htrza	nn	2	SENT_144	[p8l10t1482r155b1518],
2	rs7997012	NN	O	rs7997012	_	0	SENT_144	[p8l175t1482r406b1519],
3	Sample	NN	O	sample	nn	6	SENT_144	[p8l701t1481r854b1531],
4	n	NN	O	n	nn	6	SENT_144	[p8l1207t1492r1230b1518],
5	Genotype	NN	O	genotype	nn	6	SENT_144	[p8l1560t1482r1758b1531],
6	frequency	NN	O	frequency	dep	2	SENT_144	[p8l1777t1481r1979b1531],

1	G/G	NN	O	g/g	_	0	SENT_145	[p8l1431t1618r1515b1660],
2	C/A	NN	O	c/a	nn	3	SENT_145	[p8l1728t1618r1806b1660],
3	A/A	NN	O	a/a	dep	1	SENT_145	[p8l2022t1618r2097b1660],

1	Response	NN	O	response	nn	4	SENT_146	[p8l10t1755r208b1803],
2	HAM-A	NN	O	ham-a	nn	4	SENT_146	[p8l230t1755r386b1790],
3	LOCF	NN	O	locf	nn	4	SENT_146	[p8l407t1754r522b1791],
4	Responders	NNS	O	responder	dep	12	SENT_146	[p8l702t1753r948b1803],
5	90	CD	NUMBER	90	num	6	SENT_146	[p8l1192t1754r1245b1791],
6	0.36	CD	NUMBER	0.36	dep	4	SENT_146	[p8l1409t1754r1505b1791],
7	0.51	CD	NUMBER	0.51	number	8	SENT_146	[p8l1703t1754r1790b1791],
8	0.12	CD	NUMBER	0.12	num	9	SENT_146	[p8l1998t1754r2093b1791],
9	Nonresponders	NNS	O	nonresponder	dep	6	SENT_146	[p8l702t1814r1034b1864],
10	22	CD	NUMBER	22	dep	12	SENT_146	[p8l1192t1815r1244b1851],
11	0.36	CD	NUMBER	0.36	num	12	SENT_146	[p8l1409t1815r1505b1852],
12	0.31	CD	NUMBER	0.31	dep	15	SENT_146	[p8l1703t1815r1790b1852],
13	0.31	CD	NUMBER	0.31	num	14	SENT_146	[p8l1998t1815r2084b1852],
14	G	NN	O	g	dep	12	SENT_146	[p8l700t1875r732b1911],
15	dominant	JJ	O	dominant	_	0	SENT_146	[p8l753t1874r967b1911],
16	A	DT	O	a	det	19	SENT_146	[p8l983t1875r1014b1910],
17	recessive	JJ	O	recessive	amod	19	SENT_146	[p8l1034t1875r1221b1911],
18	(	NN	O	(	nn	19	SENT_146	[p8l1242t1874r1465b1920],
19	G/G	NN	O	g/g	dep	15	SENT_146	[p8l1242t1874r1465b1920],
20	+	CC	O	+	_	0	SENT_146	[p8l1242t1874r1465b1920],
21	G/A	NN	O	g/a	conj_+	19	SENT_146	[p8l1242t1874r1465b1920],
22	vs	CC	O	vs	_	0	SENT_146	[p8l1482t1885r1524b1911],
23	A/A	NN	O	a/a	nn	24	SENT_146	[p8l1542t1874r1638b1920],
24	)	NN	O	)	conj_vs	21	SENT_146	[p8l1542t1874r1638b1920],

1	Improvement	NN	O	improvement	nn	2	SENT_147	[p8l10t1949r304b1996],
2	CGI	NN	O	cgus	dep	9	SENT_147	[p8l323t1948r402b1984],
3	LOCF	NN	O	locf	nn	4	SENT_147	[p8l426t1948r541b1984],
4	Improvers	NNS	O	improver	dep	2	SENT_147	[p8l702t1949r915b1996],
5	91	CD	NUMBER	91	dep	9	SENT_147	[p8l1192t1948r1236b1984],
6	0.37	CD	NUMBER	0.37	num	9	SENT_147	[p8l1409t1948r1505b1984],
7	0.51	CD	NUMBER	0.51	num	9	SENT_147	[p8l1703t1948r1790b1984],
8	0.11	CD	NUMBER	0.11	num	9	SENT_147	[p8l1998t1948r2085b1984],
9	Non-improvers	NNS	O	non-improver	dep	15	SENT_147	[p8l702t2009r1028b2057],
10	21	CD	NUMBER	21	number	11	SENT_147	[p8l1192t2009r1236b2045],
11	0.33	CD	NUMBER	0.33	dep	9	SENT_147	[p8l1409t2009r1504b2045],
12	0.28	CD	NUMBER	0.28	num	14	SENT_147	[p8l1703t2009r1799b2045],
13	0.38	CD	NUMBER	0.38	num	14	SENT_147	[p8l1998t2009r2093b2045],
14	G	NN	O	g	dep	11	SENT_147	[p8l700t2069r732b2106],
15	dominant	JJ	O	dominant	_	0	SENT_147	[p8l753t2068r967b2106],
16	A	DT	O	a	det	19	SENT_147	[p8l983t2070r1014b2105],
17	recessive	JJ	O	recessive	amod	19	SENT_147	[p8l1034t2069r1221b2106],
18	(	NN	O	(	nn	19	SENT_147	[p8l1242t2068r1465b2115],
19	G/G	NN	O	g/g	dep	15	SENT_147	[p8l1242t2068r1465b2115],
20	+	CC	O	+	_	0	SENT_147	[p8l1242t2068r1465b2115],
21	G/A	NN	O	g/a	conj_+	19	SENT_147	[p8l1242t2068r1465b2115],
22	vs	CC	O	vs	_	0	SENT_147	[p8l1482t2079r1524b2106],
23	A/A	NN	O	a/a	nn	24	SENT_147	[p8l1542t2068r1638b2115],
24	)	NN	O	)	conj_vs	21	SENT_147	[p8l1542t2068r1638b2115],

1	Remission	NN	O	remission	nn	4	SENT_148	[p8l10t2142r220b2179],
2	HAM-A	NN	O	ham-a	nn	4	SENT_148	[p8l244t2143r399b2179],
3	LOCF	NN	O	locf	nn	4	SENT_148	[p8l420t2143r535b2179],
4	Remitters	NNS	O	remitter	_	0	SENT_148	[p8l702t2142r902b2179],
5	75	CD	NUMBER	75	number	6	SENT_148	[p8l1194t2143r1243b2179],
6	0.38	CD	NUMBER	0.38	dep	4	SENT_148	[p8l1409t2143r1505b2179],
7	0.49	CD	NUMBER	0.49	number	8	SENT_148	[p8l1703t2143r1799b2179],
8	0.12	CD	NUMBER	0.12	num	11	SENT_148	[p8l1998t2143r2093b2179],
9	Non	NNP	O	Non	nn	11	SENT_148	[p8l702t2203r1005b2240],
10	—	CD	NUMBER	—	num	11	SENT_148	[p8l702t2203r1005b2240],
11	remitters	NNS	O	remitter	dep	4	SENT_148	[p8l702t2203r1005b2240],
12	37	CD	NUMBER	37	number	13	SENT_148	[p8l1194t2203r1245b2240],
13	0.34	CD	NUMBER	0.34	num	11	SENT_148	[p8l1409t2203r1505b2240],
14	0.43	CD	NUMBER	0.43	num	15	SENT_148	[p8l1703t2203r1798b2240],
15	0.24	CD	NUMBER	0.24	dep	11	SENT_148	[p8l1998t2203r2093b2240],
16	C.	NNP	O	C.	dep	11	SENT_148	[p8l700t2263r732b2299],
17	dominant	JJ	O	dominant	amod	11	SENT_148	[p8l753t2262r967b2299],
18	A	DT	O	a	det	21	SENT_148	[p8l983t2263r1014b2299],
19	recessive	JJ	O	recessive	amod	21	SENT_148	[p8l1034t2263r1221b2299],
20	(	NN	O	(	nn	21	SENT_148	[p8l1242t2262r1465b2309],
21	G/G	NN	O	g/g	dep	11	SENT_148	[p8l1242t2262r1465b2309],
22	+	CC	O	+	_	0	SENT_148	[p8l1242t2262r1465b2309],
23	G/A	NN	O	g/a	dep	4	SENT_148	[p8l1242t2262r1465b2309],
24	vs	CC	O	vs	_	0	SENT_148	[p8l1482t2273r1524b2299],
25	A/A	NN	O	a/a	nn	26	SENT_148	[p8l1542t2262r1638b2309],
26	)	NN	O	)	conj_vs	23	SENT_148	[p8l1542t2262r1638b2309],

1	Remission	NN	O	remission	nn	4	SENT_149	[p8l10t2336r220b2373],
2	CGI	NN	O	cgus	nn	4	SENT_149	[p8l242t2336r320b2373],
3	LOCF	NN	O	locf	nn	4	SENT_149	[p8l344t2336r460b2373],
4	Remitters	NNS	O	remitter	_	0	SENT_149	[p8l702t2336r902b2373],
5	79	CD	NUMBER	79	number	6	SENT_149	[p8l1194t2336r1245b2373],
6	0.127	CD	NUMBER	0.127	dep	4	SENT_149	[p8l1409t2336r1533b2373],
7	0.494	CD	NUMBER	0.494	number	8	SENT_149	[p8l1703t2336r1827b2373],
8	0.380	CD	NUMBER	0.380	num	11	SENT_149	[p8l1998t2336r2122b2373],
9	Non	NNP	O	Non	nn	11	SENT_149	[p8l702t2397r1005b2433],
10	—	CD	NUMBER	—	num	11	SENT_149	[p8l702t2397r1005b2433],
11	remitters	NNS	O	remitter	dep	4	SENT_149	[p8l702t2397r1005b2433],
12	33	CD	NUMBER	33	number	13	SENT_149	[p8l1194t2397r1244b2433],
13	0.242	CD	NUMBER	0.242	num	11	SENT_149	[p8l1409t2397r1533b2433],
14	0.424	CD	NUMBER	0.424	number	15	SENT_149	[p8l1703t2397r1828b2433],
15	0.333	CD	NUMBER	0.333	num	16	SENT_149	[p8l1998t2397r2121b2433],
16	G	NN	O	g	npadvmod	17	SENT_149	[p8l700t2456r732b2493],
17	dominant	JJ	O	dominant	amod	11	SENT_149	[p8l753t2455r967b2493],
18	A	DT	O	a	det	21	SENT_149	[p8l983t2457r1014b2492],
19	recessive	JJ	O	recessive	amod	21	SENT_149	[p8l1034t2456r1221b2493],
20	(	NN	O	(	nn	21	SENT_149	[p8l1242t2455r1465b2502],
21	G/G	NN	O	g/g	dep	11	SENT_149	[p8l1242t2455r1465b2502],
22	+	CC	O	+	_	0	SENT_149	[p8l1242t2455r1465b2502],
23	G/A	NN	O	g/a	dep	4	SENT_149	[p8l1242t2455r1465b2502],
24	vs	CC	O	vs	_	0	SENT_149	[p8l1482t2466r1524b2493],
25	A/A	NN	O	a/a	nn	26	SENT_149	[p8l1542t2455r1638b2502],
26	)	NN	O	)	conj_vs	23	SENT_149	[p8l1542t2455r1638b2502],

1	P	NN	O	p	nn	4	SENT_150	[p8l299t2706r334b2765],
2	*	CD	NUMBER	*	num	4	SENT_150	[p8l350t2706r377b2734],
3	Allele	NN	O	allele	nn	4	SENT_150	[p8l701t2703r885b2766],
4	frequency	NN	O	frequency	_	0	SENT_150	[p8l916t2703r1255b2785],
5	P	NN	O	p	dep	4	SENT_150	[p8l1583t2706r1618b2765],
6	*	CD	NUMBER	*	num	7	SENT_150	[p8l1634t2706r1661b2734],
7	OR	NN	O	or	dep	4	SENT_150	[p8l2023t2704r2122b2766],

1	f	LS	O	f	_	0	SENT_151	[p8l910t2931r1045b3010],
2	(	CD	NUMBER	(	num	4	SENT_151	[p8l910t2931r1045b3010],
3	G	NN	O	g	nn	4	SENT_151	[p8l910t2931r1045b3010],
4	)	NNS	O	)	nsubj	1	SENT_151	[p8l910t2931r1045b3010],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_152	[p9l8t724r189b746],
2	:	:	O	:	_	0	SENT_152	[p9l8t724r189b746],
3	CGI	NN	O	cgus	dep	1	SENT_152	[p9l203t724r256b751],
4	,	,	O	,	_	0	SENT_152	[p9l203t724r256b751],
5	Clinical	JJ	O	clinical	amod	7	SENT_152	[p9l270t724r360b746],
6	Global	JJ	O	global	amod	7	SENT_152	[p9l373t724r454b746],
7	Impression	NN	O	impression	appos	3	SENT_152	[p9l468t724r610b753],
8	;	:	O	;	_	0	SENT_152	[p9l468t724r610b753],
9	HAM-A	NN	O	ham-a	dep	3	SENT_152	[p9l624t725r722b751],
10	,	,	O	,	_	0	SENT_152	[p9l624t725r722b751],
11	Hamilton	NNP	ORGANIZATION	Hamilton	nn	13	SENT_152	[p9l736t724r851b746],
12	Anxiety	NN	ORGANIZATION	anxiety	nn	13	SENT_152	[p9l862t724r958b753],
13	Scale	NNP	ORGANIZATION	Scale	appos	9	SENT_152	[p9l970t724r1040b751],
14	;	:	O	;	_	0	SENT_152	[p9l970t724r1040b751],
15	LOCF	NNP	LOCATION	LOCF	nsubj	19	SENT_152	[p9l1054t724r1129b751],
16	,	,	O	,	_	0	SENT_152	[p9l1054t724r1129b751],
17	last	JJ	O	last	amod	18	SENT_152	[p9l1143t724r1184b746],
18	observation	NN	O	observation	nsubj	19	SENT_152	[p9l1195t724r1341b746],
19	carried	VBD	O	carry	dep	3	SENT_152	[p9l1354t724r1438b746],
20	forward	RB	O	forward	advmod	19	SENT_152	[p9l1450t724r1556b751],
21	;	:	O	;	_	0	SENT_152	[p9l1450t724r1556b751],
22	OR	NN	O	or	dep	1	SENT_152	[p9l1569t724r1613b751],
23	,	,	O	,	_	0	SENT_152	[p9l1569t724r1613b751],
24	odds	NNS	O	odds	nn	25	SENT_152	[p9l1626t724r1687b746],
25	ratio	NN	O	ratio	appos	22	SENT_152	[p9l1699t724r1761b746],
26	.	.	O	.	_	0	SENT_152	[p9l1699t724r1761b746],

1	*	RB	O	*	advmod	2	SENT_153	[p9l9t773r30b793],
2	Indicates	VBZ	O	indicate	_	0	SENT_153	[p9l56t771r283b816],
3	trend	NN	O	trend	nsubj	2	SENT_153	[p9l305t771r442b816],
4	since	IN	O	since	mark	7	SENT_153	[p9l467t772r594b816],
5	P	NN	O	p	nn	6	SENT_153	[p9l621t773r650b815],
6	value	NN	O	value	nsubj	7	SENT_153	[p9l668t771r803b816],
7	is	VBZ	O	be	dep	3	SENT_153	[p9l829t772r861b816],
8	slightly	RB	O	slightly	advmod	7	SENT_153	[p9l884t771r1068b829],
9	above	IN	O	above	_	0	SENT_153	[p9l1091t771r1245b816],
10	0.05	CD	NUMBER	0.05	prep_above	7	SENT_153	[p9l1270t772r1400b816],
11	.	.	O	.	_	0	SENT_153	[p9l1270t772r1400b816],

1	+	CC	O	+	cc	2	SENT_154	[p9l1064t1004r1205b1046],
2	A/A	NN	O	a/a	_	0	SENT_154	[p9l1220t1002r1327b1049],
3	(	CD	NUMBER	(	num	4	SENT_154	[p9l1346t1002r1528b1063],
4	n	NN	O	n	dep	2	SENT_154	[p9l1346t1002r1528b1063],
5	=	JJ	O	=	amod	7	SENT_154	[p9l1346t1002r1528b1063],
6	18	CD	NUMBER	18	tmod	5	SENT_154	[p9l1346t1002r1528b1063],
7	)	NN	O	)	dep	4	SENT_154	[p9l1346t1002r1528b1063],

1	%	NN	O	%	_	0	SENT_155	[p9l1065t1165r1204b1211],
2	-	:	O	-	_	0	SENT_155	[p9l1065t1165r1204b1211],
3	A/G	NN	O	a/g	nn	5	SENT_155	[p9l1220t1161r1332b1212],
4	(	CD	NUMBER	(	num	5	SENT_155	[p9l1353t1161r1535b1226],
5	n	NN	O	n	dep	1	SENT_155	[p9l1353t1161r1535b1226],
6	=	JJ	O	=	amod	8	SENT_155	[p9l1353t1161r1535b1226],
7	53	CD	NUMBER	53	tmod	6	SENT_155	[p9l1353t1161r1535b1226],
8	)	NN	O	)	dep	5	SENT_155	[p9l1353t1161r1535b1226],

1	G/G	NN	O	g/g	_	0	SENT_156	[p9l1223t1328r1339b1376],
2	(	CD	NUMBER	(	num	3	SENT_156	[p9l1360t1328r1542b1389],
3	n	NN	O	n	dep	1	SENT_156	[p9l1360t1328r1542b1389],
4	=	JJ	O	=	amod	6	SENT_156	[p9l1360t1328r1542b1389],
5	41	CD	NUMBER	41	tmod	4	SENT_156	[p9l1360t1328r1542b1389],
6	)	NN	O	)	dep	3	SENT_156	[p9l1360t1328r1542b1389],

1	One-way	JJ	O	one-way	_	0	SENT_157	[p9l1622t1501r1864b1556],
2	AN	DT	O	a	det	5	SENT_157	[p9l1879t1501r1958b1546],
3	OVA	NN	O	ovum	nn	5	SENT_157	[p9l1966t1501r2079b1546],
4	[	NN	O	[	nn	5	SENT_157	[p9l1622t1574r1722b1626],
5	AIA	NN	ORGANIZATION	aium	dep	1	SENT_157	[p9l1622t1574r1722b1626],
6	vs	CC	O	vs	_	0	SENT_157	[p9l1734t1588r1784b1615],
7	Aft-i	NN	O	aft-i	conj_vs	1	SENT_157	[p9l1792t1574r2031b1626],
8	+	CC	O	+	_	0	SENT_157	[p9l1792t1574r2031b1626],
9	GIG	NN	O	gig	conj_+	7	SENT_157	[p9l1792t1574r2031b1626],
10	)	CD	NUMBER	)	num	9	SENT_157	[p9l1792t1574r2031b1626],
11	:	:	O	:	_	0	SENT_157	[p9l1792t1574r2031b1626],
12	(	CD	NUMBER	(	number	13	SENT_157	[p9l1622t1689r1698b1754],
13	*	CD	NUMBER	*	num	18	SENT_157	[p9l1622t1689r1698b1754],
14	)	NN	O	)	nn	18	SENT_157	[p9l1622t1689r1698b1754],
15	p	NN	O	p	nn	18	SENT_157	[p9l1719t1692r1954b1754],
16	=	JJ	O	=	amod	18	SENT_157	[p9l1719t1692r1954b1754],
17	0.057	CD	NUMBER	0.057	num	18	SENT_157	[p9l1719t1692r1954b1754],
18	[	NN	O	[	dep	7	SENT_157	[p9l1479t1799r1507b1842],
19	+	CC	O	+	_	0	SENT_157	[p9l1479t1799r1507b1842],
20	[	NN	O	[	dep	7	SENT_157	[p9l1530t1801r1542b1824],
21	+	CC	O	+	_	0	SENT_157	[p9l1530t1801r1542b1824],
22	[	NN	O	[	dep	7	SENT_157	[p9l1556t1800r1566b1842],
23	+	CC	O	+	_	0	SENT_157	[p9l1556t1800r1566b1842],
24	*	NN	O	*	nn	25	SENT_157	[p9l1622t1817r1653b1848],
25	p	NN	O	p	conj_+	22	SENT_157	[p9l1723t1821r1923b1879],
26	<	JJR	O	<	dep	25	SENT_157	[p9l1723t1821r1923b1879],
27	0.05	CD	NUMBER	0.05	num	29	SENT_157	[p9l1723t1821r1923b1879],
28	**	NN	O	**	nn	29	SENT_157	[p9l1622t1946r1691b1977],
29	p	NN	O	p	dep	1	SENT_157	[p9l1709t1950r1948b2011],
30	=	JJ	O	=	amod	29	SENT_157	[p9l1709t1950r1948b2011],
31	0.008	CD	NUMBER	0.008	tmod	30	SENT_157	[p9l1709t1950r1948b2011],

1	o	NN	O	o	_	0	SENT_158	[p9l330t2061r367b2100],
2	vs	CC	O	vs	_	0	SENT_158	[p9l617t2053r654b2098],
3	Q	NNP	O	Q	conj_vs	1	SENT_158	[p9l751t2054r795b2099],
4	)	CD	NUMBER	)	number	5	SENT_158	[p9l751t2054r795b2099],
5	1	CD	NUMBER	1	dep	3	SENT_158	[p9l896t2054r942b2100],
6	:	:	O	:	_	0	SENT_158	[p9l896t2054r942b2100],
7	‘	CD	NUMBER	‘	num	10	SENT_158	[p9l1038t2054r1089b2105],
8	ir	NN	O	ir	nn	10	SENT_158	[p9l1038t2054r1089b2105],
9	Q5	NN	O	q5	nn	10	SENT_158	[p9l1185t2054r1229b2099],
10	o	NN	O	o	dep	1	SENT_158	[p9l1327t2054r1371b2099],
11	ix	NN	O	ix	nn	13	SENT_158	[p9l1476t2054r1516b2097],
12	x9	NN	O	x9	nn	13	SENT_158	[p9l273t2086r347b2145],
13	a9	NN	O	a9	dep	10	SENT_158	[p9l425t2054r513b2145],
14	as	IN	O	as	dep	1	SENT_158	[p9l570t2082r633b2144],
15	as	IN	O	as	mark	17	SENT_158	[p9l712t2083r779b2145],
16	s	NNS	O	s	nsubj	17	SENT_158	[p9l857t2082r921b2145],
17	‘	VBP	O	‘	pcomp	14	SENT_158	[p9l987t2079r1057b2149],
18	£	CD	MONEY	£	number	19	SENT_158	[p9l987t2079r1057b2149],
19	5	CD	MONEY	5	num	20	SENT_158	[p9l987t2079r1057b2149],
20	‘	NN	O	‘	dobj	17	SENT_158	[p9l1132t2079r1199b2149],
21	£	CD	MONEY	£	number	22	SENT_158	[p9l1132t2079r1199b2149],
22	5	CD	MONEY	5	num	20	SENT_158	[p9l1132t2079r1199b2149],
23	&	CC	O	&	_	0	SENT_158	[p9l1275t2078r1352b2149],
24	a	DT	O	a	det	25	SENT_158	[p9l1419t2078r1495b2149],
25	90	CD	MONEY	90	conj_and	20	SENT_158	[p9l235t2129r298b2191],
26	$	$	MONEY	$	dep	27	SENT_158	[p9l345t2132r437b2211],
27	o	NN	MONEY	o	dep	40	SENT_158	[p9l345t2132r437b2211],
28	$	$	MONEY	$	dep	27	SENT_158	[p9l487t2132r582b2212],
29	o	NN	MONEY	o	dep	30	SENT_158	[p9l487t2132r582b2212],
30	$	$	MONEY	$	num	28	SENT_158	[p9l629t2132r724b2212],
31	Q	NNP	MONEY	Q	dep	30	SENT_158	[p9l629t2132r724b2212],
32	:	:	O	:	_	0	SENT_158	[p9l629t2132r724b2212],
33	$	$	MONEY	$	dep	28	SENT_158	[p9l774t2132r869b2212],
34	o	NN	MONEY	o	dep	33	SENT_158	[p9l774t2132r869b2212],
35	‘	CD	MONEY	‘	number	33	SENT_158	[p9l893t2132r1012b2232],
36	$	$	MONEY	$	amod	28	SENT_158	[p9l893t2132r1012b2232],
37	oo	JJ	MONEY	oo	dep	36	SENT_158	[p9l893t2132r1012b2232],
38	Awe	NN	O	awe	dep	40	SENT_158	[p9l1035t2132r1156b2232],
39	‘	CD	NUMBER	‘	num	38	SENT_158	[p9l1181t2132r1299b2232],
40	$	$	MONEY	$	dep	20	SENT_158	[p9l1181t2132r1299b2232],
41	oo	CD	MONEY	oo	num	40	SENT_158	[p9l1181t2132r1299b2232],
42	“	CD	MONEY	“	num	43	SENT_158	[p9l1323t2132r1441b2232],
43	yo	NN	O	yo	dep	40	SENT_158	[p9l1323t2132r1441b2232],

1	Figure	NNP	O	Figure	_	0	SENT_159	[p9l12t2319r204b2387],
2	1	CD	NUMBER	1	num	4	SENT_159	[p9l249t2320r270b2370],
3	HTR2A	NN	O	htr2a	nn	4	SENT_159	[p9l352t2320r551b2370],
4	rs7997012	NN	O	rs7997012	dep	1	SENT_159	[p9l591t2320r922b2371],
5	:	:	O	:	_	0	SENT_159	[p9l591t2320r922b2371],
6	treatment	NN	O	treatment	nn	7	SENT_159	[p9l965t2325r1262b2371],
7	response	NN	O	response	dep	1	SENT_159	[p9l1302t2334r1559b2387],
8	to	TO	O	to	_	0	SENT_159	[p9l1598t2325r1657b2371],
9	venlafaxine	NN	O	venlafaxine	nn	10	SENT_159	[p9l1696t2319r2031b2371],
10	XR	NN	O	xr	prep_to	7	SENT_159	[p9l2071t2320r2150b2370],
11	(	CD	NUMBER	(	num	16	SENT_159	[p9l10t2404r179b2469],
12	VEN	NNP	O	VEN	nn	16	SENT_159	[p9l10t2404r179b2469],
13	)	CD	NUMBER	)	num	16	SENT_159	[p9l10t2404r179b2469],
14	(	CD	NUMBER	(	num	16	SENT_159	[p9l220t2404r341b2469],
15	last	JJ	O	last	amod	16	SENT_159	[p9l220t2404r341b2469],
16	observation	NN	O	observation	nsubj	17	SENT_159	[p9l379t2404r721b2456],
17	carried	VBD	O	carry	rcmod	10	SENT_159	[p9l762t2404r960b2456],
18	forward	RB	O	forward	advmod	17	SENT_159	[p9l999t2404r1228b2456],
19	(	CD	NUMBER	(	num	20	SENT_159	[p9l1270t2404r1502b2469],
20	LOCF	NN	O	locf	pobj	18	SENT_159	[p9l1270t2404r1502b2469],
21	)	CD	NUMBER	)	num	22	SENT_159	[p9l1270t2404r1502b2469],
22	)	NN	O	)	dobj	17	SENT_159	[p9l1270t2404r1502b2469],
23	based	VBN	O	base	_	0	SENT_159	[p9l1545t2404r1712b2456],
24	on	IN	O	on	prepc_based_on	22	SENT_159	[p9l1753t2419r1825b2456],
25	genotype	NN	O	genotype	pobj	22	SENT_159	[p9l1867t2410r2149b2472],
26	(	CD	NUMBER	(	npadvmod	27	SENT_159	[p9l10t2489r655b2556],
27	European	JJ	MISC	european	amod	25	SENT_159	[p9l10t2489r655b2556],
28	.	.	O	.	_	0	SENT_159	[p9l10t2489r655b2556],

1	—	NN	O	—	_	0	SENT_160	[p9l10t2489r655b2556],
2	.	.	O	.	_	0	SENT_160	[p9l10t2489r655b2556],

1	Americans	NNPS	MISC	Americans	nsubj	2	SENT_161	[p9l10t2489r655b2556],
2	(	VBP	O	(	_	0	SENT_161	[p9l683t2489r800b2553],
3	EA	NN	O	ea	nn	5	SENT_161	[p9l683t2489r800b2553],
4	)	CD	NUMBER	)	num	5	SENT_161	[p9l683t2489r800b2553],
5	sample	NN	O	sample	dobj	2	SENT_161	[p9l828t2489r1052b2556],
6	,	,	O	,	_	0	SENT_161	[p9l828t2489r1052b2556],
7	N	NN	O	n	appos	5	SENT_161	[p9l1085t2491r1192b2540],
8	:	:	O	:	_	0	SENT_161	[p9l1085t2491r1192b2540],
9	1	CD	NUMBER	1	number	10	SENT_161	[p9l1212t2490r1230b2540],
10	12	CD	NUMBER	12	num	11	SENT_161	[p9l1251t2489r1361b2553],
11	)	NN	O	)	dep	7	SENT_161	[p9l1251t2489r1361b2553],
12	.	.	O	.	_	0	SENT_161	[p9l1251t2489r1361b2553],

1	As	IN	O	as	mark	9	SENT_162	[p9l84t2693r164b2749],
2	the	DT	O	the	det	6	SENT_162	[p9l194t2691r307b2749],
3	HTR2A	NN	O	htr2a	nn	6	SENT_162	[p9l338t2693r588b2748],
4	rs799	NN	O	rs799	nn	6	SENT_162	[p9l617t2693r803b2749],
5	7012	CD	NUMBER	7012	num	6	SENT_162	[p9l814t2693r980b2749],
6	variant	NN	O	variant	nsubjpass	9	SENT_162	[p9l1007t2694r1259b2749],
7	was	VBD	O	be	auxpass	9	SENT_162	[p9l1286t2708r1414b2749],
8	initially	RB	O	initially	advmod	9	SENT_162	[p9l1445t2691r1723b2767],
9	reported	VBN	O	report	advcl	24	SENT_162	[p9l1750t2691r2050b2767],
10	to	TO	O	to	aux	12	SENT_162	[p9l2078t2698r2148b2749],
11	be	VB	O	be	auxpass	12	SENT_162	[p9l7t2786r87b2844],
12	involved	VBN	O	involve	xcomp	9	SENT_162	[p9l110t2786r419b2844],
13	in	IN	O	in	_	0	SENT_162	[p9l440t2789r511b2843],
14	treatment	NN	O	treatment	nn	15	SENT_162	[p9l533t2794r883b2844],
15	response	NN	O	response	prep_in	12	SENT_162	[p9l905t2803r1210b2862],
16	to	TO	O	to	_	0	SENT_162	[p9l1234t2794r1303b2844],
17	antidepressant	JJ	O	antidepressant	amod	18	SENT_162	[p9l1327t2786r1843b2862],
18	drugs	NNS	O	drug	prep_to	12	SENT_162	[p9l1866t2786r2056b2862],
19	in	IN	O	in	_	0	SENT_162	[p9l2078t2789r2149b2843],
20	MDD	NN	ORGANIZATION	mdd	nn	21	SENT_162	[p9l8t2885r197b2940],
21	populations	NNS	O	population	prep_in	18	SENT_162	[p9l222t2883r664b2959],
22	,	,	O	,	_	0	SENT_162	[p9l222t2883r664b2959],
23	We	PRP	O	we	nsubj	24	SENT_162	[p9l692t2900r788b2941],
24	conducted	VBD	O	conduct	_	0	SENT_162	[p9l815t2883r1188b2941],
25	secondary	JJ	O	secondary	amod	26	SENT_162	[p9l1215t2883r1573b2959],
26	analysis	NN	O	analysis	dobj	24	SENT_162	[p9l1596t2883r1872b2959],
27	using	VBG	O	use	xcomp	24	SENT_162	[p9l1897t2886r2090b2959],
28	a	DT	O	a	det	31	SENT_162	[p9l2114t2900r2149b2941],
29	depression	NN	O	depression	nn	31	SENT_162	[p9l9t2978r385b3054],
30	rating	NN	O	rating	nn	31	SENT_162	[p9l423t2981r633b3054],
31	scale	NN	O	scale	dobj	27	SENT_162	[p9l671t2978r834b3036],
32	to	TO	O	to	aux	33	SENT_162	[p9l873t2986r943b3036],
33	evaluate	VB	O	evaluate	xcomp	27	SENT_162	[p9l981t2978r1273b3036],
34	a	DT	O	a	det	36	SENT_162	[p9l1312t2995r1347b3036],
35	potential	JJ	O	potential	amod	36	SENT_162	[p9l1383t2978r1704b3054],
36	role	NN	O	role	nn	52	SENT_162	[p9l1742t2978r1874b3036],
37	of	IN	O	of	_	0	SENT_162	[p9l1913t2978r1985b3036],
38	this	DT	O	this	det	40	SENT_162	[p9l2018t2978r2148b3036],
39	genetic	JJ	O	genetic	amod	40	SENT_162	[p9l9t3078r263b3151],
40	marker	NN	O	marker	prep_of	36	SENT_162	[p9l299t3075r547b3133],
41	on	IN	O	on	_	0	SENT_162	[p9l583t3092r674b3133],
42	depressive	JJ	O	depressive	amod	43	SENT_162	[p9l711t3075r1071b3151],
43	symptomatology	NN	O	symptomatology	prep_on	40	SENT_162	[p9l1109t3075r1711b3151],
44	in	IN	O	in	_	0	SENT_162	[p9l1745t3078r1815b3132],
45	EA	NN	ORGANIZATION	ea	nn	47	SENT_162	[p9l1851t3077r1944b3132],
46	GAD	NN	ORGANIZATION	gad	nn	47	SENT_162	[p9l1981t3077r2148b3133],
47	patients	NNS	O	patient	prep_in	43	SENT_162	[p9l8t3174r290b3247],
48	(	CD	NUMBER	(	num	49	SENT_162	[p9l318t3171r382b3243],
49	n	NN	O	n	dep	36	SENT_162	[p9l318t3171r382b3243],
50	=	JJ	O	=	amod	52	SENT_162	[p9l401t3199r452b3217],
51	112	CD	NUMBER	112	tmod	50	SENT_162	[p9l476t3171r643b3243],
52	)	NN	O	)	dobj	33	SENT_162	[p9l476t3171r643b3243],
53	.	.	O	.	_	0	SENT_162	[p9l476t3171r643b3243],

1	HAM-D	NN	O	ham-d	nn	2	SENT_163	[p9l673t3173r940b3228],
2	scores	NNS	O	score	nsubj	4	SENT_163	[p9l967t3188r1173b3229],
3	were	VBD	O	be	cop	4	SENT_163	[p9l1196t3188r1360b3229],
4	available	JJ	O	available	_	0	SENT_163	[p9l1385t3171r1694b3229],
5	for	IN	O	for	_	0	SENT_163	[p9l1719t3171r1818b3229],
6	baseline	NN	O	baseline	prep_for	4	SENT_163	[p9l1838t3171r2144b3241],
7	,	,	O	,	_	0	SENT_163	[p9l1838t3171r2144b3241],
8	week	NN	DURATION	week	prep_for	4	SENT_163	[p9l7t3267r186b3325],
9	12	CD	NUMBER	12	num	8	SENT_163	[p9l217t3268r295b3324],
10	and	CC	O	and	_	0	SENT_163	[p9l323t3267r454b3324],
11	week	NN	DURATION	week	prep_for	4	SENT_163	[p9l478t3267r658b3325],
12	24	CD	NUMBER	24	num	11	SENT_163	[p9l684t3268r785b3324],
13	.	.	O	.	_	0	SENT_163	[p9l684t3268r785b3324],

1	There	EX	O	there	expl	2	SENT_164	[p9l814t3267r1015b3324],
2	were	VBD	O	be	_	0	SENT_164	[p9l1041t3283r1204b3324],
3	no	DT	O	no	det	6	SENT_164	[p9l1232t3283r1323b3324],
4	statistically	RB	O	statistically	advmod	5	SENT_164	[p9l1353t3267r1752b3342],
5	significant	JJ	O	significant	amod	6	SENT_164	[p9l1778t3266r2149b3342],
6	differences	NNS	O	difference	nsubj	2	SENT_164	[p9l9t3363r390b3421],
7	between	IN	O	between	_	0	SENT_164	[p9l416t3363r713b3421],
8	genotype	NN	O	genotype	nn	9	SENT_164	[p9l741t3370r1067b3439],
9	groups	NNS	O	group	prep_between	6	SENT_164	[p9l1095t3380r1331b3439],
10	in	IN	O	in	_	0	SENT_164	[p9l1360t3366r1430b3420],
11	HAM-D	JJ	O	ham-d	amod	12	SENT_164	[p9l1458t3365r1725b3420],
12	score	NN	NUMBER	score	prep_in	9	SENT_164	[p9l1755t3380r1930b3421],
13	using	VBG	O	use	partmod	12	SENT_164	[p9l1957t3366r2150b3439],
14	LOCF	NN	O	locf	nn	15	SENT_164	[p9l9t3460r207b3516],
15	data	NNS	O	datum	dobj	13	SENT_164	[p9l240t3458r389b3516],
16	at	IN	O	at	_	0	SENT_164	[p9l422t3465r486b3516],
17	baseline	NN	O	baseline	prep_at	13	SENT_164	[p9l516t3458r802b3516],
18	or	CC	O	or	_	0	SENT_164	[p9l837t3475r909b3516],
19	week	NN	DURATION	week	prep_at	13	SENT_164	[p9l939t3458r1119b3516],
20	12	CD	NUMBER	12	num	19	SENT_164	[p9l1155t3460r1251b3528],
21	;	:	O	;	_	0	SENT_164	[p9l1155t3460r1251b3528],
22	however	RB	O	however	advmod	25	SENT_164	[p9l1288t3458r1603b3528],
23	,	,	O	,	_	0	SENT_164	[p9l1288t3458r1603b3528],
24	we	PRP	O	we	nsubj	25	SENT_164	[p9l1638t3475r1734b3516],
25	observed	VBD	O	observe	parataxis	2	SENT_164	[p9l1769t3458r2081b3516],
26	a	DT	O	a	det	28	SENT_164	[p9l2114t3475r2149b3516],
27	significant	JJ	O	significant	amod	28	SENT_164	[p10l10t20r381b96],
28	difference	NN	O	difference	dobj	25	SENT_164	[p10l417t20r766b78],
29	in	IN	O	in	_	0	SENT_164	[p10l802t23r872b77],
30	HAM	NN	O	ham	prep_in	25	SENT_164	[p10l909t21r1175b77],
31	.	.	O	.	_	0	SENT_164	[p10l909t21r1175b77],

1	—	NN	O	—	_	0	SENT_165	[p10l909t21r1175b77],
2	.	.	O	.	_	0	SENT_165	[p10l909t21r1175b77],

1	D	NN	O	d	nn	2	SENT_166	[p10l909t21r1175b77],
2	score	NN	NUMBER	score	_	0	SENT_166	[p10l1213t37r1389b78],
3	at	IN	O	at	_	0	SENT_166	[p10l1426t27r1489b77],
4	week	NN	DURATION	week	prep_at	2	SENT_166	[p10l1522t20r1701b78],
5	24	CD	NUMBER	24	num	4	SENT_166	[p10l1736t21r1817b77],
6	between	IN	O	between	_	0	SENT_166	[p10l1851t20r2148b78],
7	patients	NNS	O	patient	prep_between	2	SENT_166	[p10l8t119r290b192],
8	with	IN	O	with	_	0	SENT_166	[p10l319t116r480b174],
9	the	DT	O	the	det	13	SENT_166	[p10l510t116r622b174],
10	A/A	NNP	O	A/A	nn	13	SENT_166	[p10l652t116r785b181],
11	genotype	NN	O	genotype	nn	13	SENT_166	[p10l814t123r1140b192],
12	(	CD	NUMBER	(	num	13	SENT_166	[p10l1174t117r1411b188],
13	mean	NN	O	mean	prep_with	7	SENT_166	[p10l1174t117r1411b188],
14	:	:	O	:	_	0	SENT_166	[p10l1174t117r1411b188],
15	9.33	CD	NUMBER	9.33	dep	13	SENT_166	[p10l1447t118r1614b186],
16	;	:	O	;	_	0	SENT_166	[p10l1447t118r1614b186],
17	s.e.	NN	O	s.e.	dep	13	SENT_166	[p10l1650t133r1776b174],
18	:	:	O	:	_	0	SENT_166	[p10l1650t133r1776b174],
19	1.17	CD	NUMBER	1.17	num	20	SENT_166	[p10l1816t117r1983b188],
20	)	NN	O	)	dep	13	SENT_166	[p10l1816t117r1983b188],
21	and	CC	O	and	_	0	SENT_166	[p10l2018t116r2149b174],
22	G/A	NN	O	g/a	dep	13	SENT_166	[p10l10t211r148b276],
23	+	CC	O	+	_	0	SENT_166	[p10l166t223r217b274],
24	G/G	NN	O	g/g	nn	25	SENT_166	[p10l237t211r382b277],
25	group	NN	O	group	dep	13	SENT_166	[p10l407t228r612b287],
26	(	CD	NUMBER	(	num	27	SENT_166	[p10l640t212r878b284],
27	mean	NN	O	mean	dep	25	SENT_166	[p10l640t212r878b284],
28	:	:	O	:	_	0	SENT_166	[p10l640t212r878b284],
29	5.31	CD	NUMBER	5.31	dep	13	SENT_166	[p10l909t213r1075b281],
30	;	:	O	;	_	0	SENT_166	[p10l909t213r1075b281],
31	s.e.	NNP	O	s.e.	dep	13	SENT_166	[p10l1105t228r1231b269],
32	:	:	O	:	_	0	SENT_166	[p10l1105t228r1231b269],
33	0.51	CD	NUMBER	0.51	dep	13	SENT_166	[p10l1260t213r1428b281],
34	;	:	O	;	_	0	SENT_166	[p10l1260t213r1428b281],
35	F	NN	O	f	dep	13	SENT_166	[p10l1457t214r1492b268],
36	=	JJ	O	=	amod	35	SENT_166	[p10l1511t240r1562b258],
37	9.83	CD	NUMBER	9.83	tmod	36	SENT_166	[p10l1581t213r1748b281],
38	;	:	O	;	_	0	SENT_166	[p10l1581t213r1748b281],
39	P	NN	O	p	dep	13	SENT_166	[p10l1773t214r1887b268],
40	:	:	O	:	_	0	SENT_166	[p10l1773t214r1887b268],
41	0.002	CD	NUMBER	0.002	num	42	SENT_166	[p10l1905t212r2144b284],
42	)	NN	O	)	dep	13	SENT_166	[p10l1905t212r2144b284],
43	.	.	O	.	_	0	SENT_166	[p10l1905t212r2144b284],

1	Discussion	NN	O	discussion	_	0	SENT_167	[p10l11t441r404b499],

1	In	IN	O	in	_	0	SENT_168	[p10l9t633r81b688],
2	the	DT	O	the	det	4	SENT_168	[p10l117t631r228b688],
3	present	JJ	DATE	present	amod	4	SENT_168	[p10l264t638r520b706],
4	study	NN	O	study	prep_in	7	SENT_168	[p10l556t631r754b706],
5	,	,	O	,	_	0	SENT_168	[p10l556t631r754b706],
6	we	PRP	O	we	nsubj	7	SENT_168	[p10l793t647r889b688],
7	show	VBP	O	show	_	0	SENT_168	[p10l927t631r1109b688],
8	for	IN	O	for	_	0	SENT_168	[p10l1143t630r1240b688],
9	the	DT	O	the	det	11	SENT_168	[p10l1274t631r1385b688],
10	first	JJ	ORDINAL	first	amod	11	SENT_168	[p10l1422t630r1556b688],
11	time	NN	O	time	prep_for	7	SENT_168	[p10l1591t634r1747b688],
12	a	DT	O	a	det	14	SENT_168	[p10l1785t647r1819b688],
13	pharmacogenetic	JJ	O	pharmacogenetic	amod	14	SENT_168	[p10l1855t631r2148b706, p10l9t729r339b802],
14	effect	NN	O	effect	dobj	7	SENT_168	[p10l374t726r561b784],
15	of	IN	O	of	_	0	SENT_168	[p10l595t726r666b784],
16	the	DT	O	the	det	19	SENT_168	[p10l695t726r806b784],
17	HTRZA	NNP	O	HTRZA	nn	19	SENT_168	[p10l841t728r1087b783],
18	rs7997012	NN	O	rs7997012	nn	19	SENT_168	[p10l1120t728r1478b784],
19	variant	NN	O	variant	prep_of	14	SENT_168	[p10l1508t729r1755b784],
20	in	IN	O	in	_	0	SENT_168	[p10l1788t729r1858b783],
21	anxiety	NN	O	anxiety	nn	22	SENT_168	[p10l1892t729r2152b802],
22	disorders	NNS	O	disorder	prep_in	7	SENT_168	[p10l9t820r336b877],
23	.	.	O	.	_	0	SENT_168	[p10l9t820r336b877],

1	Our	PRP$	O	we	poss	2	SENT_169	[p10l376t822r509b877],
2	data	NNS	O	datum	nsubj	3	SENT_169	[p10l542t820r690b877],
3	document	VBP	O	document	_	0	SENT_169	[p10l723t820r1080b877],
4	that	IN	O	that	complm	11	SENT_169	[p10l1113t820r1253b877],
5	individuals	NNS	O	individual	nsubj	11	SENT_169	[p10l1287t820r1672b877],
6	with	IN	O	with	_	0	SENT_169	[p10l1705t820r1865b877],
7	at	IN	O	at	quantmod	9	SENT_169	[p10l1899t827r1962b877],
8	least	JJS	O	least	mwe	7	SENT_169	[p10l1995t820r2149b877],
9	one	CD	NUMBER	one	num	10	SENT_169	[p10l9t932r136b972],
10	G-allele	NN	MISC	g-allele	prep_with	5	SENT_169	[p10l161t915r423b972],
11	have	VBP	O	have	ccomp	3	SENT_169	[p10l446t915r610b972],
12	better	JJR	O	better	amod	14	SENT_169	[p10l631t915r834b972],
13	treatment	NN	O	treatment	nn	14	SENT_169	[p10l855t922r1200b972],
14	outcome	NN	O	outcome	dobj	11	SENT_169	[p10l1223t922r1527b972],
15	to	TO	O	to	_	0	SENT_169	[p10l1551t922r1619b972],
16	VEN	NNP	O	VEN	prep_to	11	SENT_169	[p10l1641t917r1798b971],
17	over	IN	O	over	_	0	SENT_169	[p10l1821t932r1971b972],
18	time	NN	O	time	prep_over	16	SENT_169	[p10l1992t918r2148b972],

1	The	DT	O	the	det	3	SENT_170	[p10l7t1164r109b1209],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_170	[p10l136t1164r677b1223],
3	Journal	NNP	O	Journal	_	0	SENT_170	[p10l699t1164r893b1219],

1	(	NN	O	(	nn	2	SENT_171	[p10l14t1376r247b1452],
2	Figure	NN	O	figure	_	0	SENT_171	[p10l14t1376r247b1452],
3	1	CD	NUMBER	1	num	4	SENT_171	[p10l307t1376r384b1448],
4	)	NN	O	)	dep	2	SENT_171	[p10l307t1376r384b1448],
5	.	.	O	.	_	0	SENT_171	[p10l307t1376r384b1448],

1	Interestingly	RB	O	interestingly	advmod	9	SENT_172	[p10l442t1376r892b1452],
2	,	,	O	,	_	0	SENT_172	[p10l442t1376r892b1452],
3	this	DT	O	this	det	5	SENT_172	[p10l950t1376r1077b1433],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_172	[p10l1129t1376r1734b1452],
5	effect	NN	O	effect	nsubj	9	SENT_172	[p10l1786t1376r1974b1434],
6	was	VBD	O	be	cop	9	SENT_172	[p10l2024t1393r2150b1433],
7	increasingly	RB	O	increasingly	advmod	9	SENT_172	[p10l10t1470r431b1546],
8	statistically	RB	O	statistically	advmod	9	SENT_172	[p10l464t1470r854b1546],
9	significant	JJ	O	significant	_	0	SENT_172	[p10l886t1470r1249b1546],
10	as	IN	O	as	mark	12	SENT_172	[p10l1283t1487r1348b1528],
11	time	NN	O	time	nsubj	12	SENT_172	[p10l1381t1473r1537b1528],
12	progressed	VBD	O	progress	ccomp	9	SENT_172	[p10l1572t1471r1955b1546],
13	,	,	O	,	_	0	SENT_172	[p10l1572t1471r1955b1546],
14	with	IN	O	with	_	0	SENT_172	[p10l1992t1471r2151b1528],
15	a	DT	O	a	det	17	SENT_172	[p10l11t1583r46b1623],
16	mean	JJ	O	mean	amod	17	SENT_172	[p10l83t1583r277b1624],
17	HAM	NN	O	ham	prep_with	9	SENT_172	[p10l314t1567r573b1623],
18	.	.	O	.	_	0	SENT_172	[p10l314t1567r573b1623],

1	—	NN	O	—	_	0	SENT_173	[p10l314t1567r573b1623],
2	.	.	O	.	_	0	SENT_173	[p10l314t1567r573b1623],

1	A	DT	O	a	det	2	SENT_174	[p10l314t1567r573b1623],
2	difference	NN	O	difference	_	0	SENT_174	[p10l610t1566r952b1624],
3	between	IN	O	between	_	0	SENT_174	[p10l988t1566r1280b1624],
4	the	DT	O	the	det	6	SENT_174	[p10l1317t1566r1428b1624],
5	A/A	NNP	O	A/A	nn	6	SENT_174	[p10l1464t1566r1596b1631],
6	group	NN	O	group	prep_between	2	SENT_174	[p10l1632t1583r1834b1642],
7	and	CC	O	and	_	0	SENT_174	[p10l1872t1566r2002b1623],
8	the	DT	O	the	det	12	SENT_174	[p10l2039t1566r2150b1624],
9	G/A	NN	O	g/a	nn	12	SENT_174	[p10l12t1661r217b1726],
10	+	CC	O	+	_	0	SENT_174	[p10l12t1661r217b1726],
11	G/G	NN	O	g/g	nn	12	SENT_174	[p10l236t1661r380b1726],
12	group	NN	O	group	prep_between	2	SENT_174	[p10l408t1678r610b1737],
13	of	IN	O	of	_	0	SENT_174	[p10l639t1661r711b1719],
14	4.8	CD	NUMBER	4.8	number	16	SENT_174	[p10l734t1663r836b1719],
15	at	IN	O	at	quantmod	16	SENT_174	[p10l867t1668r930b1719],
16	6	CD	DURATION	6	num	17	SENT_174	[p10l959t1663r996b1719],
17	months	NNS	NUMBER	month	prep_of	2	SENT_174	[p10l1025t1661r1312b1719],
18	.	.	O	.	_	0	SENT_174	[p10l1025t1661r1312b1719],

1	Similar	JJ	O	similar	dep	21	SENT_175	[p10l1345t1661r1588b1719],
2	to	TO	O	to	_	0	SENT_175	[p10l1615t1668r1683b1719],
3	our	PRP$	O	we	poss	6	SENT_175	[p10l1713t1678r1829b1719],
4	previous	JJ	O	previous	amod	6	SENT_175	[p10l1856t1664r2150b1737],
5	clinical	JJ	O	clinical	amod	6	SENT_175	[p10l11t1755r261b1813],
6	studies	NNS	O	study	prep_to	1	SENT_175	[p10l304t1756r539b1813],
7	that	WDT	O	that	nsubj	8	SENT_175	[p10l582t1755r722b1813],
8	show	VBP	O	show	rcmod	6	SENT_175	[p10l765t1755r947b1813],
9	that	IN	O	that	complm	12	SENT_175	[p10l986t1756r1127b1813],
10	GAD	NN	O	gad	nn	11	SENT_175	[p10l1170t1757r1335b1813],
11	patients	NNS	O	patient	nsubj	12	SENT_175	[p10l1377t1758r1653b1831],
12	benefit	VBP	O	benefit	ccomp	8	SENT_175	[p10l1694t1755r1938b1813],
13	most	RBS	O	most	advmod	12	SENT_175	[p10l1979t1763r2151b1813],
14	from	IN	O	from	_	0	SENT_175	[p10l10t1849r178b1907],
15	long-term	JJ	O	long-term	amod	17	SENT_175	[p10l226t1849r571b1925],
16	antidepressant	JJ	O	antidepressant	amod	17	SENT_175	[p10l621t1849r1126b1925],
17	treatment	NN	O	treatment	prep_from	12	SENT_175	[p10l1174t1842r1602b1919],
18	,	,	O	,	_	0	SENT_175	[p10l1174t1842r1602b1919],
19	”	CD	NUMBER	”	appos	17	SENT_175	[p10l1174t1842r1602b1919],
20	we	PRP	O	we	nsubj	21	SENT_175	[p10l1650t1866r1744b1907],
21	document	VBP	O	document	_	0	SENT_175	[p10l1795t1849r2151b1907],
22	here	RB	O	here	advmod	21	SENT_175	[p10l10t1945r160b2003],
23	that	IN	O	that	complm	30	SENT_175	[p10l198t1945r339b2003],
24	treatment	NN	O	treatment	nn	25	SENT_175	[p10l377t1952r722b2003],
25	response	NN	O	response	nsubjpass	30	SENT_175	[p10l759t1962r1059b2021],
26	in	IN	O	in	_	0	SENT_175	[p10l1098t1948r1168b2002],
27	GAD	NN	O	gad	prep_in	25	SENT_175	[p10l1207t1947r1373b2003],
28	is	VBZ	O	be	auxpass	30	SENT_175	[p10l1412t1948r1462b2003],
29	furthermore	RB	O	furthermore	advmod	30	SENT_175	[p10l1500t1945r1922b2003],
30	inﬂuenced	VBN	O	inﬂuenced	ccomp	21	SENT_175	[p10l1961t1945r2150b2003, p10l11t2040r214b2097],
31	by	IN	O	by	_	0	SENT_175	[p10l246t2040r332b2115],
32	the	DT	O	the	det	35	SENT_175	[p10l363t2040r474b2097],
33	HTRZA	NNP	O	HTRZA	nn	35	SENT_175	[p10l509t2041r756b2097],
34	rs7997012	NN	O	rs7997012	nn	35	SENT_175	[p10l789t2041r1146b2097],
35	variant	NN	O	variant	agent	30	SENT_175	[p10l1177t2043r1441b2097],
36	.	.	O	.	_	0	SENT_175	[p10l1177t2043r1441b2097],

1	Our	PRP$	O	we	poss	2	SENT_176	[p10l1480t2041r1613b2097],
2	results	NNS	O	result	nsubj	3	SENT_176	[p10l1646t2040r1865b2097],
3	suggest	VBP	O	suggest	_	0	SENT_176	[p10l1902t2047r2151b2115],
4	that	IN	O	that	complm	15	SENT_176	[p10l10t2135r152b2193],
5	patients	NNS	O	patient	nsubj	15	SENT_176	[p10l174t2138r450b2211],
6	with	IN	O	with	_	0	SENT_176	[p10l473t2135r632b2193],
7	GAD	NN	O	gad	prep_with	5	SENT_176	[p10l658t2137r823b2193],
8	who	WP	O	who	nsubj	9	SENT_176	[p10l845t2135r998b2193],
9	have	VBP	O	have	rcmod	7	SENT_176	[p10l1022t2135r1185b2193],
10	at	IN	O	at	quantmod	12	SENT_176	[p10l1211t2142r1274b2193],
11	least	JJS	O	least	mwe	10	SENT_176	[p10l1297t2135r1450b2193],
12	one	CD	NUMBER	one	num	13	SENT_176	[p10l1475t2152r1602b2193],
13	G-allele	NN	MISC	g-allele	dobj	9	SENT_176	[p10l1628t2135r1889b2193],
14	should	MD	O	should	aux	15	SENT_176	[p10l1916t2135r2152b2193],
15	continue	VB	O	continue	ccomp	3	SENT_176	[p10l11t2233r322b2288],
16	antidepressant	JJ	O	antidepressant	amod	17	SENT_176	[p10l346t2230r852b2306],
17	treatment	NN	O	treatment	dobj	15	SENT_176	[p10l874t2237r1218b2288],
18	beyond	IN	O	beyond	_	0	SENT_176	[p10l1239t2230r1500b2306],
19	12	CD	DURATION	12	num	20	SENT_176	[p10l1528t2231r1606b2287],
20	weeks	NNS	NUMBER	week	prep_beyond	15	SENT_176	[p10l1627t2230r1848b2300],
21	,	,	O	,	_	0	SENT_176	[p10l1627t2230r1848b2300],
22	in	IN	O	in	mark	25	SENT_176	[p10l1876t2233r1946b2287],
23	order	NN	O	order	dep	25	SENT_176	[p10l1969t2230r2151b2288],
24	to	TO	O	to	aux	25	SENT_176	[p10l10t2332r80b2383],
25	maximize	VB	O	maximize	purpcl	15	SENT_176	[p10l108t2328r448b2383],
26	their	PRP$	O	they	poss	27	SENT_176	[p10l477t2325r642b2383],
27	potential	NN	O	potential	dobj	25	SENT_176	[p10l669t2325r983b2401],
28	for	IN	O	for	_	0	SENT_176	[p10l1012t2325r1109b2382],
29	response	NN	O	response	prep_for	25	SENT_176	[p10l1136t2342r1436b2401],
30	and	CC	O	and	_	0	SENT_176	[p10l1466t2325r1596b2383],
31	remission	NN	O	remission	prep_for	25	SENT_176	[p10l1623t2328r1977b2383],
32	.	.	O	.	_	0	SENT_176	[p10l1623t2328r1977b2383],

1	Interestingly	RB	O	interestingly	advmod	9	SENT_177	[p10l88t2420r544b2495],
2	,	,	O	,	_	0	SENT_177	[p10l88t2420r544b2495],
3	several	JJ	O	several	amod	5	SENT_177	[p10l618t2419r853b2477],
4	previous	JJ	O	previous	amod	5	SENT_177	[p10l919t2422r1216b2495],
5	studies	NNS	O	study	nsubj	9	SENT_177	[p10l1286t2420r1524b2477],
6	in	IN	O	in	_	0	SENT_177	[p10l1592t2422r1663b2476],
7	MDD	NN	ORGANIZATION	mdd	prep_in	5	SENT_177	[p10l1729t2422r1917b2477],
8	have	VBP	O	have	aux	9	SENT_177	[p10l1986t2419r2149b2477],
9	documented	VBN	O	document	_	0	SENT_177	[p10l11t2514r454b2571],
10	a	DT	O	a	det	11	SENT_177	[p10l481t2531r516b2571],
11	role	NN	O	role	dobj	9	SENT_177	[p10l542t2514r673b2571],
12	of	IN	O	of	_	0	SENT_177	[p10l702t2514r773b2571],
13	the	DT	O	the	det	14	SENT_177	[p10l795t2514r906b2571],
14	HTRZA	NNP	O	HTRZA	prep_of	11	SENT_177	[p10l935t2516r1183b2570],
15	rs799	CD	NUMBER	rs799	num	14	SENT_177	[p10l1209t2516r1394b2571],
16	7012	CD	NUMBER	7012	num	17	SENT_177	[p10l1405t2516r1570b2571],
17	variant	NN	O	variant	dep	14	SENT_177	[p10l1594t2517r1843b2571],
18	in	IN	O	in	_	0	SENT_177	[p10l1870t2517r1940b2570],
19	treatment	NN	O	treatment	nn	20	SENT_177	[p10l1966t2521r2150b2571, p10l10t2616r195b2667],
20	response	NN	O	response	prep_in	9	SENT_177	[p10l218t2626r521b2685],
21	to	TO	O	to	_	0	SENT_177	[p10l545t2616r614b2667],
22	antidepressants	NNS	O	antidepressant	prep_to	9	SENT_177	[p10l638t2609r1180b2685],
23	(	RB	O	(	dep	24	SENT_177	[p10l1206t2609r1411b2681],
24	Table	NNP	O	Table	dep	22	SENT_177	[p10l1206t2609r1411b2681],
25	1	CD	NUMBER	1	number	26	SENT_177	[p10l1441t2609r1520b2681],
26	)	CD	NUMBER	)	num	24	SENT_177	[p10l1441t2609r1520b2681],
27	.	.	O	.	_	0	SENT_177	[p10l1441t2609r1520b2681],

1	Similar	JJ	O	similar	ccomp	15	SENT_178	[p10l1548t2609r1793b2667],
2	to	TO	O	to	_	0	SENT_178	[p10l1815t2616r1884b2667],
3	reports	NNS	O	report	prep_to	1	SENT_178	[p10l1908t2616r2150b2685],
4	in	IN	O	in	_	0	SENT_178	[p10l11t2707r81b2761],
5	depression	NN	O	depression	prep_in	3	SENT_178	[p10l119t2704r491b2779],
6	and	CC	O	and	_	0	SENT_178	[p10l530t2704r661b2761],
7	despite	IN	O	despite	_	0	SENT_178	[p10l699t2704r943b2779],
8	our	PRP$	O	we	poss	12	SENT_178	[p10l983t2720r1101b2761],
9	relatively	RB	O	relatively	advmod	10	SENT_178	[p10l1137t2704r1462b2779],
10	small	JJ	O	small	amod	12	SENT_178	[p10l1500t2704r1683b2761],
11	sample	NN	O	sample	nn	12	SENT_178	[p10l1722t2704r1966b2779],
12	size	NN	O	size	prep_despite	1	SENT_178	[p10l2006t2707r2146b2774],
13	,	,	O	,	_	0	SENT_178	[p10l2006t2707r2146b2774],
14	we	PRP	O	we	nsubj	15	SENT_178	[p10l9t2816r104b2857],
15	observed	VBD	O	observe	_	0	SENT_178	[p10l136t2799r447b2857],
16	strong	JJ	O	strong	amod	18	SENT_178	[p10l478t2806r699b2875],
17	effect	NN	O	effect	nn	18	SENT_178	[p10l729t2799r919b2857],
18	sizes	NNS	O	size	dobj	15	SENT_178	[p10l951t2802r1104b2857],
19	in	IN	O	in	_	0	SENT_178	[p10l1135t2802r1205b2856],
20	particular	JJ	O	particular	prep_in	15	SENT_178	[p10l1235t2799r1574b2875],
21	when	WRB	O	when	advmod	22	SENT_178	[p10l1603t2799r1799b2857],
22	considering	VBG	O	consider	advcl	15	SENT_178	[p10l1831t2799r2150b2857, p10l10t2897r123b2970],
23	a	DT	O	a	det	25	SENT_178	[p10l144t2911r178b2952],
24	dominant	JJ	O	dominant	amod	25	SENT_178	[p10l200t2894r550b2952],
25	model	NN	O	model	dobj	22	SENT_178	[p10l571t2894r810b2964],
26	,	,	O	,	_	0	SENT_178	[p10l571t2894r810b2964],
27	suggesting	VBG	O	suggest	dep	22	SENT_178	[p10l837t2897r1205b2970],
28	that	IN	O	that	complm	36	SENT_178	[p10l1224t2894r1367b2952],
29	the	DT	O	the	det	30	SENT_178	[p10l1387t2894r1499b2952],
30	r5799	NN	O	r5799	nsubj	36	SENT_178	[p10l1522t2896r1706b2952],
31	7012	CD	NUMBER	7012	npadvmod	32	SENT_178	[p10l1718t2896r1883b2952],
32	Variant	JJ	O	variant	amod	30	SENT_178	[p10l1902t2897r2151b2952],
33	might	MD	O	might	aux	36	SENT_178	[p10l11t2989r223b3064],
34	be	VB	O	be	cop	36	SENT_178	[p10l262t2989r342b3046],
35	a	DT	O	a	det	36	SENT_178	[p10l386t3005r420b3046],
36	predictor	NN	O	predictor	ccomp	27	SENT_178	[p10l461t2989r781b3064],
37	of	IN	O	of	_	0	SENT_178	[p10l823t2988r894b3046],
38	the	DT	O	the	det	40	SENT_178	[p10l932t2989r1043b3046],
39	general	JJ	O	general	amod	40	SENT_178	[p10l1087t2989r1341b3064],
40	ability	NN	O	ability	prep_of	36	SENT_178	[p10l1384t2989r1606b3064],
41	to	TO	O	to	aux	42	SENT_178	[p10l1646t2996r1715b3046],
42	respond	VB	O	respond	infmod	40	SENT_178	[p10l1758t2989r2039b3064],
43	to	TO	O	to	_	0	SENT_178	[p10l2080t2996r2150b3046],
44	antidepressant	JJ	O	antidepressant	amod	45	SENT_178	[p10l11t3084r523b3160],
45	therapy	NN	O	therapy	prep_to	42	SENT_178	[p10l581t3084r852b3160],
46	regardless	RB	O	regardless	_	0	SENT_178	[p10l908t3084r1248b3160],
47	of	IN	O	of	_	0	SENT_178	[p10l1307t3084r1379b3142],
48	underlying	VBG	O	underlie	amod	50	SENT_178	[p10l1431t3084r1820b3160],
49	DSM-IV	NN	O	dsm-iv	nn	50	SENT_178	[p10l1878t3086r2152b3142],
50	diagnosis	NN	O	diagnosis	prep_regardless_of	42	SENT_178	[p10l11t3179r355b3255],
51	.	.	O	.	_	0	SENT_178	[p10l11t3179r355b3255],

1	This	DT	O	this	nsubj	3	SENT_179	[p10l386t3179r535b3237],
2	is	VBZ	O	be	cop	3	SENT_179	[p10l567t3182r617b3237],
3	further	JJ	O	further	dep	25	SENT_179	[p10l648t3179r893b3237],
4	supported	VBN	O	support	partmod	3	SENT_179	[p10l924t3179r1275b3255],
5	by	IN	O	by	_	0	SENT_179	[p10l1303t3179r1391b3255],
6	our	PRP$	O	we	poss	7	SENT_179	[p10l1419t3196r1536b3237],
7	observation	NN	O	observation	agent	4	SENT_179	[p10l1567t3179r1978b3237],
8	that	IN	O	that	complm	14	SENT_179	[p10l2009t3179r2151b3237],
9	GAD	NN	O	gad	nn	10	SENT_179	[p10l12t3275r178b3331],
10	patients	NNS	O	patient	nsubj	14	SENT_179	[p10l222t3277r502b3350],
11	treated	VBN	O	treat	partmod	10	SENT_179	[p10l546t3274r789b3332],
12	with	IN	O	with	_	0	SENT_179	[p10l831t3274r992b3331],
13	VEN	NN	ORGANIZATION	ven	prep_with	11	SENT_179	[p10l1034t3276r1192b3331],
14	showed	VBD	O	show	ccomp	4	SENT_179	[p10l1235t3274r1500b3332],
15	also	RB	O	also	advmod	14	SENT_179	[p10l1545t3274r1678b3331],
16	a	DT	O	a	det	18	SENT_179	[p10l1723t3291r1757b3331],
17	genotypedependent	JJ	O	genotypedependent	amod	18	SENT_179	[p10l1801t3281r2150b3350, p10l11t3368r387b3444],
18	improvement	NN	O	improvement	dobj	14	SENT_179	[p10l412t3371r893b3444],
19	in	IN	O	in	_	0	SENT_179	[p10l919t3371r989b3425],
20	depressive	JJ	O	depressive	amod	21	SENT_179	[p10l1015t3368r1371b3444],
21	symptomatology	NN	O	symptomatology	prep_in	14	SENT_179	[p10l1400t3369r1998b3444],
22	at	IN	O	at	_	0	SENT_179	[p10l2022t3376r2085b3426],
23	6	CD	DURATION	6	num	24	SENT_179	[p10l2113t3370r2150b3426],
24	months	NNS	NUMBER	month	prep_at	14	SENT_179	[p10l10t3463r283b3521],
25	(	VBP	O	(	_	0	SENT_179	[p10l347t3463r518b3535],
26	A/A	NN	O	a/a	dobj	25	SENT_179	[p10l347t3463r518b3535],
27	:	:	O	:	_	0	SENT_179	[p10l347t3463r518b3535],
28	HAM-D	NN	O	ham-d	dep	26	SENT_179	[p10l584t3465r849b3520],
29	=	JJ	O	=	amod	30	SENT_179	[p10l869t3491r920b3510],
30	9.33	CD	NUMBER	9.33	nsubj	25	SENT_179	[p10l939t3465r1104b3533],
31	,	,	O	,	_	0	SENT_179	[p10l939t3465r1104b3533],
32	G/A	NN	O	g/a	appos	30	SENT_179	[p10l1171t3463r1309b3528],
33	+	CC	O	+	_	0	SENT_179	[p10l1326t3474r1377b3526],
34	G/G	NN	O	g/g	appos	30	SENT_179	[p10l1397t3463r1559b3528],
35	:	:	O	:	_	0	SENT_179	[p10l1397t3463r1559b3528],
36	HAM-D	NN	O	ham-d	dep	32	SENT_179	[p10l1625t3465r1891b3520],
37	=	JJ	O	=	amod	36	SENT_179	[p10l1910t3491r1961b3510],
38	5.31	CD	NUMBER	5.31	tmod	37	SENT_179	[p10l1981t3465r2147b3533],
39	;	:	O	;	_	0	SENT_179	[p10l1981t3465r2147b3533],
40	P	NN	O	p	dep	32	SENT_179	[p10l7t3561r120b3615],
41	:	:	O	:	_	0	SENT_179	[p10l7t3561r120b3615],
42	0.002	CD	NUMBER	0.002	num	43	SENT_179	[p10l138t3558r375b3630],
43	)	NN	O	)	dep	40	SENT_179	[p10l138t3558r375b3630],
44	.	.	O	.	_	0	SENT_179	[p10l138t3558r375b3630],

1	It	PRP	O	it	nsubj	4	SENT_180	[p10l407t3561r458b3616],
2	is	VBZ	O	be	cop	4	SENT_180	[p10l484t3561r535b3616],
3	still	RB	O	still	advmod	4	SENT_180	[p10l563t3558r688b3616],
4	unknown	JJ	O	unknown	_	0	SENT_180	[p10l714t3558r1072b3628],
5	,	,	O	,	_	0	SENT_180	[p10l714t3558r1072b3628],
6	if	IN	O	if	mark	12	SENT_180	[p10l1103t3558r1154b3615],
7	the	DT	O	the	det	9	SENT_180	[p10l1176t3558r1287b3616],
8	HTRZA	NN	O	htrza	nn	9	SENT_180	[p10l1316t3560r1565b3615],
9	variant	NN	O	variant	nsubj	12	SENT_180	[p10l1586t3561r1836b3616],
10	will	MD	O	will	aux	12	SENT_180	[p10l1860t3558r1989b3615],
11	also	RB	O	also	advmod	12	SENT_180	[p10l2017t3558r2149b3616],
12	have	VB	O	have	advcl	4	SENT_180	[p11l10t19r174b76],
13	an	DT	O	a	det	14	SENT_180	[p11l214t35r298b76],
14	effect	NN	O	effect	dobj	12	SENT_180	[p11l337t18r527b76],
15	on	IN	O	on	_	0	SENT_180	[p11l564t35r656b76],
16	non	JJ	O	non	amod	19	SENT_180	[p11l693t19r1448b94],
17	—	JJ	O	—	amod	19	SENT_180	[p11l693t19r1448b94],
18	pharmacological	JJ	O	pharmacological	amod	19	SENT_180	[p11l693t19r1448b94],
19	interventions	NNS	O	intervention	prep_on	14	SENT_180	[p11l1487t22r1976b89],
20	,	,	O	,	_	0	SENT_180	[p11l1487t22r1976b89],
21	and	CC	O	and	_	0	SENT_180	[p11l2021t19r2151b76],
22	future	JJ	DATE	future	amod	23	SENT_180	[p11l10t114r221b172],
23	studies	NNS	O	study	nsubj	25	SENT_180	[p11l278t114r516b172],
24	will	MD	O	will	aux	25	SENT_180	[p11l570t114r699b171],
25	have	VB	O	have	conj_and	4	SENT_180	[p11l754t114r919b172],
26	to	TO	O	to	aux	27	SENT_180	[p11l975t121r1044b172],
27	incorporate	VB	O	incorporate	xcomp	25	SENT_180	[p11l1099t117r1505b190],
28	other	JJ	O	other	amod	30	SENT_180	[p11l1562t114r1749b172],
29	treatment	NN	O	treatment	nn	30	SENT_180	[p11l1803t121r2151b172],
30	modalities	NNS	O	modality	dobj	27	SENT_180	[p11l10t209r376b267],
31	and	CC	O	and	cc	30	SENT_180	[p11l406t209r537b267],
32	preferably	RB	O	preferably	advmod	30	SENT_180	[p11l564t209r918b285],
33	a	DT	O	a	det	35	SENT_180	[p11l946t226r980b267],
34	placebo	NN	O	placebo	nn	35	SENT_180	[p11l1009t209r1278b285],
35	arm	NN	O	arm	dep	30	SENT_180	[p11l1308t226r1462b267],
36	.	.	O	.	_	0	SENT_180	[p11l1308t226r1462b267],

1	While	IN	O	while	mark	5	SENT_181	[p11l86t304r299b361],
2	no	DT	O	no	det	4	SENT_181	[p11l342t320r432b361],
3	clear	JJ	O	clear	amod	4	SENT_181	[p11l476t304r640b361],
4	data	NNS	O	datum	nsubj	5	SENT_181	[p11l682t304r831b361],
5	exist	VBP	O	exist	advcl	21	SENT_181	[p11l873t307r1035b361],
6	on	IN	O	on	_	0	SENT_181	[p11l1077t320r1168b361],
7	the	DT	O	the	det	9	SENT_181	[p11l1210t304r1322b361],
8	biological	JJ	O	biological	amod	9	SENT_181	[p11l1363t304r1710b379],
9	role	NN	O	role	prep_on	5	SENT_181	[p11l1752t304r1885b361],
10	of	IN	O	of	_	0	SENT_181	[p11l1928t303r2000b361],
11	the	DT	O	the	det	14	SENT_181	[p11l2037t304r2149b361],
12	HTRZA	NNP	O	HTRZA	nn	14	SENT_181	[p11l11t401r261b456],
13	rs7997012	CD	NUMBER	rs7997012	num	14	SENT_181	[p11l301t401r665b457],
14	SNP	NN	ORGANIZATION	snp	prep_of	9	SENT_181	[p11l707t401r853b470],
15	,	,	O	,	_	0	SENT_181	[p11l707t401r853b470],
16	a	DT	O	a	det	18	SENT_181	[p11l901t416r935b457],
17	large	JJ	O	large	amod	18	SENT_181	[p11l976t399r1143b475],
18	body	NN	O	body	nsubj	21	SENT_181	[p11l1184t399r1363b475],
19	of	IN	O	of	_	0	SENT_181	[p11l1403t399r1474b457],
20	evidence	NN	O	evidence	prep_of	18	SENT_181	[p11l1512t399r1822b457],
21	suggests	VBZ	O	suggest	_	0	SENT_181	[p11l1866t406r2150b475],
22	a	DT	O	a	det	23	SENT_181	[p11l11t511r46b552],
23	role	NN	O	role	dobj	21	SENT_181	[p11l97t494r229b552],
24	of	IN	O	of	_	0	SENT_181	[p11l283t494r354b552],
25	the	DT	O	the	det	30	SENT_181	[p11l401t494r514b552],
26	HTRZA	NN	O	htrza	nn	30	SENT_181	[p11l567t496r817b551],
27	receptor	NN	O	receptor	nn	30	SENT_181	[p11l868t501r1159b570],
28	(	CD	NUMBER	(	num	30	SENT_181	[p11l1213t494r1584b566],
29	HTRZA-R	NN	O	htrza-r	nn	30	SENT_181	[p11l1213t494r1584b566],
30	)	NN	O	)	prep_of	23	SENT_181	[p11l1213t494r1584b566],
31	in	IN	O	in	_	0	SENT_181	[p11l1639t497r1709b551],
32	mood	NN	O	mood	nn	35	SENT_181	[p11l1761t494r1967b552],
33	and	CC	O	and	_	0	SENT_181	[p11l2020t494r2150b552],
34	anxiety	NN	O	anxiety	conj_and	32	SENT_181	[p11l11t590r275b663],
35	disorders	NNS	O	disorder	prep_in	30	SENT_181	[p11l317t587r633b645],
36	as	RB	O	as	_	0	SENT_181	[p11l678t604r743b645],
37	well	RB	O	well	_	0	SENT_181	[p11l786t587r930b645],
38	as	IN	O	as	_	0	SENT_181	[p11l974t604r1039b645],
39	other	JJ	O	other	amod	41	SENT_181	[p11l1084t587r1273b645],
40	psychiatric	JJ	O	psychiatric	amod	41	SENT_181	[p11l1315t587r1701b663],
41	disorders	NNS	O	disorder	dobj	21	SENT_181	[p11l1746t580r2150b645],
42	.	.	O	.	_	0	SENT_181	[p11l1746t580r2150b645],

1	“	CD	NUMBER	“	nsubj	9	SENT_182	[p11l1746t580r2150b645],
2	The	DT	O	the	det	4	SENT_182	[p11l9t683r141b740],
3	HT	NN	O	ht	nn	4	SENT_182	[p11l183t685r289b739],
4	RZA-R	NN	O	rza-r	dep	1	SENT_182	[p11l292t684r508b739],
5	is	VBZ	O	be	cop	9	SENT_182	[p11l547t685r598b740],
6	a	DT	O	a	det	9	SENT_182	[p11l640t699r675b740],
7	G-protein	NN	MISC	g-protein	nn	9	SENT_182	[p11l717t684r1060b758],
8	postsynaptic	JJ	O	postsynaptic	amod	9	SENT_182	[p11l1100t685r1547b758],
9	receptor	NN	O	receptor	_	0	SENT_182	[p11l1588t690r1878b758],
10	widely	RB	O	widely	advmod	11	SENT_182	[p11l1917t682r2153b758],
11	expressed	VBN	O	express	dep	9	SENT_182	[p11l11t778r350b854],
12	in	IN	O	in	_	0	SENT_182	[p11l397t781r467b835],
13	human	JJ	O	human	amod	14	SENT_182	[p11l515t778r771b836],
14	brain	NN	O	brain	prep_in	11	SENT_182	[p11l816t778r1002b836],
15	and	CC	O	and	_	0	SENT_182	[p11l1051t778r1182b836],
16	implicated	VBN	O	implicate	dep	9	SENT_182	[p11l1229t778r1606b854],
17	in	IN	O	in	_	0	SENT_182	[p11l1654t781r1724b835],
18	prefrontalsubcortical	JJ	O	prefrontalsubcortical	amod	19	SENT_182	[p11l1771t778r2149b854, p11l12t873r394b931],
19	circuits	NNS	O	circuit	prep_in	16	SENT_182	[p11l462t876r715b931],
20	regulating	VBG	O	regulate	xcomp	16	SENT_182	[p11l783t873r1144b949],
21	mood/anxiety	NN	O	mood/anxiety	dobj	20	SENT_182	[p11l1209t873r1723b949],
22	.	.	O	.	_	0	SENT_182	[p11l1209t873r1723b949],

1	Neurobiological	JJ	O	neurobiological	amod	2	SENT_183	[p11l1793t873r2149b931, p11l10t968r241b1043],
2	data	NNS	O	datum	nsubj	3	SENT_183	[p11l288t968r436b1025],
3	suggest	VBP	O	suggest	dep	18	SENT_183	[p11l483t975r737b1043],
4	that	IN	O	that	complm	7	SENT_183	[p11l782t968r925b1025],
5	the	DT	O	the	det	6	SENT_183	[p11l970t968r1082b1025],
6	HTRZA-R	NN	O	htrza-r	nsubj	7	SENT_183	[p11l1129t969r1454b1025],
7	has	VBZ	O	have	ccomp	3	SENT_183	[p11l1498t968r1613b1025],
8	an	DT	O	a	det	10	SENT_183	[p11l1660t984r1745b1025],
9	important	JJ	O	important	amod	10	SENT_183	[p11l1790t971r2151b1043],
10	role	NN	O	role	dobj	7	SENT_183	[p11l10t1063r142b1121],
11	in	IN	O	in	_	0	SENT_183	[p11l170t1066r241b1120],
12	antidepressant	JJ	O	antidepressant	amod	14	SENT_183	[p11l268t1063r784b1139],
13	drug	NN	O	drug	nn	14	SENT_183	[p11l811t1063r972b1139],
14	action	NN	O	action	prep_in	10	SENT_183	[p11l998t1066r1218b1121],
15	as	IN	O	as	_	0	SENT_183	[p11l1245t1080r1310b1121],
16	several	JJ	O	several	amod	17	SENT_183	[p11l1339t1063r1576b1121],
17	antidepressants	NNS	O	antidepressant	prep_as	14	SENT_183	[p11l1604t1063r2150b1139],
18	downregulate	VBP	O	downregulate	_	0	SENT_183	[p11l11t1158r494b1234],
19	HTRZA-Rs	NNS	O	htrza-r	dobj	18	SENT_183	[p11l540t1160r894b1216],
20	in	IN	O	in	_	0	SENT_183	[p11l939t1161r1009b1215],
21	rodent	JJ	O	rodent	amod	24	SENT_183	[p11l1054t1158r1288b1216],
22	and	CC	O	and	_	0	SENT_183	[p11l1333t1158r1464b1216],
23	primate	JJ	O	primate	conj_and	21	SENT_183	[p11l1508t1161r1782b1234],
24	forebrain	NN	O	forebrain	prep_in	18	SENT_183	[p11l1827t1158r2150b1216],
25	correlating	VBG	O	correlate	partmod	24	SENT_183	[p11l11t1253r395b1329],
26	with	IN	O	with	_	0	SENT_183	[p11l447t1253r609b1310],
27	the	DT	O	the	det	28	SENT_183	[p11l664t1253r776b1311],
28	timeframe	NN	O	timeframe	prep_with	25	SENT_183	[p11l833t1253r1196b1311],
29	of	IN	O	of	_	0	SENT_183	[p11l1254t1253r1325b1310],
30	therapeutic	JJ	O	therapeutic	amod	31	SENT_183	[p11l1376t1253r1780b1329],
31	onset	NN	O	onset	prep_of	28	SENT_183	[p11l1836t1260r2025b1311],
32	in	IN	O	in	_	0	SENT_183	[p11l2080t1256r2150b1310],
33	humans	NNS	O	human	prep_in	25	SENT_183	[p11l9t1339r476b1404],
34	.17	CD	NUMBER	.17	number	35	SENT_183	[p11l9t1339r476b1404],
35	‘	CD	NUMBER	‘	dep	33	SENT_183	[p11l9t1339r476b1404],
36	19	CD	NUMBER	19	num	38	SENT_183	[p11l9t1339r476b1404],
37	Selective	JJ	O	selective	amod	38	SENT_183	[p11l525t1346r829b1404],
38	HTR2A	NN	O	htr2a	nsubj	18	SENT_183	[p11l878t1347r1203b1403],
39	.	.	O	.	_	0	SENT_183	[p11l878t1347r1203b1403],

1	—	NN	O	—	_	0	SENT_184	[p11l878t1347r1203b1403],
2	.	.	O	.	_	0	SENT_184	[p11l878t1347r1203b1403],

1	R	NN	O	r	nn	2	SENT_185	[p11l878t1347r1203b1403],
2	antagonists	NNS	O	antagonist	nsubj	4	SENT_185	[p11l1250t1349r1654b1422],
3	are	VBP	O	be	cop	4	SENT_185	[p11l1703t1363r1804b1404],
4	effective	JJ	O	effective	_	0	SENT_185	[p11l1854t1346r2148b1404],
5	in	IN	O	in	_	0	SENT_185	[p11l9t1444r79b1498],
6	animal	NN	O	animal	nn	7	SENT_185	[p11l140t1441r383b1499],
7	models	NNS	O	model	prep_in	4	SENT_185	[p11l444t1441r697b1499],
8	of	IN	O	of	_	0	SENT_185	[p11l758t1441r830b1499],
9	depression	NN	O	depression	prep_of	7	SENT_185	[p11l886t1441r1279b1517],
10	,	,	O	,	_	0	SENT_185	[p11l886t1441r1279b1517],
11	further	RB	O	further	advmod	12	SENT_185	[p11l1344t1441r1591b1499],
12	strengthening	VBG	O	strengthen	xcomp	4	SENT_185	[p11l1652t1441r2150b1517],
13	the	DT	O	the	det	14	SENT_185	[p11l9t1537r121b1595],
14	involvement	NN	O	involvement	dobj	12	SENT_185	[p11l172t1537r624b1595],
15	of	IN	O	of	_	0	SENT_185	[p11l675t1537r746b1594],
16	the	DT	O	the	det	17	SENT_185	[p11l792t1537r904b1595],
17	HTR2A	NN	O	htr2a	prep_of	14	SENT_185	[p11l956t1538r1280b1594],
18	.	.	O	.	_	0	SENT_185	[p11l956t1538r1280b1594],

1	—	NN	O	—	_	0	SENT_186	[p11l956t1538r1280b1594],
2	.	.	O	.	_	0	SENT_186	[p11l956t1538r1280b1594],

1	R	NN	O	r	nsubj	16	SENT_187	[p11l956t1538r1280b1594],
2	in	IN	O	in	_	0	SENT_187	[p11l1329t1540r1399b1594],
3	mood	NN	O	mood	nn	7	SENT_187	[p11l1449t1537r1655b1595],
4	and	CC	O	and	_	0	SENT_187	[p11l1705t1537r1837b1594],
5	anxiety	NN	O	anxiety	nn	7	SENT_187	[p11l1887t1540r2151b1613],
6	disorders	NNS	O	disorder	nn	7	SENT_187	[p11l9t1623r509b1688],
7	.2	NN	NUMBER	.2	prep_in	1	SENT_187	[p11l9t1623r509b1688],
8	°	CD	NUMBER	°	number	9	SENT_187	[p11l9t1623r509b1688],
9	‘	CD	NUMBER	‘	num	10	SENT_187	[p11l9t1623r509b1688],
10	22	CD	NUMBER	22	dep	7	SENT_187	[p11l9t1623r509b1688],
11	Interestingly	RB	O	interestingly	advmod	7	SENT_187	[p11l561t1630r1022b1706],
12	,	,	O	,	_	0	SENT_187	[p11l561t1630r1022b1706],
13	a	DT	O	a	det	15	SENT_187	[p11l1080t1647r1114b1688],
14	recent	JJ	O	recent	amod	15	SENT_187	[p11l1166t1637r1385b1688],
15	report	NN	O	report	appos	7	SENT_187	[p11l1436t1637r1650b1706],
16	documented	VBD	O	document	_	0	SENT_187	[p11l1703t1630r2149b1688],
17	that	IN	O	that	complm	26	SENT_187	[p11l9t1725r152b1781],
18	null	JJ	O	null	amod	21	SENT_187	[p11l211t1724r644b1781],
19	—	NN	O	—	nn	21	SENT_187	[p11l211t1724r644b1781],
20	mutant	JJ	O	mutant	amod	21	SENT_187	[p11l211t1724r644b1781],
21	mice	NNS	O	mouse	nsubj	26	SENT_187	[p11l704t1727r870b1781],
22	for	IN	O	for	_	0	SENT_187	[p11l931t1724r1029b1781],
23	the	DT	O	the	det	24	SENT_187	[p11l1088t1724r1200b1781],
24	HTRZA-R	NN	O	htrza-r	prep_for	21	SENT_187	[p11l1261t1726r1586b1781],
25	have	VBP	O	have	aux	26	SENT_187	[p11l1644t1725r1809b1781],
26	reduced	VBN	O	reduce	ccomp	16	SENT_187	[p11l1869t1724r2149b1781],
27	inhibition	NN	O	inhibition	dobj	26	SENT_187	[p11l9t1820r370b1878],
28	in	IN	O	in	_	0	SENT_187	[p11l401t1823r471b1877],
29	conﬂict	NN	O	conﬂict	nn	30	SENT_187	[p11l503t1820r772b1878],
30	anxiety	NN	O	anxiety	prep_in	26	SENT_187	[p11l804t1823r1078b1896],
31	,	,	O	,	_	0	SENT_187	[p11l804t1823r1078b1896],
32	without	IN	O	without	_	0	SENT_187	[p11l1112t1820r1395b1878],
33	affecting	VBG	O	affect	prepc_without	26	SENT_187	[p11l1426t1820r1735b1896],
34	fearconditioned	JJ	O	fearconditioned	acomp	33	SENT_187	[p11l1765t1820r2148b1878, p11l9t1913r238b1970],
35	or	CC	O	or	_	0	SENT_187	[p11l291t1930r362b1970],
36	depression	NN	O	depression	nn	39	SENT_187	[p11l414t1913r1060b1988],
37	—	NN	O	—	nn	39	SENT_187	[p11l414t1913r1060b1988],
38	related	JJ	O	related	amod	39	SENT_187	[p11l414t1913r1060b1988],
39	behaviors	NNS	O	behavior	conj_or	34	SENT_187	[p11l1110t1905r1538b1970],
40	.	.	O	.	_	0	SENT_187	[p11l1110t1905r1538b1970],

1	”	NN	O	”	nsubj	6	SENT_188	[p11l1110t1905r1538b1970],
2	This	DT	O	this	det	4	SENT_188	[p11l1591t1913r1740b1970],
3	anxiolytic	JJ	O	anxiolytic	amod	4	SENT_188	[p11l1795t1913r2149b1988],
4	effect	NN	O	effect	dep	1	SENT_188	[p11l9t2008r200b2066],
5	is	VBZ	O	be	cop	6	SENT_188	[p11l239t2012r289b2066],
6	consistent	JJ	O	consistent	_	0	SENT_188	[p11l330t2012r691b2066],
7	with	IN	O	with	_	0	SENT_188	[p11l728t2009r890b2066],
8	the	DT	O	the	det	9	SENT_188	[p11l928t2009r1041b2066],
9	downregulation	NN	O	downregulation	prep_with	6	SENT_188	[p11l1082t2009r1647b2084],
10	of	IN	O	of	_	0	SENT_188	[p11l1687t2008r1759b2066],
11	HT	NNP	O	HT	nn	12	SENT_188	[p11l1794t2011r1900b2066],
12	R2A	NNP	O	R2A	prep_of	9	SENT_188	[p11l1903t2010r2148b2066],
13	.	.	O	.	_	0	SENT_188	[p11l1903t2010r2148b2066],

1	—	NN	O	—	_	0	SENT_189	[p11l1903t2010r2148b2066],
2	.	.	O	.	_	0	SENT_189	[p11l1903t2010r2148b2066],

1	Rs	NN	O	r	_	0	SENT_190	[p11l1903t2010r2148b2066],
2	under	IN	O	under	_	0	SENT_190	[p11l7t2104r217b2162],
3	chronic	JJ	O	chronic	amod	8	SENT_190	[p11l296t2104r566b2162],
4	selective	JJ	O	selective	amod	8	SENT_190	[p11l648t2104r944b2162],
5	serotonin	NN	O	serotonin	nn	8	SENT_190	[p11l1028t2107r1365b2162],
6	reuptake	NN	O	reuptake	nn	8	SENT_190	[p11l1446t2104r1750b2180],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_190	[p11l1832t2104r2149b2162],
8	therapy	NN	O	therapy	prep_under	1	SENT_190	[p11l9t2199r291b2275],
9	.	.	O	.	_	0	SENT_190	[p11l9t2199r291b2275],

1	It	PRP	O	it	nsubj	4	SENT_191	[p11l330t2201r382b2256],
2	is	VBZ	O	be	cop	4	SENT_191	[p11l416t2202r466b2257],
3	thus	RB	O	thus	advmod	4	SENT_191	[p11l501t2199r654b2257],
4	feasible	JJ	O	feasible	_	0	SENT_191	[p11l688t2199r949b2257],
5	to	TO	O	to	aux	6	SENT_191	[p11l984t2206r1053b2257],
6	hypothesize	VB	O	hypothesize	xcomp	4	SENT_191	[p11l1088t2199r1514b2275],
7	that	DT	O	that	det	8	SENT_191	[p11l1549t2199r1692b2256],
8	variation	NN	O	variation	nsubj	14	SENT_191	[p11l1724t2202r2044b2257],
9	in	IN	O	in	_	0	SENT_191	[p11l2078t2202r2149b2256],
10	the	DT	O	the	det	12	SENT_191	[p11l9t2294r121b2352],
11	HTRA2	NN	O	htra2	nn	12	SENT_191	[p11l160t2295r412b2351],
12	gene	NN	O	gene	prep_in	8	SENT_191	[p11l453t2311r616b2370],
13	might	MD	O	might	aux	14	SENT_191	[p11l659t2294r872b2370],
14	contribute	VB	O	contribute	ccomp	6	SENT_191	[p11l914t2294r1282b2352],
15	to	TO	O	to	_	0	SENT_191	[p11l1325t2301r1395b2352],
16	the	DT	O	the	det	17	SENT_191	[p11l1437t2294r1550b2352],
17	effectiveness	NN	O	effectiveness	prep_to	14	SENT_191	[p11l1593t2294r2038b2352],
18	of	IN	O	of	_	0	SENT_191	[p11l2081t2294r2153b2351],
19	antidepressants	NNS	O	antidepressant	prep_of	17	SENT_191	[p11l9t2388r556b2464],
20	by	IN	O	by	_	0	SENT_191	[p11l589t2389r676b2464],
21	having	VBG	O	have	prepc_by	14	SENT_191	[p11l708t2389r953b2464],
22	functional	JJ	O	functional	amod	23	SENT_191	[p11l986t2388r1354b2446],
23	effects	NNS	O	effect	dobj	21	SENT_191	[p11l1389t2388r1610b2446],
24	on	IN	O	on	_	0	SENT_191	[p11l1646t2405r1737b2446],
25	HTRZA-Rs	NNS	O	htrza-r	prep_on	21	SENT_191	[p11l1772t2390r2144b2446],
26	.	.	O	.	_	0	SENT_191	[p11l1772t2390r2144b2446],

1	To	TO	O	to	_	0	SENT_192	[p11l7t2486r91b2541],
2	our	PRP$	O	we	poss	3	SENT_192	[p11l121t2501r239b2541],
3	knowledge	NN	O	knowledge	prep_to	6	SENT_192	[p11l265t2484r665b2560],
4	,	,	O	,	_	0	SENT_192	[p11l265t2484r665b2560],
5	there	EX	O	there	expl	6	SENT_192	[p11l698t2484r878b2542],
6	are	VBP	O	be	_	0	SENT_192	[p11l908t2501r1008b2542],
7	no	DT	O	no	det	8	SENT_192	[p11l1037t2501r1128b2541],
8	data	NNS	O	datum	nsubj	10	SENT_192	[p11l1157t2484r1306b2541],
9	available	JJ	O	available	dep	10	SENT_192	[p11l1334t2484r1642b2542],
10	documenting	VBG	O	document	xcomp	6	SENT_192	[p11l1671t2484r2150b2560],
11	an	DT	O	a	det	15	SENT_192	[p11l9t2596r94b2637],
12	allele	NN	O	allele	nn	15	SENT_192	[p11l137t2579r610b2655],
13	—	NN	O	—	nn	15	SENT_192	[p11l137t2579r610b2655],
14	specific	JJ	O	specific	amod	15	SENT_192	[p11l137t2579r610b2655],
15	effect	NN	O	effect	dobj	10	SENT_192	[p11l653t2579r844b2637],
16	of	IN	O	of	_	0	SENT_192	[p11l886t2579r957b2637],
17	rs7997012	NN	O	rs7997012	prep_of	15	SENT_192	[p11l995t2581r1359b2637],
18	on	IN	O	on	_	0	SENT_192	[p11l1402t2596r1493b2637],
19	HTRZA	NN	O	htrza	nn	20	SENT_192	[p11l1536t2581r1786b2636],
20	signaling	NN	O	signaling	prep_on	17	SENT_192	[p11l1829t2579r2150b2655],
21	in	FW	O	in	nn	22	SENT_192	[p11l11t2673r71b2729],
22	vitro	FW	O	vitro	advmod	10	SENT_192	[p11l100t2673r264b2730],
23	.	.	O	.	_	0	SENT_192	[p11l100t2673r264b2730],

1	Future	JJ	DATE	future	amod	2	SENT_193	[p11l299t2675r524b2730],
2	studies	NNS	O	study	nsubjpass	4	SENT_193	[p11l555t2673r795b2730],
3	are	VBP	O	be	auxpass	4	SENT_193	[p11l827t2689r928b2730],
4	needed	VBN	O	need	_	0	SENT_193	[p11l958t2673r1212b2730],
5	in	IN	O	in	_	0	SENT_193	[p11l1241t2676r1312b2729],
6	this	DT	O	this	det	7	SENT_193	[p11l1341t2673r1470b2730],
7	area	NN	O	area	prep_in	4	SENT_193	[p11l1502t2689r1661b2730],
8	.	.	O	.	_	0	SENT_193	[p11l1502t2689r1661b2730],

1	Although	IN	O	although	mark	4	SENT_194	[p11l84t2768r421b2844],
2	our	PRP$	O	we	poss	3	SENT_194	[p11l450t2785r569b2826],
3	results	NNS	O	result	nsubj	4	SENT_194	[p11l597t2768r822b2826],
4	document	VBP	O	document	advcl	20	SENT_194	[p11l852t2768r1214b2826],
5	a	DT	O	a	det	6	SENT_194	[p11l1244t2785r1278b2826],
6	role	NN	O	role	dobj	4	SENT_194	[p11l1306t2768r1439b2826],
7	of	IN	O	of	_	0	SENT_194	[p11l1469t2768r1541b2826],
8	the	DT	O	the	det	10	SENT_194	[p11l1566t2768r1678b2826],
9	HTRZA	NN	O	htrza	nn	10	SENT_194	[p11l1705t2770r1952b2825],
10	gene	NN	O	gene	prep_of	6	SENT_194	[p11l1985t2785r2148b2844],
11	and	CC	O	and	_	0	SENT_194	[p11l9t2863r141b2920],
12	treatment	NN	O	treatment	nn	13	SENT_194	[p11l190t2870r540b2920],
13	response	NN	O	response	prep_of	6	SENT_194	[p11l589t2879r895b2938],
14	to	TO	O	to	_	0	SENT_194	[p11l945t2870r1015b2920],
15	VEN	NNP	O	VEN	prep_to	4	SENT_194	[p11l1063t2865r1222b2920],
16	in	IN	O	in	_	0	SENT_194	[p11l1269t2866r1340b2920],
17	GAD	NN	O	gad	prep_in	15	SENT_194	[p11l1390t2864r1575b2933],
18	,	,	O	,	_	0	SENT_194	[p11l1390t2864r1575b2933],
19	there	EX	O	there	expl	20	SENT_194	[p11l1630t2863r1810b2920],
20	are	VBP	O	be	_	0	SENT_194	[p11l1861t2879r1963b2920],
21	also	RB	O	also	advmod	20	SENT_194	[p11l2014t2863r2148b2920],
22	several	JJ	O	several	amod	23	SENT_194	[p11l10t2958r247b3015],
23	limitations	NNS	O	limitation	nsubj	20	SENT_194	[p11l272t2958r659b3015],
24	that	WDT	O	that	nsubjpass	27	SENT_194	[p11l685t2958r828b3015],
25	should	MD	O	should	aux	27	SENT_194	[p11l855t2958r1094b3015],
26	be	VB	O	be	auxpass	27	SENT_194	[p11l1117t2958r1197b3015],
27	considered	VBN	O	consider	rcmod	23	SENT_194	[p11l1224t2958r1606b3015],
28	carefully	RB	O	carefully	advmod	27	SENT_194	[p11l1632t2957r1947b3033],
29	.	.	O	.	_	0	SENT_194	[p11l1632t2957r1947b3033],

1	First	RB	ORDINAL	first	advmod	6	SENT_195	[p11l1978t2960r2144b3028],
2	,	,	O	,	_	0	SENT_195	[p11l1978t2960r2144b3028],
3	it	PRP	O	it	nsubjpass	6	SENT_195	[p11l9t3056r58b3111],
4	should	MD	O	should	aux	6	SENT_195	[p11l85t3053r323b3111],
5	be	VB	O	be	auxpass	6	SENT_195	[p11l346t3053r426b3111],
6	noted	VBN	O	note	_	0	SENT_195	[p11l453t3053r658b3111],
7	that	IN	O	that	complm	12	SENT_195	[p11l684t3053r827b3111],
8	patients	NNS	O	patient	nsubj	12	SENT_195	[p11l852t3056r1134b3129],
9	in	IN	O	in	_	0	SENT_195	[p11l1161t3056r1231b3110],
10	this	DT	O	this	det	11	SENT_195	[p11l1256t3053r1386b3111],
11	study	NN	O	study	prep_in	8	SENT_195	[p11l1414t3053r1606b3129],
12	participated	VBD	O	participate	ccomp	6	SENT_195	[p11l1628t3053r2053b3129],
13	in	IN	O	in	_	0	SENT_195	[p11l2078t3056r2149b3110],
14	an	DT	O	a	det	20	SENT_195	[p11l9t3165r94b3205],
15	18-month	JJ	DURATION	18-month	amod	20	SENT_195	[p11l137t3148r487b3205],
16	long	JJ	O	long	amod	20	SENT_195	[p11l524t3148r875b3224],
17	—	NN	O	—	nn	20	SENT_195	[p11l524t3148r875b3224],
18	term	NN	O	term	nn	20	SENT_195	[p11l524t3148r875b3224],
19	treatment	NN	O	treatment	nn	20	SENT_195	[p11l912t3155r1263b3206],
20	trial	NN	O	trial	prep_in	12	SENT_195	[p11l1300t3148r1441b3205],
21	of	IN	O	of	_	0	SENT_195	[p11l1479t3148r1550b3205],
22	GAD	NN	O	gad	prep_of	20	SENT_195	[p11l1584t3149r1769b3218],
23	,	,	O	,	_	0	SENT_195	[p11l1584t3149r1769b3218],
24	and	CC	O	and	_	0	SENT_195	[p11l1812t3148r1943b3205],
25	DNA	NN	O	dna	nn	26	SENT_195	[p11l1981t3149r2150b3205],
26	samples	NNS	O	sample	nsubjpass	28	SENT_195	[p11l10t3244r286b3320],
27	were	VBD	O	be	auxpass	28	SENT_195	[p11l335t3261r499b3302],
28	collected	VBN	O	collect	conj_and	12	SENT_195	[p11l550t3244r866b3302],
29	retrospectively	RB	O	retrospectively	advmod	28	SENT_195	[p11l916t3244r1438b3320],
30	and	CC	O	and	_	0	SENT_195	[p11l1486t3244r1617b3301],
31	overrepresent	JJ	O	overrepresent	amod	32	SENT_195	[p11l1668t3251r2149b3320],
32	completers	NNS	O	completer	nsubj	40	SENT_195	[p11l9t3339r414b3414],
33	,	,	O	,	_	0	SENT_195	[p11l9t3339r414b3414],
34	thus	RB	O	thus	advmod	40	SENT_195	[p11l469t3339r622b3396],
35	there	EX	O	there	expl	40	SENT_195	[p11l674t3338r854b3396],
36	might	MD	O	might	aux	40	SENT_195	[p11l907t3339r1119b3414],
37	be	VB	O	be	cop	40	SENT_195	[p11l1168t3339r1248b3396],
38	an	DT	O	a	det	40	SENT_195	[p11l1301t3355r1386b3396],
39	ascertainment	NN	O	ascertainment	nn	40	SENT_195	[p11l1438t3341r1940b3396],
40	bias	NN	O	bias	ccomp	6	SENT_195	[p11l1989t3338r2144b3396],
41	.	.	O	.	_	0	SENT_195	[p11l1989t3338r2144b3396],

1	Future	JJ	DATE	future	amod	2	SENT_196	[p11l9t3436r234b3492],
2	studies	NNS	O	study	nsubj	4	SENT_196	[p11l276t3434r517b3492],
3	will	MD	O	will	aux	4	SENT_196	[p11l555t3434r685b3491],
4	have	VB	O	have	_	0	SENT_196	[p11l725t3434r890b3492],
5	to	TO	O	to	aux	6	SENT_196	[p11l931t3441r1000b3491],
6	use	VB	O	use	xcomp	4	SENT_196	[p11l1040t3451r1152b3492],
7	a	DT	O	a	det	11	SENT_196	[p11l1194t3451r1229b3491],
8	prospective	JJ	O	prospective	amod	11	SENT_196	[p11l1268t3437r1671b3510],
9	clinical	JJ	O	clinical	amod	11	SENT_196	[p11l1712t3434r1967b3492],
10	trial	NN	O	trial	nn	11	SENT_196	[p11l2007t3434r2148b3491],
11	design	NN	O	design	dobj	6	SENT_196	[p11l9t3529r236b3605],
12	to	TO	O	to	aux	14	SENT_196	[p11l269t3536r339b3587],
13	adequately	RB	O	adequately	advmod	14	SENT_196	[p11l375t3529r762b3605],
14	address	VB	O	address	xcomp	6	SENT_196	[p11l794t3529r1050b3587],
15	this	DT	O	this	det	16	SENT_196	[p11l1085t3529r1214b3587],
16	concern	NN	O	concern	dobj	14	SENT_196	[p11l1249t3546r1551b3587],
17	.	.	O	.	_	0	SENT_196	[p11l1249t3546r1551b3587],

1	Another	DT	O	another	det	2	SENT_197	[p11l1589t3529r1882b3587],
2	limitation	NN	O	limitation	nsubj	3	SENT_197	[p11l1915t3529r2147b3587, p11l9t3626r153b3681],
3	includes	VBZ	O	include	_	0	SENT_197	[p11l192t3623r485b3681],
4	the	DT	O	the	det	5	SENT_197	[p11l524t3624r637b3681],
5	lack	NN	O	lack	nsubj	11	SENT_197	[p11l676t3623r817b3681],
6	of	IN	O	of	_	0	SENT_197	[p11l855t3623r926b3681],
7	a	DT	O	a	det	9	SENT_197	[p11l961t3640r996b3681],
8	placebo	NN	O	placebo	nn	9	SENT_197	[p11l1033t3624r1304b3699],
9	arm	NN	O	arm	prep_of	5	SENT_197	[p11l1345t3640r1481b3681],
10	thus	RB	O	thus	advmod	11	SENT_197	[p11l1520t3624r1672b3681],
11	limiting	VBG	O	limit	dep	3	SENT_197	[p11l1712t3624r1998b3699],
12	the	DT	O	the	det	13	SENT_197	[p11l2035t3623r2147b3681],
13	specificity	NN	O	specificity	dobj	11	SENT_197	[p11l10t3719r367b3795],
14	of	IN	O	of	_	0	SENT_197	[p11l433t3719r505b3777],
15	HTRZA	NN	O	htrza	nn	17	SENT_197	[p11l570t3721r820b3776],
16	rs7997012	NN	O	rs7997012	nn	17	SENT_197	[p11l888t3721r1251b3777],
17	variant	NN	O	variant	prep_of	13	SENT_197	[p11l1318t3722r1569b3777],
18	on	IN	O	on	_	0	SENT_197	[p11l1638t3736r1730b3777],
19	treatment	NN	O	treatment	nn	20	SENT_197	[p11l1798t3726r2149b3777],
20	response	NN	O	response	prep_on	17	SENT_197	[p12l9t33r314b92],
21	to	TO	O	to	_	0	SENT_197	[p12l370t23r440b74],
22	VEN	NNP	O	VEN	prep_to	11	SENT_197	[p12l496t19r670b74],
23	.	.	O	.	_	0	SENT_197	[p12l496t19r670b74],

1	While	IN	O	while	mark	5	SENT_198	[p12l729t16r942b74],
2	it	PRP	O	it	nsubj	5	SENT_198	[p12l999t19r1048b74],
3	is	VBZ	O	be	cop	5	SENT_198	[p12l1103t19r1154b74],
4	ethically	RB	O	ethically	advmod	5	SENT_198	[p12l1211t16r1516b92],
5	questionable	JJ	O	questionable	advcl	36	SENT_198	[p12l1570t16r2021b92],
6	to	TO	O	to	aux	7	SENT_198	[p12l2078t23r2148b74],
7	withhold	VB	O	withhold	xcomp	5	SENT_198	[p12l7t111r334b168],
8	FDA	NNP	O	FDA	dobj	7	SENT_198	[p12l375t111r881b186],
9	—	CD	NUMBER	—	num	8	SENT_198	[p12l375t111r881b186],
10	approVed	VBD	O	approve	rcmod	8	SENT_198	[p12l375t111r881b186],
11	treatment	NN	O	treatment	dobj	10	SENT_198	[p12l921t118r1271b168],
12	from	IN	O	from	_	0	SENT_198	[p12l1311t110r1480b168],
13	GAD	NN	O	gad	nn	14	SENT_198	[p12l1522t112r1688b168],
14	patients	NNS	O	patient	prep_from	10	SENT_198	[p12l1729t114r2011b186],
15	for	IN	O	for	_	0	SENT_198	[p12l2051t110r2150b168],
16	an	DT	O	a	det	18	SENT_198	[p12l9t223r94b264],
17	extended	JJ	O	extended	amod	18	SENT_198	[p12l119t206r445b264],
18	period	NN	O	period	prep_for	10	SENT_198	[p12l468t206r695b282],
19	of	IN	O	of	_	0	SENT_198	[p12l720t206r791b264],
20	time	NN	O	time	prep_of	18	SENT_198	[p12l812t209r989b276],
21	,	,	O	,	_	0	SENT_198	[p12l812t209r989b276],
22	such	JJ	O	such	_	0	SENT_198	[p12l1020t206r1180b264],
23	as	IN	O	as	_	0	SENT_198	[p12l1205t223r1270b264],
24	a	DT	O	a	det	31	SENT_198	[p12l1296t223r1331b264],
25	6-month	JJ	DURATION	6-month	amod	31	SENT_198	[p12l1357t206r1668b264],
26	double-blind	JJ	O	double-blind	amod	31	SENT_198	[p12l1693t206r2149b264],
27	placebo	NN	O	placebo	nn	31	SENT_198	[p12l8t301r674b377],
28	—	NN	O	—	nn	31	SENT_198	[p12l8t301r674b377],
29	controlled	JJ	O	controlled	amod	31	SENT_198	[p12l8t301r674b377],
30	treatment	NN	O	treatment	nn	31	SENT_198	[p12l736t308r1087b359],
31	trial	NN	O	trial	prep_such_as	18	SENT_198	[p12l1148t301r1307b371],
32	,	,	O	,	_	0	SENT_198	[p12l1148t301r1307b371],
33	future	JJ	DATE	future	amod	34	SENT_198	[p12l1373t301r1585b359],
34	studies	NNS	O	study	nsubj	36	SENT_198	[p12l1650t301r1890b359],
35	could	MD	O	could	aux	36	SENT_198	[p12l1953t301r2148b359],
36	include	VB	O	include	_	0	SENT_198	[p12l9t396r271b454],
37	comparison	NN	O	comparison	nn	38	SENT_198	[p12l305t399r721b472],
38	drugs	NNS	O	drug	nsubj	40	SENT_198	[p12l755t396r945b472],
39	and/or	JJ	O	and/or	amod	40	SENT_198	[p12l979t396r1215b461],
40	interventions	NNS	O	intervention	xcomp	36	SENT_198	[p12l1247t399r1724b454],
41	in	IN	O	in	mark	44	SENT_198	[p12l1757t399r1828b453],
42	order	NN	O	order	dep	44	SENT_198	[p12l1861t396r2047b454],
43	to	TO	O	to	aux	44	SENT_198	[p12l2078t403r2148b453],
44	assess	VB	O	assess	purpcl	36	SENT_198	[p12l9t507r206b548],
45	the	DT	O	the	det	46	SENT_198	[p12l236t491r348b548],
46	specificity	NN	O	specificity	dobj	44	SENT_198	[p12l381t490r737b566],
47	of	IN	O	of	_	0	SENT_198	[p12l765t490r836b548],
48	the	DT	O	the	det	51	SENT_198	[p12l862t491r975b548],
49	rs799	NN	O	rs799	nn	51	SENT_198	[p12l1005t492r1191b548],
50	7012	CD	NUMBER	7012	num	51	SENT_198	[p12l1203t492r1368b548],
51	variant	NN	O	variant	prep_of	46	SENT_198	[p12l1396t493r1647b548],
52	on	IN	O	on	_	0	SENT_198	[p12l1678t507r1769b548],
53	treatment	NN	O	treatment	nn	54	SENT_198	[p12l1798t498r2149b548],
54	outcome	NN	O	outcome	prep_on	51	SENT_198	[p12l9t593r337b644],
55	.	.	O	.	_	0	SENT_198	[p12l9t593r337b644],

1	Comorbidity	NN	O	comorbidity	nsubj	8	SENT_199	[p12l376t586r832b662],
2	of	IN	O	of	_	0	SENT_199	[p12l863t586r934b643],
3	anxiety	NN	O	anxiety	nn	4	SENT_199	[p12l964t589r1228b662],
4	disorders	NNS	O	disorder	prep_of	1	SENT_199	[p12l1258t586r1574b644],
5	and	CC	O	and	_	0	SENT_199	[p12l1609t586r1740b643],
6	depression	NN	O	depression	prep_of	1	SENT_199	[p12l1773t586r2148b662],
7	is	VBZ	O	be	cop	8	SENT_199	[p12l9t684r59b739],
8	common	JJ	O	common	_	0	SENT_199	[p12l119t698r456b751],
9	,	,	O	,	_	0	SENT_199	[p12l119t698r456b751],
10	and	CC	O	and	_	0	SENT_199	[p12l521t681r652b739],
11	should	MD	O	should	aux	13	SENT_199	[p12l712t681r951b739],
12	be	VB	O	be	auxpass	13	SENT_199	[p12l1008t681r1088b739],
13	considered	VBN	O	consider	conj_and	8	SENT_199	[p12l1149t681r1531b739],
14	carefully	RB	O	carefully	advmod	13	SENT_199	[p12l1590t681r1896b757],
15	when	WRB	O	when	advmod	16	SENT_199	[p12l1951t681r2148b739],
16	interpreting	VBG	O	interpret	advcl	13	SENT_199	[p12l9t778r435b851],
17	results	NNS	O	result	dobj	16	SENT_199	[p12l480t776r723b833],
18	.	.	O	.	_	0	SENT_199	[p12l480t776r723b833],

1	Although	IN	O	although	mark	8	SENT_200	[p12l773t775r1110b851],
2	our	PRP$	O	we	poss	3	SENT_200	[p12l1157t792r1275b833],
3	sample	NN	O	sample	nsubj	8	SENT_200	[p12l1323t775r1567b851],
4	was	VBD	O	be	cop	8	SENT_200	[p12l1612t792r1740b833],
5	a	DT	O	a	det	8	SENT_200	[p12l1788t792r1823b833],
6	primary	JJ	O	primary	amod	8	SENT_200	[p12l1868t778r2151b851],
7	GAD	NN	O	gad	nn	8	SENT_200	[p12l10t873r176b929],
8	sample	NN	O	sample	advcl	22	SENT_200	[p12l208t871r470b947],
9	,	,	O	,	_	0	SENT_200	[p12l208t871r470b947],
10	with	IN	O	with	_	0	SENT_200	[p12l502t871r663b929],
11	current	JJ	DATE	current	amod	12	SENT_200	[p12l692t878r948b929],
12	MDD	NN	ORGANIZATION	mdd	prep_with	8	SENT_200	[p12l975t874r1164b928],
13	as	IN	O	as	_	0	SENT_200	[p12l1195t888r1259b929],
14	exclusion	NN	O	exclusion	nn	15	SENT_200	[p12l1289t871r1625b929],
15	criterion	NN	O	criterion	prep_as	12	SENT_200	[p12l1655t874r1974b941],
16	,	,	O	,	_	0	SENT_200	[p12l1655t874r1974b941],
17	past	JJ	DATE	past	amod	18	SENT_200	[p12l2006t878r2149b947],
18	episodes	NNS	O	episode	nsubjpass	22	SENT_200	[p12l9t966r304b1042],
19	of	IN	O	of	_	0	SENT_200	[p12l338t966r410b1024],
20	MDD	NN	ORGANIZATION	mdd	prep_of	18	SENT_200	[p12l436t969r625b1023],
21	were	VBD	O	be	auxpass	22	SENT_200	[p12l657t983r820b1024],
22	allowed	VBN	O	allow	_	0	SENT_200	[p12l854t966r1127b1024],
23	and	CC	O	and	_	0	SENT_200	[p12l1160t966r1291b1024],
24	patients	NNS	O	patient	nsubj	27	SENT_200	[p12l1322t969r1604b1042],
25	may	MD	O	may	aux	27	SENT_200	[p12l1637t983r1789b1042],
26	have	VB	O	have	aux	27	SENT_200	[p12l1819t966r1984b1024],
27	had	VBD	O	have	conj_and	22	SENT_200	[p12l2017t966r2149b1024],
28	some	DT	O	some	det	31	SENT_200	[p12l10t1077r191b1118],
29	moderate	JJ	O	moderate	amod	31	SENT_200	[p12l230t1061r563b1118],
30	depressive	JJ	O	depressive	amod	31	SENT_200	[p12l603t1061r963b1136],
31	symptoms	NNS	O	symptom	dobj	27	SENT_200	[p12l1004t1068r1367b1136],
32	at	IN	O	at	_	0	SENT_200	[p12l1408t1068r1471b1118],
33	baseline	NN	O	baseline	prep_at	31	SENT_200	[p12l1507t1061r1812b1118],
34	.	.	O	.	_	0	SENT_200	[p12l1507t1061r1812b1118],

1	Interestingly	RB	O	interestingly	advmod	6	SENT_201	[p12l1856t1063r2148b1118, p12l9t1156r198b1232],
2	,	,	O	,	_	0	SENT_201	[p12l1856t1063r2148b1118, p12l9t1156r198b1232],
3	our	PRP$	O	we	poss	5	SENT_201	[p12l232t1173r351b1214],
4	GAD	NN	O	gad	nn	5	SENT_201	[p12l380t1158r547b1214],
5	patients	NNS	O	patient	nsubj	6	SENT_201	[p12l576t1159r859b1232],
6	improved	VBD	O	improve	_	0	SENT_201	[p12l888t1156r1229b1232],
7	also	RB	O	also	advmod	6	SENT_201	[p12l1259t1156r1393b1214],
8	on	IN	O	on	_	0	SENT_201	[p12l1423t1173r1514b1214],
9	the	DT	O	the	det	11	SENT_201	[p12l1543t1156r1655b1214],
10	HAM-D	NN	MISC	ham-d	nn	11	SENT_201	[p12l1686t1158r1952b1213],
11	scale	NN	O	scale	prep_on	6	SENT_201	[p12l1984t1156r2147b1214],
12	depending	VBG	O	depend	_	0	SENT_201	[p12l9t1251r387b1327],
13	on	IN	O	on	prepc_depending_on	6	SENT_201	[p12l418t1268r508b1308],
14	the	DT	O	the	det	16	SENT_201	[p12l539t1251r652b1309],
15	rs7997012	NN	O	rs7997012	nn	16	SENT_201	[p12l683t1252r1047b1309],
16	genotype	NN	O	genotype	pobj	6	SENT_201	[p12l1078t1258r1423b1327],
17	.	.	O	.	_	0	SENT_201	[p12l1078t1258r1423b1327],

1	Future	JJ	DATE	future	amod	2	SENT_202	[p12l1459t1253r1684b1309],
2	studies	NNS	O	study	nsubjpass	19	SENT_202	[p12l1717t1251r1957b1309],
3	with	IN	O	with	_	0	SENT_202	[p12l1987t1251r2148b1308],
4	various	JJ	O	various	amod	6	SENT_202	[p12l7t1349r262b1403],
5	phenotypic	JJ	O	phenotypic	amod	6	SENT_202	[p12l288t1346r694b1422],
6	definitions	NNS	O	definition	prep_with	2	SENT_202	[p12l720t1346r1121b1416],
7	,	,	O	,	_	0	SENT_202	[p12l720t1346r1121b1416],
8	such	JJ	O	such	_	0	SENT_202	[p12l1154t1346r1314b1404],
9	as	IN	O	as	_	0	SENT_202	[p12l1340t1363r1405b1403],
10	anxious	JJ	O	anxious	amod	12	SENT_202	[p12l1431t1346r2143b1422],
11	—	NN	O	—	nn	12	SENT_202	[p12l1431t1346r2143b1422],
12	depression	NN	O	depression	prep_such_as	6	SENT_202	[p12l1431t1346r2143b1422],
13	,	,	O	,	_	0	SENT_202	[p12l1431t1346r2143b1422],
14	versus	CC	O	versus	prep	6	SENT_202	[p12l6t1457r223b1498],
15	strict	JJ	O	strict	amod	16	SENT_202	[p12l255t1443r429b1498],
16	GAD	NN	O	gad	dep	14	SENT_202	[p12l460t1442r626b1498],
17	might	MD	O	might	aux	19	SENT_202	[p12l657t1440r870b1516],
18	be	VB	O	be	auxpass	19	SENT_202	[p12l897t1440r977b1498],
19	warranted	VBN	O	warrant	_	0	SENT_202	[p12l1006t1440r1383b1498],
20	.	.	O	.	_	0	SENT_202	[p12l1006t1440r1383b1498],

1	From	IN	O	from	_	0	SENT_203	[p12l86t1538r267b1593],
2	a	DT	O	a	det	4	SENT_203	[p12l295t1553r330b1593],
3	genetic	JJ	O	genetic	amod	4	SENT_203	[p12l357t1539r608b1612],
4	perspective	NN	O	perspective	prep_from	7	SENT_203	[p12l635t1539r1042b1612],
5	,	,	O	,	_	0	SENT_203	[p12l635t1539r1042b1612],
6	there	EX	O	there	expl	7	SENT_203	[p12l1075t1536r1252b1594],
7	are	VBP	O	be	_	0	SENT_203	[p12l1282t1553r1382b1594],
8	several	JJ	O	several	amod	9	SENT_203	[p12l1412t1536r1645b1594],
9	limitations	NNS	O	limitation	nsubj	7	SENT_203	[p12l1673t1536r2053b1593],
10	of	IN	O	of	_	0	SENT_203	[p12l2082t1536r2153b1593],
11	our	PRP$	O	we	poss	12	SENT_203	[p12l9t1648r126b1689],
12	study	NN	O	study	prep_of	9	SENT_203	[p12l164t1631r354b1707],
13	that	IN	O	that	nsubjpass	16	SENT_203	[p12l388t1631r529b1689],
14	should	MD	O	should	aux	16	SENT_203	[p12l567t1631r803b1689],
15	be	VB	O	be	auxpass	16	SENT_203	[p12l837t1631r917b1689],
16	considered	VBN	O	consider	rcmod	9	SENT_203	[p12l955t1631r1348b1689],
17	.	.	O	.	_	0	SENT_203	[p12l955t1631r1348b1689],

1	We	PRP	O	we	nsubj	2	SENT_204	[p12l1388t1634r1497b1689],
2	investigated	VBD	O	investigate	_	0	SENT_204	[p12l1535t1631r1956b1707],
3	only	RB	O	only	advmod	5	SENT_204	[p12l1993t1631r2152b1707],
4	one	CD	NUMBER	one	num	5	SENT_204	[p12l9t1741r136b1782],
5	SNP	NN	ORGANIZATION	snp	dobj	2	SENT_204	[p12l163t1726r299b1782],
6	in	IN	O	in	_	0	SENT_204	[p12l324t1727r394b1781],
7	the	DT	O	the	det	10	SENT_204	[p12l417t1724r528b1782],
8	HT	NNP	O	HT	nn	10	SENT_204	[p12l550t1727r665b1781],
9	RZA	NNP	O	RZA	nn	10	SENT_204	[p12l656t1726r795b1781],
10	gene	NN	O	gene	prep_in	2	SENT_204	[p12l823t1741r1001b1800],
11	,	,	O	,	_	0	SENT_204	[p12l823t1741r1001b1800],
12	based	VBN	O	base	_	0	SENT_204	[p12l1029t1724r1224b1782],
13	on	IN	O	on	prepc_based_on	2	SENT_204	[p12l1249t1741r1340b1782],
14	the	DT	O	the	det	17	SENT_204	[p12l1364t1724r1475b1782],
15	a	DT	O	a	det	16	SENT_204	[p12l1500t1742r1537b1782],
16	priory	NN	O	priory	nn	17	SENT_204	[p12l1554t1725r1751b1801],
17	hypothesis	NN	O	hypothesis	pobj	2	SENT_204	[p12l1771t1724r2149b1800],
18	that	IN	O	that	complm	35	SENT_204	[p12l9t1820r150b1878],
19	this	DT	O	this	det	20	SENT_204	[p12l206t1820r333b1878],
20	variant	NN	O	variant	nsubj	35	SENT_204	[p12l388t1823r653b1890],
21	,	,	O	,	_	0	SENT_204	[p12l388t1823r653b1890],
22	which	WDT	O	which	nsubjpass	25	SENT_204	[p12l711t1820r929b1878],
23	was	VBD	O	be	auxpass	25	SENT_204	[p12l984t1837r1111b1878],
24	previously	RB	DATE	previously	advmod	25	SENT_204	[p12l1167t1820r1530b1896],
25	associated	VBN	O	associate	rcmod	20	SENT_204	[p12l1585t1820r1935b1878],
26	with	IN	O	with	_	0	SENT_204	[p12l1989t1820r2149b1878],
27	antidepressant	JJ	O	antidepressant	amod	29	SENT_204	[p12l9t1915r517b1991],
28	treatment	NN	O	treatment	nn	29	SENT_204	[p12l556t1922r903b1973],
29	response	NN	O	response	prep_with	25	SENT_204	[p12l942t1932r1243b1991],
30	in	IN	O	in	_	0	SENT_204	[p12l1284t1918r1354b1972],
31	MDD	NN	ORGANIZATION	mdd	prep_in	29	SENT_204	[p12l1393t1918r1599b1985],
32	,	,	O	,	_	0	SENT_204	[p12l1393t1918r1599b1985],
33	will	MD	O	will	aux	35	SENT_204	[p12l1642t1915r1771b1972],
34	also	RB	O	also	advmod	35	SENT_204	[p12l1812t1915r1944b1973],
35	have	VB	O	have	dep	17	SENT_204	[p12l1985t1915r2148b1973],
36	an	DT	O	a	det	37	SENT_204	[p12l9t2026r94b2067],
37	effect	NN	O	effect	dobj	35	SENT_204	[p12l161t2009r350b2067],
38	in	IN	O	in	_	0	SENT_204	[p12l416t2013r487b2067],
39	a	DT	O	a	det	40	SENT_204	[p12l554t2026r589b2067],
40	sample	NN	O	sample	prep_in	37	SENT_204	[p12l658t2010r899b2085],
41	of	IN	O	of	_	0	SENT_204	[p12l968t2009r1040b2067],
42	GAD	NN	O	gad	nn	43	SENT_204	[p12l1104t2011r1269b2067],
43	patients	NNS	O	patient	prep_of	40	SENT_204	[p12l1337t2013r1615b2085],
44	treated	VBN	O	treat	partmod	43	SENT_204	[p12l1683t2010r1924b2067],
45	with	IN	O	with	_	0	SENT_204	[p12l1989t2010r2148b2067],
46	antidepressant	JJ	O	antidepressant	amod	47	SENT_204	[p12l9t2105r517b2181],
47	drugs	NNS	O	drug	prep_with	44	SENT_204	[p12l564t2105r769b2181],
48	.	.	O	.	_	0	SENT_204	[p12l564t2105r769b2181],

1	It	PRP	O	it	nsubj	3	SENT_205	[p12l821t2108r872b2163],
2	is	VBZ	O	be	cop	3	SENT_205	[p12l917t2108r968b2163],
3	possible	JJ	O	possible	_	0	SENT_205	[p12l1014t2105r1289b2181],
4	that	IN	O	that	complm	9	SENT_205	[p12l1337t2105r1478b2163],
5	other	JJ	O	other	amod	6	SENT_205	[p12l1525t2105r1710b2163],
6	variants	NNS	O	variant	nsubj	9	SENT_205	[p12l1754t2108r2032b2163],
7	or	CC	O	or	_	0	SENT_205	[p12l2079t2122r2150b2163],
8	haplotypes	NNS	O	haplotype	nsubj	9	SENT_205	[p12l9t2200r389b2276],
9	have	VBP	O	have	ccomp	3	SENT_205	[p12l434t2200r598b2258],
10	an	DT	O	a	det	11	SENT_205	[p12l643t2217r728b2258],
11	effect	NN	O	effect	dobj	9	SENT_205	[p12l772t2200r960b2258],
12	on	IN	O	on	_	0	SENT_205	[p12l1004t2217r1095b2258],
13	treatment	NN	O	treatment	nn	14	SENT_205	[p12l1139t2207r1485b2258],
14	response	NN	O	response	prep_on	11	SENT_205	[p12l1528t2217r1828b2276],
15	to	TO	O	to	_	0	SENT_205	[p12l1874t2207r1944b2258],
16	antidepressant	JJ	O	antidepressant	amod	17	SENT_205	[p12l1989t2203r2148b2258, p12l9t2295r377b2371],
17	drugs	NNS	O	drug	prep_to	9	SENT_205	[p12l423t2295r629b2371],
18	.	.	O	.	_	0	SENT_205	[p12l423t2295r629b2371],

1	Future	JJ	DATE	future	amod	2	SENT_206	[p12l678t2297r900b2353],
2	studies	NNS	O	study	nsubj	4	SENT_206	[p12l948t2295r1184b2353],
3	will	MD	O	will	aux	4	SENT_206	[p12l1228t2295r1357b2352],
4	have	VB	O	have	_	0	SENT_206	[p12l1401t2295r1565b2353],
5	to	TO	O	to	aux	7	SENT_206	[p12l1610t2302r1680b2353],
6	comprehensively	RB	O	comprehensively	advmod	7	SENT_206	[p12l1726t2295r2148b2371, p12l10t2390r206b2465],
7	genotype	NN	O	genotype	xcomp	4	SENT_206	[p12l226t2397r548b2465],
8	the	DT	O	the	det	12	SENT_206	[p12l572t2390r683b2447],
9	H	NN	O	h	nn	12	SENT_206	[p12l704t2392r768b2446],
10	TRZA	NN	O	trza	nn	12	SENT_206	[p12l769t2391r950b2446],
11	gene	NN	O	gene	nn	12	SENT_206	[p12l976t2406r1137b2465],
12	region	NN	O	region	npadvmod	7	SENT_206	[p12l1161t2392r1384b2465],
13	for	IN	O	for	_	0	SENT_206	[p12l1406t2389r1503b2447],
14	common	JJ	O	common	amod	17	SENT_206	[p12l1525t2406r1842b2447],
15	and	CC	O	and	_	0	SENT_206	[p12l1865t2389r1995b2447],
16	rare	JJ	O	rare	conj_and	14	SENT_206	[p12l2019t2406r2148b2447],
17	variants	NNS	O	variant	prep_for	7	SENT_206	[p12l7t2488r284b2543],
18	that	WDT	O	that	nsubj	20	SENT_206	[p12l332t2485r473b2543],
19	might	MD	O	might	aux	20	SENT_206	[p12l520t2485r731b2561],
20	inﬂuence	VB	O	inﬂuence	ccomp	4	SENT_206	[p12l779t2485r1105b2543],
21	HTR2A	NN	O	htr2a	dobj	20	SENT_206	[p12l1154t2486r1475b2542],
22	.	.	O	.	_	0	SENT_206	[p12l1154t2486r1475b2542],

1	—	NN	O	—	_	0	SENT_207	[p12l1154t2486r1475b2542],
2	.	.	O	.	_	0	SENT_207	[p12l1154t2486r1475b2542],

1	R	NN	O	r	_	0	SENT_208	[p12l1154t2486r1475b2542],
2	biology	NN	O	biology	dep	1	SENT_208	[p12l1518t2485r1782b2561],
3	and	CC	O	and	_	0	SENT_208	[p12l1828t2485r1958b2542],
4	ultimately	RB	O	ultimately	advmod	2	SENT_208	[p12l2005t2485r2148b2542, p12l9t2580r249b2656],
5	treatment	NN	O	treatment	nn	6	SENT_208	[p12l267t2587r613b2638],
6	outcome	NN	O	outcome	dep	1	SENT_208	[p12l635t2587r958b2638],
7	.	.	O	.	_	0	SENT_208	[p12l635t2587r958b2638],

1	The	DT	O	the	det	2	SENT_209	[p12l983t2580r1115b2638],
2	rs799	NN	O	rs799	nsubj	7	SENT_209	[p12l1137t2582r1321b2638],
3	7012	CD	NUMBER	7012	dep	2	SENT_209	[p12l1332t2582r1495b2638],
4	is	VBZ	O	be	cop	7	SENT_209	[p12l1517t2583r1568b2638],
5	an	DT	O	a	det	7	SENT_209	[p12l1591t2597r1676b2638],
6	intronic	JJ	O	intronic	amod	7	SENT_209	[p12l1697t2583r1978b2638],
7	SNP	NN	ORGANIZATION	snp	_	0	SENT_209	[p12l2000t2582r2144b2650],
8	,	,	O	,	_	0	SENT_209	[p12l2000t2582r2144b2650],
9	for	IN	O	for	_	0	SENT_209	[p12l9t2674r106b2732],
10	which	WDT	O	which	rel	17	SENT_209	[p12l140t2674r358b2732],
11	no	DT	O	no	det	14	SENT_209	[p12l395t2691r487b2732],
12	clear	JJ	O	clear	amod	14	SENT_209	[p12l524t2674r686b2732],
13	biological	JJ	O	biological	amod	14	SENT_209	[p12l720t2675r1061b2750],
14	function	NN	O	function	nsubj	21	SENT_209	[p12l1099t2674r1400b2732],
15	has	VBZ	O	have	aux	17	SENT_209	[p12l1436t2674r1551b2732],
16	been	VBN	O	be	auxpass	17	SENT_209	[p12l1586t2675r1754b2732],
17	identified	VBN	O	identify	rcmod	7	SENT_209	[p12l1791t2674r2144b2745],
18	,	,	O	,	_	0	SENT_209	[p12l1791t2674r2144b2745],
19	and	CC	O	and	_	0	SENT_209	[p12l9t2770r139b2828],
20	might	MD	O	might	aux	21	SENT_209	[p12l204t2770r415b2846],
21	be	VB	O	be	rcmod	7	SENT_209	[p12l478t2770r558b2828],
22	in	IN	O	in	_	0	SENT_209	[p12l625t2773r695b2827],
23	linkage	NN	O	linkage	nn	24	SENT_209	[p12l759t2770r1010b2846],
24	disequilibrium	NN	O	disequilibrium	prep_in	21	SENT_209	[p12l1077t2770r1586b2846],
25	with	IN	O	with	_	0	SENT_209	[p12l1650t2770r1810b2828],
26	another	DT	O	another	det	28	SENT_209	[p12l1876t2770r2150b2828],
27	functional	JJ	O	functional	amod	28	SENT_209	[p12l9t2865r371b2923],
28	variant	NN	O	variant	prep_with	21	SENT_209	[p12l415t2868r662b2923],
29	in	IN	O	in	_	0	SENT_209	[p12l709t2868r779b2922],
30	the	DT	O	the	det	33	SENT_209	[p12l825t2865r935b2923],
31	HT	NNP	O	HT	nn	33	SENT_209	[p12l979t2868r1094b2922],
32	R2/l	NN	O	r2/l	nn	33	SENT_209	[p12l1086t2867r1225b2922],
33	gene	NN	O	gene	prep_in	28	SENT_209	[p12l1274t2882r1453b2941],
34	.	.	O	.	_	0	SENT_209	[p12l1274t2882r1453b2941],

1	This	DT	O	this	det	2	SENT_210	[p12l1502t2865r1650b2923],
2	possibility	NN	O	possibility	nsubjpass	4	SENT_210	[p12l1697t2865r2055b2941],
3	is	VBZ	O	be	auxpass	4	SENT_210	[p12l2098t2868r2149b2923],
4	supported	VBN	O	support	_	0	SENT_210	[p12l10t2960r359b3035],
5	by	IN	O	by	_	0	SENT_210	[p12l399t2960r487b3035],
6	the	DT	O	the	det	7	SENT_210	[p12l527t2960r638b3017],
7	observation	NN	O	observation	agent	4	SENT_210	[p12l683t2960r1091b3017],
8	that	IN	O	that	complm	12	SENT_210	[p12l1134t2960r1276b3017],
9	both	CC	O	both	advmod	12	SENT_210	[p12l1317t2960r1482b3017],
10	alleles	NNS	O	allele	nsubj	12	SENT_210	[p12l1526t2960r1735b3017],
11	were	VBD	O	be	cop	12	SENT_210	[p12l1777t2976r1939b3017],
12	assoHTRZA	NN	O	assohtrza	ccomp	4	SENT_210	[p12l1984t2976r2148b3017, p12l10t3202r170b3245],

1	and	CC	O	and	dep	4	SENT_211	[p12l188t3200r276b3245],
2	antidepressant	JJ	O	antidepressant	amod	4	SENT_211	[p12l296t3200r656b3260],
3	treatment	NN	O	treatment	nn	4	SENT_211	[p12l674t3205r921b3245],
4	response	NN	O	response	_	0	SENT_211	[p12l941t3214r1151b3260],
5	in	IN	O	in	_	0	SENT_211	[p12l1171t3200r1213b3245],
6	GAD	NN	O	gad	prep_in	4	SENT_211	[p12l1233t3202r1337b3245],
7	@	IN	O	@	_	0	SENT_211	[p12l2024t3188r2151b3312],
8	FW	NNP	O	FW	nn	9	SENT_211	[p12l11t3273r74b3313],
9	Lohoff	NNP	O	Lohoff	prep_@	6	SENT_211	[p12l93t3272r221b3313],
10	et	FW	O	et	nn	11	SENT_211	[p12l239t3277r275b3313],
11	al	FW	O	al	dep	9	SENT_211	[p12l292t3272r328b3313],
12	'	''	O	'	_	0	SENT_211	[p12l2116t3267r2142b3284],

1	ciated	VBN	O	ciate	_	0	SENT_212	[p12l10t3561r217b3618],
2	in	IN	O	in	_	0	SENT_212	[p12l277t3564r347b3617],
3	different	JJ	O	different	amod	4	SENT_212	[p12l409t3560r707b3618],
4	directions	NNS	O	direction	prep_in	1	SENT_212	[p12l769t3561r1113b3618],
5	in	IN	O	in	_	0	SENT_212	[p12l1175t3564r1245b3617],
6	various	JJ	O	various	amod	7	SENT_212	[p12l1303t3564r1556b3618],
7	studies	NNS	O	study	prep_in	4	SENT_212	[p12l1620t3561r1873b3618],
8	.	.	O	.	_	0	SENT_212	[p12l1620t3561r1873b3618],

1	While	IN	O	while	_	0	SENT_213	[p12l1938t3561r2148b3618],

1	McMahon	NNP	PERSON	McMahon	dep	6	SENT_214	[p13l8t25r370b83],
2	et	FW	O	et	dep	1	SENT_214	[p13l397t31r458b83],
3	al	FW	O	al	nn	4	SENT_214	[p13l478t25r539b83],
4	(	FW	O	(	amod	2	SENT_214	[p13l567t25r782b97],
5	2006	CD	DATE	2006	dep	6	SENT_214	[p13l567t25r782b97],
6	)	NN	O	)	dep	9	SENT_214	[p13l567t25r782b97],
7	and	CC	O	and	_	0	SENT_214	[p13l813t25r943b83],
8	Peters	NNP	PERSON	Peters	dep	9	SENT_214	[p13l970t28r1172b83],
9	et	FW	O	et	_	0	SENT_214	[p13l1199t31r1260b83],
10	al	FW	O	al	nn	13	SENT_214	[p13l1280t25r1341b83],
11	(	FW	O	(	dep	13	SENT_214	[p13l1369t25r1584b97],
12	2009	CD	DATE	2009	num	13	SENT_214	[p13l1369t25r1584b97],
13	)	NN	O	)	advmod	14	SENT_214	[p13l1369t25r1584b97],
14	observed	VBN	O	observe	partmod	9	SENT_214	[p13l1615t25r1922b83],
15	better	JJR	O	better	amod	16	SENT_214	[p13l1947t25r2150b83],
16	outcome	NN	O	outcome	dobj	14	SENT_214	[p13l10t126r315b177],
17	with	IN	O	with	_	0	SENT_214	[p13l359t119r519b177],
18	the	DT	O	the	det	19	SENT_214	[p13l563t119r674b177],
19	A-allele	NN	O	a-allele	prep_with	14	SENT_214	[p13l719t119r994b189],
20	,	,	O	,	_	0	SENT_214	[p13l719t119r994b189],
21	Lucae	NNP	O	Lucae	appos	19	SENT_214	[p13l1044t121r1241b177],
22	et	FW	O	et	nn	24	SENT_214	[p13l1288t125r1348b177],
23	al.	FW	O	al.	nn	24	SENT_214	[p13l1386t111r1532b177],
24	”	NN	O	”	dep	21	SENT_214	[p13l1386t111r1532b177],
25	and	CC	O	and	_	0	SENT_214	[p13l1576t119r1706b177],
26	Horstmann	NNP	PERSON	Horstmann	conj_and	9	SENT_214	[p13l1751t121r2150b177],
27	et	FW	O	et	nn	28	SENT_214	[p13l10t219r70b271],
28	(	FW	O	(	dep	26	SENT_214	[p13l86t206r230b271],
29	11.13	CD	NUMBER	11.13	dep	28	SENT_214	[p13l86t206r230b271],
30	and	CC	O	and	_	0	SENT_214	[p13l255t213r384b271],
31	our	PRP$	O	we	poss	32	SENT_214	[p13l408t230r526b271],
32	results	NNS	O	result	nsubj	33	SENT_214	[p13l547t213r768b271],
33	suggest	VBP	O	suggest	conj_and	28	SENT_214	[p13l794t220r1043b289],
34	that	IN	O	that	complm	37	SENT_214	[p13l1066t213r1208b271],
35	the	DT	O	the	det	36	SENT_214	[p13l1230t213r1341b271],
36	G-allele	JJ	MISC	g-allele	nsubj	37	SENT_214	[p13l1367t213r1629b271],
37	predicts	VBZ	O	predict	ccomp	33	SENT_214	[p13l1653t213r1926b289],
38	better	JJR	O	better	amod	39	SENT_214	[p13l1947t213r2150b271],
39	outcome	NN	O	outcome	dobj	37	SENT_214	[p13l10t315r334b364],
40	.	.	O	.	_	0	SENT_214	[p13l10t315r334b364],

1	One	CD	NUMBER	one	num	3	SENT_215	[p13l364t309r506b364],
2	main	JJ	O	main	amod	3	SENT_215	[p13l532t310r712b364],
3	difference	NN	O	difference	nsubj	9	SENT_215	[p13l737t307r1080b364],
4	between	IN	O	between	_	0	SENT_215	[p13l1103t307r1397b364],
5	these	DT	O	these	det	6	SENT_215	[p13l1420t308r1600b364],
6	studies	NNS	O	study	prep_between	3	SENT_215	[p13l1627t308r1862b364],
7	was	VBD	O	be	cop	9	SENT_215	[p13l1886t324r2013b364],
8	the	DT	O	the	det	9	SENT_215	[p13l2037t308r2148b364],
9	use	NN	O	use	_	0	SENT_215	[p13l8t420r120b461],
10	of	IN	O	of	_	0	SENT_215	[p13l143t403r214b461],
11	a	DT	O	a	det	13	SENT_215	[p13l231t420r265b461],
12	mixed-ethnicity	JJ	O	mixed-ethnicity	amod	13	SENT_215	[p13l287t403r851b479],
13	sample	NN	O	sample	prep_of	9	SENT_215	[p13l870t403r1112b479],
14	by	IN	O	by	_	0	SENT_215	[p13l1132t403r1220b479],
15	McMahon	NNP	PERSON	McMahon	dep	18	SENT_215	[p13l1237t403r1599b461],
16	et	FW	O	et	nn	18	SENT_215	[p13l1621t409r1681b461],
17	al	FW	O	al	nn	18	SENT_215	[p13l1696t403r1757b461],
18	(	FW	O	(	prepc_by	13	SENT_215	[p13l1779t403r1995b475],
19	2006	CD	DATE	2006	num	20	SENT_215	[p13l1779t403r1995b475],
20	)	NN	O	)	dep	13	SENT_215	[p13l1779t403r1995b475],
21	and	CC	O	and	_	0	SENT_215	[p13l2020t403r2150b461],
22	Peters	NNP	PERSON	Peters	conj_and	13	SENT_215	[p13l10t500r211b555],
23	et	FW	O	et	dep	22	SENT_215	[p13l260t503r320b555],
24	al	FW	O	al	nn	27	SENT_215	[p13l362t498r423b555],
25	(	FW	O	(	dep	27	SENT_215	[p13l472t498r708b570],
26	2009	CD	DATE	2009	num	27	SENT_215	[p13l472t498r708b570],
27	)	CD	NUMBER	)	advmod	9	SENT_215	[p13l472t498r708b570],
28	.	.	O	.	_	0	SENT_215	[p13l472t498r708b570],

1	Another	DT	O	another	det	2	SENT_216	[p13l759t498r1048b555],
2	concern	NN	O	concern	nsubj	8	SENT_216	[p13l1095t514r1375b555],
3	of	IN	O	of	_	0	SENT_216	[p13l1423t497r1495b555],
4	our	PRP$	O	we	poss	5	SENT_216	[p13l1539t514r1655b555],
5	study	NN	O	study	prep_of	2	SENT_216	[p13l1704t498r1894b573],
6	is	VBZ	O	be	cop	8	SENT_216	[p13l1939t501r1989b555],
7	the	DT	O	the	det	8	SENT_216	[p13l2037t498r2148b555],
8	possibility	NN	O	possibility	_	0	SENT_216	[p13l9t593r367b668],
9	of	IN	O	of	_	0	SENT_216	[p13l421t592r493b650],
10	a	DT	O	a	det	12	SENT_216	[p13l545t609r579b650],
11	false-positive	JJ	O	false-positive	amod	12	SENT_216	[p13l636t592r1086b668],
12	finding	NN	O	finding	prep_of	8	SENT_216	[p13l1143t592r1399b668],
13	due	JJ	O	due	_	0	SENT_216	[p13l1455t593r1579b650],
14	to	TO	O	to	_	0	SENT_216	[p13l1637t600r1706b650],
15	population	NN	O	population	nn	16	SENT_216	[p13l1762t593r2150b668],
16	stratification	NN	O	stratification	prep_due_to	12	SENT_216	[p13l11t688r471b746],
17	.	.	O	.	_	0	SENT_216	[p13l11t688r471b746],

1	Although	IN	O	although	mark	6	SENT_217	[p13l510t688r842b764],
2	our	PRP$	O	we	poss	4	SENT_217	[p13l879t705r996b746],
3	primary	JJ	O	primary	amod	4	SENT_217	[p13l1031t691r1310b764],
4	analysis	NN	O	analysis	nsubj	6	SENT_217	[p13l1344t688r1616b764],
5	only	RB	O	only	advmod	6	SENT_217	[p13l1653t688r1811b764],
6	included	VBD	O	include	advcl	36	SENT_217	[p13l1845t688r2150b746],
7	individuals	NNS	O	individual	dobj	6	SENT_217	[p13l9t783r396b841],
8	of	IN	O	of	_	0	SENT_217	[p13l442t783r514b841],
9	European	JJ	MISC	european	amod	10	SENT_217	[p13l555t785r886b859],
10	descent	NN	O	descent	prep_of	7	SENT_217	[p13l931t783r1193b841],
11	due	JJ	O	due	_	0	SENT_217	[p13l1238t783r1363b841],
12	to	TO	O	to	_	0	SENT_217	[p13l1409t790r1479b840],
13	the	DT	O	the	det	14	SENT_217	[p13l1524t783r1635b841],
14	fact	NN	O	fact	prep_due_to	6	SENT_217	[p13l1681t783r1808b841],
15	that	IN	O	that	complm	23	SENT_217	[p13l1852t783r1993b841],
16	the	DT	O	the	det	20	SENT_217	[p13l2037t783r2148b841],
17	rs7997012	NN	O	rs7997012	nn	20	SENT_217	[p13l9t879r368b935],
18	A	NN	O	a	nn	20	SENT_217	[p13l399t878r656b936],
19	—	CD	NUMBER	—	num	20	SENT_217	[p13l399t878r656b936],
20	allele	NN	O	allele	nsubj	23	SENT_217	[p13l399t878r656b936],
21	is	VBZ	O	be	cop	23	SENT_217	[p13l689t881r740b935],
22	nearly	RB	O	nearly	advmod	23	SENT_217	[p13l772t878r991b954],
23	absent	JJ	O	absent	dep	14	SENT_217	[p13l1021t878r1246b936],
24	in	IN	O	in	_	0	SENT_217	[p13l1277t881r1348b935],
25	individuals	NNS	O	individual	prep_in	23	SENT_217	[p13l1379t878r1766b935],
26	of	IN	O	of	_	0	SENT_217	[p13l1799t878r1871b935],
27	African	JJ	LOCATION	african	amod	28	SENT_217	[p13l1898t878r2150b936],
28	descent	NN	O	descent	prep_of	25	SENT_217	[p13l10t972r288b1043],
29	,	,	O	,	_	0	SENT_217	[p13l10t972r288b1043],
30	undetected	JJ	O	undetected	amod	31	SENT_217	[p13l357t972r749b1030],
31	differences	NNS	O	difference	nsubj	36	SENT_217	[p13l814t972r1188b1030],
32	in	IN	O	in	_	0	SENT_217	[p13l1255t975r1325b1029],
33	population	NN	O	population	nn	34	SENT_217	[p13l1389t972r1776b1048],
34	structure	NN	O	structure	prep_in	31	SENT_217	[p13l1843t980r2148b1030],
35	might	MD	O	might	aux	36	SENT_217	[p13l9t1066r220b1142],
36	contribute	VB	O	contribute	_	0	SENT_217	[p13l256t1066r619b1124],
37	to	TO	O	to	_	0	SENT_217	[p13l655t1073r724b1124],
38	false	JJ	O	false	amod	39	SENT_217	[p13l760t1066r1210b1142],
39	—	NN	O	—	prep_to	36	SENT_217	[p13l760t1066r1210b1142],
40	positive	JJ	O	positive	amod	41	SENT_217	[p13l760t1066r1210b1142],
41	results	NNS	O	result	dep	39	SENT_217	[p13l1247t1058r1633b1124],
42	.24	CD	NUMBER	.24	number	43	SENT_217	[p13l1247t1058r1633b1124],
43	'25	CD	NUMBER	'25	num	45	SENT_217	[p13l1247t1058r1633b1124],
44	Effective	JJ	O	effective	amod	45	SENT_217	[p13l1671t1066r1965b1124],
45	strategies	NNS	O	strategy	dep	41	SENT_217	[p13l2004t1073r2149b1124, p13l9t1165r203b1238],
46	to	TO	O	to	aux	47	SENT_217	[p13l229t1169r297b1220],
47	control	VB	O	control	xcomp	36	SENT_217	[p13l324t1162r576b1220],
48	for	IN	O	for	mark	52	SENT_217	[p13l601t1162r699b1220],
49	these	DT	O	these	det	51	SENT_217	[p13l723t1162r902b1220],
50	stratification	NN	O	stratification	nn	51	SENT_217	[p13l929t1162r1372b1220],
51	issues	NNS	O	issue	nsubj	52	SENT_217	[p13l1396t1165r1591b1220],
52	include	VBP	O	include	advcl	47	SENT_217	[p13l1617t1162r1875b1220],
53	the	DT	O	the	det	54	SENT_217	[p13l1901t1162r2012b1220],
54	use	NN	O	use	dobj	52	SENT_217	[p13l2037t1179r2149b1220],
55	of	IN	O	of	_	0	SENT_217	[p13l10t1254r81b1312],
56	genomic	JJ	O	genomic	amod	57	SENT_217	[p13l105t1258r407b1330],
57	controls	NNS	O	control	prep_of	54	SENT_217	[p13l436t1255r718b1312],
58	in	IN	O	in	_	0	SENT_217	[p13l747t1258r818b1312],
59	future	JJ	DATE	future	amod	60	SENT_217	[p13l845t1254r1055b1312],
60	studies	NNS	O	study	prep_in	57	SENT_217	[p13l1085t1248r1487b1312],
61	.26	CD	NUMBER	.26	number	62	SENT_217	[p13l1085t1248r1487b1312],
62	'27	CD	NUMBER	'27	num	60	SENT_217	[p13l1085t1248r1487b1312],

1	In	IN	O	in	_	0	SENT_218	[p13l87t1353r159b1408],
2	conclusion	NN	O	conclusion	prep_in	5	SENT_218	[p13l202t1351r607b1421],
3	,	,	O	,	_	0	SENT_218	[p13l202t1351r607b1421],
4	we	PRP	O	we	nsubj	5	SENT_218	[p13l653t1368r748b1409],
5	show	VBP	O	show	_	0	SENT_218	[p13l793t1351r977b1409],
6	for	IN	O	for	_	0	SENT_218	[p13l1017t1351r1115b1409],
7	the	DT	O	the	det	9	SENT_218	[p13l1156t1351r1269b1409],
8	first	JJ	ORDINAL	first	amod	9	SENT_218	[p13l1312t1351r1447b1409],
9	time	NN	O	time	prep_for	5	SENT_218	[p13l1489t1354r1648b1409],
10	a	DT	O	a	det	12	SENT_218	[p13l1692t1368r1726b1409],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_218	[p13l1768t1351r2148b1427, p13l10t1449r264b1521],
12	effect	NN	O	effect	dobj	5	SENT_218	[p13l304t1445r495b1503],
13	of	IN	O	of	_	0	SENT_218	[p13l536t1445r607b1503],
14	the	DT	O	the	det	17	SENT_218	[p13l642t1446r754b1503],
15	HTRZA	NNP	O	HTRZA	nn	17	SENT_218	[p13l796t1447r1046b1503],
16	rs7997012	NN	O	rs7997012	nn	17	SENT_218	[p13l1085t1447r1448b1503],
17	variant	NN	O	variant	prep_of	12	SENT_218	[p13l1486t1449r1738b1503],
18	in	IN	O	in	_	0	SENT_218	[p13l1777t1449r1847b1503],
19	anxiety	NN	O	anxiety	nn	20	SENT_218	[p13l1888t1449r2152b1521],
20	disorders	NNS	O	disorder	prep_in	17	SENT_218	[p13l10t1541r344b1611],
21	,	,	O	,	_	0	SENT_218	[p13l10t1541r344b1611],
22	supporting	VBG	O	support	partmod	5	SENT_218	[p13l395t1544r781b1616],
23	the	DT	O	the	det	24	SENT_218	[p13l824t1541r937b1598],
24	hypothesis	NN	O	hypothesis	dobj	22	SENT_218	[p13l981t1541r1364b1616],
25	that	IN	O	that	complm	32	SENT_218	[p13l1410t1541r1553b1598],
26	variants	NNS	O	variant	nsubj	32	SENT_218	[p13l1595t1544r1876b1598],
27	in	IN	O	in	_	0	SENT_218	[p13l1921t1544r1991b1598],
28	the	DT	O	the	det	31	SENT_218	[p13l2036t1541r2148b1598],
29	HT	NNP	O	HT	nn	31	SENT_218	[p13l6t1639r121b1693],
30	RZA	NNP	O	RZA	nn	31	SENT_218	[p13l113t1638r254b1693],
31	gene	NN	O	gene	prep_in	26	SENT_218	[p13l296t1653r459b1712],
32	predict	VBP	O	predict	ccomp	22	SENT_218	[p13l498t1636r745b1712],
33	treatment	NN	O	treatment	nn	34	SENT_218	[p13l784t1643r1135b1694],
34	outcome	NN	O	outcome	dobj	32	SENT_218	[p13l1174t1643r1483b1694],
35	to	TO	O	to	_	0	SENT_218	[p13l1523t1643r1593b1694],
36	antidepressant	JJ	O	antidepressant	amod	37	SENT_218	[p13l1633t1636r2150b1712],
37	drugs	NNS	O	drug	prep_to	32	SENT_218	[p13l10t1731r218b1807],
38	,	,	O	,	_	0	SENT_218	[p13l10t1731r218b1807],
39	independent	JJ	O	independent	dep	32	SENT_218	[p13l259t1731r712b1807],
40	of	IN	O	of	_	0	SENT_218	[p13l747t1731r819b1788],
41	underlying	VBG	O	underlie	amod	42	SENT_218	[p13l848t1731r1240b1807],
42	DSM	NNP	O	DSM	prep_of	39	SENT_218	[p13l1275t1732r1551b1788],
43	.	.	O	.	_	0	SENT_218	[p13l1275t1732r1551b1788],

1	—	NN	O	—	_	0	SENT_219	[p13l1275t1732r1551b1788],
2	.	.	O	.	_	0	SENT_219	[p13l1275t1732r1551b1788],

1	IV	CD	NUMBER	iv	_	0	SENT_220	[p13l1275t1732r1551b1788],
2	diagnostic	JJ	O	diagnostic	amod	3	SENT_220	[p13l1586t1731r1949b1807],
3	category	NN	O	category	dep	1	SENT_220	[p13l1985t1738r2148b1789, p13l10t1843r177b1902],
4	.	.	O	.	_	0	SENT_220	[p13l1985t1738r2148b1789, p13l10t1843r177b1902],

1	Our	PRP$	O	we	poss	2	SENT_221	[p13l229t1827r364b1883],
2	results	NNS	O	result	nsubj	3	SENT_221	[p13l409t1826r634b1884],
3	require	VBP	O	require	_	0	SENT_221	[p13l681t1829r929b1902],
4	careful	JJ	O	careful	amod	5	SENT_221	[p13l977t1826r1213b1884],
5	replication	NN	O	replication	dobj	3	SENT_221	[p13l1260t1826r1643b1902],
6	using	VBG	O	use	partmod	5	SENT_221	[p13l1688t1829r1880b1902],
7	a	DT	O	a	det	11	SENT_221	[p13l1926t1843r1960b1883],
8	prospective	JJ	O	prospective	amod	11	SENT_221	[p13l2006t1843r2148b1902, p13l11t1923r290b1996],
9	clinical	JJ	O	clinical	amod	11	SENT_221	[p13l345t1920r599b1978],
10	trial	NN	O	trial	nn	11	SENT_221	[p13l652t1920r792b1978],
11	design	NN	O	design	dobj	6	SENT_221	[p13l846t1920r1072b1996],
12	to	TO	O	to	aux	14	SENT_221	[p13l1124t1928r1194b1978],
13	further	RB	O	further	advmod	14	SENT_221	[p13l1247t1920r1493b1978],
14	characterize	VB	O	characterize	xcomp	6	SENT_221	[p13l1544t1921r1966b1978],
15	this	DT	O	this	det	16	SENT_221	[p13l2020t1920r2149b1978],
16	effect	NN	O	effect	dobj	14	SENT_221	[p13l10t2016r201b2074],
17	in	IN	O	in	_	0	SENT_221	[p13l230t2019r300b2073],
18	treatment	NN	O	treatment	nn	19	SENT_221	[p13l330t2023r680b2074],
19	response	NN	O	response	prep_in	16	SENT_221	[p13l709t2033r1015b2092],
20	to	TO	O	to	_	0	SENT_221	[p13l1045t2023r1115b2074],
21	antidepressants	NNS	O	antidepressant	prep_to	14	SENT_221	[p13l1146t2016r1692b2092],
22	in	IN	O	in	_	0	SENT_221	[p13l1722t2019r1792b2073],
23	GAD	NN	O	gad	prep_in	14	SENT_221	[p13l1823t2018r2009b2074],
24	.	.	O	.	_	0	SENT_221	[p13l1823t2018r2009b2074],

1	Conflict	NN	O	conflict	_	0	SENT_222	[p13l10t2246r314b2303],
2	of	IN	O	of	_	0	SENT_222	[p13l343t2246r423b2303],
3	interest	NN	O	interest	prep_of	1	SENT_222	[p13l452t2246r750b2303],

1	The	DT	O	the	det	2	SENT_223	[p13l7t2435r140b2492],
2	authors	NNS	O	author	nsubj	3	SENT_223	[p13l171t2435r437b2492],
3	declare	VBP	O	declare	_	0	SENT_223	[p13l468t2435r714b2492],
4	no	DT	O	no	det	5	SENT_223	[p13l745t2452r836b2492],
5	conﬂicts	NNS	O	conﬂicts	dobj	3	SENT_223	[p13l868t2435r1166b2492],
6	of	IN	O	of	_	0	SENT_223	[p13l1198t2435r1269b2492],
7	interest	NN	O	interest	prep_of	5	SENT_223	[p13l1294t2438r1576b2492],
8	.	.	O	.	_	0	SENT_223	[p13l1294t2438r1576b2492],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_224	[p13l8t2626r729b2702],

1	This	DT	O	this	det	2	SENT_225	[p13l7t2811r140b2862],
2	research	NN	O	research	nsubjpass	4	SENT_225	[p13l175t2811r431b2862],
3	was	VBD	O	be	auxpass	4	SENT_225	[p13l464t2825r578b2862],
4	supported	VBN	O	support	_	0	SENT_225	[p13l614t2811r928b2878],
5	by	IN	O	by	_	0	SENT_225	[p13l961t2811r1038b2878],
6	US	NNP	ORGANIZATION	US	nn	11	SENT_225	[p13l1070t2812r1153b2862],
7	Public	NNP	ORGANIZATION	Public	nn	11	SENT_225	[p13l1189t2811r1381b2862],
8	Health	NNP	ORGANIZATION	Health	nn	11	SENT_225	[p13l1416t2811r1627b2862],
9	Research	NNP	ORGANIZATION	Research	nn	11	SENT_225	[p13l1662t2811r1934b2862],
10	Grant	NNP	ORGANIZATION	Grant	nn	11	SENT_225	[p13l1970t2812r2150b2862],
11	MH065963	NN	O	mh065963	agent	4	SENT_225	[p13l8t2897r356b2947],
12	(	CD	NUMBER	(	num	14	SENT_225	[p13l388t2896r515b2960],
13	KR	NN	O	kr	nn	14	SENT_225	[p13l388t2896r515b2960],
14	)	NN	O	)	tmod	4	SENT_225	[p13l388t2896r515b2960],
15	and	CC	O	and	_	0	SENT_225	[p13l545t2896r662b2947],
16	KO8MHO80372	NN	O	ko8mho80372	nn	19	SENT_225	[p13l688t2897r1160b2947],
17	(	CD	NUMBER	(	num	19	SENT_225	[p13l1190t2896r1393b2960],
18	FWL	NN	O	fwl	nn	19	SENT_225	[p13l1190t2896r1393b2960],
19	)	NN	O	)	tmod	4	SENT_225	[p13l1190t2896r1393b2960],
20	.	.	O	.	_	0	SENT_225	[p13l1190t2896r1393b2960],

1	The	DT	O	the	det	2	SENT_226	[p13l1421t2896r1539b2947],
2	data	NNS	O	datum	nsubjpass	7	SENT_226	[p13l1567t2896r1699b2947],
3	for	IN	O	for	_	0	SENT_226	[p13l1725t2895r1812b2947],
4	this	DT	O	this	det	5	SENT_226	[p13l1838t2896r1953b2947],
5	study	NN	O	study	prep_for	2	SENT_226	[p13l1982t2896r2152b2963],
6	were	VBD	O	be	auxpass	7	SENT_226	[p13l8t2996r153b3032],
7	collected	VBN	O	collect	_	0	SENT_226	[p13l185t2981r464b3032],
8	between	IN	O	between	_	0	SENT_226	[p13l493t2981r757b3032],
9	2005	CD	DATE	2005	prep_between	7	SENT_226	[p13l789t2982r937b3032],
10	and	CC	DATE	and	_	0	SENT_226	[p13l971t2981r1087b3032],
11	2009	CD	DATE	2009	conj_and	9	SENT_226	[p13l1119t2982r1286b3032],
12	.	.	O	.	_	0	SENT_226	[p13l1119t2982r1286b3032],

1	We	PRP	O	we	nsubj	2	SENT_227	[p13l1320t2983r1416b3032],
2	want	VBP	O	want	_	0	SENT_227	[p13l1446t2987r1604b3032],
3	to	TO	O	to	aux	4	SENT_227	[p13l1634t2987r1696b3032],
4	thank	VB	O	thank	xcomp	2	SENT_227	[p13l1727t2981r1912b3032],
5	Wyeth	NN	ORGANIZATION	wyeth	nn	6	SENT_227	[p13l1940t2981r2150b3048],
6	Laboratories	NNPS	ORGANIZATION	Laboratories	dobj	4	SENT_227	[p13l10t3066r394b3118],
7	for	IN	O	for	_	0	SENT_227	[p13l437t3066r525b3118],
8	providing	VBG	O	provide	prepc_for	6	SENT_227	[p13l566t3066r874b3134],
9	all	DT	O	all	det	11	SENT_227	[p13l916t3066r989b3118],
10	study	NN	O	study	nn	11	SENT_227	[p13l1034t3066r1205b3134],
11	medication	NN	O	medication	dobj	8	SENT_227	[p13l1245t3066r1617b3118],
12	.	.	O	.	_	0	SENT_227	[p13l1245t3066r1617b3118],

1	We	PRP	O	we	nsubj	3	SENT_228	[p13l1662t3069r1760b3118],
2	also	RB	O	also	advmod	3	SENT_228	[p13l1804t3066r1923b3118],
3	thank	VBP	O	thank	_	0	SENT_228	[p13l1966t3066r2152b3118],
4	Rachel	NNP	PERSON	Rachel	nn	5	SENT_228	[p13l10t3150r216b3202],
5	Hodge	NNP	PERSON	Hodge	dobj	3	SENT_228	[p13l260t3151r462b3218],
6	for	IN	O	for	_	0	SENT_228	[p13l507t3150r594b3202],
7	technical	JJ	O	technical	amod	8	SENT_228	[p13l636t3151r925b3202],
8	assistance	NN	O	assistance	prep_for	5	SENT_228	[p13l968t3153r1274b3202],
9	in	IN	O	in	_	0	SENT_228	[p13l1318t3153r1380b3201],
10	genotyping	NN	O	genotyping	prep_in	8	SENT_228	[p13l1424t3153r1784b3218],
11	and	CC	O	and	_	0	SENT_228	[p13l1827t3151r1943b3202],
12	Dana	NNP	PERSON	Dana	nn	13	SENT_228	[p13l1987t3153r2150b3202],
13	Patsch	NNP	PERSON	Patsch	conj_and	10	SENT_228	[p13l10t3236r210b3287],
14	for	IN	O	for	_	0	SENT_228	[p13l241t3236r328b3287],
15	assisting	VBG	O	assist	prepc_for	3	SENT_228	[p13l358t3238r622b3303],
16	in	IN	O	in	_	0	SENT_228	[p13l652t3238r714b3287],
17	management	NN	O	management	nn	20	SENT_228	[p13l745t3242r1159b3303],
18	and	CC	O	and	_	0	SENT_228	[p13l1189t3236r1306b3287],
19	quality	NN	O	quality	nn	20	SENT_228	[p13l1337t3236r1558b3303],
20	assurance	NN	O	assurance	prep_in	15	SENT_228	[p13l1587t3251r1886b3287],
21	for	IN	O	for	_	0	SENT_228	[p13l1917t3236r2005b3287],
22	this	DT	O	this	det	23	SENT_228	[p13l2034t3236r2149b3287],
23	project	NN	O	project	prep_for	15	SENT_228	[p13l9t3324r244b3389],
24	.	.	O	.	_	0	SENT_228	[p13l9t3324r244b3389],

1	This	DT	O	this	det	2	SENT_229	[p13l271t3321r404b3372],
2	study	NN	O	study	nsubjpass	4	SENT_229	[p13l431t3321r602b3389],
3	was	VBD	O	be	auxpass	4	SENT_229	[p13l623t3336r737b3372],
4	registered	VBN	O	register	_	0	SENT_229	[p13l763t3321r1067b3388],
5	under	IN	O	under	_	0	SENT_229	[p13l1090t3321r1276b3372],
6	clinical	JJ	O	clinical	prep_under	4	SENT_229	[p13l1301t3321r1528b3372],
7	trails	VBZ	O	trail	dep	6	SENT_229	[p13l1553t3321r2151b3388],
8	.	.	O	.	_	0	SENT_229	[p13l1553t3321r2151b3388],

1	gov.	NNP	O	gov.	nn	2	SENT_230	[p13l1553t3321r2151b3388],
2	Identifier	NNP	MISC	Identifier	_	0	SENT_230	[p13l1553t3321r2151b3388],
3	NCTOO183274	NN	MISC	nctoo183274	dep	2	SENT_230	[p13l8t3406r478b3455],
4	.	.	O	.	_	0	SENT_230	[p13l8t3406r478b3455],

1	KR	NN	O	kr	nsubj	6	SENT_231	[p13l524t3407r610b3455],
2	has	VBZ	O	have	aux	3	SENT_231	[p13l650t3405r752b3455],
3	received	VBN	O	receive	_	0	SENT_231	[p13l794t3405r1053b3455],
4	honoraria	NN	O	honorarium	dobj	3	SENT_231	[p13l1093t3405r1402b3455],
5	and	CC	O	and	_	0	SENT_231	[p13l1444t3405r1561b3455],
6	served	VBD	O	serve	conj_and	3	SENT_231	[p13l1603t3405r1799b3455],
7	as	IN	O	as	_	0	SENT_231	[p13l1840t3419r1898b3455],
8	a	DT	O	a	det	9	SENT_231	[p13l1941t3419r1972b3455],
9	consultant	NN	O	consultant	prep_as	6	SENT_231	[p13l2013t3419r2149b3455, p13l11t3490r227b3541],
10	or	CC	O	or	_	0	SENT_231	[p13l262t3505r325b3541],
11	on	IN	O	on	_	0	SENT_231	[p13l360t3505r441b3541],
12	advisory	JJ	O	advisory	amod	13	SENT_231	[p13l476t3490r741b3557],
13	boards	NNS	O	board	prep_on	6	SENT_231	[p13l771t3490r979b3541],
14	to	TO	O	to	_	0	SENT_231	[p13l1014t3496r1076b3541],
15	Cephalon	NNP	ORGANIZATION	Cephalon	prep_to	6	SENT_231	[p13l1113t3490r1434b3557],
16	,	,	O	,	_	0	SENT_231	[p13l1113t3490r1434b3557],
17	Eli	NNP	PERSON	Eli	nn	18	SENT_231	[p13l1474t3490r1551b3541],
18	Lilly	NNP	PERSON	Lilly	appos	15	SENT_231	[p13l1586t3490r1733b3557],
19	,	,	O	,	_	0	SENT_231	[p13l1586t3490r1733b3557],
20	Hoffman-La	NNP	PERSON	Hoffman-La	nn	21	SENT_231	[p13l1773t3490r2150b3541],
21	Roche	NNP	PERSON	Roche	appos	18	SENT_231	[p13l10t3574r217b3637],
22	,	,	O	,	_	0	SENT_231	[p13l10t3574r217b3637],
23	Jazz	NN	ORGANIZATION	jazz	nn	24	SENT_231	[p13l235t3576r362b3637],
24	Pharmaceuticals	NNS	ORGANIZATION	pharmaceutical	appos	18	SENT_231	[p13l385t3574r912b3636],
25	,	,	O	,	_	0	SENT_231	[p13l385t3574r912b3636],
26	Johnson	NNP	ORGANIZATION	Johnson	appos	18	SENT_231	[p13l931t3574r1201b3637],
27	&	CC	ORGANIZATION	&	_	0	SENT_231	[p13l1225t3575r1275b3626],
28	Johnson	NNP	ORGANIZATION	Johnson	appos	18	SENT_231	[p13l1290t3574r1576b3637],
29	,	,	O	,	_	0	SENT_231	[p13l1290t3574r1576b3637],
30	Novartis	NNP	ORGANIZATION	Novartis	nn	31	SENT_231	[p13l1601t3576r1864b3626],
31	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	18	SENT_231	[p13l1888t3574r2149b3625, p14l10t18r294b81],
32	,	,	O	,	_	0	SENT_231	[p13l1888t3574r2149b3625, p14l10t18r294b81],

1	Pfizer	NNP	ORGANIZATION	Pfizer	_	0	SENT_232	[p14l318t18r502b81],
2	,	,	O	,	_	0	SENT_232	[p14l318t18r502b81],
3	Epix	NNP	ORGANIZATION	Epix	nn	7	SENT_232	[p14l527t20r664b86],
4	(	CD	NUMBER	(	num	7	SENT_232	[p14l685t18r936b82],
5	PreDix	NNP	O	PreDix	nn	7	SENT_232	[p14l685t18r936b82],
6	)	NNP	O	)	nn	7	SENT_232	[p14l685t18r936b82],
7	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	1	SENT_232	[p14l960t18r1471b69],
8	and	CC	O	and	_	0	SENT_232	[p14l1492t18r1608b69],
9	PGX	NNP	ORGANIZATION	PGX	nn	11	SENT_232	[p14l1628t19r1757b69],
10	Health	NNP	ORGANIZATION	Health	nn	11	SENT_232	[p14l1776t18r1986b69],
11	LLC	NNP	ORGANIZATION	LLC	appos	1	SENT_232	[p14l2006t19r2146b69],
12	.	.	O	.	_	0	SENT_232	[p14l2006t19r2146b69],

1	KR	NN	O	kr	nsubj	2	SENT_233	[p14l10t105r96b154],
2	received	VBD	O	receive	_	0	SENT_233	[p14l122t103r380b154],
3	research	NN	O	research	nn	4	SENT_233	[p14l407t103r663b154],
4	grants	NNS	O	grant	nsubj	5	SENT_233	[p14l691t109r882b170],
5	(	VBP	O	(	ccomp	2	SENT_233	[p14l913t103r1124b167],
6	issued	VBN	O	issue	dep	5	SENT_233	[p14l913t103r1124b167],
7	to	TO	O	to	_	0	SENT_233	[p14l1152t109r1213b154],
8	the	DT	O	the	det	23	SENT_233	[p14l1242t103r1342b154],
9	University	NNP	ORGANIZATION	University	dep	23	SENT_233	[p14l1370t105r1697b170],
10	of	IN	ORGANIZATION	of	_	0	SENT_233	[p14l1723t103r1786b154],
11	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	prep_of	9	SENT_233	[p14l1811t103r2150b170, p14l9t188r127b252],
12	)	CD	NUMBER	)	num	11	SENT_233	[p14l1811t103r2150b170, p14l9t188r127b252],
13	from	IN	O	from	_	0	SENT_233	[p14l156t188r306b239],
14	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	9	SENT_233	[p14l332t189r726b250],
15	,	,	O	,	_	0	SENT_233	[p14l332t189r726b250],
16	Epix	NNP	ORGANIZATION	Epix	nn	17	SENT_233	[p14l756t190r894b255],
17	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	14	SENT_233	[p14l918t188r1446b250],
18	,	,	O	,	_	0	SENT_233	[p14l918t188r1446b250],
19	Genaissance	NNP	ORGANIZATION	Genaissance	nn	20	SENT_233	[p14l1477t189r1861b239],
20	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	appos	17	SENT_233	[p14l1888t188r2149b239, p14l10t273r278b324],
21	(	NN	O	(	nn	23	SENT_233	[p14l335t273r699b337],
22	PGXHealth	NN	ORGANIZATION	pgxhealth	nn	23	SENT_233	[p14l335t273r699b337],
23	LLC	NN	ORGANIZATION	llc	prep_to	6	SENT_233	[p14l752t273r916b337],
24	)	CD	NUMBER	)	dobj	6	SENT_233	[p14l752t273r916b337],
25	,	,	O	,	_	0	SENT_233	[p14l752t273r916b337],
26	NIMH	NNP	ORGANIZATION	NIMH	dobj	6	SENT_233	[p14l972t275r1184b336],
27	,	,	O	,	_	0	SENT_233	[p14l972t275r1184b336],
28	Pamlab	NNP	PERSON	Pamlab	dobj	6	SENT_233	[p14l1242t273r1487b335],
29	,	,	O	,	_	0	SENT_233	[p14l1242t273r1487b335],
30	Pfizer	NNP	ORGANIZATION	Pfizer	dobj	6	SENT_233	[p14l1545t273r1718b324],
31	and	CC	O	and	_	0	SENT_233	[p14l1771t273r1888b324],
32	Wyeth	NN	ORGANIZATION	wyeth	nn	33	SENT_233	[p14l1940t273r2150b341],
33	Laboratories	NNPS	ORGANIZATION	Laboratories	dobj	6	SENT_233	[p14l10t358r411b410],
34	.	.	O	.	_	0	SENT_233	[p14l10t358r411b410],

1	All	DT	O	all	det	3	SENT_234	[p14l455t358r542b409],
2	other	JJ	O	other	amod	3	SENT_234	[p14l584t358r752b410],
3	authors	NNS	O	author	nsubj	4	SENT_234	[p14l794t358r1030b410],
4	report	VBP	O	report	_	0	SENT_234	[p14l1072t365r1262b426],
5	no	DT	O	no	det	7	SENT_234	[p14l1303t373r1384b410],
6	financial	JJ	O	financial	amod	7	SENT_234	[p14l1427t358r1701b410],
7	relationships	NNS	O	relationship	dobj	4	SENT_234	[p14l1744t358r2149b426],
8	with	IN	O	with	_	0	SENT_234	[p14l8t442r151b492],
9	commercial	JJ	O	commercial	amod	10	SENT_234	[p14l177t442r545b493],
10	interests	NNS	O	interest	prep_with	7	SENT_234	[p14l571t444r850b493],
11	.	.	O	.	_	0	SENT_234	[p14l571t444r850b493],

1	References	NNS	O	reference	_	0	SENT_235	[p14l12t627r425b684],

1	Baldwin	NNP	PERSON	Baldwin	nn	2	SENT_236	[p14l144t805r360b854],
2	DS	NN	O	d	_	0	SENT_236	[p14l404t807r492b864],
3	,	,	O	,	_	0	SENT_236	[p14l404t807r492b864],
4	Nair	NNP	PERSON	Nair	nn	5	SENT_236	[p14l539t806r653b854],
5	RV	NN	O	rv	appos	2	SENT_236	[p14l693t807r775b854],
6	.	.	O	.	_	0	SENT_236	[p14l693t807r775b854],

1	Escitalopram	NNP	O	Escitalopram	nsubj	6	SENT_237	[p14l820t805r1167b869],
2	in	IN	O	in	_	0	SENT_237	[p14l1211t806r1256b853],
3	the	DT	O	the	det	4	SENT_237	[p14l1296t805r1385b854],
4	treatment	NN	O	treatment	prep_in	1	SENT_237	[p14l1423t811r1701b854],
5	of	IN	O	of	prep	4	SENT_237	[p14l1739t805r1793b854],
6	generalized	VBN	O	generalize	_	0	SENT_237	[p14l1830t805r2147b869],
7	anxiety	NN	O	anxiety	nn	8	SENT_237	[p14l142t882r343b944],
8	disorder	NN	O	disorder	dobj	6	SENT_237	[p14l368t881r608b929],
9	.	.	O	.	_	0	SENT_237	[p14l368t881r608b929],

1	Expert	NN	O	expert	nn	3	SENT_238	[p14l638t883r801b944],
2	Rev	NN	O	rev	nn	3	SENT_238	[p14l825t883r918b929],
3	Neurotherapeutics	NNS	O	neurotherapeutic	_	0	SENT_238	[p14l939t881r1428b944],
4	2005	CD	DATE	2005	dep	3	SENT_238	[p14l1452t882r1609b939],
5	;	:	O	;	_	0	SENT_238	[p14l1452t882r1609b939],
6	5	CD	NUMBER	5	num	8	SENT_238	[p14l1638t883r1686b929],
7	:	:	O	:	_	0	SENT_238	[p14l1638t883r1686b929],
8	443-449	CD	NUMBER	443-449	dep	3	SENT_238	[p14l1713t882r1977b929],
9	.	.	O	.	_	0	SENT_238	[p14l1713t882r1977b929],

1	Gelenberg	NNP	O	Gelenberg	nn	3	SENT_239	[p14l142t957r431b1020],
2	A	NNP	O	A	nn	3	SENT_239	[p14l460t959r529b1017],
3	]	NN	O	]	nsubj	23	SENT_239	[p14l460t959r529b1017],
4	,	,	O	,	_	0	SENT_239	[p14l460t959r529b1017],
5	Lydiard	NNP	O	Lydiard	nn	6	SENT_239	[p14l564t957r762b1020],
6	RB	NN	O	rb	appos	3	SENT_239	[p14l796t959r876b1016],
7	,	,	O	,	_	0	SENT_239	[p14l796t959r876b1016],
8	Rudolph	NNP	PERSON	Rudolph	nn	9	SENT_239	[p14l911t957r1138b1020],
9	RL	NNP	PERSON	RL	appos	3	SENT_239	[p14l1172t959r1246b1016],
10	,	,	O	,	_	0	SENT_239	[p14l1172t959r1246b1016],
11	Aguiar	NNP	PERSON	Aguiar	nn	12	SENT_239	[p14l1276t958r1460b1020],
12	L	NNP	PERSON	L	appos	3	SENT_239	[p14l1489t959r1527b1016],
13	,	,	O	,	_	0	SENT_239	[p14l1489t959r1527b1016],
14	Haskins	NNP	PERSON	Haskins	nn	16	SENT_239	[p14l1562t957r1765b1005],
15	]	CD	NUMBER	]	num	16	SENT_239	[p14l1792t959r1856b1017],
16	T	NN	O	t	appos	3	SENT_239	[p14l1792t959r1856b1017],
17	,	,	O	,	_	0	SENT_239	[p14l1792t959r1856b1017],
18	Salinas	NNP	PERSON	Salinas	nn	20	SENT_239	[p14l1890t957r2074b1005],
19	E.	NNP	PERSON	E.	nn	20	SENT_239	[p14l2106t959r2146b1005],
20	Efficacy	NNP	PERSON	Efficacy	appos	3	SENT_239	[p14l144t1032r348b1096],
21	of	IN	O	of	_	0	SENT_239	[p14l396t1033r450b1081],
22	venlafaxine	NN	O	venlafaxine	prep_of	20	SENT_239	[p14l495t1032r809b1081],
23	extended	VBD	O	extend	_	0	SENT_239	[p14l859t1032r1333b1081],
24	—	CD	NUMBER	—	num	26	SENT_239	[p14l859t1032r1333b1081],
25	re	NN	O	re	nn	26	SENT_239	[p14l859t1032r1333b1081],
26	|	NNS	O	|	nsubj	27	SENT_239	[p14l859t1032r1333b1081],
27	ease	VBP	O	ease	ccomp	23	SENT_239	[p14l859t1032r1333b1081],
28	capsules	NNS	O	capsule	dobj	27	SENT_239	[p14l1383t1032r1613b1096],
29	in	IN	O	in	_	0	SENT_239	[p14l1663t1034r1708b1080],
30	nondepressed	JJ	O	nondepressed	amod	31	SENT_239	[p14l1762t1032r2147b1096],
31	outpatients	NNS	O	outpatient	prep_in	28	SENT_239	[p14l142t1110r456b1173],
32	with	IN	O	with	_	0	SENT_239	[p14l484t1109r603b1158],
33	generalized	VBN	O	generalize	prepc_with	27	SENT_239	[p14l635t1109r952b1173],
34	anxiety	NN	O	anxiety	nn	35	SENT_239	[p14l984t1110r1185b1173],
35	disorder	NN	O	disorder	dobj	33	SENT_239	[p14l1214t1109r1453b1158],
36	:	:	O	:	_	0	SENT_239	[p14l1214t1109r1453b1158],
37	a	DT	O	a	det	38	SENT_239	[p14l1486t1123r1513b1158],
38	6-month	JJ	DURATION	6-month	dep	35	SENT_239	[p14l1544t1109r1785b1158],
39	randomized	VBN	O	randomize	partmod	38	SENT_239	[p14l1819t1109r2147b1158],
40	controlled	JJ	O	controlled	amod	41	SENT_239	[p14l142t1184r421b1232],
41	trial	NN	O	trial	dobj	39	SENT_239	[p14l448t1184r567b1232],
42	.	.	O	.	_	0	SENT_239	[p14l448t1184r567b1232],

1	/	:	O	/	punct	2	SENT_240	[p14l592t1186r739b1243],
2	AMA	NNP	O	AMA	_	0	SENT_240	[p14l592t1186r739b1243],
3	2000	CD	DATE	2000	dep	2	SENT_240	[p14l764t1185r920b1242],
4	;	:	O	;	_	0	SENT_240	[p14l764t1185r920b1242],
5	283	CD	NUMBER	283	dep	2	SENT_240	[p14l950t1185r1071b1232],
6	:	:	O	:	_	0	SENT_240	[p14l950t1185r1071b1232],
7	3082-3088	CD	DURATION	3082-3088	dep	5	SENT_240	[p14l1102t1185r1435b1232],
8	.	.	O	.	_	0	SENT_240	[p14l1102t1185r1435b1232],

1	Rickels	NNS	PERSON	rickel	nn	2	SENT_241	[p14l144t1259r322b1308],
2	K	NNP	PERSON	K	_	0	SENT_241	[p14l348t1261r394b1318],
3	,	,	O	,	_	0	SENT_241	[p14l348t1261r394b1318],
4	Downing	NNP	O	Downing	nn	5	SENT_241	[p14l425t1261r677b1323],
5	R	NNP	O	R	appos	2	SENT_241	[p14l706t1262r749b1318],
6	,	,	O	,	_	0	SENT_241	[p14l706t1262r749b1318],
7	Schweizer	NNP	PERSON	Schweizer	nn	8	SENT_241	[p14l778t1259r1057b1308],
8	E	NNP	O	E	appos	2	SENT_241	[p14l1081t1262r1121b1318],
9	,	,	O	,	_	0	SENT_241	[p14l1081t1262r1121b1318],
10	Hassman	NNP	O	Hassman	nn	12	SENT_241	[p14l1151t1262r1394b1308],
11	H.	NNP	O	H.	nn	12	SENT_241	[p14l1423t1262r1477b1308],
12	Antidepressants	NNPS	O	Antidepressants	appos	2	SENT_241	[p14l1501t1259r1941b1323],
13	for	IN	O	for	_	0	SENT_241	[p14l1962t1260r2040b1308],
14	the	DT	O	the	det	15	SENT_241	[p14l2061t1259r2149b1308],
15	treatment	NN	O	treatment	prep_for	12	SENT_241	[p14l141t1342r418b1385],
16	of	IN	O	of	_	0	SENT_241	[p14l477t1336r531b1385],
17	generalized	VBN	O	generalize	prepc_of	15	SENT_241	[p14l587t1336r904b1400],
18	anxiety	NN	O	anxiety	nn	19	SENT_241	[p14l966t1337r1167b1400],
19	disorder	NN	O	disorder	dobj	17	SENT_241	[p14l1226t1336r1466b1385],
20	.	.	O	.	_	0	SENT_241	[p14l1226t1336r1466b1385],

1	A	DT	O	a	det	3	SENT_242	[p14l1527t1338r1566b1384],
2	placebo-controlled	JJ	O	placebo-controlled	amod	3	SENT_242	[p14l1625t1336r2147b1400],
3	comparison	NN	O	comparison	_	0	SENT_242	[p14l142t1413r465b1475],
4	of	IN	O	of	_	0	SENT_242	[p14l522t1412r576b1460],
5	imipramine	NN	O	imipramine	prep_of	3	SENT_242	[p14l629t1413r960b1475],
6	,	,	O	,	_	0	SENT_242	[p14l629t1413r960b1475],
7	trazodone	NN	O	trazodone	prep_of	3	SENT_242	[p14l1018t1412r1315b1470],
8	,	,	O	,	_	0	SENT_242	[p14l1018t1412r1315b1470],
9	and	CC	O	and	_	0	SENT_242	[p14l1373t1412r1474b1460],
10	diazepam	NN	O	diazepam	prep_of	3	SENT_242	[p14l1531t1412r1815b1475],
11	.	.	O	.	_	0	SENT_242	[p14l1531t1412r1815b1475],

1	Arch	NNP	O	Arch	nn	3	SENT_243	[p14l1872t1412r1991b1460],
2	Gen	NN	O	gen	nn	3	SENT_243	[p14l2048t1413r2151b1460],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_243	[p14l144t1488r415b1551],
4	1993	CD	DATE	1993	dep	3	SENT_243	[p14l437t1489r591b1546],
5	;	:	O	;	_	0	SENT_243	[p14l437t1489r591b1546],
6	50	CD	NUMBER	50	num	8	SENT_243	[p14l620t1489r705b1536],
7	:	:	O	:	_	0	SENT_243	[p14l620t1489r705b1536],
8	884-895	CD	NUMBER	884-895	dep	3	SENT_243	[p14l734t1489r995b1536],
9	.	.	O	.	_	0	SENT_243	[p14l734t1489r995b1536],

1	Rickels	NNS	PERSON	rickel	nn	2	SENT_244	[p14l144t1563r322b1612],
2	K	NNP	PERSON	K	_	0	SENT_244	[p14l348t1565r394b1622],
3	,	,	O	,	_	0	SENT_244	[p14l348t1565r394b1622],
4	Rynn	NNP	PERSON	Rynn	nn	5	SENT_244	[p14l424t1566r557b1627],
5	M	NN	PERSON	m	appos	2	SENT_244	[p14l586t1566r653b1622],
6	,	,	O	,	_	0	SENT_244	[p14l586t1566r653b1622],
7	lyengar	NN	O	lyengar	nn	8	SENT_244	[p14l683t1566r888b1627],
8	M	NN	O	m	appos	5	SENT_244	[p14l913t1566r980b1622],
9	,	,	O	,	_	0	SENT_244	[p14l913t1566r980b1622],
10	Duff	NNP	PERSON	Duff	nn	12	SENT_244	[p14l1010t1563r1127b1612],
11	D.	NNP	O	D.	nn	12	SENT_244	[p14l1151t1566r1206b1612],
12	Remission	NNP	O	Remission	appos	5	SENT_244	[p14l1236t1565r1505b1612],
13	of	IN	O	of	_	0	SENT_244	[p14l1531t1564r1585b1612],
14	generalized	VBN	O	generalize	prepc_of	12	SENT_244	[p14l1606t1563r1923b1627],
15	anxiety	NN	O	anxiety	nn	16	SENT_244	[p14l1949t1565r2150b1627],
16	disorder	NN	O	disorder	dobj	14	SENT_244	[p14l142t1640r382b1689],
17	:	:	O	:	_	0	SENT_244	[p14l142t1640r382b1689],
18	a	DT	O	a	det	19	SENT_244	[p14l428t1654r455b1689],
19	review	NN	O	review	dep	5	SENT_244	[p14l501t1641r680b1689],
20	of	IN	O	of	_	0	SENT_244	[p14l721t1640r775b1689],
21	the	DT	O	the	det	22	SENT_244	[p14l814t1640r902b1689],
22	paroxetine	NN	O	paroxetine	prep_of	19	SENT_244	[p14l948t1641r1242b1704],
23	clinical	JJ	O	clinical	amod	25	SENT_244	[p14l1286t1640r1470b1689],
24	trials	NNS	O	trial	nn	25	SENT_244	[p14l1515t1640r1643b1689],
25	database	NN	O	database	dep	19	SENT_244	[p14l1686t1640r1947b1689],
26	.	.	O	.	_	0	SENT_244	[p14l1686t1640r1947b1689],

1	/	:	O	/	punct	3	SENT_245	[p14l1990t1642r2010b1700],
2	Clin	NNP	O	Clin	nn	3	SENT_245	[p14l2054t1640r2151b1689],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_245	[p14l144t1716r415b1779],
4	2006	CD	DATE	2006	dep	3	SENT_245	[p14l434t1717r591b1774],
5	;	:	O	;	_	0	SENT_245	[p14l434t1717r591b1774],
6	67	CD	NUMBER	67	dep	3	SENT_245	[p14l619t1717r705b1764],
7	:	:	O	:	_	0	SENT_245	[p14l619t1717r705b1764],
8	41-47	CD	NUMBER	41-47	dep	6	SENT_245	[p14l732t1717r922b1764],
9	.	.	O	.	_	0	SENT_245	[p14l732t1717r922b1764],

1	The	DT	O	the	det	4	SENT_246	[p14l1261t1971r1363b2016],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	4	SENT_246	[p14l1390t1971r1931b2030],
3	]	NN	O	]	nn	4	SENT_246	[p14l1954t1971r2147b2026],
4	ourna	NN	O	ourna	_	0	SENT_246	[p14l1954t1971r2147b2026],
5	|	NN	O	|	dep	4	SENT_246	[p14l1954t1971r2147b2026],

1	HTRZA	NN	O	htrza	nn	5	SENT_247	[p14l821t2146r982b2189],
2	and	CC	O	and	_	0	SENT_247	[p14l1000t2144r1087b2189],
3	antidepressant	JJ	O	antidepressant	conj_and	1	SENT_247	[p14l1107t2144r1467b2204],
4	treatment	NN	O	treatment	nn	5	SENT_247	[p14l1485t2149r1732b2189],
5	response	NN	O	response	_	0	SENT_247	[p14l1751t2158r1961b2204],
6	in	IN	O	in	_	0	SENT_247	[p14l1981t2144r2022b2189],
7	GAD	NN	O	gad	nn	9	SENT_247	[p14l2043t2146r2147b2189],
8	FW	NN	O	fw	nn	9	SENT_247	[p14l1835t2217r1897b2257],
9	Lohoff	NNP	O	Lohoff	prep_in	5	SENT_247	[p14l1917t2216r2045b2257],
10	et	FW	O	et	nn	11	SENT_247	[p14l2063t2221r2099b2257],
11	al	FW	O	al	dep	5	SENT_247	[p14l2115t2216r2151b2257],

1	Rickels	NNS	PERSON	rickel	nn	2	SENT_248	[p14l145t2504r321b2552],
2	K	NNP	PERSON	K	_	0	SENT_248	[p14l357t2506r402b2562],
3	,	,	O	,	_	0	SENT_248	[p14l357t2506r402b2562],
4	Rynn	NNP	PERSON	Rynn	nn	6	SENT_248	[p14l441t2506r573b2567],
5	M.	NNP	PERSON	M.	nn	6	SENT_248	[p14l610t2506r678b2552],
6	Pharmacotherapy	NNP	PERSON	Pharmacotherapy	appos	2	SENT_248	[p14l716t2504r1207b2567],
7	of	IN	O	of	_	0	SENT_248	[p14l1238t2504r1291b2552],
8	generalized	VBN	O	generalize	prepc_of	6	SENT_248	[p14l1321t2504r1637b2567],
9	anxiety	NN	O	anxiety	nn	10	SENT_248	[p14l1672t2505r1873b2567],
10	disorder	NN	O	disorder	dobj	8	SENT_248	[p14l1904t2504r2143b2552],
11	.	.	O	.	_	0	SENT_248	[p14l1904t2504r2143b2552],

1	/	:	O	/	punct	3	SENT_249	[p14l138t2581r159b2638],
2	Clin	NNP	O	Clin	nn	3	SENT_249	[p14l184t2579r281b2626],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_249	[p14l308t2579r578b2641],
4	2002	CD	DATE	2002	dep	3	SENT_249	[p14l597t2580r754b2636],
5	;	:	O	;	_	0	SENT_249	[p14l597t2580r754b2636],
6	63	CD	NUMBER	63	number	7	SENT_249	[p14l782t2579r1032b2641],
7	(	CD	NUMBER	(	dep	4	SENT_249	[p14l782t2579r1032b2641],
8	Supp	NNP	O	Supp	dep	7	SENT_249	[p14l782t2579r1032b2641],
9	|	CD	NUMBER	|	num	8	SENT_249	[p14l782t2579r1032b2641],
10	14	CD	NUMBER	14	num	11	SENT_249	[p14l1064t2579r1168b2638],
11	)	NN	O	)	dep	7	SENT_249	[p14l1064t2579r1168b2638],
12	:	:	O	:	_	0	SENT_249	[p14l1064t2579r1168b2638],
13	9-16	CD	NUMBER	9-16	dep	4	SENT_249	[p14l1197t2580r1349b2626],
14	.	.	O	.	_	0	SENT_249	[p14l1197t2580r1349b2626],

1	Andrews	NNP	PERSON	Andrews	_	0	SENT_250	[p14l139t2654r381b2702],
2	(	CD	NUMBER	(	number	3	SENT_250	[p14l406t2656r464b2712],
3	3	CD	NUMBER	3	dep	1	SENT_250	[p14l406t2656r464b2712],
4	,	,	O	,	_	0	SENT_250	[p14l406t2656r464b2712],
5	Sanderson	NNP	PERSON	Sanderson	nn	6	SENT_250	[p14l494t2654r779b2702],
6	K	NNP	PERSON	K	appos	1	SENT_250	[p14l809t2656r855b2712],
7	,	,	O	,	_	0	SENT_250	[p14l809t2656r855b2712],
8	Slade	NNP	ORGANIZATION	Slade	nn	9	SENT_250	[p14l885t2654r1030b2702],
9	T	NN	ORGANIZATION	t	appos	6	SENT_250	[p14l1054t2656r1102b2712],
10	,	,	O	,	_	0	SENT_250	[p14l1054t2656r1102b2712],
11	lssakidis	NN	O	lssakidi	nn	12	SENT_250	[p14l1134t2654r1348b2702],
12	C.	NNP	O	C.	appos	6	SENT_250	[p14l1374t2656r1428b2702],
13	Why	WRB	O	why	advmod	14	SENT_250	[p14l1454t2654r1582b2717],
14	does	VBZ	O	do	rcmod	12	SENT_250	[p14l1605t2654r1733b2702],
15	the	DT	O	the	det	16	SENT_250	[p14l1758t2654r1845b2702],
16	burden	NN	O	burden	nsubj	19	SENT_250	[p14l1873t2654r2068b2702],
17	of	IN	O	of	_	0	SENT_250	[p14l2096t2654r2149b2702],
18	disease	NN	O	disease	prep_of	16	SENT_250	[p14l142t2729r336b2777],
19	persist	VB	O	persist	ccomp	14	SENT_250	[p14l383t2729r584b2791],
20	?	.	O	?	_	0	SENT_250	[p14l383t2729r584b2791],

1	Relating	VBG	O	relate	_	0	SENT_251	[p14l631t2729r848b2791],
2	the	DT	O	the	det	3	SENT_251	[p14l893t2729r981b2777],
3	burden	NN	O	burden	dobj	1	SENT_251	[p14l1027t2729r1222b2777],
4	of	IN	O	of	_	0	SENT_251	[p14l1269t2729r1322b2777],
5	anxiety	NN	O	anxiety	prep_of	3	SENT_251	[p14l1363t2730r1563b2792],
6	and	CC	O	and	_	0	SENT_251	[p14l1606t2729r1706b2777],
7	depression	NN	O	depression	prep_of	3	SENT_251	[p14l1752t2729r2046b2791],
8	to	TO	O	to	_	0	SENT_251	[p14l2091t2734r2146b2777],
9	effectiveness	NN	O	effectiveness	prep_to	1	SENT_251	[p14l142t2804r490b2852],
10	of	IN	O	of	_	0	SENT_251	[p14l514t2804r567b2852],
11	treatment	NN	O	treatment	prep_of	9	SENT_251	[p14l587t2810r877b2852],
12	.	.	O	.	_	0	SENT_251	[p14l587t2810r877b2852],

1	Bull	NNP	MISC	Bull	nn	4	SENT_252	[p14l907t2804r1002b2852],
2	World	NNP	MISC	World	nn	4	SENT_252	[p14l1026t2804r1181b2852],
3	Health	NNP	MISC	Health	nn	4	SENT_252	[p14l1201t2804r1374b2852],
4	Organ	NNP	MISC	Organ	_	0	SENT_252	[p14l1399t2806r1565b2867],
5	2000	CD	DATE	2000	num	4	SENT_252	[p14l1587t2806r1744b2862],
6	;	:	O	;	_	0	SENT_252	[p14l1587t2806r1744b2862],
7	78	CD	NUMBER	78	num	9	SENT_252	[p14l1773t2806r1855b2852],
8	:	:	O	:	_	0	SENT_252	[p14l1773t2806r1855b2852],
9	446-454	CD	NUMBER	446-454	dep	4	SENT_252	[p14l1880t2806r2143b2852],
10	.	.	O	.	_	0	SENT_252	[p14l1880t2806r2143b2852],

1	Pollack	NNP	PERSON	Pollack	nn	2	SENT_253	[p14l145t2879r334b2926],
2	MH	NNP	O	MH	_	0	SENT_253	[p14l370t2881r482b2926],
3	.	.	O	.	_	0	SENT_253	[p14l370t2881r482b2926],

1	Refractory	JJ	O	refractory	nsubj	2	SENT_254	[p14l523t2879r800b2941],
2	generalized	VBN	O	generalize	_	0	SENT_254	[p14l833t2879r1150b2941],
3	anxiety	NN	O	anxiety	nn	4	SENT_254	[p14l1187t2880r1388b2941],
4	disorder	NN	O	disorder	dobj	2	SENT_254	[p14l1422t2879r1661b2926],
5	.	.	O	.	_	0	SENT_254	[p14l1422t2879r1661b2926],

1	/	:	O	/	punct	3	SENT_255	[p14l1695t2881r1715b2937],
2	Clin	NNP	O	Clin	nn	3	SENT_255	[p14l1750t2879r1847b2926],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_255	[p14l1883t2879r2153b2941],
4	2009	CD	DATE	2009	dep	3	SENT_255	[p14l142t2956r299b3012],
5	;	:	O	;	_	0	SENT_255	[p14l142t2956r299b3012],
6	70	CD	NUMBER	70	number	7	SENT_255	[p14l330t2954r577b3017],
7	(	CD	NUMBER	(	dep	4	SENT_255	[p14l330t2954r577b3017],
8	Supp	NNP	O	Supp	nn	9	SENT_255	[p14l330t2954r577b3017],
9	|	NN	O	|	dep	7	SENT_255	[p14l330t2954r577b3017],
10	2	CD	NUMBER	2	num	11	SENT_255	[p14l606t2955r676b3014],
11	)	CD	NUMBER	)	dep	7	SENT_255	[p14l606t2955r676b3014],
12	:	:	O	:	_	0	SENT_255	[p14l606t2955r676b3014],
13	32-38	CD	NUMBER	32-38	dep	4	SENT_255	[p14l708t2956r893b3002],
14	.	.	O	.	_	0	SENT_255	[p14l708t2956r893b3002],

1	Kato	NNP	PERSON	Kato	nn	2	SENT_256	[p14l145t3031r265b3077],
2	M	NNP	PERSON	M	_	0	SENT_256	[p14l323t3031r390b3087],
3	,	,	O	,	_	0	SENT_256	[p14l323t3031r390b3087],
4	Serretti	NNP	PERSON	Serretti	nn	6	SENT_256	[p14l449t3030r642b3077],
5	A.	NNP	PERSON	A.	nn	6	SENT_256	[p14l696t3031r749b3076],
6	Review	NNP	PERSON	Review	appos	2	SENT_256	[p14l809t3030r1000b3077],
7	and	CC	O	and	_	0	SENT_256	[p14l1053t3029r1153b3077],
8	meta-analysis	NN	O	meta-analysis	appos	2	SENT_256	[p14l1212t3029r1582b3091],
9	of	IN	O	of	_	0	SENT_256	[p14l1636t3029r1690b3077],
10	antidepressant	JJ	O	antidepressant	amod	12	SENT_256	[p14l1741t3029r2148b3091],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_256	[p14l144t3104r631b3166],
12	findings	NNS	O	finding	prep_of	8	SENT_256	[p14l656t3104r878b3166],
13	in	IN	O	in	_	0	SENT_256	[p14l907t3105r952b3151],
14	major	JJ	O	major	amod	16	SENT_256	[p14l984t3105r1143b3166],
15	depressive	JJ	O	depressive	amod	16	SENT_256	[p14l1168t3104r1454b3166],
16	disorder	NN	O	disorder	prep_in	12	SENT_256	[p14l1483t3104r1721b3151],
17	.	.	O	.	_	0	SENT_256	[p14l1483t3104r1721b3151],

1	Mol	NNP	O	Mol	nn	2	SENT_257	[p14l1755t3104r1858b3151],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_257	[p14l1883t3104r2153b3166],
3	2010	CD	DATE	2010	num	2	SENT_257	[p14l142t3181r299b3237],
4	;	:	O	;	_	0	SENT_257	[p14l142t3181r299b3237],
5	15	CD	NUMBER	15	num	7	SENT_257	[p14l332t3181r412b3227],
6	:	:	O	:	_	0	SENT_257	[p14l332t3181r412b3227],
7	473-500	CD	NUMBER	473-500	dep	2	SENT_257	[p14l440t3181r703b3227],
8	.	.	O	.	_	0	SENT_257	[p14l440t3181r703b3227],

1	Tiwari	NNP	ORGANIZATION	Tiwari	nn	2	SENT_258	[p14l140t3255r305b3302],
2	AK	NNP	ORGANIZATION	AK	_	0	SENT_258	[p14l332t3256r422b3312],
3	,	,	O	,	_	0	SENT_258	[p14l332t3256r422b3312],
4	Souza	NNP	PERSON	Souza	nn	5	SENT_258	[p14l454t3256r614b3302],
5	RP	NNP	O	RP	appos	2	SENT_258	[p14l646t3256r724b3312],
6	,	,	O	,	_	0	SENT_258	[p14l646t3256r724b3312],
7	Muller	NNP	PERSON	Muller	nn	9	SENT_258	[p14l758t3254r934b3302],
8	D	NNP	O	D	nn	9	SENT_258	[p14l962t3256r1034b3313],
9	]	NN	O	]	appos	5	SENT_258	[p14l962t3256r1034b3313],
10	.	.	O	.	_	0	SENT_258	[p14l962t3256r1034b3313],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_259	[p14l1068t3254r1575b3317],
2	of	IN	O	of	_	0	SENT_259	[p14l1602t3254r1656b3302],
3	anxiolytic	JJ	O	anxiolytic	amod	4	SENT_259	[p14l1681t3254r1946b3317],
4	drugs	NNS	O	drug	prep_of	1	SENT_259	[p14l1973t3254r2143b3317],
5	.	.	O	.	_	0	SENT_259	[p14l1973t3254r2143b3317],

1	/	:	O	/	punct	2	SENT_260	[p14l138t3331r158b3388],
2	Neural	JJ	O	neural	_	0	SENT_260	[p14l183t3329r363b3377],
3	Transm	FW	O	transm	dep	2	SENT_260	[p14l389t3331r583b3377],
4	2009	CD	DATE	2009	dep	3	SENT_260	[p14l607t3331r764b3387],
5	;	:	O	;	_	0	SENT_260	[p14l607t3331r764b3387],
6	116	CD	NUMBER	116	dep	4	SENT_260	[p14l797t3330r914b3377],
7	:	:	O	:	_	0	SENT_260	[p14l797t3330r914b3377],
8	667-677	CD	NUMBER	667-677	dep	6	SENT_260	[p14l943t3331r1204b3377],
9	.	.	O	.	_	0	SENT_260	[p14l943t3331r1204b3377],

1	10	CD	NUMBER	10	num	2	SENT_261	[p14l13t3405r78b3451],
2	Rush	NN	MISC	rush	_	0	SENT_261	[p14l149t3404r273b3451],
3	A	DT	MISC	a	det	4	SENT_261	[p14l305t3406r374b3462],
4	]	NN	O	]	dep	2	SENT_261	[p14l305t3406r374b3462],
5	,	,	O	,	_	0	SENT_261	[p14l305t3406r374b3462],
6	Fava	NN	O	fava	nn	7	SENT_261	[p14l411t3406r529b3451],
7	M	NN	O	m	appos	4	SENT_261	[p14l563t3406r630b3462],
8	,	,	O	,	_	0	SENT_261	[p14l563t3406r630b3462],
9	Wisniewski	NNP	PERSON	Wisniewski	nn	10	SENT_261	[p14l663t3404r963b3451],
10	SR	NN	O	sr	appos	4	SENT_261	[p14l997t3405r1075b3461],
11	,	,	O	,	_	0	SENT_261	[p14l997t3405r1075b3461],
12	Lavori	NNP	PERSON	Lavori	nn	13	SENT_261	[p14l1112t3405r1271b3451],
13	PW	NNP	O	PW	appos	4	SENT_261	[p14l1307t3405r1408b3461],
14	,	,	O	,	_	0	SENT_261	[p14l1307t3405r1408b3461],
15	Trivedi	NNP	PERSON	Trivedi	nn	16	SENT_261	[p14l1441t3404r1626b3451],
16	MH	NNP	O	MH	appos	4	SENT_261	[p14l1662t3406r1774b3461],
17	,	,	O	,	_	0	SENT_261	[p14l1662t3406r1774b3461],
18	Sackeim	NNP	LOCATION	Sackeim	nn	19	SENT_261	[p14l1809t3404r2032b3451],
19	HA	NNP	LOCATION	HA	appos	4	SENT_261	[p14l2069t3406r2149b3451],

1	et	FW	O	et	_	0	SENT_262	[p14l148t3485r197b3527],
2	al.	FW	O	al.	dep	1	SENT_262	[p14l219t3479r276b3527],
3	.	.	O	.	_	0	SENT_262	[p14l219t3479r276b3527],

1	Sequenced	VBN	O	sequence	_	0	SENT_263	[p14l305t3479r607b3542],
2	treatment	NN	O	treatment	nn	3	SENT_263	[p14l632t3485r911b3527],
3	alternatives	NNS	O	alternative	nsubj	5	SENT_263	[p14l932t3479r1247b3527],
4	to	TO	O	to	aux	5	SENT_263	[p14l1269t3485r1324b3527],
5	relieve	VB	O	relieve	xcomp	1	SENT_263	[p14l1351t3479r1525b3527],
6	depression	NN	O	depression	nn	9	SENT_263	[p14l1549t3479r1843b3542],
7	(	CD	NUMBER	(	num	9	SENT_263	[p14l1870t3479r2143b3539],
8	STAR	NN	O	star	nn	9	SENT_263	[p14l1870t3479r2143b3539],
9	*	NN	O	*	dobj	5	SENT_263	[p14l1870t3479r2143b3539],
10	D	NN	O	d	dep	9	SENT_263	[p14l1870t3479r2143b3539],
11	)	CD	NUMBER	)	num	10	SENT_263	[p14l1870t3479r2143b3539],
12	:	:	O	:	_	0	SENT_263	[p14l1870t3479r2143b3539],
13	rationale	NN	O	rationale	dep	9	SENT_263	[p14l149t3554r386b3602],
14	and	CC	O	and	_	0	SENT_263	[p14l412t3554r513b3602],
15	design	NN	O	design	dep	9	SENT_263	[p14l541t3554r737b3616],
16	.	.	O	.	_	0	SENT_263	[p14l541t3554r737b3616],

1	Control	NNP	O	Control	nn	3	SENT_264	[p14l769t3554r965b3602],
2	Clin	NNP	O	Clin	nn	3	SENT_264	[p14l989t3554r1086b3602],
3	Trials	NNPS	O	Trials	_	0	SENT_264	[p14l1116t3554r1252b3602],
4	2004	CD	DATE	2004	dep	3	SENT_264	[p14l1276t3555r1432b3612],
5	;	:	O	;	_	0	SENT_264	[p14l1276t3555r1432b3612],
6	25	CD	NUMBER	25	num	8	SENT_264	[p14l1462t3555r1545b3602],
7	:	:	O	:	_	0	SENT_264	[p14l1462t3555r1545b3602],
8	119-142	CD	NUMBER	119-142	dep	3	SENT_264	[p14l1577t3555r1836b3601],
9	.	.	O	.	_	0	SENT_264	[p14l1577t3555r1836b3601],

1	McMahon	NNP	PERSON	McMahon	nn	3	SENT_265	[p14l149t3629r431b3676],
2	F	NN	O	f	nn	3	SENT_265	[p14l467t3631r523b3687],
3	]	NN	O	]	_	0	SENT_265	[p14l467t3631r523b3687],
4	,	,	O	,	_	0	SENT_265	[p14l467t3631r523b3687],
5	Buervenich	NNP	O	Buervenich	nn	6	SENT_265	[p14l560t3629r863b3676],
6	S	NNP	O	S	appos	3	SENT_265	[p14l896t3630r939b3686],
7	,	,	O	,	_	0	SENT_265	[p14l896t3630r939b3686],
8	Charney	NNP	PERSON	Charney	nn	9	SENT_265	[p14l974t3629r1207b3691],
9	D	NNP	PERSON	D	appos	3	SENT_265	[p14l1239t3631r1294b3686],
10	,	,	O	,	_	0	SENT_265	[p14l1239t3631r1294b3686],
11	Lipsky	NNP	PERSON	Lipsky	nn	12	SENT_265	[p14l1331t3629r1496b3691],
12	R	NNP	PERSON	R	appos	3	SENT_265	[p14l1528t3631r1571b3686],
13	,	,	O	,	_	0	SENT_265	[p14l1528t3631r1571b3686],
14	Rush	NNP	MISC	Rush	nn	16	SENT_265	[p14l1608t3629r1732b3676],
15	A	NNP	MISC	A	nn	16	SENT_265	[p14l1763t3631r1832b3687],
16	]	NN	O	]	appos	3	SENT_265	[p14l1763t3631r1832b3687],
17	,	,	O	,	_	0	SENT_265	[p14l1763t3631r1832b3687],
18	Wilson	NNP	PERSON	Wilson	nn	19	SENT_265	[p14l1864t3629r2048b3676],
19	AF	NNP	O	AF	appos	3	SENT_265	[p14l2079t3631r2146b3676],
20	et	FW	O	et	nn	21	SENT_265	[p14l148t3710r197b3752],
21	al.	FW	O	al.	dep	19	SENT_265	[p14l234t3704r291b3752],
22	.	.	O	.	_	0	SENT_265	[p14l234t3704r291b3752],

1	Variation	NN	O	variation	nsubjpass	11	SENT_266	[p14l331t3705r576b3752],
2	in	IN	O	in	_	0	SENT_266	[p14l619t3705r663b3751],
3	the	DT	O	the	det	4	SENT_266	[p14l704t3704r792b3752],
4	gene	NN	O	gene	prep_in	1	SENT_266	[p14l831t3718r966b3767],
5	encoding	VBG	O	encode	partmod	4	SENT_266	[p14l1006t3704r1264b3767],
6	the	DT	O	the	det	9	SENT_266	[p14l1305t3704r1393b3752],
7	serotonin	NN	O	serotonin	nn	9	SENT_266	[p14l1431t3705r1689b3752],
8	2A	NN	O	2a	nn	9	SENT_266	[p14l1730t3706r1803b3751],
9	receptor	NN	O	receptor	dobj	5	SENT_266	[p14l1843t3710r2074b3767],
10	is	VBZ	O	be	auxpass	11	SENT_266	[p14l2113t3705r2147b3752],
11	associated	VBN	O	associate	_	0	SENT_266	[p15l147t13r428b61],
12	with	IN	O	with	_	0	SENT_266	[p15l453t13r572b61],
13	outcome	NN	O	outcome	prep_with	11	SENT_266	[p15l599t19r846b61],
14	of	IN	O	of	_	0	SENT_266	[p15l871t13r924b61],
15	antidepressant	JJ	O	antidepressant	amod	16	SENT_266	[p15l946t13r1354b76],
16	treatment	NN	O	treatment	prep_of	13	SENT_266	[p15l1375t19r1666b61],
17	.	.	O	.	_	0	SENT_266	[p15l1375t19r1666b61],

1	Am	VBP	O	be	_	0	SENT_267	[p15l1692t15r1780b60],
2	/	:	O	/	punct	3	SENT_267	[p15l1799t15r1820b72],
3	Hum	NNP	O	Hum	nsubj	5	SENT_267	[p15l1843t15r1968b61],
4	Genet	NNP	O	Genet	dep	5	SENT_267	[p15l1994t15r2151b61],
5	2006	CD	DATE	2006	ccomp	1	SENT_267	[p15l147t90r304b146],
6	;	:	O	;	_	0	SENT_267	[p15l147t90r304b146],
7	78	CD	NUMBER	78	dobj	1	SENT_267	[p15l335t90r417b136],
8	:	:	O	:	_	0	SENT_267	[p15l335t90r417b136],
9	804-814	CD	NUMBER	804-814	dep	7	SENT_267	[p15l446t89r708b136],
10	.	.	O	.	_	0	SENT_267	[p15l446t89r708b136],

1	Lucae	FW	O	lucae	_	0	SENT_268	[p15l149t165r304b210],
2	S	NN	O	s	dep	1	SENT_268	[p15l337t164r380b220],
3	,	,	O	,	_	0	SENT_268	[p15l337t164r380b220],
4	Ising	NN	O	ising	nn	5	SENT_268	[p15l418t164r540b225],
5	M	NN	O	m	appos	2	SENT_268	[p15l577t165r644b220],
6	,	,	O	,	_	0	SENT_268	[p15l577t165r644b220],
7	Horstmann	NNP	PERSON	Horstmann	nn	8	SENT_268	[p15l682t165r985b210],
8	S	NNP	O	S	appos	2	SENT_268	[p15l1021t164r1064b220],
9	,	,	O	,	_	0	SENT_268	[p15l1021t164r1064b220],
10	Baune	NNP	O	Baune	nn	11	SENT_268	[p15l1102t165r1269b210],
11	BT	NNP	O	BT	appos	2	SENT_268	[p15l1304t165r1384b220],
12	,	,	O	,	_	0	SENT_268	[p15l1304t165r1384b220],
13	Arolt	NNP	O	Arolt	nn	14	SENT_268	[p15l1416t163r1551b210],
14	V	NNP	O	V	appos	2	SENT_268	[p15l1579t164r1630b220],
15	,	,	O	,	_	0	SENT_268	[p15l1579t164r1630b220],
16	Muller-Myhsok	JJ	O	muller-myhsok	amod	17	SENT_268	[p15l1668t163r2084b225],
17	B	NN	O	b	appos	2	SENT_268	[p15l2117t165r2145b210],
18	et	FW	O	et	nn	19	SENT_268	[p15l148t244r197b286],
19	al.	FW	O	al.	dep	17	SENT_268	[p15l232t238r289b286],
20	.	.	O	.	_	0	SENT_268	[p15l232t238r289b286],

1	HTR2A	NN	O	htr2a	nn	3	SENT_269	[p15l332t240r518b286],
2	gene	NN	O	gene	nn	3	SENT_269	[p15l553t252r689b301],
3	variation	NN	O	variation	nsubjpass	5	SENT_269	[p15l724t239r963b286],
4	is	VBZ	O	be	auxpass	5	SENT_269	[p15l1004t239r1038b286],
5	involved	VBN	O	involve	_	0	SENT_269	[p15l1076t238r1305b286],
6	in	IN	O	in	_	0	SENT_269	[p15l1346t239r1391b285],
7	antidepressant	JJ	O	antidepressant	amod	9	SENT_269	[p15l1430t238r1836b301],
8	treatment	NN	O	treatment	nn	9	SENT_269	[p15l1871t244r2148b286],
9	response	NN	O	response	prep_in	5	SENT_269	[p15l149t327r405b376],
10	.	.	O	.	_	0	SENT_269	[p15l149t327r405b376],

1	Eur	NNP	O	Eur	nn	2	SENT_270	[p15l437t315r522b361],
2	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	_	0	SENT_270	[p15l543t313r1179b376],
3	2010	CD	DATE	2010	num	2	SENT_270	[p15l1199t314r1356b370],
4	;	:	O	;	_	0	SENT_270	[p15l1199t314r1356b370],
5	20	CD	NUMBER	20	num	7	SENT_270	[p15l1385t314r1469b361],
6	:	:	O	:	_	0	SENT_270	[p15l1385t314r1469b361],
7	65-68	CD	NUMBER	65-68	dep	2	SENT_270	[p15l1499t314r1687b361],
8	.	.	O	.	_	0	SENT_270	[p15l1499t314r1687b361],

1	Horstmann	NNP	PERSON	Horstmann	nn	2	SENT_271	[p15l149t390r453b435],
2	S	NNP	O	S	_	0	SENT_271	[p15l481t389r523b445],
3	,	,	O	,	_	0	SENT_271	[p15l481t389r523b445],
4	Lucae	NNP	O	Lucae	nn	5	SENT_271	[p15l553t390r707b435],
5	S	NNP	O	S	appos	2	SENT_271	[p15l733t389r775b445],
6	,	,	O	,	_	0	SENT_271	[p15l733t389r775b445],
7	Menke	NNP	PERSON	Menke	nn	8	SENT_271	[p15l805t387r989b435],
8	A	NNP	O	A	appos	2	SENT_271	[p15l1011t390r1063b445],
9	,	,	O	,	_	0	SENT_271	[p15l1011t390r1063b445],
10	Hennings	NNP	PERSON	Hennings	nn	11	SENT_271	[p15l1092t389r1353b450],
11	JM	NN	O	jm	appos	2	SENT_271	[p15l1374t390r1463b446],
12	,	,	O	,	_	0	SENT_271	[p15l1374t390r1463b446],
13	Ising	NN	O	ising	nn	14	SENT_271	[p15l1493t389r1615b450],
14	M	NN	O	m	appos	2	SENT_271	[p15l1643t390r1710b445],
15	,	,	O	,	_	0	SENT_271	[p15l1643t390r1710b445],
16	Roeske	NN	PERSON	roeske	nn	17	SENT_271	[p15l1740t387r1924b435],
17	D	NN	O	d	appos	2	SENT_271	[p15l1951t390r1990b434],
18	et	FW	O	et	nn	19	SENT_271	[p15l2016t393r2065b435],
19	al.	FW	O	al.	dep	17	SENT_271	[p15l2085t387r2143b435],
20	.	.	O	.	_	0	SENT_271	[p15l2085t387r2143b435],

1	Polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_272	[p15l149t463r572b525],
2	in	IN	O	in	_	0	SENT_272	[p15l597t464r641b510],
3	GRIK4	NN	O	grik4	prep_in	1	SENT_272	[p15l667t464r850b520],
4	,	,	O	,	_	0	SENT_272	[p15l667t464r850b520],
5	HTR2A	NN	O	htr2a	prep_in	1	SENT_272	[p15l879t464r1078b520],
6	,	,	O	,	_	0	SENT_272	[p15l879t464r1078b520],
7	and	CC	O	and	_	0	SENT_272	[p15l1105t463r1205b510],
8	FKBP5	NN	O	fkbp5	conj_and	3	SENT_272	[p15l1233t465r1399b510],
9	show	VBP	O	show	_	0	SENT_272	[p15l1423t463r1569b510],
10	interactive	JJ	O	interactive	amod	11	SENT_272	[p15l1592t464r1878b510],
11	effects	NNS	O	effect	dobj	9	SENT_272	[p15l1901t463r2075b510],
12	in	IN	O	in	_	0	SENT_272	[p15l2100t464r2144b510],
13	predicting	VBG	O	predict	prepc_in	9	SENT_272	[p15l149t538r428b601],
14	remission	NN	O	remission	dobj	13	SENT_272	[p15l457t539r714b586],
15	to	TO	O	to	_	0	SENT_272	[p15l740t544r795b586],
16	antidepressant	JJ	O	antidepressant	amod	17	SENT_272	[p15l820t538r1226b601],
17	treatment	NN	O	treatment	prep_to	13	SENT_272	[p15l1249t544r1539b586],
18	.	.	O	.	_	0	SENT_272	[p15l1249t544r1539b586],

1	Neuropsychopharmacology	NNP	O	Neuropsychopharmacology	_	0	SENT_273	[p15l1569t538r2147b601, p15l148t613r321b675],
2	2010	CD	DATE	2010	num	1	SENT_273	[p15l340t614r497b671],
3	;	:	O	;	_	0	SENT_273	[p15l340t614r497b671],
4	35	CD	NUMBER	35	num	6	SENT_273	[p15l527t614r610b661],
5	:	:	O	:	_	0	SENT_273	[p15l527t614r610b661],
6	727-740	CD	NUMBER	727-740	dep	1	SENT_273	[p15l642t614r901b661],
7	.	.	O	.	_	0	SENT_273	[p15l642t614r901b661],

1	Uher	NNP	PERSON	Uher	nn	2	SENT_274	[p15l149t688r280b735],
2	R	NNP	O	R	_	0	SENT_274	[p15l308t690r351b745],
3	,	,	O	,	_	0	SENT_274	[p15l308t690r351b745],
4	Huezo-Diaz	NNP	PERSON	Huezo-Diaz	nn	5	SENT_274	[p15l384t689r702b735],
5	P	NN	PERSON	p	appos	2	SENT_274	[p15l731t690r773b745],
6	,	,	O	,	_	0	SENT_274	[p15l731t690r773b745],
7	Perroud	NNP	PERSON	Perroud	nn	8	SENT_274	[p15l807t688r1019b735],
8	N	NNP	PERSON	N	appos	2	SENT_274	[p15l1051t690r1109b745],
9	,	,	O	,	_	0	SENT_274	[p15l1051t690r1109b745],
10	Smith	NNP	PERSON	Smith	nn	11	SENT_274	[p15l1141t688r1298b735],
11	R	NNP	O	R	appos	2	SENT_274	[p15l1330t690r1373b746],
12	,	,	O	,	_	0	SENT_274	[p15l1330t690r1373b746],
13	Rietschel	NNP	O	Rietschel	nn	14	SENT_274	[p15l1407t688r1642b735],
14	M	NNP	O	M	appos	2	SENT_274	[p15l1674t690r1741b745],
15	,	,	O	,	_	0	SENT_274	[p15l1674t690r1741b745],
16	Mors	NNP	O	Mors	nn	17	SENT_274	[p15l1775t690r1910b735],
17	O	NNP	O	O	appos	2	SENT_274	[p15l1937t689r1982b735],
18	et	FW	O	et	nn	19	SENT_274	[p15l2012t693r2061b735],
19	al.	FW	O	al.	dep	17	SENT_274	[p15l2085t688r2143b735],
20	.	.	O	.	_	0	SENT_274	[p15l2085t688r2143b735],

1	Genetic	JJ	O	genetic	amod	2	SENT_275	[p15l147t764r360b811],
2	predictors	NNS	O	predictor	_	0	SENT_275	[p15l407t763r681b826],
3	of	IN	O	of	_	0	SENT_275	[p15l726t763r780b811],
4	response	NN	O	response	prep_of	2	SENT_275	[p15l824t777r1064b826],
5	to	TO	O	to	_	0	SENT_275	[p15l1109t769r1164b811],
6	antidepressants	NNS	O	antidepressant	prep_to	2	SENT_275	[p15l1209t763r1638b826],
7	in	IN	O	in	_	0	SENT_275	[p15l1684t764r1729b810],
8	the	DT	O	the	det	10	SENT_275	[p15l1775t763r1863b811],
9	GENDEP	NN	O	gendep	nn	10	SENT_275	[p15l1908t765r2146b811],
10	project	NN	O	project	prep_in	6	SENT_275	[p15l149t839r354b900],
11	.	.	O	.	_	0	SENT_275	[p15l149t839r354b900],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_276	[p15l386t838r905b900],
2	/	:	O	/	punct	3	SENT_276	[p15l923t840r944b897],
3	2009	CD	DATE	2009	dep	1	SENT_276	[p15l966t839r1123b895],
4	;	:	O	;	_	0	SENT_276	[p15l966t839r1123b895],
5	9	CD	NUMBER	9	num	7	SENT_276	[p15l1151t839r1199b885],
6	:	:	O	:	_	0	SENT_276	[p15l1151t839r1199b885],
7	225-233	CD	NUMBER	225-233	dep	3	SENT_276	[p15l1229t839r1490b886],
8	.	.	O	.	_	0	SENT_276	[p15l1229t839r1490b886],

1	Rickels	NNS	PERSON	rickel	_	0	SENT_277	[p15l150t913r326b961],
2	K	NNP	PERSON	K	dep	1	SENT_277	[p15l361t915r406b971],
3	,	,	O	,	_	0	SENT_277	[p15l361t915r406b971],
4	Etemad	NNP	O	Etemad	nn	5	SENT_277	[p15l445t913r649b961],
5	B	NNP	O	B	appos	2	SENT_277	[p15l686t915r730b971],
6	,	,	O	,	_	0	SENT_277	[p15l686t915r730b971],
7	Khalid-Khan	NNP	PERSON	Khalid-Khan	nn	8	SENT_277	[p15l768t913r1099b961],
8	S	NNP	O	S	appos	2	SENT_277	[p15l1136t915r1178b971],
9	,	,	O	,	_	0	SENT_277	[p15l1136t915r1178b971],
10	Lohoff	NNP	ORGANIZATION	Lohoff	nn	11	SENT_277	[p15l1216t913r1390b961],
11	FW	NNP	ORGANIZATION	FW	appos	2	SENT_277	[p15l1422t915r1519b971],
12	,	,	O	,	_	0	SENT_277	[p15l1422t915r1519b971],
13	Rynn	NNP	PERSON	Rynn	nn	14	SENT_277	[p15l1557t915r1690b976],
14	MA	NNP	PERSON	MA	appos	2	SENT_277	[p15l1727t915r1833b971],
15	,	,	O	,	_	0	SENT_277	[p15l1727t915r1833b971],
16	Gallop	NNP	O	Gallop	nn	18	SENT_277	[p15l1869t913r2048b976],
17	R	NNP	O	R	nn	18	SENT_277	[p15l2082t915r2143b972],
18	]	NN	O	]	appos	2	SENT_277	[p15l2082t915r2143b972],
19	.	.	O	.	_	0	SENT_277	[p15l2082t915r2143b972],

1	Time	NNP	O	Time	nsubj	17	SENT_278	[p15l145t989r282b1035],
2	to	TO	O	to	_	0	SENT_278	[p15l302t993r356b1035],
3	relapse	NN	O	relapse	prep_to	1	SENT_278	[p15l379t988r568b1050],
4	after	IN	O	after	_	0	SENT_278	[p15l589t988r714b1035],
5	6	CD	NUMBER	6	nn	8	SENT_278	[p15l732t989r763b1035],
6	and	CC	O	and	_	0	SENT_278	[p15l783t988r883b1035],
7	12	CD	DURATION	12	nn	8	SENT_278	[p15l909t989r973b1035],
8	months	NNS	NUMBER	month	prep_after	17	SENT_278	[p15l996t988r1221b1035],
9	’	JJ	O	’	amod	10	SENT_278	[p15l996t988r1221b1035],
10	treatment	NN	O	treatment	nsubj	17	SENT_278	[p15l1241t993r1519b1035],
11	of	IN	O	of	_	0	SENT_278	[p15l1537t988r1591b1035],
12	generalized	VBN	O	generalize	prepc_of	10	SENT_278	[p15l1608t988r1924b1050],
13	anxiety	NN	O	anxiety	nn	14	SENT_278	[p15l1947t989r2147b1050],
14	disorder	NN	O	disorder	dobj	12	SENT_278	[p15l147t1063r373b1111],
15	with	IN	O	with	_	0	SENT_278	[p15l398t1063r517b1111],
16	venlafaxine	NN	O	venlafaxine	prep_with	12	SENT_278	[p15l546t1063r860b1111],
17	extended	VBD	O	extend	_	0	SENT_278	[p15l889t1063r1148b1111],
18	release	NN	O	release	dobj	17	SENT_278	[p15l1181t1063r1381b1111],
19	.	.	O	.	_	0	SENT_278	[p15l1181t1063r1381b1111],

1	Arch	NNP	O	Arch	nn	3	SENT_279	[p15l1411t1063r1530b1111],
2	Gen	NN	O	gen	nn	3	SENT_279	[p15l1561t1065r1665b1111],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_279	[p15l1694t1063r1964b1126],
4	2010	CD	DATE	2010	dep	3	SENT_279	[p15l1986t1065r2143b1121],
5	;	:	O	;	_	0	SENT_279	[p15l1986t1065r2143b1121],
6	67	CD	NUMBER	67	num	8	SENT_279	[p15l146t1140r231b1187],
7	:	:	O	:	_	0	SENT_279	[p15l146t1140r231b1187],
8	1274-1281	CD	DATE	1274-1281	dep	3	SENT_279	[p15l262t1140r595b1187],
9	.	.	O	.	_	0	SENT_279	[p15l262t1140r595b1187],

1	Norton	NNP	PERSON	Norton	nn	2	SENT_280	[p15l149t1216r344b1261],
2	N	NNP	O	N	_	0	SENT_280	[p15l387t1216r445b1271],
3	,	,	O	,	_	0	SENT_280	[p15l387t1216r445b1271],
4	Owen	NNP	PERSON	Owen	nn	5	SENT_280	[p15l487t1215r649b1261],
5	MJ	NNP	PERSON	MJ	appos	2	SENT_280	[p15l692t1216r777b1272],
6	.	.	O	.	_	0	SENT_280	[p15l692t1216r777b1272],

1	HTR2A	NN	O	htr2a	_	0	SENT_281	[p15l820t1215r1020b1261],
2	:	:	O	:	_	0	SENT_281	[p15l820t1215r1020b1261],
3	association	NN	O	association	nn	6	SENT_281	[p15l1062t1215r1361b1261],
4	and	CC	O	and	_	0	SENT_281	[p15l1401t1214r1502b1261],
5	expression	NN	O	expression	nn	6	SENT_281	[p15l1542t1215r1831b1276],
6	studies	NNS	O	study	dep	1	SENT_281	[p15l1870t1214r2060b1261],
7	in	IN	O	in	_	0	SENT_281	[p15l2100t1215r2144b1261],
8	neuropsychiatric	JJ	O	neuropsychiatric	amod	9	SENT_281	[p15l149t1289r606b1352],
9	genetics	NNS	O	genetics	prep_in	6	SENT_281	[p15l632t1290r875b1352],
10	.	.	O	.	_	0	SENT_281	[p15l632t1290r875b1352],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_282	[p15l902t1291r1008b1336],
2	Med	NNP	O	Med	_	0	SENT_282	[p15l1034t1289r1153b1337],
3	2005	CD	DATE	2005	num	2	SENT_282	[p15l1173t1291r1330b1347],
4	;	:	O	;	_	0	SENT_282	[p15l1173t1291r1330b1347],
5	37	CD	NUMBER	37	num	7	SENT_282	[p15l1361t1291r1444b1337],
6	:	:	O	:	_	0	SENT_282	[p15l1361t1291r1444b1337],
7	121-129	CD	NUMBER	121-129	dep	2	SENT_282	[p15l1475t1291r1735b1337],
8	.	.	O	.	_	0	SENT_282	[p15l1475t1291r1735b1337],

1	The	DT	O	the	det	3	SENT_283	[p15l8t1544r110b1589],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_283	[p15l137t1544r677b1603],
3	Journal	NNP	O	Journal	_	0	SENT_283	[p15l699t1544r892b1599],
4	17	CD	NUMBER	17	dep	3	SENT_283	[p15l10t1617r75b1663],

1	Strome	NNP	ORGANIZATION	Strome	nn	2	SENT_284	[p15l145t1617r342b1664],
2	EM	NNP	ORGANIZATION	EM	_	0	SENT_284	[p15l385t1618r485b1674],
3	,	,	O	,	_	0	SENT_284	[p15l385t1618r485b1674],
4	Clark	NNP	PERSON	Clark	nn	5	SENT_284	[p15l528t1616r668b1664],
5	CM	NN	PERSON	cm	appos	2	SENT_284	[p15l707t1617r820b1674],
6	,	,	O	,	_	0	SENT_284	[p15l707t1617r820b1674],
7	Zis	NNP	ORGANIZATION	Zis	nn	8	SENT_284	[p15l864t1617r939b1664],
8	AP	NNP	ORGANIZATION	AP	appos	2	SENT_284	[p15l976t1618r1063b1674],
9	,	,	O	,	_	0	SENT_284	[p15l976t1618r1063b1674],
10	Doudet	NNP	O	Doudet	nn	11	SENT_284	[p15l1109t1616r1317b1664],
11	DJ	NNP	O	DJ	appos	2	SENT_284	[p15l1357t1618r1430b1675],
12	.	.	O	.	_	0	SENT_284	[p15l1357t1618r1430b1675],

1	Electroconvulsive	JJ	O	electroconvulsive	amod	2	SENT_285	[p15l1476t1616r1951b1664],
2	shock	NN	O	shock	nsubj	3	SENT_285	[p15l1990t1616r2147b1664],
3	decreases	VBZ	O	decrease	_	0	SENT_285	[p15l143t1691r408b1740],
4	binding	VBG	O	bind	dobj	3	SENT_285	[p15l432t1691r643b1755],
5	to	TO	O	to	_	0	SENT_285	[p15l666t1697r720b1740],
6	5	CD	NUMBER	5	prep_to	3	SENT_285	[p15l743t1693r911b1740],
7	.	.	O	.	_	0	SENT_285	[p15l743t1693r911b1740],

1	—	NN	O	—	_	0	SENT_286	[p15l743t1693r911b1740],
2	.	.	O	.	_	0	SENT_286	[p15l743t1693r911b1740],

1	HT2	NN	O	ht2	nn	2	SENT_287	[p15l743t1693r911b1740],
2	receptors	NNS	O	receptor	_	0	SENT_287	[p15l937t1697r1191b1755],
3	in	IN	O	in	_	0	SENT_287	[p15l1214t1693r1258b1739],
4	nonhuman	JJ	O	nonhuman	amod	5	SENT_287	[p15l1285t1691r1587b1740],
5	primates	NNS	O	primate	prep_in	2	SENT_287	[p15l1613t1693r1865b1755],
6	:	:	O	:	_	0	SENT_287	[p15l1613t1693r1865b1755],
7	an	DT	O	a	dep	2	SENT_287	[p15l1890t1706r1953b1740],
8	in	FW	O	in	dep	14	SENT_287	[p15l1979t1693r2024b1739],
9	vivo	FW	O	vivo	nn	10	SENT_287	[p15l2047t1693r2148b1740],
10	positron	FW	O	positron	pobj	8	SENT_287	[p15l146t1769r369b1832],
11	emission	NN	O	emission	nn	13	SENT_287	[p15l405t1769r642b1817],
12	tomography	NN	O	tomography	nn	13	SENT_287	[p15l676t1768r1026b1832],
13	study	NN	O	study	dep	14	SENT_287	[p15l1057t1768r1207b1832],
14	with	IN	O	with	dep	7	SENT_287	[p15l1238t1768r1357b1817],
15	setoperone	NN	O	setoperone	pobj	14	SENT_287	[p15l1392t1774r1718b1832],
16	.	.	O	.	_	0	SENT_287	[p15l1392t1774r1718b1832],

1	Biol	NNP	O	Biol	nn	2	SENT_288	[p15l1757t1768r1852b1817],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_288	[p15l1882t1768r2152b1832],
3	2005	CD	DATE	2005	num	2	SENT_288	[p15l144t1844r301b1901],
4	;	:	O	;	_	0	SENT_288	[p15l144t1844r301b1901],
5	57	CD	NUMBER	57	num	7	SENT_288	[p15l330t1845r414b1891],
6	:	:	O	:	_	0	SENT_288	[p15l330t1845r414b1891],
7	1004-1010	CD	DATE	1004-1010	dep	2	SENT_288	[p15l446t1844r779b1891],
8	.	.	O	.	_	0	SENT_288	[p15l446t1844r779b1891],

1	Drevets	NNPS	O	Drevets	_	0	SENT_289	[p15l146t1921r351b1967],
2	WC	NNP	O	WC	dep	1	SENT_289	[p15l379t1920r496b1967],
3	.	.	O	.	_	0	SENT_289	[p15l379t1920r496b1967],

1	Neuroimaging	VBG	O	neuroimage	amod	2	SENT_290	[p15l532t1920r933b1982],
2	studies	NNS	O	study	_	0	SENT_290	[p15l965t1919r1155b1967],
3	of	IN	O	of	_	0	SENT_290	[p15l1185t1919r1239b1967],
4	mood	NN	O	mood	nn	5	SENT_290	[p15l1268t1919r1428b1967],
5	disorders	NNS	O	disorder	prep_of	2	SENT_290	[p15l1460t1919r1725b1967],
6	.	.	O	.	_	0	SENT_290	[p15l1460t1919r1725b1967],

1	Biol	NNP	O	Biol	nn	2	SENT_291	[p15l1761t1919r1855b1967],
2	Psychiatry	NNP	O	Psychiatry	_	0	SENT_291	[p15l1882t1919r2152b1982],
3	2000	CD	DATE	2000	num	2	SENT_291	[p15l144t1995r301b2051],
4	;	:	O	;	_	0	SENT_291	[p15l144t1995r301b2051],
5	48	CD	NUMBER	48	num	7	SENT_291	[p15l329t1995r414b2041],
6	:	:	O	:	_	0	SENT_291	[p15l329t1995r414b2041],
7	813-829	CD	NUMBER	813-829	dep	2	SENT_291	[p15l443t1995r706b2041],
8	.	.	O	.	_	0	SENT_291	[p15l443t1995r706b2041],

1	Peremans	NNPS	O	Peremans	nn	2	SENT_292	[p15l146t2072r412b2119],
2	K	NNP	O	K	_	0	SENT_292	[p15l436t2072r482b2129],
3	,	,	O	,	_	0	SENT_292	[p15l436t2072r482b2129],
4	Audenaert	NNP	PERSON	Audenaert	nn	5	SENT_292	[p15l505t2070r797b2119],
5	K	NNP	PERSON	K	appos	2	SENT_292	[p15l820t2072r865b2129],
6	,	,	O	,	_	0	SENT_292	[p15l820t2072r865b2129],
7	Hoybergs	NNP	O	Hoybergs	nn	8	SENT_292	[p15l893t2070r1155b2134],
8	Y	NN	O	y	appos	2	SENT_292	[p15l1174t2072r1222b2129],
9	,	,	O	,	_	0	SENT_292	[p15l1174t2072r1222b2129],
10	Otte	NNP	PERSON	Otte	nn	11	SENT_292	[p15l1248t2072r1369b2119],
11	A	NNP	O	A	appos	2	SENT_292	[p15l1389t2072r1442b2129],
12	,	,	O	,	_	0	SENT_292	[p15l1389t2072r1442b2129],
13	Goethals	NNP	O	Goethals	nn	17	SENT_292	[p15l1467t2070r1710b2119],
14	I	PRP	O	I	dep	17	SENT_292	[p15l1735t2072r1759b2129],
15	,	,	O	,	_	0	SENT_292	[p15l1735t2072r1759b2129],
16	Gielen	NNP	PERSON	Gielen	dep	17	SENT_292	[p15l1784t2070r1957b2119],
17	I	NNP	O	I	appos	2	SENT_292	[p15l1984t2072r1991b2118],
18	et	FW	O	et	nn	19	SENT_292	[p15l2017t2076r2066b2119],
19	al.	FW	O	al.	dep	17	SENT_292	[p15l2085t2070r2143b2119],
20	.	.	O	.	_	0	SENT_292	[p15l2085t2070r2143b2119],

1	The	DT	O	the	det	2	SENT_293	[p15l141t2146r244b2194],
2	effect	NN	O	effect	_	0	SENT_293	[p15l281t2146r434b2194],
3	of	IN	O	of	_	0	SENT_293	[p15l469t2146r523b2194],
4	citalopram	NN	O	citalopram	nn	5	SENT_293	[p15l556t2146r850b2209],
5	hydrobromide	NN	O	hydrobromide	prep_of	2	SENT_293	[p15l892t2146r1290b2209],
6	on	IN	O	on	_	0	SENT_293	[p15l1327t2160r1394b2194],
7	5	CD	NUMBER	5	prep_on	2	SENT_293	[p15l1434t2147r1645b2194],
8	.	.	O	.	_	0	SENT_293	[p15l1434t2147r1645b2194],

1	—	NN	O	—	_	0	SENT_294	[p15l1434t2147r1645b2194],
2	.	.	O	.	_	0	SENT_294	[p15l1434t2147r1645b2194],

1	HT2A	NN	O	ht2a	nn	2	SENT_295	[p15l1434t2147r1645b2194],
2	receptors	NNS	O	receptor	_	0	SENT_295	[p15l1682t2152r1936b2209],
3	in	IN	O	in	_	0	SENT_295	[p15l1975t2147r2020b2194],
4	the	DT	O	the	det	10	SENT_295	[p15l2058t2146r2146b2194],
5	impu	FW	O	impu	nn	10	SENT_295	[p15l145t2221r717b2285],
6	|	FW	O	|	nn	10	SENT_295	[p15l145t2221r717b2285],
7	sive	FW	O	sive	nn	10	SENT_295	[p15l145t2221r717b2285],
8	—	FW	O	—	nn	10	SENT_295	[p15l145t2221r717b2285],
9	aggressive	JJ	O	aggressive	amod	10	SENT_295	[p15l145t2221r717b2285],
10	dog	NN	O	dog	prep_in	2	SENT_295	[p15l752t2221r875b2285],
11	,	,	O	,	_	0	SENT_295	[p15l752t2221r875b2285],
12	as	IN	O	as	mark	13	SENT_295	[p15l914t2236r965b2270],
13	measured	VBN	O	measure	dep	10	SENT_295	[p15l1003t2221r1269b2270],
14	with	IN	O	with	_	0	SENT_295	[p15l1304t2221r1424b2270],
15	123	CD	NUMBER	123	num	16	SENT_295	[p15l1464t2223r1917b2270],
16	|	NN	O	|	prep_with	13	SENT_295	[p15l1464t2223r1917b2270],
17	.	.	O	.	_	0	SENT_295	[p15l1464t2223r1917b2270],

1	—	NN	O	—	_	0	SENT_296	[p15l1464t2223r1917b2270],
2	.	.	O	.	_	0	SENT_296	[p15l1464t2223r1917b2270],

1	5	CD	NUMBER	5	_	0	SENT_297	[p15l1464t2223r1917b2270],
2	.	.	O	.	_	0	SENT_297	[p15l1464t2223r1917b2270],

1	—	NN	O	—	_	0	SENT_298	[p15l1464t2223r1917b2270],
2	.	.	O	.	_	0	SENT_298	[p15l1464t2223r1917b2270],

1	|	NN	O	|	_	0	SENT_299	[p15l1464t2223r1917b2270],
2	.	.	O	.	_	0	SENT_299	[p15l1464t2223r1917b2270],

1	—	NN	O	—	_	0	SENT_300	[p15l1464t2223r1917b2270],
2	.	.	O	.	_	0	SENT_300	[p15l1464t2223r1917b2270],

1	R91150	NN	O	r91150	_	0	SENT_301	[p15l1464t2223r1917b2270],
2	SPECT	NN	ORGANIZATION	spect	dep	1	SENT_301	[p15l1954t2223r2143b2270],
3	.	.	O	.	_	0	SENT_301	[p15l1954t2223r2143b2270],

1	Eur	NNP	O	Eur	nn	6	SENT_302	[p15l146t2300r267b2358],
2	]	NNP	O	]	nn	6	SENT_302	[p15l146t2300r267b2358],
3	Nucl	NNP	O	Nucl	nn	6	SENT_302	[p15l291t2298r413b2347],
4	Med	NNP	O	Med	nn	6	SENT_302	[p15l435t2298r554b2347],
5	Mol	NNP	O	Mol	nn	6	SENT_302	[p15l577t2298r680b2347],
6	Imaging	NNP	O	Imaging	_	0	SENT_302	[p15l702t2299r921b2362],
7	2005	CD	DATE	2005	num	6	SENT_302	[p15l945t2300r1102b2357],
8	;	:	O	;	_	0	SENT_302	[p15l945t2300r1102b2357],
9	32	CD	NUMBER	32	num	11	SENT_302	[p15l1132t2300r1215b2347],
10	:	:	O	:	_	0	SENT_302	[p15l1132t2300r1215b2347],
11	708-716	CD	NUMBER	708-716	dep	6	SENT_302	[p15l1247t2300r1506b2347],
12	.	.	O	.	_	0	SENT_302	[p15l1247t2300r1506b2347],

1	Aloyo	NNP	O	Aloyo	nn	2	SENT_303	[p15l141t2374r298b2438],
2	VJ	NNP	O	VJ	_	0	SENT_303	[p15l319t2376r388b2434],
3	,	,	O	,	_	0	SENT_303	[p15l319t2376r388b2434],
4	Berg	NNP	LOCATION	Berg	nn	5	SENT_303	[p15l418t2376r537b2438],
5	KA	NN	LOCATION	ka	appos	2	SENT_303	[p15l566t2376r651b2433],
6	,	,	O	,	_	0	SENT_303	[p15l566t2376r651b2433],
7	Spampinato	NNP	PERSON	Spampinato	nn	8	SENT_303	[p15l679t2375r1014b2438],
8	U	NNP	PERSON	U	appos	2	SENT_303	[p15l1040t2376r1092b2433],
9	,	,	O	,	_	0	SENT_303	[p15l1040t2376r1092b2433],
10	Clarke	NNP	PERSON	Clarke	nn	11	SENT_303	[p15l1120t2374r1290b2423],
11	WP	NNP	O	WP	appos	2	SENT_303	[p15l1312t2376r1418b2433],
12	,	,	O	,	_	0	SENT_303	[p15l1312t2376r1418b2433],
13	Harvey	NNP	PERSON	Harvey	nn	14	SENT_303	[p15l1449t2376r1638b2438],
14	JA	NNP	PERSON	JA	appos	2	SENT_303	[p15l1658t2376r1727b2434],
15	.	.	O	.	_	0	SENT_303	[p15l1658t2376r1727b2434],

1	Current	JJ	DATE	current	amod	2	SENT_304	[p15l1754t2376r1967b2423],
2	status	NN	O	status	_	0	SENT_304	[p15l1988t2380r2146b2423],
3	of	IN	O	of	_	0	SENT_304	[p15l143t2450r197b2498],
4	inverse	JJ	O	inverse	amod	5	SENT_304	[p15l232t2451r421b2498],
5	agonism	NN	O	agonism	prep_of	2	SENT_304	[p15l459t2451r692b2513],
6	at	IN	O	at	_	0	SENT_304	[p15l731t2456r783b2498],
7	serotonin2A	NN	O	serotonin2a	prep_at	2	SENT_304	[p15l817t2451r1155b2498],
8	(	CD	NUMBER	(	number	9	SENT_304	[p15l1190t2450r1443b2510],
9	5	CD	NUMBER	5	num	7	SENT_304	[p15l1190t2450r1443b2510],
10	.	.	O	.	_	0	SENT_304	[p15l1190t2450r1443b2510],

1	—	NN	O	—	_	0	SENT_305	[p15l1190t2450r1443b2510],
2	.	.	O	.	_	0	SENT_305	[p15l1190t2450r1443b2510],

1	HT2A	NN	O	ht2a	_	0	SENT_306	[p15l1190t2450r1443b2510],
2	)	NN	O	)	nn	5	SENT_306	[p15l1190t2450r1443b2510],
3	and	CC	O	and	_	0	SENT_306	[p15l1481t2450r1581b2498],
4	5-HT2C	NN	O	5-ht2c	nn	5	SENT_306	[p15l1620t2451r1834b2498],
5	receptors	NNS	O	receptor	dep	1	SENT_306	[p15l1873t2455r2142b2513],
6	.	.	O	.	_	0	SENT_306	[p15l1873t2455r2142b2513],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_307	[p15l146t2525r431b2572],
2	Ther	NNP	O	Ther	_	0	SENT_307	[p15l457t2525r575b2572],
3	2009	CD	DATE	2009	num	2	SENT_307	[p15l594t2526r750b2582],
4	;	:	O	;	_	0	SENT_307	[p15l594t2526r750b2582],
5	121	CD	NUMBER	121	num	7	SENT_307	[p15l783t2526r900b2572],
6	:	:	O	:	_	0	SENT_307	[p15l783t2526r900b2572],
7	160-173	CD	NUMBER	160-173	dep	2	SENT_307	[p15l932t2526r1191b2572],
8	.	.	O	.	_	0	SENT_307	[p15l932t2526r1191b2572],

1	Berg	NNP	LOCATION	Berg	nn	2	SENT_308	[p15l146t2603r266b2665],
2	KA	NN	LOCATION	ka	_	0	SENT_308	[p15l296t2603r381b2660],
3	,	,	O	,	_	0	SENT_308	[p15l296t2603r381b2660],
4	Harvey	NNP	PERSON	Harvey	nn	5	SENT_308	[p15l414t2603r602b2665],
5	JA	NNP	PERSON	JA	appos	2	SENT_308	[p15l625t2603r694b2661],
6	,	,	O	,	_	0	SENT_308	[p15l625t2603r694b2661],
7	Spampinato	NNP	PERSON	Spampinato	nn	8	SENT_308	[p15l724t2602r1059b2665],
8	U	NNP	O	U	appos	2	SENT_308	[p15l1087t2603r1140b2660],
9	,	,	O	,	_	0	SENT_308	[p15l1087t2603r1140b2660],
10	Clarke	NNP	PERSON	Clarke	nn	11	SENT_308	[p15l1169t2601r1340b2650],
11	WP	NNP	O	WP	appos	2	SENT_308	[p15l1364t2603r1471b2650],
12	.	.	O	.	_	0	SENT_308	[p15l1364t2603r1471b2650],

1	Physiological	JJ	O	physiological	amod	2	SENT_309	[p15l1503t2601r1856b2665],
2	relevance	NN	O	relevance	_	0	SENT_309	[p15l1887t2601r2146b2650],
3	of	IN	O	of	_	0	SENT_309	[p15l143t2677r197b2725],
4	constitutive	JJ	O	constitutive	amod	5	SENT_309	[p15l245t2678r566b2725],
5	activity	NN	O	activity	prep_of	2	SENT_309	[p15l618t2678r815b2741],
6	of	IN	O	of	_	0	SENT_309	[p15l864t2677r918b2725],
7	5	CD	NUMBER	5	prep_of	2	SENT_309	[p15l966t2678r1177b2725],
8	.	.	O	.	_	0	SENT_309	[p15l966t2678r1177b2725],

1	—	NN	O	—	_	0	SENT_310	[p15l966t2678r1177b2725],
2	.	.	O	.	_	0	SENT_310	[p15l966t2678r1177b2725],

1	HT2A	NN	O	ht2a	_	0	SENT_311	[p15l966t2678r1177b2725],
2	and	CC	O	and	_	0	SENT_311	[p15l1226t2677r1327b2725],
3	5-HT2C	NN	O	5-ht2c	conj_and	1	SENT_311	[p15l1380t2678r1594b2725],
4	receptors	NNS	O	receptor	dep	1	SENT_311	[p15l1647t2682r1916b2740],
5	.	.	O	.	_	0	SENT_311	[p15l1647t2682r1916b2740],

1	Trends	NNS	O	trend	_	0	SENT_312	[p15l1977t2677r2148b2725],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_312	[p15l146t2752r431b2799],
3	Sci	NNP	O	Sci	dep	1	SENT_312	[p15l453t2753r526b2799],
4	2005	CD	DATE	2005	num	3	SENT_312	[p15l547t2753r704b2809],
5	;	:	O	;	_	0	SENT_312	[p15l547t2753r704b2809],
6	26	CD	NUMBER	26	num	8	SENT_312	[p15l733t2753r818b2799],
7	:	:	O	:	_	0	SENT_312	[p15l733t2753r818b2799],
8	625-630	CD	NUMBER	625-630	dep	1	SENT_312	[p15l847t2753r1109b2799],
9	.	.	O	.	_	0	SENT_312	[p15l847t2753r1109b2799],

1	Berg	NNP	LOCATION	Berg	nn	2	SENT_313	[p15l146t2830r260b2892],
2	KA	NN	LOCATION	ka	_	0	SENT_313	[p15l283t2830r364b2887],
3	,	,	O	,	_	0	SENT_313	[p15l283t2830r364b2887],
4	Harvey	NNP	PERSON	Harvey	nn	5	SENT_313	[p15l387t2830r567b2892],
5	JA	NNP	PERSON	JA	appos	2	SENT_313	[p15l582t2830r647b2888],
6	,	,	O	,	_	0	SENT_313	[p15l582t2830r647b2888],
7	Spampinato	NNP	PERSON	Spampinato	nn	8	SENT_313	[p15l669t2829r987b2892],
8	U	NNP	O	U	appos	2	SENT_313	[p15l1006t2830r1057b2887],
9	,	,	O	,	_	0	SENT_313	[p15l1006t2830r1057b2887],
10	Clarke	NNP	PERSON	Clarke	nn	11	SENT_313	[p15l1078t2828r1239b2877],
11	WP	NNP	O	WP	appos	2	SENT_313	[p15l1255t2830r1358b2877],
12	.	.	O	.	_	0	SENT_313	[p15l1255t2830r1358b2877],

1	Physiological	JJ	O	physiological	amod	4	SENT_314	[p15l1382t2828r1712b2892],
2	and	CC	O	and	_	0	SENT_314	[p15l1732t2828r1828b2877],
3	therapeutic	JJ	O	therapeutic	conj_and	1	SENT_314	[p15l1847t2828r2146b2892],
4	relevance	NN	O	relevance	_	0	SENT_314	[p15l146t2904r390b2953],
5	of	IN	O	of	_	0	SENT_314	[p15l414t2904r465b2953],
6	constitutive	JJ	O	constitutive	amod	7	SENT_314	[p15l486t2905r787b2953],
7	activity	NN	O	activity	prep_of	4	SENT_314	[p15l810t2905r994b2968],
8	of	IN	O	of	_	0	SENT_314	[p15l1016t2904r1068b2953],
9	5-HT	NN	O	5-ht	nn	10	SENT_314	[p15l1089t2906r1219b2953],
10	2A	NN	O	2a	prep_of	4	SENT_314	[p15l1241t2906r1312b2952],
11	and	CC	O	and	_	0	SENT_314	[p15l1334t2904r1430b2953],
12	5-HT	NN	O	5-ht	nn	14	SENT_314	[p15l1456t2906r1586b2953],
13	2C	NN	O	2c	nn	14	SENT_314	[p15l1608t2906r1682b2953],
14	receptors	NNS	O	receptor	prep_of	4	SENT_314	[p15l1707t2910r1946b2968],
15	for	IN	O	for	_	0	SENT_314	[p15l1967t2904r2042b2953],
16	the	DT	O	the	det	17	SENT_314	[p15l2062t2904r2146b2953],
17	treatment	NN	O	treatment	prep_for	4	SENT_314	[p15l142t2986r405b3029],
18	of	IN	O	of	_	0	SENT_314	[p15l427t2980r479b3029],
19	depression	NN	O	depression	prep_of	17	SENT_314	[p15l500t2980r793b3044],
20	.	.	O	.	_	0	SENT_314	[p15l500t2980r793b3044],

1	Prog	NN	O	prog	nn	2	SENT_315	[p15l822t2982r935b3044],
2	Brain	NN	O	brain	_	0	SENT_315	[p15l958t2981r1085b3029],
3	Res	NNP	O	Res	dep	2	SENT_315	[p15l1110t2982r1190b3029],
4	2008	CD	DATE	2008	num	3	SENT_315	[p15l1211t2982r1361b3039],
5	;	:	O	;	_	0	SENT_315	[p15l1211t2982r1361b3039],
6	172	CD	NUMBER	172	num	8	SENT_315	[p15l1391t2981r1502b3028],
7	:	:	O	:	_	0	SENT_315	[p15l1391t2981r1502b3028],
8	287-305	CD	NUMBER	287-305	dep	2	SENT_315	[p15l1530t2982r1779b3029],
9	.	.	O	.	_	0	SENT_315	[p15l1530t2982r1779b3029],

1	Weisstaub	NNP	ORGANIZATION	Weisstaub	nn	2	SENT_316	[p15l141t3056r423b3104],
2	NV	NNP	ORGANIZATION	NV	_	0	SENT_316	[p15l448t3057r543b3114],
3	,	,	O	,	_	0	SENT_316	[p15l448t3057r543b3114],
4	Zhou	NNP	PERSON	Zhou	nn	5	SENT_316	[p15l568t3056r711b3104],
5	M	NNP	PERSON	M	appos	2	SENT_316	[p15l737t3058r805b3114],
6	,	,	O	,	_	0	SENT_316	[p15l737t3058r805b3114],
7	Lira	NNP	O	Lira	nn	8	SENT_316	[p15l832t3057r924b3104],
8	A	NNP	O	A	appos	2	SENT_316	[p15l944t3058r996b3114],
9	,	,	O	,	_	0	SENT_316	[p15l944t3058r996b3114],
10	Lambe	NNP	PERSON	Lambe	nn	11	SENT_316	[p15l1023t3056r1206b3104],
11	E	NNP	O	E	appos	2	SENT_316	[p15l1230t3058r1270b3114],
12	,	,	O	,	_	0	SENT_316	[p15l1230t3058r1270b3114],
13	Gonzalez-Maeso	NNP	O	Gonzalez-Maeso	nn	14	SENT_316	[p15l1296t3056r1754b3104],
14	J	NNP	O	J	appos	2	SENT_316	[p15l1775t3058r1804b3115],
15	,	,	O	,	_	0	SENT_316	[p15l1775t3058r1804b3115],
16	Hornung	NNP	PERSON	Hornung	nn	17	SENT_316	[p15l1831t3058r2075b3119],
17	JP	NNP	O	JP	appos	2	SENT_316	[p15l2097t3058r2146b3115],
18	et	FW	O	et	nn	19	SENT_316	[p15l145t3138r194b3181],
19	al.	FW	O	al.	dep	17	SENT_316	[p15l247t3132r304b3181],
20	.	.	O	.	_	0	SENT_316	[p15l247t3132r304b3181],

1	Cortical	JJ	O	cortical	_	0	SENT_317	[p15l363t3132r573b3181],
2	5	CD	NUMBER	5	dep	1	SENT_317	[p15l631t3134r842b3181],
3	.	.	O	.	_	0	SENT_317	[p15l631t3134r842b3181],

1	—	NN	O	—	_	0	SENT_318	[p15l631t3134r842b3181],
2	.	.	O	.	_	0	SENT_318	[p15l631t3134r842b3181],

1	HT2A	NN	O	ht2a	nn	3	SENT_319	[p15l631t3134r842b3181],
2	receptor	NN	O	receptor	nn	3	SENT_319	[p15l897t3138r1129b3196],
3	signaling	NN	O	signaling	nsubj	4	SENT_319	[p15l1182t3132r1428b3196],
4	modulates	VBZ	O	modulate	_	0	SENT_319	[p15l1488t3132r1776b3181],
5	anxiety	NN	O	anxiety	dobj	4	SENT_319	[p15l1831t3132r2145b3196],
6	—	CD	NUMBER	—	num	9	SENT_319	[p15l1831t3132r2145b3196],
7	|	NN	O	|	nn	9	SENT_319	[p15l1831t3132r2145b3196],
8	ike	NN	O	ike	nn	9	SENT_319	[p15l1831t3132r2145b3196],
9	behaviors	NNS	O	behavior	tmod	4	SENT_319	[p15l145t3207r408b3255],
10	in	IN	O	in	_	0	SENT_319	[p15l436t3208r480b3254],
11	mice	NNS	O	mouse	prep_in	9	SENT_319	[p15l510t3208r655b3255],
12	.	.	O	.	_	0	SENT_319	[p15l510t3208r655b3255],

1	Science	NNP	O	Science	nn	4	SENT_320	[p15l686t3208r878b3255],
2	(	CD	NUMBER	(	num	4	SENT_320	[p15l903t3207r1047b3267],
3	New	NNP	LOCATION	New	nn	4	SENT_320	[p15l903t3207r1047b3267],
4	York	NNP	LOCATION	York	_	0	SENT_320	[p15l1073t3207r1193b3264],
5	,	,	O	,	_	0	SENT_320	[p15l1073t3207r1193b3264],
6	NY	NNP	LOCATION	NY	appos	4	SENT_320	[p15l1225t3207r1322b3266],
7	)	CD	NUMBER	)	num	6	SENT_320	[p15l1225t3207r1322b3266],
8	2006	CD	DATE	2006	dep	6	SENT_320	[p15l1347t3208r1504b3265],
9	;	:	O	;	_	0	SENT_320	[p15l1347t3208r1504b3265],
10	313	CD	NUMBER	313	num	12	SENT_320	[p15l1535t3208r1654b3255],
11	:	:	O	:	_	0	SENT_320	[p15l1535t3208r1654b3255],
12	536-540	CD	NUMBER	536-540	dep	4	SENT_320	[p15l1683t3208r1945b3255],
13	.	.	O	.	_	0	SENT_320	[p15l1683t3208r1945b3255],

1	Freedman	NNP	ORGANIZATION	Freedman	nn	2	SENT_321	[p15l146t3283r418b3331],
2	ML	NNP	ORGANIZATION	ML	_	0	SENT_321	[p15l470t3285r568b3341],
3	,	,	O	,	_	0	SENT_321	[p15l470t3285r568b3341],
4	Reich	NNP	PERSON	Reich	nn	5	SENT_321	[p15l620t3283r761b3331],
5	D	NNP	PERSON	D	appos	2	SENT_321	[p15l812t3285r868b3341],
6	,	,	O	,	_	0	SENT_321	[p15l812t3285r868b3341],
7	Penney	NNP	ORGANIZATION	Penney	nn	8	SENT_321	[p15l920t3285r1120b3346],
8	KL	NNP	ORGANIZATION	KL	appos	2	SENT_321	[p15l1168t3285r1244b3341],
9	,	,	O	,	_	0	SENT_321	[p15l1168t3285r1244b3341],
10	McDonald	NNP	ORGANIZATION	McDonald	nn	12	SENT_321	[p15l1297t3283r1583b3331],
11	G	NNP	ORGANIZATION	G	nn	12	SENT_321	[p15l1632t3284r1706b3342],
12	]	NNS	O	]	appos	2	SENT_321	[p15l1632t3284r1706b3342],
13	,	,	O	,	_	0	SENT_321	[p15l1632t3284r1706b3342],
14	Mignault	NNP	ORGANIZATION	Mignault	nn	15	SENT_321	[p15l1759t3283r2009b3346],
15	AA	NNP	ORGANIZATION	AA	appos	2	SENT_321	[p15l2051t3285r2143b3341],
16	,	,	O	,	_	0	SENT_321	[p15l2051t3285r2143b3341],
17	Patterson	NNP	PERSON	Patterson	nn	18	SENT_321	[p15l146t3361r400b3407],
18	N	NNP	O	N	appos	2	SENT_321	[p15l434t3361r474b3406],
19	et	FW	O	et	nn	20	SENT_321	[p15l508t3364r557b3407],
20	al.	FW	O	al.	dep	18	SENT_321	[p15l583t3359r640b3407],
21	.	.	O	.	_	0	SENT_321	[p15l583t3359r640b3407],

1	Assessing	VBG	O	assess	_	0	SENT_322	[p15l671t3360r928b3422],
2	the	DT	O	the	det	3	SENT_322	[p15l958t3359r1046b3407],
3	impact	NN	O	impact	dobj	1	SENT_322	[p15l1077t3360r1268b3422],
4	of	IN	O	of	_	0	SENT_322	[p15l1295t3359r1349b3407],
5	population	NN	O	population	nn	6	SENT_322	[p15l1377t3359r1675b3422],
6	stratification	NN	O	stratification	prep_of	3	SENT_322	[p15l1706t3359r2045b3407],
7	on	IN	O	on	_	0	SENT_322	[p15l2077t3373r2144b3407],
8	genetic	JJ	O	genetic	amod	10	SENT_322	[p15l143t3436r348b3499],
9	association	NN	O	association	nn	10	SENT_322	[p15l373t3436r673b3484],
10	studies	NNS	O	study	prep_on	1	SENT_322	[p15l701t3435r906b3484],
11	.	.	O	.	_	0	SENT_322	[p15l701t3435r906b3484],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_323	[p15l937t3437r1038b3484],
2	Genet	NNP	PERSON	Genet	_	0	SENT_323	[p15l1063t3437r1219b3484],
3	2004	CD	DATE	2004	num	2	SENT_323	[p15l1241t3437r1398b3494],
4	;	:	O	;	_	0	SENT_323	[p15l1241t3437r1398b3494],
5	36	CD	NUMBER	36	num	7	SENT_323	[p15l1428t3437r1511b3484],
6	:	:	O	:	_	0	SENT_323	[p15l1428t3437r1511b3484],
7	388-393	CD	NUMBER	388-393	dep	2	SENT_323	[p15l1543t3437r1803b3484],
8	.	.	O	.	_	0	SENT_323	[p15l1543t3437r1803b3484],

1	Pritchard	NNP	PERSON	Pritchard	nn	2	SENT_324	[p15l146t3511r390b3560],
2	JK	NNP	O	JK	_	0	SENT_324	[p15l462t3513r529b3571],
3	,	,	O	,	_	0	SENT_324	[p15l462t3513r529b3571],
4	Donnelly	NNP	PERSON	Donnelly	nn	7	SENT_324	[p15l606t3511r853b3575],
5	P.	NNP	O	P.	nn	7	SENT_324	[p15l925t3513r968b3559],
6	Case-control	JJ	MISC	case-control	amod	7	SENT_324	[p15l1043t3511r1389b3560],
7	studies	NNS	O	study	appos	2	SENT_324	[p15l1462t3511r1652b3560],
8	of	IN	O	of	_	0	SENT_324	[p15l1722t3511r1776b3560],
9	association	NN	O	association	prep_of	7	SENT_324	[p15l1844t3512r2144b3560],
10	in	IN	O	in	_	0	SENT_324	[p15l145t3588r189b3635],
11	structured	JJ	O	structured	amod	14	SENT_324	[p15l235t3587r515b3635],
12	or	CC	O	or	_	0	SENT_324	[p15l562t3601r619b3635],
13	admixed	JJ	O	admixed	amod	14	SENT_324	[p15l660t3587r899b3635],
14	populations	NNS	O	population	prep_in	9	SENT_324	[p15l948t3587r1288b3650],
15	.	.	O	.	_	0	SENT_324	[p15l948t3587r1288b3650],

1	Theor	NNP	O	Theor	nn	3	SENT_325	[p15l1342t3587r1492b3635],
2	Popul	NNP	O	Popul	nn	3	SENT_325	[p15l1532t3587r1681b3650],
3	Biol	NNP	O	Biol	_	0	SENT_325	[p15l1722t3587r1816b3635],
4	2001	CD	DATE	2001	num	3	SENT_325	[p15l1855t3588r2011b3645],
5	;	:	O	;	_	0	SENT_325	[p15l1855t3588r2011b3645],
6	60	CD	NUMBER	60	num	8	SENT_325	[p15l2058t3588r2143b3635],
7	:	:	O	:	_	0	SENT_325	[p15l2058t3588r2143b3635],
8	227-237	CD	NUMBER	227-237	dep	3	SENT_325	[p15l144t3665r406b3711],
9	.	.	O	.	_	0	SENT_325	[p15l144t3665r406b3711],

1	Devlin	JJ	PERSON	devlin	amod	2	SENT_326	[p16l146t20r316b68],
2	B	NN	PERSON	b	_	0	SENT_326	[p16l347t22r391b78],
3	,	,	O	,	_	0	SENT_326	[p16l347t22r391b78],
4	Roeder	NNP	PERSON	Roeder	nn	7	SENT_326	[p16l424t20r616b68],
5	K.	NNP	O	K.	nn	7	SENT_326	[p16l642t22r688b67],
6	Genomic	JJ	O	genomic	amod	7	SENT_326	[p16l718t21r971b68],
7	control	NN	O	control	appos	2	SENT_326	[p16l996t20r1189b68],
8	for	IN	O	for	_	0	SENT_326	[p16l1215t20r1293b68],
9	association	NN	O	association	nn	10	SENT_326	[p16l1316t21r1616b68],
10	studies	NNS	O	study	prep_for	7	SENT_326	[p16l1644t20r1849b68],
11	.	.	O	.	_	0	SENT_326	[p16l1644t20r1849b68],

1	Biometrics	NNS	O	biometric	_	0	SENT_327	[p16l1881t21r2148b68],
2	1999	CD	DATE	1999	num	1	SENT_327	[p16l146t96r300b153],
3	;	:	O	;	_	0	SENT_327	[p16l146t96r300b153],
4	55	CD	NUMBER	55	num	6	SENT_327	[p16l330t97r414b143],
5	:	:	O	:	_	0	SENT_327	[p16l330t97r414b143],
6	997-1004	CD	NUMBER	997-1004	dep	1	SENT_327	[p16l443t96r742b143],
7	.	.	O	.	_	0	SENT_327	[p16l443t96r742b143],

1	Bacanu	NNP	ORGANIZATION	Bacanu	nn	2	SENT_328	[p16l146t173r341b219],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_328	[p16l376t172r458b229],
3	,	,	O	,	_	0	SENT_328	[p16l376t172r458b229],
4	Devlin	NNP	PERSON	Devlin	nn	5	SENT_328	[p16l495t171r664b219],
5	B	NNP	PERSON	B	appos	2	SENT_328	[p16l699t173r744b229],
6	,	,	O	,	_	0	SENT_328	[p16l699t173r744b229],
7	Roeder	NNP	PERSON	Roeder	nn	8	SENT_328	[p16l780t171r973b219],
8	K.	NNP	O	K.	appos	2	SENT_328	[p16l1003t172r1049b219],
9	The	DT	O	the	det	10	SENT_328	[p16l1081t171r1183b219],
10	power	NN	O	power	dep	8	SENT_328	[p16l1216t185r1391b234],
11	of	IN	O	of	_	0	SENT_328	[p16l1419t171r1473b219],
12	genomic	JJ	O	genomic	amod	13	SENT_328	[p16l1500t172r1743b234],
13	control	NN	O	control	prep_of	10	SENT_328	[p16l1774t171r1984b219],
14	.	.	O	.	_	0	SENT_328	[p16l1774t171r1984b219],

1	Am	VBP	O	be	dep	4	SENT_329	[p16l2017t173r2150b230],
2	]	CD	NUMBER	]	num	4	SENT_329	[p16l2017t173r2150b230],
3	Hum	NNP	O	Hum	nn	4	SENT_329	[p16l146t248r270b294],
4	Genet	NNP	O	Genet	_	0	SENT_329	[p16l298t248r455b294],
5	2000	CD	DATE	2000	num	4	SENT_329	[p16l476t248r633b304],
6	;	:	O	;	_	0	SENT_329	[p16l476t248r633b304],
7	66	CD	NUMBER	66	dep	4	SENT_329	[p16l662t248r747b294],
8	:	:	O	:	_	0	SENT_329	[p16l662t248r747b294],
9	1933-1944	CD	DATE	1933-1944	dep	7	SENT_329	[p16l779t248r1111b294],
10	.	.	O	.	_	0	SENT_329	[p16l779t248r1111b294],

1	Peters	NNP	PERSON	Peters	nn	2	SENT_330	[p16l146t324r307b370],
2	E	NNP	O	E	_	0	SENT_330	[p16l331t324r388b382],
3	]	NN	O	]	dep	2	SENT_330	[p16l331t324r388b382],
4	,	,	O	,	_	0	SENT_330	[p16l331t324r388b382],
5	Slager	NNP	PERSON	Slager	nn	6	SENT_330	[p16l414t322r583b385],
6	SL	NNP	O	SL	appos	3	SENT_330	[p16l603t323r676b381],
7	,	,	O	,	_	0	SENT_330	[p16l603t323r676b381],
8	Jenkins	NNP	PERSON	Jenkins	nn	9	SENT_330	[p16l699t322r891b382],
9	GD	NN	MISC	gd	appos	3	SENT_330	[p16l913t323r1017b380],
10	,	,	O	,	_	0	SENT_330	[p16l913t323r1017b380],
11	Reinalda	NNP	PERSON	Reinalda	nn	12	SENT_330	[p16l1044t322r1273b370],
12	MS	NN	O	m	appos	3	SENT_330	[p16l1298t323r1398b380],
13	,	,	O	,	_	0	SENT_330	[p16l1298t323r1398b380],
14	Garriock	NNP	LOCATION	Garriock	nn	15	SENT_330	[p16l1423t322r1656b370],
15	HA	NNP	LOCATION	HA	appos	3	SENT_330	[p16l1678t324r1770b380],
16	,	,	O	,	_	0	SENT_330	[p16l1678t324r1770b380],
17	Shyn	NNP	O	Shyn	nn	18	SENT_330	[p16l1795t322r1927b386],
18	SI	NNP	O	SI	appos	3	SENT_330	[p16l1952t323r1993b370],
19	et	FW	O	et	nn	20	SENT_330	[p16l2018t327r2067b370],
20	al.	FW	O	al.	dep	18	SENT_330	[p16l2085t322r2143b370],
21	.	.	O	.	_	0	SENT_330	[p16l2085t322r2143b370],

1	Resequencing	NN	O	resequencing	_	0	SENT_331	[p16l146t399r527b461],
2	of	IN	O	of	_	0	SENT_331	[p16l567t398r621b446],
3	serotonin-related	JJ	O	serotonin-related	amod	4	SENT_331	[p16l654t398r1126b446],
4	genes	NNS	O	gene	prep_of	1	SENT_331	[p16l1167t412r1327b461],
5	and	CC	O	and	_	0	SENT_331	[p16l1364t398r1465b446],
6	association	NN	O	association	prep_of	1	SENT_331	[p16l1503t399r1803b446],
7	of	IN	O	of	_	0	SENT_331	[p16l1842t398r1896b446],
8	tagging	VBG	O	tag	prepc_of	6	SENT_331	[p16l1929t399r2143b461],
9	SNPs	NNS	O	snp	dobj	8	SENT_331	[p16l145t476r282b523],
10	to	TO	O	to	_	0	SENT_331	[p16l302t480r357b523],
11	citalopram	NN	O	citalopram	nn	12	SENT_331	[p16l379t474r672b538],
12	response	NN	O	response	prep_to	8	SENT_331	[p16l699t488r956b538],
13	.	.	O	.	_	0	SENT_331	[p16l699t488r956b538],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_332	[p16l983t474r1403b538],
2	Genomics	NNP	O	Genomics	_	0	SENT_332	[p16l1423t475r1680b523],
3	2009	CD	DATE	2009	num	2	SENT_332	[p16l1700t476r1856b533],
4	;	:	O	;	_	0	SENT_332	[p16l1700t476r1856b533],
5	19	CD	NUMBER	19	num	7	SENT_332	[p16l1885t476r1966b523],
6	:	:	O	:	_	0	SENT_332	[p16l1885t476r1966b523],
7	1-10	CD	NUMBER	1-10	dep	2	SENT_332	[p16l1993t476r2143b523],
8	.	.	O	.	_	0	SENT_332	[p16l1993t476r2143b523],

